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Heart rate variability (HRV) reflects the modulation of cardiac function by 
autonomic and other physiological regulatory systems. HRV is accepted as a reliable 
and reproducible technique for assessing autonomic activity. Impaired autonomic 
function (measured through a reduction in HRV) predicts mortality and is associated 
with several disease states. Excess adiposity is also associated with higher risk of 
cardiovascular diseases, type 2 diabetes, cancer and other health disorders. Body 
composition analysis involves the measurement of adipose tissue and other 
components such as muscle, bone and minerals in the human body. The relationship 
between excess adiposity and autonomic dysfunction has also been reported. 
 
The present thesis is divided into three parts: (i) validation studies, (ii) control 
studies and (iii) heart failure studies. The first validation study compares HRV 
(rMSSD) measured simultaneously with a Polar s810i and Ithlete on an iPod touch, 
in both healthy and heart failure populations. The second study examines 
measurement options for body composition by comparing several bioelectrical 
impedance analysis devices in a healthy population. 
 
Four studies were then undertaken with control subjects, assessing differences in 
gender, ethnicity and lifestyle factors using the devices validated in the previous 
chapters. Finally, Ithlete software was used with heart failure participants to gauge 
the feasibility of using the device daily and obtaining user feedback. Ithlete was then 
used in a cardiac rehabilitation programme to help participants get the most out of 
the programme, by guiding their exercise to rest ratio.  
 
The relationships between HRV, HR and body composition have been explored in 
this research work and have contributed to the knowledge around how these 
relationships can be used in healthcare. The benefit of novel devices to measure 
these relationships in both clinical and healthy populations has also been 
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GLOSSARY OF TERMS 
Anaerobic threshold: Exercise oxygen consumption that marks the transition 
between no change or little change in arterial lactate concentration and the sustained 
increase in concentration of lactate (also known as the lactate threshold). Postulated 
by some authors to be the oxygen consumption above which anaerobic energy 
production substantially supplements aerobic energy production.  
 
Aperiodic: irregular; not periodic 
 
Arrhythmogenic: producing or promoting arrhythmia 
 
Atrial fibrillation: Irregular and insufficient contraction of the atrial muscle most 
often caused by atherosclerosis, chronic rheumatic heart disease and hypertensive 
heart disease 
 
Attenuation: to make slender, fine or small; the opposite of amplification. 
 
Autonomic function: regulatory involuntary function; the part of the nervous 
system concerned with regulation of activity of cardiac muscle, smooth muscle, and 
glands. 
 
Baroreflex sensitivity: The reactivity of the arterial baroreflex to alter blood 
pressure- usually in response to orthostatic challenge 
 
Basal level: Associated with the base of an organism or structure 
 
Borg scale: A 6-19 point scale which is used for individual to rate their perceived 
level of exertion during exercise. 
  




Bruce protocol: Treadmill exercise test which is conducted in three minute stages. 
Each three minutes the workload is increased by a combination of increasing the 
speed and the grade of the treadmill. 
 
Ejection fraction: The fraction or % of blood (usually in the left ventricle) at the 
end of systole as a function of the volume during diastole 
 
Fat-free mass: The mass (weight) of the body that is not fat, including muscles, 
bone, skin and organs 
 
Heart failure: A condition that can result from any structural and functional cardiac 
disorder that impairs the ability of the heart to fill with blood or pump a sufficient 
amount of blood through the body.  
 
High-frequency power: the frequency domain band in the range from 0.15 to 0.4 
Hz; this band reflects parasympathetic (vagal) tone and fluctuations caused by 
spontaneous respiration known as respiratory sinus arrhythmia. 
 
Lean body mass: The sum of the body’s fat-free mass and essential fat.  
 
Likert scale: A rating scale measuring the strength of agreement towards a set of 
clear statements. 
 
Low-frequency power: The frequency domain band in the range from 0.04 to 0.15; 
this band can reflect both sympathetic and parasympathetic tone. 
 
Meta-analysis: Methods focused on contrasting and combining results from 
different studies.  
 
Myocardium: Muscle tissue of the heart 
 




Oxygen consumption: The amount of oxygen utilized by the body’s metabolic 
processes in a given time, expressed in millilitres or litres per minute, STPD 
 
Oxygen uptake: The amount of oxygen extracted from the inspired air in a given 
period of time, expressed in millilitres or litres per minute. This can be differed from 
oxygen consumption under conditions in which oxygen is flowing into or being 
utilized from the body’s stores.  In the steady-state, oxygen uptake equals oxygen 
consumption. 
 
Modified Bruce Protocol: A treadmill exercise test containing two preliminary 
three- minute stages of 2.7 km per hour at 0% incline and 2.7 km per hour at 5% 
incline. It is then followed by the standard Bruce protocol.   
 
Myopathy: A muscular disease in which the muscle fibres do not function for any one 
or many reasons. 
 
Parasympathetic nervous system: branch of the autonomic nervous system 
associated with promoting calm and return to regular function 
 
Pathophysiological: explains the physiological processes or mechanisms whereby 
such condition develops and progresses. 
 
Peak oxygen consumption: The highest oxygen consumption achieved during a 
maximum work rate test. 
 
Psychosocial: relates to one’s psychological development in, and interaction with, a 
social environment. 
 
QRS complex: name for the combination of three of the graphical defelctions seen 
on a typical electrocardiogram 
 
Respiratory exchange ratio: The ratio of carbon dioxide output to oxygen uptake 




R-R interval: The interval from the peak of one QRS complex to the peak of the 
next as shown on an electrocardiogram 
 
Sympathetic nervous system: branch of the autonomic nervous system associated 
with arousal and energy generation 
 
Tachycardia: Heart rate that exceeds the normal range (usually over 100 beats per 
minute) 
 
Vagal: Activity of the vagus nerve (associated with parasympathetic function) 
 
Variable: A variable is a quantity whose value may vary over the course of an 
experiment (including simulations), across samples, or during the operation of a 
system.  Variables are generally distinct from parameters, although what is a variable 
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CHAPTER 1: INTRODUCTION TO THE THESIS 
1.1 Introduction 
The significance of the impact of lifestyle factors such as diet and exercise on disease 
risk has become more apparent. Over time, government initiatives have been put in 
place to encourage healthier lifestyles (Attree 2006; Kelly & Stanner 2003; Kraak et al. 
2009; Vallgarda 2001). Measurement techniques with proven prognostic value may help 
this initiative by providing early warning signs for risk of disease. Measurements such 
as BMI are already in use, but more specific measurements such as body composition 
and cardio-respiratory measures may provide greater distinction. Body composition 
involves measurement of adipose tissue and other components such as muscle, bone and 
minerals in the human body. The relationship between excess adiposity and disease risk 
has been reported in several studies (Abbasi et al. 2002; Burton & Foster 1985; Must et 
al. 1999; Pi-Sunyer 1991). The diseases linked with increased adiposity include 
diabetes, cancers, lung and heart disease; these diseases are projected to cause 52 
million global deaths annually by 2030 (World Health Organization 2010).  
 
1.1.1 Heart failure 
There are approximately 900,000 people known to be living with heart failure (HF) in 
the UK and a similar number are believed to be undiagnosed (National Clinical 
Guideline Centre 2010). The prevalence of HF is highly correlated with age, with the 
average age of diagnosis being 76 (Cowie et al. 1999).  HF is one of the most common 
reasons for hospital admission (Cleland et al. 2005). The mortality of HF is less than 
10% per year, with 30-40% of patients diagnosed with HF dying in the first year (Cowie 
et al. 2000).  
 
First presentation or slow onset of symptoms is referred to as acute heart failure (AHF) 
while persistent, stable, or worsening symptoms are known as chronic heart failure 
(CHF) (Dickstein et al. 2008). HF can be complex and progressive, resulting in 
increased strain over time which can lead to hospital readmissions (Annema et al. 2009). 
Rates of readmission range between 25% and 50% within 6 months of the first 
hospitalization and are often seen as preventable in 23% to 31% of these cases (ibid). 
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Hospital admissions due to HF cause considerable public health expenditure (Brotons et 
al. 2009), costing the NHS an estimated £716 million per year (Petersen et al. 2002). 
 
Early detection of critical changes in patients’ vital signs can help in identification of 
worsening HF and prevent rehospitalisation (Cleland et al. 2005). The use of 
communication technology to monitor patients’ clinical status is gaining attention as an 
important strategy to improve the care of patients with chronic disease (Chaudhry et al. 
2007). Intervention techniques such as cardiac rehabilitation, daily monitoring of vital 
signs and weight monitoring can aid in preventing readmission by highlighting 
deterioration before it is severe enough for readmission.   
 
1.1.2 Cardiac rehabilitation 
Documented benefits of cardiac rehabilitation (CR) consist of improvement in exercise 
tolerance, improvement in symptoms, improvement in blood lipid levels, reduction in 
cigarette smoking, improvement in psychosocial well-being, reduction of stress and 
reductions in mortality (Wenger 2008).  The benefits of exercise training were reported 
in a controlled cross-over trial where they observed a 20-25% increase in exercise 
tolerance, peak oxygen consumption and symptoms in patients with CHF (Coats et al. 
1990). CR through exercise has been associated with a reduction in the debilitating 
symptoms caused by HF (ExTraMATCH Collaborative 2004). The intensity of CR and 
the physiological response to it requires careful monitoring. Heart rate variability (HRV) 
may be a viable alternative to present monitoring methods, such as heart rate, blood 
pressure and oxygen consumption.  
 
HRV is accepted as a valid and reproducible technique for assessing autonomic activity 
(Nolan et al. 1998). Changes to HRV occur during exercise, and are caused by an 
increase in sympathetic activity and a decrease in parasympathetic activity (Gladwell et 
al. 2010; Perini & Veicsteinas 2003). An initial decrease in HRV has been demonstrated 
within minutes or hours following exercise in several studies (Mourot et al. 2004b; 
Parekh & Lee 2005; Terziotti et al. 2001). HRV measurements have been demonstrated 
as good tools for use in the prevention of overtraining, a state that occurs when the body 
has not had enough time to recover from exercise (Hedelin et al. 2000; Mourot et al. 
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2004a). By monitoring HRV levels daily, individuals can ensure they do not over-
exercise. Since it has been recognized that HF patients are prone to impaired autonomic 
function (Nolan et al. 1998; Saul et al. 1988), the benefits of HRV measurement in 
patients with HF have been demonstrated (De Jong & Randall 2005; Sandercock & 
Brodie 2006).  
 
1.1.3 Heart rate variability 
HRV is a non-invasive measurement tool with great prognostic value. HRV has been 
defined as the amount of heart rate fluctuation found in the mean heart rate. HRV 
reflects the modulation of cardiac function by autonomic and other physiological 
regulatory systems (Akselrod et al. 1981). Since HRV has been demonstrated as an 
effective non-invasive measurement, its prognostic value has been utilized in the general 
population (Agelink et al. 2001; Amara & Wolfe 1998; Cowan et al. 1994; Yeragani et 
al. 1997; Zulfiqar et al. 2010) and diseased populations alike (De Jong & Randall 2005; 
Kataoka et al. 2004; Kudat et al. 2006; Nolan et al. 1998; Ponikowski et al. 1997; 
Sandercock & Brodie 2006; Schroeder et al. 2005; Tsuji et al. 1996; Tuininga et al. 
1994). Impaired autonomic function, characterized by a decreased HRV is known to be 
predictive of death, especially in CHF (Marijon et al. 2010). In a prospective study of 
patients with CHF, a reduction in HRV was found to be the most powerful predictor of a 
risk of death due to progressive HF (Nolan et al. 1998).  
 
The use of communication technology to monitor patients’ clinical status has gained 
attention as an important strategy to improve the care of patients with chronic disease 
(Chaudhry et al. 2007).  Daily monitoring may provide patients with more access to care 
and can potentially give clinicians more information to help improve outcomes of 
chronic diseases (Dar et al. 2009). The present thesis uses a new daily monitoring device 
called Ithlete. Ithlete is an ECG receiver that attaches to a mobile device and takes one-
minute measurements of HRV (rMSSD) and heart rate (HR), through the use of a 
standard heart rate monitor chest strap. As HRV can assess cardiac autonomic function, 
Ithlete measurements may provide a way to quantify the body’s autonomic response to 
exercise. Ithlete was developed as a tool for preventing overtraining in endurance 




Therefore, the idea came about to apply HRV measurement by means of a simple, user 
friendly device, to guide exercise rehabilitation in patients with HF. The Ithlete device is 
a tool that can provide daily monitoring of HRV and HR, making these measurements 
available for both patients and clinicians. Ithlete could potentially help improve 
outcomes of chronic diseases by providing feedback on patient’s responses to 
exercise/stress while also monitoring their risk for cardiac events. Daily HRV 
monitoring using Ithlete in patients with HF may have great potential as an easy to use, 
low cost medical device. 
 
The proposed research study will deepen the understanding of HRV measurements in 
patients with HF using novel equipment that is easily accessible to the general 
population. Important questions will be answered about the ability of patients to monitor 
their own HRV on a daily basis. Therefore the main research aim of this thesis was to 
explore the potential use of home-based devices such as Ithlete and bioelectrical 
impedance analysis to supplement clinical care for patients with HF.  
 
1.1.4 Body Composition 
In the human body, body composition describes the percentages of fat, muscle and bone. 
The most common method used for measuring body composition at the population level 
is body  mass index (BMI) (Department of Health 2011); however BMI is limited 
because it fails to discriminate between percent fat mass and lean mass (Romero-Corral 
et al. 2008). Due to these limitations, the use of other methods of body composition is 
becoming more mainstream. Body fat % can also be measured through a number of 
other methods, including skin-fold thickness, waist-circumference, waist-to-hip ratio, 




1.2 Aims and Objectives for this thesis 
The aims for this thesis were: 
1. To determine the feasibility of collecting daily measurements using a new 
personal HRV monitor (Ithlete) in healthy participants and patients with HF.   
2. To define the normal range of rMSSD measurements in healthy participants and 
patients with HF using Ithlete software.   
3. To test the reproducibility of rMSSD and HR measurements using the Ithlete 
software.   
4. To look at how other correlates, such as exercise capacity, body composition or 
clinical symptoms, might affect HRV measurements. 
5. To determine if Ithlete software can effectively aid CR programmes for patients 
with HF. 
The objectives of this thesis were: 
1. To assess the agreement between Ithlete software and the most popular field-
based HRV measurement device (Polar s810i) in measurements of HRV 
(rMSSD) and HR, in both healthy participants and patients with HF.  
2. To assess the ease of use of Ithlete software for measurement of rMSSD and HR 
in healthy participants and participants with HF, by evaluating compliance with 
day-to-day measurements in the home. 
3. To determine the reproducibility of rMSSD measurements using a new personal 
HRV monitor (Ithlete) on a daily basis in healthy participants and patients with 
HF. 
4. To explore the relationship between rMSSD and body composition 
measurements. 
5. To examine interventions that take into account HF patients’ measurements of 
rMSSD, by utilizing Ithlete software to establish when the patient should train, 






The majority of the empirical work undertaken for this thesis utilised a novel mobile 
application called Ithlete for measurement of HRV and HR. These measurements were 
validated against Polar heart rate software which has commonly been used for 
measurements of HRV and HR in both healthy (Earnest et al. 2004; Nunan et al. 2009; 
Vanderlei et al. 2008) and clinical populations (Conraads et al. 2004; Porto & Junqueira 
Jr 2009; Wisløff et al. 2007).  
 
Chapter two is a review of the literature, which covers three main topics. First the 
review examines HRV and its value in clinical practice. Then HF is discussed and the 
importance of CR in treatment of the disease. Finally the review examines body 
composition, and how it can be measured. The empirical chapters (three-eleven) begin 
with two validation studies, the first compares HRV (rMSSD) and HR measured 
simultaneously with a Polar s810i and Ithlete on an iPod Touch. Chapter four examines 
measurement options for body composition by comparing several bioelectrical 
impedance analysis (BIA) devices of varying cost. The devices each measured weight, 
total body water and percentage body fat, with some devices measuring other items such 
as muscle mass or basal metabolic rate.  
 
The next four chapters involve control subjects, first in chapter five the Ithlete 
application was used to explore the relationship between HRV and body composition 
measurements in healthy participants. The impact that these measurements could have 
on clinical populations was also discussed throughout that chapter. Chapter six used 
Ithlete software on an iPod touch for measurements of rMSSD and HR in healthy 
Caucasian and South Asian participants; this study investigated whether any ethnic or 
gender differences were demonstrated in various physiological measurements. Chapter 
seven assessed the relationship between HRV, body composition and aerobic capacity 
measurements in the same group of participants. Chapter eight assessed the use of HRV 
measurements to monitor exercise recovery in healthy participants. Participants 
completed HRV measurements daily, first thing in the morning, for a period of one-




Chapters’ nine to eleven present empirical works undertaken in HF patients. In chapter 
nine, patients with HF completed daily HRV measurements first thing in the morning, 
for a period of one-month, while also filling in a physical activity diary. Chapter ten 
evaluated the adherence, user assessment and estimated a normal range for rMSSD in 
patients with HF. Chapter eleven discusses the implementation and evaluation of a CR 
programme using the Ithlete application for HRV measurements, as a guide for exercise 
intensity in patients with HF. Patients performed a six-minute walk test before and after 
the six-to-eight week CR programme, which involved home-based walking exercises 
with a pedometer to record the number of steps patients took each day.   
 
Chapter twelve summarizes the findings of this thesis and provides recommendations 
for future research. 
 
1.4 Thesis notes format 
Within this thesis each chapter represents a separate piece of work linked by common 
themes (Figure 1-1). A common methodology was used in the work depicted in chapters 
six and seven; then chapters eight, nine, ten and eleven also share their methodology. 
Any repetition of material from one chapter to another is to give the individual chapters 
the look and feel of a full-length research paper. At the beginning of each chapter is a 
short executive summary. This is equivalent to an abstract, which could be used when 
the chapters are published. References conform to the format of Harvard referencing 
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variability (rMSSD) analysis using Polar s810i and Ithlete 
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CHAPTER 2: HEART RATE VARIABILITY, HEART FAILURE AND BODY 
COMPOSITION: REVIEW OF THE LITERATURE 
The amount of heart rate fluctuation known as heart rate variability (HRV) reflects the 
modulation of cardiac function by the autonomic and other physiological regulatory 
systems. HRV is accepted as a reliable technique for assessing autonomic function. 
Impaired autonomic function (measured through a reduction in HRV) is known to 
predict mortality from cardiovascular disease. 
 
HF is a complex and progressive diagnosis which results in increased strain to the heart 
over time, which can lead to complications and associated hospital admissions. HF in 
various forms is highly correlated with age. Hospital admissions resulting from HF costs 
the NHS over £700 million per year, and is one of the most common causes for hospital 
readmission. 
 
Cardiac rehabilitation has been credited with improvement in exercise tolerance, 
improvement in symptoms, reduction in cigarette smoking, reduction of stress and 
improvement in psychosocial well-being. A benefit from cardiac rehabilitation 
programmes of a 20-25% increase in exercise tolerance and symptoms has been cited in 
patients with chronic heart failure. Cardiac rehabilitation through exercise has been 
associated with reducing the debilitating symptoms caused by heart failure and 
providing patients with increased quality of life. 
 
Obesity has become a global epidemic. Monitoring body composition can help identify 
those at greater risk of cardiovascular disease. It is recommended that nutritional status 
be measured on a regular basis in both hospitalised patients and those nutritionally at 
risk to reduce complications.  
 
Identifying increased disease risk has become more important as diseases such as 
diabetes, cancer, heart and lung disease are on the rise; by 2030 it is projected that these 
diseases will cause more than fifty million global deaths annually (World Health 
Organization 2010b). Tools to monitor these risks are in growing demand and the 
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accessibility of such devices for the general public may have an impact on the 
occurrence in the population. The aim of the present review is to discuss heart rate 
variability, heart failure, exercise in the form of cardiac rehabilitation and body 
composition measurements. This review will provide an introduction to methods of 
HRV analysis, the established prognostic value of HRV in both healthy and clinical 
populations, some limitations in the measurement of HRV, and discuss the effect of 
exercise on HRV. This review will also focus on one clinical population in particular, 
heart failure; and will examine the interactions that may occur between HRV, body 
composition and heart failure. These interactions will then be explored to see how they 
can help in the treatment of heart failure. 
. 
  
2.1 Heart Rate Variability 
2.1.1 Physiology of cardiovascular autonomic regulation 
The human body is a complex system that has several subsystems interacting within it to 
keep it operational.  One of those subsystems is the autonomic nervous system (ANS) 
which is part of the peripheral nervous system. It acts as the control system for visceral 
functions and works largely below the level of consciousness. The ANS can affect 
digestion, heart rate, respiration rate, salivations, perspiration, urination, sexual arousal 
and more. There are two branches of the ANS: the sympathetic nervous system (SNS) 
and parasympathetic nervous system (PNS); the SNS generally coincides with arousal 
and energy generation while the PNS promotes calm and return to regular function 
(Brown et al. 2006). These two branches of the ANS control the rate at which the heart 
beats, working together to maintain homeostasis (Brown et al. 2006). At rest, the 
rhythmic beating of the heart was originally thought to be quite regular. However this 
view has changed to recognize that under healthy conditions the rhythm of a healthy 
heart is actually not at a steady rhythm. Heart rate variability (HRV) is a measurement 
of those beat-to-beat naturally occurring changes (Akselrod et al. 1981).  There is a 
complex interaction between the sympathetic and parasympathetic branches which can 
be assessed using the non-invasive technique of HRV. This is achieved through analysis 
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of the beat-to-beat oscillations of the R-R interval under various steady state conditions 
(Pagani et al. 1986). 
2.1.2 Heart rate variability: definition and background 
HRV was defined by Akselrod et al. (1981) as the amount of heart rate fluctuation found 
in the mean heart rate and reflects the modulation of cardiac function by autonomic and 
other physiological regulatory systems. Although various physiological regulatory 
systems are constantly at work throughout the body, the affect of respiration on heart 
rate variation in particular is an important factor to consider (Berntson et al. 1993). RSA 
(respiratory sinus arrhythmia) is a rhythmical fluctuation in heartbeat intervals (ibid). 
Changes in the length of these intervals occur in a phased relationship with inspiration 
and expiration (shortening during inspiration and lengthening during expiration). 
Current perspectives on RSA originated with Anrep et al. (1936) furthered by Daly 
(1985) and Feldman & Ellenberger (1988), which presented a clearer picture of 
determinants and underlying mechanisms of RSA (Berntson et al. 1993). HRV is a 
technique that measures the beat-to-beat variability in heart rate most often through an 
electrocardiogram (ECG). The cardiac cycle (heart beat) is represented in a typical ECG 
tracing by the QRS complex. From that QRS complex HRV is derived from one peak of 
the wave to the other (R to R) within the ECG. R-R intervals reflect the influence of 
changes in autonomic activity on cardiac function (Akselrod et al. 1981). 
 
Homeostasis is maintained at the basal level through autonomic activity by balancing 
input from both branches of the ANS. HRV is mainly vagal, indicating parasympathetic 
influence which lowers heart rate. Some HRV measures are completely under vagal 
influence while others may represent sympathetic baroreflex activity. At rest vagal tone 
dominates over sympathetic tone; under normal physiological conditions abrupt 
activation of the PNS inhibits tonic SNS activation both at rest and during exercise 
(Levy & Zieske 1969; Yang & Levy 1984). Clinical application of HRV is somewhat 
limited due to a lack of standardization; this is due to practical problems such as noisy 
data, artefacts and ectopic beats (Kamath & Fallen 1995; Malik 1995). A task force set 
up in 1996 attempted to standardize and unify methodology (Task Force of the 
European Society of Cardiology the North American Society of Pacing 
Electrophysiology 1996). This important paper is herein referred to as Task Force 
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(1996). There has since been other publications reporting normal HRV values (Agelink 
et al. 2001; Nunan et al. 2010); despite these efforts, there is still no consensus.   
 
High variability in heart rate is an indication of good adaptability, which implies that an 
individual has well functioning autonomic control mechanisms. Cardiovascular 
autonomic regulation is associated with aerobic fitness; and enhanced autonomic 
nervous system function is associated with prolonged aerobic training. Aerobic training 
may protect the heart against harmful cardiac events, through a decrease in sympathetic 
outflow and an increase in cardiac modulation of heart rate (Billman 2002).   
   
2.1.3 Introduction to methods of analysis 
Measurement of HRV is typically undertaken using electrocardiogram (ECG) 
equipment with a sampling rate that is usually 1,000 Hz, providing accuracy at ±1 ms 
between R-R intervals. There is a large range in the recommended duration of recording 
throughout the literature. The duration can be as short as 30 seconds or as long as a 48-
hour continuous recording. The significance of many HRV measures is often more 
complicated than generally appreciated, which leads to the potential for incorrect 
conclusions or unfounded extrapolations (Task Force, 1996). This led to the European 
Society of Cardiology and the North American Society of Pacing and Electrophysiology 
creating a task force to develop appropriate standards. Task Force (1996) advised and 
recommended definitions of terms, standards of measurement, defined physiological and 
pathophysiological correlates, described clinical applications and identified areas for 
future research. The task force provides the basis for many subsequent HRV 
measurements.  
 
Different modes of analysis can be used for HRV measurement. There are three main 
modes which are time domain analysis (statistical measures), geometric methods and 
frequency domain analysis (also known as spectral analysis). All of these are discussed 





2.1.3.1 Time domain variables 
Time domain measurements are determined by either the heart rate at any given point in 
time or between successive normal complexes (Task Force, 1996). Using a continuous 
ECG recording, each QRS complex is detected and either instantaneous heart rate or all 
intervals between adjacent QRS complexes are used to derive HRV measurements 
(ibid). Each QRS complex results from sinus node depolarisations called normal to 
normal (NN) intervals and time domain variables can be derived either directly from the 
peak of one QRS complex to the peak of the other (R-R) interval measurements or from 
the difference between R-R intervals (Maud & Foster 2006). Time domain variables 
calculated directly from the measurement of R-R intervals are displayed in Table 2.1. 
Several of the time-domain measurements correlate highly with one other; due to its 
better statistical properties, rMSSD is preferred compared to pNN50 and NN50 (Task 
Force, 1996).  
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Table 2.1 Description of each time domain measurement 
Measure Description 
Mean R-R 
(ms or seconds) 
The mean R-R interval between all normal 
beats 
R-Rmax – R-Rmin 
(ms or seconds) 
Difference between the maximum R-R 
interval and the minimum R-R interval in the 
window of measurement or during a single 
or few breaths (Fouad et al, 1984) 
SDNN 
(ms or seconds) 
Standard deviation of all R-R intervals or 
normal heart periods 
SDNN index 
(ms or seconds) 
The mean of the standard deviations of all 
normal R-R intervals, usually five minute 
segments of the entire recording period in 
long-term recording e.g. the mean of 288 NN 
standard deviations  
SDANN 
(ms or seconds) 
The standard deviation of the average NN 
intervals calculated over short periods, 
usually for five minute segments which is an 
estimate of the changes in heart rate due to 
cycles longer than five minutes e.g. the 




The number of adjacent R-R intervals that 
varied by more  than 50 ms 
pNN50 
(%) 
The percentage of adjacent R-R intervals 
that varied by more than 50 ms 
rMSSD 
 (ms) 
The root mean square of the successive 
difference between the coupling intervals of 





2.1.3.2 Geometric methods 
Geometric methods represent R-R intervals in geometric patterns such as the triangular 
index and the triangular interpolation of NN. In the triangular index measure, the lengths 
of the R--R intervals are used to form the x-axis of the plot and the number of each R-R 
interval length is used for the y-axis. The triangular interpolation measure provides the 
baseline width of the distribution, measured as a base of a triangle which approximates 
the NN interval distribution of HRV (Maud & Foster 2006). This method is used less 
frequently compared to the others and further information can be found in the above 
reference. The advantage of geometric methods is their relative insensitivity to the 
analytical quality of a series of NN intervals (Malik et al. 1993); however a large 
number of NN intervals (at least 20 minutes, preferable 24 hours) are necessary to 
construct the geometric pattern, thus eliminating the option of short-term measurement 
(Task Force, 1996).  
 
 
Figure 2-1 Geometric HRV measures on the NN interval histogram representing a 24 
hour period (Task Force, 1996) 
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2.1.3.3 Frequency domain methods 
Frequency domain analysis (spectral analysis) provides an understanding of the effects 
of sympathetic and parasympathetic nervous systems on HRV (Akselrod et al. 1981). 
Frequency domain measures are thought to have an advantage over time domain 
measurements because they offer more information about the relative contributions of 
sympathetic and parasympathetic function. How power (i.e. variance) is distributed as a 
function of frequency is demonstrated through power spectral density (PSD) (Task 
Force, 1996). There are three main activities recognized within the power spectrum 
described in Table 2.2. 
 
Table 2.2 Description of each frequency domain measurement 
Measure Description 
Very low-frequency (VLF) Usually associated with less than 0.04 Hz and 
thought to represent fluctuations that occur 
very slowly and are possibly due to circadian 
rhythms and peripheral vasomotor and 
thermoregulatory influences (Appel et al. 
1989) 
Low-frequency (LF) Usually associated with around 0.1 Hz and is 
partly dependent on sympathetic tone because 
of baroreceptor activity (Malliani et al. 1991) 
High-frequency (HFr) Synchronous with the respiration rate usually 
associated with a wide range of frequencies 
ranging from 0.2 Hz to 0.5 Hz depending on 
the breathing frequency and considered an 
indicator of vagal activity (Akselrod et al, 
1981) 
 
In physiological and environmental conditions where rapid dynamic changes in 
autonomic control may occur, investigators have used non-linear methods of measuring 
the complexity of heart dynamics (Goldberger 1996). Non-linear methods make the 
assumption that much of heart’s beating behaviour is aperiodic, but not totally random 
(Maud & Foster 2006).  
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Each method of HRV analysis has advantages and disadvantages to consider. HRV is 
mainly vagal (Karemaker & Lie 2000); some measures are totally vagal while others 
may represent sympathetic baroreflex activity. Factors that have an influence on HRV 
cause confounding effects, which limit the use of HRV in clinical populations (Huikuri 
et al. 1999). The next section will discuss some of those factors (both acute and 
chronic), which can influence HRV analysis.  
 
2.1.4 Influences on HRV 
There are various fundamental physiological acute and chronic factors that can have an 
effect on HRV. Acute factors include postural changes and time of day (Burger et al. 
1999); various drug therapies such as beta-blockers (Chattipakorn et al. 2007); and 
caffeine has also been reported to improve autonomic function in both healthy 
participants and diabetic patients (Richardson et al. 2004). Chronic factors include the 
influence of age, aerobic fitness exercise, and overtraining; all of which have been 
reported in previous studies (De Meersman & Stein 2007; Hautala et al. 2009; Hedelin 
et al. 2000). Both factors will be discussed in more detail below. 
 
2.1.4.1 Acute factors 
Time of Day: Research into the affect of time of day on HRV is conflicting. In a study 
that analysed HRV measurements at three different times of day (morning, afternoon, 
evening) there was significant variation found and low reproducibility (Lord et al. 
2001). When considering foetal HRV, Lange et al. (2005) found no effect of time of 
day. Another study however, on healthy male volunteers found that the reproducibility 
of some autonomic nervous tests varied throughout the day (Kowalewski & Urban 
2004).  
 
Postural changes: Vagal modulation in normal subjects did not reflect any changes due 
to different body positions (Avbelj et al. 2003). In a study of autonomic cardiovascular 
function in healthy young adults, autonomic activity was not significantly different in 
varying body positions (Watanabe et al., 2007). However HRV parameters within that 
study indicated sympathetic dominance during seated measurements (ibid). The short- 
and long-term reproducibility of autonomic measures in supine and standing positions 
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found that HRV indices with the exception of the LF:HF ratio were independent of body 
position (Kowalewski & Urban 2004). 
 
Exercise vs. Rest: The autonomic nervous system during exercise and physical training 
influences different mechanisms in the body. People that exercise regularly generally 
demonstrate an increased parasympathetic activity and lower heart rate when compared 
with sedentary people; this is especially noticeable at rest (Dixon et al. 1992). A high 
HRV at rest improves the capacity for adaptation to varying or unpredictable stimuli 
(Goldberger 1991). Athletes have a higher HRV at rest (this reflects a parasympathetic 
predominance) than sedentary people (Mourot et al. 2004). Different patterns of HRV 
measurements are found at rest and during aerobic exercise in both healthy subjects and 
acute myocardial infarction patients (de la Cruz Torres et al., 2008). Gender differences, 
hormonal regulation, thermoregulation and haemoglobin concentration have all been 
cited as potential influences on recovery and adaptation to exercise training and should 
be considered in the application of HRV training prescription (Kiviniemi et al. 2010b). 
 
Overtraining or insufficient recovery period post exercise: An autonomic nervous 
system disturbance is suggested as a possible cause for symptoms such as reduced 
performance and pronounced fatigue (Hedelin et al. 2000). Overtraining is thought to 
have a negative impact on autonomic cardiovascular control (Hedelin et al. 2000). 
Female endurance athletes have displayed that increased training load and overtraining 
did not cause significant changes to cardiac autonomic modulation or intrinsic heart rate 
(Uusitalo 1998). Overtraining has a stronger effect on HRV in untrained women 
compared with their trained counterparts (Winsley et al., 2005). Abrupt changes in 
workload appear to signal changes in autonomic control compared with a progressively 
increasing load which triggers cardiovascular adaptation effects (Baumert et al. 2006). 
 
Drugs (infusion studies/caffeine ingestion): An infusion study which assessed the role of 
free fatty acids (FFA) on the cardiac autonomic nervous system demonstrated that 
changes in plasma FFA levels may produce a parallel effect on cardiac sympathetic and 
parasympathetic balance in non-insulin dependent diabetic patients. Improved 
autonomic function was demonstrated with modest amounts of caffeine intake in both 
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healthy and diabetic participants (Richardson et al. 2004). Caffeine intake in post 
myocardial infarction patients has been linked with an increase in parasympathetic 
autonomic function (Richardson et al. 2009). In a study of 30 male regular caffeine 
users, the effect of 100-200g of caffeine on HRV demonstrated no negative or positive 
effect from the drug (Rauh et al. 2006). Research on the effects of caffeine on HRV 
appears to be inconclusive.  
 
Considering the influence of the acute factors on HRV, this thesis will attempt to 
streamline measurements. Participants will be encouraged to take their measurements in 
a seated position, first thing when they wake up to ensure it is a resting measurement. 
Participants will also be asked to take measurements before they have anything to eat or 
drink (including medication) to ensure measurements are taken under similar 
circumstances daily. 
 
2.1.4.2 Chronic factors 
Gender: Gender is an important determinant of HRV in healthy subjects (Antelmi et al. 
2004). The majority of research looking at gender differences in adults cites women 
with a higher vagal influence than men (Antelmi et al. 2004; Gregoire et al. 1996; Liao 
et al. 1995). In contrast studies looking at gender differences in children have found girls 
to have a lower HRV compared to boys (Faulkner et al. 2003; Umetani et al. 1998). This 
signifies that the effect of gender may be modulated by age. 
 
Age: There appears to be an inverse relationship between age and HRV: as age increases 
HRV decreases (Pomeranz et al. 1985). In the literature, this decline in HRV has been 
attributed to a decline in the efferent vagal cardiac tone and decreased B-adrenergic 
responsiveness (Mølgaard et al. 1991). HRV-parasympathetic function in particular has 
been connected to healthy longevity. A progressive decrease in HRV is associated with 
age and can be predictive of mortality in different clinical populations (Zulfiqar et al. 
2010). The preservation of autonomic function was a key determinant of longevity; age 




Measurements of rMSSD and pNN50 rapidly decreased with aging, especially in the 
second to fifth decades of life. SDNN and SDANN measures also decreased with age, 
also highlighted in the second and fifth decades of life. The decrease in HRV-
parasympathetic function with aging reversed in the eighth decade suggesting a critical 
threshold for long-term survival (Zulfiqar et al. 2010). Limitations to these finding 
however are important to consider as the study was cross-sectional. In order to make 
definitive analysis of age-related changes a prospective longitudinal study would be 
needed. The presence of other conditions that may have impacted the results were also 
not necessarily explored properly as no exercise testing, echocardiographic examination 
or other measures were used to help get a better assessment of overall health status. A 
constant decline of cardiac vagal modulation is associated with normal aging and is the 
result of a significant decrease in nocturnal parasympathetic activity (Bonnemeier et al. 
2003). 
 
Exercise: In a review of the effects of exercise on HRV, exercise training resulted in 
significant increases in R-R interval and high frequency spectral power following 
exercise (Sandercock et al. 2005a); this however, was influenced by study population 
age (ibid). Several other reviews have summarized the effects of exercise training on 
HRV (Aubert et al. 2003; Carter et al. 2003; Nunan et al. 2010b; Sandercock et al. 
2005a). The largest increase in R-R interval was found in the youngest subjects and 
subgroup analysis demonstrated age, gender and previous physical activity level 
influenced R-R interval response. From the present review it is clear that HRV is an 
important tool to be utilized in several populations, but more research is needed to refine 
this technique. 
 
Higher HRV values of rMSSD have been demonstrated in aerobically trained and 
anaerobically trained athletes when compared to their sedentary counterparts (Aubert et 
al. 2003). A lower resting heart rate in athletes was also demonstrated in several studies, 
after endurance training resulted in enhanced vagal tone in athletes (ibid). Endurance 
training results in decreased sympathetic activity and increased parasympathetic activity 
and increased HRV in the human heart at rest (Carter et al. 2003). In healthy individuals, 
Sandercock et al., (2005a) reported that exercise training causes increased cardiac vagal 
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modulation accompanied by resting bradycardia. Before, during and after a graded 
exercise test, resting short-term HRV measurements have been recommended for 
assessing cardiac autonomic health (Nunan et al. 2010a). 
 
A meta-analysis in 2005 demonstrated that exercise training lasting at least four weeks 
in duration resulted in significant increases in R-R interval and high frequency spectral 
power (Sandercock et al. 2005a). Hautala et al., (2009) confirmed that regular aerobic 
training is linked with increased cardiac vagal modulation of heart rate (HR) and 
autonomic nervous system function is an important determinant of a healthy individual’s 
response to aerobic training. In contrast, low variability in HR is an indication of 
abnormal and insufficient adaptability of the autonomic system; implying the presence 
of a physiological malfunction in the individual (Pumprla et al. 2002). 
 
Prescription Drugs: In heart failure patients (NYHA class III and IV2) a significant 
improvement by 41% was observed in the HF component of those who used beta 
blockers (Aronson & Burger 2001). Tricyclic antidepressants have demonstrated 
reductions in HRV compared with selective serotonin inhibitor, paroxetine, which 
normalizes HRV (Gorman & Sloan 2000). Findings concerning oestrogen replacement 
therapy appear to be controversial with some citing moderate improvements to HRV 
(Gökçe et al. 2005; Rosa Brito-Zurita et al. 2003); and others citing no affect on HRV 
(Carnethon et al. 2003; Virtanen et al. 2000). Digoxin is known to increase HRV 
especially in measures thought to represent parasympathetic activity (Flapan et al. 
1997).   
 
Ethnicity: Ethnic differences in HRV have been reported in the literature with 
conflicting findings. In one study HRV measures were lower with larger sympathetic 
contribution to power in black adolescents (Faulkner et al. 2003). In other studies 
African American youth demonstrated a higher HRV when compared with European 
American youth (Urbina et al. 1998; Wang et al. 2005). A lower sympathetic drive was 
found in an age matched racial (black- white) comparison within an adult population 
(Guzzetti et al. 2000). The prognostic value of these ethnic differences in HRV are 
                                                
2 NYHA classes are explained in detail on page 33 
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unknown, researchers are beginning to look at how much physical activity and fitness 
contribute to these differences (Eyre et al. 2013). 
  
2.1.5 The use of HRV for prognosis 
For many years HRV was utilized as a measurement of cardiac autonomic modulation in 
scientific publications, despite clear concurrent validity or retest reliability ever fully 
being established. These qualities of validity and reliability should be identified for any 
clinical measurement (Task Force, 1996). Considering what factors may influence HRV 
is essential to consider when using its measurement as a prognostic tool. When 
considering specific populations, impaired autonomic function (measured through HRV) 
is known to predict death, especially in chronic heart failure patients (Marijon et al. 
2010). Early detection of critical changes in patients’ vital signs such as HRV can help 
in the identification of worsening heart failure and prevent rehospitalisation and other 
outcomes (Cleland et al. 2005). The use of HRV in clinical populations is on the rise; 
however there are limitations of this method to consider. 
 
It is unclear whether measures of decreased HRV and mortality are causative or if it acts 
as a marker that can reflect the severity of disease (Sueta 2003). Various medications act 
directly or indirectly on the autonomic nervous system which can affect the reliability of 
HRV measurements, especially when studying HRV in specific patient populations 
(Task Force, 1996). Previous studies have cited HRV to have low predictive value 
which can be improved with the addition of other ECG derived parameters measured at 
the same time (Chattipakorn et al. 2007).  
 
An association between decreased HRV and mortality has been established throughout 
recent literature. Most studies however, did this after controlling for other known risk 
factors such as hypertension (Thayer et al. 2010). Reduced HRV may also lead to those 
other known risk factors, which could make those studies underestimate the role of 
vagal function in death and disease (Thayer et al. 2010). Isolated HRV measurements 
have inadequate prognostic accuracy with low sensitivity and low positive prognostic 
accuracy as a univariate predictor (Kleiger et al. 2005). As a result, therapeutic 
28 
 
implications of HRV are in doubt. Combining HRV with other risk variables has 
however been demonstrated as beneficial in practice (Kleiger et al. 2005). 
 
The prognostic value of HRV in patients with myocardial infarction was demonstrated 
in a study by (Zuanetti et al. 1996) where all indexes of low HRV identified patients 
with higher total mortality. Low HRV as an independent predictive value was also 
confirmed by adjusted analysis of measures such as SDNN, rMSSD, advanced age and 
previous myocardial infarction (ibid).  
 
2.1.6 Reliability of HRV analysis  
All measures routinely used in clinical practice and research need to be both valid and 
reliable to ensure that future utilization of these measures cause no unforeseen harm to 
participants. Validity and reliability are dependent on appropriate statistical analysis. A 
valid and reliable study implies that the research presented was based on true facts and 
was written ethically by the researcher (Wood & Ross-Kerr 2011). HRV was reported as 
a reliable and reproducible technique for assessing autonomic activity in the late 90s 
(Noland et al. 1998). Several reliability studies have been completed; however there is 
still little consensus on what normal HRV values should be.  Reference ranges for the 
healthy population were provided by Nunan et al, (2010) with stipulation that 
consideration of underlying disparate values and methodological factors be taken into 
account.  
 
Laboratory recordings of HRV are carried out using many different experimental 
conditions including sitting, standing, tilt tests, lower body negative pressure and more. 
Some experimental conditions are more reliable than others; for example spontaneous 
breathing is less reliable than paced breathing (Pinna et al. 2007).  Specific values of LF 
power in normal units and LF/HFr were improved by paced breathing, leading to a 
dramatic reduction (>50%) in the estimated sample size needed (ibid). The authors 
suggest this is due to better stabilization of LF oscillations caused by virtual abolition of 
respiratory-related frequency components within the LF band. At a 70 ° tilt, HRV 
measurements decreased with a reciprocal increase in sympathetic activity when 




To ensure HRV measurements are reliable, it is important to make reference to the 
literature to make certain there is similarity in data collection methods, data treatment 
and study population (Sandercock et al. 2005b). Appropriate reliability coefficients need 
to be established within each particular study for accurate sample size calculation and 
quantification of the likely variation from test to retest to prevent non-significant 
findings due to low statistical power (ibid). For HRV comparison experiments to fulfil 
statistical assumptions, measurement should not be too far apart in time or too close to 
avoid carryover (Pinna et al. 2007). Studies in the literature that look at reliability 
demonstrated reduced reliability in clinical populations when compared to healthy 
subjects (Sandercock et al. 2005b). Good reliability in the HRV measures within the 
clinical population should be established by ensuring the measurement has been 
validated in that population in previous literature (ibid).  
 
2.1.7 HRV: Some limitations 
Despite HRV being an important research tool for both clinical and basic scientists 
(Tulppo & Huikuri 2004) there are still limitations of published reliability studies which 
have been documented throughout the literature. These include: (i) inadequate protocol 
(e.g. replicating measurements were taken too far from each other); (ii) insufficient 
sample size; (iii) too short or too long recordings according to current guidelines; (iv) 
limited selection of studied HRV parameters; (v) inadequate assessment of reliability 
due to the use of inappropriate reliability indices or to misapplication/incomplete 
inclusion of appropriate indices; and (vi) lack of indications on the practical implications 
of computed reliability indices (e.g. for the assessment of individual responses or for 
sample size estimation) (Pinna et al. 2007). 
 
HRV has not yet been used consistently as a routine clinical method for a number of 
reasons. There are methodological problems involved in recording and analysing ECG 
traces (Lu & Yang 2009). There are different factors that may contribute to daily HRV 





The potential influence of respiration on RSA and consequently HRV must be 
considered in measurement analysis. Respiratory measures should be accounted for in 
HRV analysis as different patterns can affect the outcome of analysis (Berntson et al. 
1997). Control of breathing under experimental conditions may have moderate effects 
on relationships between respiration and HRV (Brown et al. 1993). If respiratory control 
requires considerable effort it may affect RSA and could be problematic for accuracy 
and reliability.  
 
A single ECG measurement can produce a large number of HRV indices as described 
above. The best HRV measurement variable to use in disease prognosis is unclear 
(Kleiger et al. 2005). A variety of non-liner variables, conventional time domain, 
baroreflex sensitivity, heart rate turbulence, spectral measures and geometric measures 
have each been significantly linked with outcome, with no variable consistently superior 
over the other (Kleiger et al. 2005). Coupling HRV measurements with other clinical 
prognostic tools in specific populations is found in the literature. For example, ejection 
fraction, exercise testing, late potentials or ventricular arrhythmias combined with HRV 
may differentiate subgroups of patients with both very low and very high total cardiac 
and arrhythmic mortality after myocardial infarction (Kleiger et al. 2005). Patients with 
heart failure are the specific population that will be explored in the next section. 
 
2.2 Heart Failure 
The British Heart Foundation defines heart failure as the condition in which the heart 
cannot pump enough blood to meet the needs of the body. Heart failure (HF) is 
recognized as an increasing health concern in industrialized nations especially within 
aging populations (Stewart & Blue 2001).  Determining the extent of the impact of HF 
in each nation is challenging because of two associated issues. The first issue is due to 
HF representing a complex pathological process that is manifested from a number of 
different disease states such as valve disease or pericardial problems. The second issue 
results from there being no large-scale, systematic investigation of the epidemiology of 
HF from both physiological and clinical perspectives, making accuracy of diagnosis 
difficult (Petersen et al. 2002). This inaccuracy could lead to misdiagnosis or leave 




HF results from any structural or functional disorder that impairs the pumping ability of 
the heart. Problems within the heart, which have weakened the heart’s pumping action, 
lead to difficulties in other parts of the body receiving blood and therefore oxygen. 
Systolic HF and diastolic HF are the two main types. Systolic HF arises when the heart 
lacks sufficient force to eject enough blood into the circulation because its ability to 
contract deteriorates. Diastolic HF is a reduction in the heart’s ability to relax and fill 
with blood as a result of stiffening of the heart muscle. The most common cause of HF 
is systolic dysfunction which accounts for approximately 60-80% of patients compared 
with 20-40% from diastolic dysfunction. HF can be caused by different factors. Some 
common risk factors include high blood pressure, coronary artery disease, damaged 
heart valves, diabetes, and weakened heart muscle due to viral infections or toxins. For 
prevention of HF, maintaining a healthy weight, not smoking, eating a balanced diet and 




When considering the UK as a whole, the British Heart Foundation’s statistical database 
estimated a total prevalence of approximately 900,000 and a similar number as yet 
undiagnosed (National Clinical Guideline Centre, 2010).  That estimation is based on 
the application of age-specific heart failure rates derived from several UK studies of 
population demographics. A large scale survey of patients being treated for HF 
determined prevalence rates to be 8-16 per 1000 in the general population; which rises 
to 40-60 cases per 1000 among those aged 70 and above (Clark et al. 1995). In 2002 
around 650,000 people in the UK had definite HF while another 225,000 probably have 
HF (British Heart Foundation Health Promotion Research Group, 2002).   
 
HF has a complex, progressive nature leading to adverse outcomes such as 
hospitalization. Readmission rates to hospital vary between 25% and 50% within 6 
months of the first hospitalization for HF (Inglis et al. 2006).  Hospital admissions due 
to HF cause considerable public health expenditure (Brotons et al. 2009), costing the 
NHS an estimated £716 million per year (Petersen et al. 2002). HF is one of the most 
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common reasons for hospital admission and has a three-year mortality rate of 
approximately 60% (Cleland et al. 2005). Advances in treatment have improved 
outcomes in chronic heart failure (CHF) but high morbidity and mortality still persist 
and remain an increasing health problem (Investigators 2005). Potentially preventable 
factors such as non-adherence to drugs and diet, inadequate social support and failure to 
seek prompt medical attention when symptoms worsen result in an increased risk of 
readmission (ibid). 
 
The prevalence of HF is highly correlated with age, with the average age of diagnosis 
being 76 (Cowie et al. 1999).  The mortality of HF is 30-40% for patients in the first 
year of diagnosis but less than 10% per year after (Cowie et al. 2000). In the 
industrialized world, a predicted increase in the prevalence of HF is parallel with life 
expectancy. This is due to the successes of medical therapy for conditions such as 
hypertension which is known as one of the risk factors of HF (Senni et al. 1999).  
 
Worldwide, HF affects many people and is expected to increase with the aging 
population and better rates of survival for patients after myocardial infarction (Annema 
et al. 2009). CHF is a syndrome that affects approximately seven million Europeans and 
five million North Americans each year (Inglis et al. 2006). Acute HF is the rapid onset 
of symptoms and signs secondary to normal cardiac function (Nieminen et al. 2005). 
This occurs when there is decompensation in chronic stable HF which usually happens 
in accordance with intercurrent illnesses such as pneumonia, uncontrolled hypertension 
etc. This is often life-threatening and requires urgent treatment (Nieminen et al. 2005). 
The most common cause of HF has been cited as coronary heart disease often in 
combination with hypertension but also on its own (Stewart & Blue 2001). There are 
also other common precursors including valvular dysfunction, cardiac arrhythmias, 
conduction disturbance, pericardial disease or infections (Stewart 2002).  
 
2.2.2 Symptoms and classification 
CHF usually involves symptoms such as breathlessness on exertion, fatigue, signs of 
fluid retention and/or other signs associated with the cardiac disorder (Scottish 
International Guidance Network 2007). Sometimes the cause of HF may be a congenital 
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heart defect, infection of the heart valves or heart muscle itself, or can be unknown 
(ibid).   
 
The New York Heart Association (NYHA) established functional stages of HF relating 
to everyday activities and patient quality of life. The best course of therapy is usually 
based on this assessment of which details are described in Table 2.3. 
 




Class I (Mild) No limitation of physical activity. Ordinary physical activity 
does not cause undue fatigue, palpitation, or dyspnea 
(shortness of breath). 
Class II (Mild) Slight limitation of physical activity. Comfortable at rest, but 
ordinary physical activity results in fatigue, palpitation, or 
dyspnea. 
Class III (Moderate) Marked limitation of physical activity. Comfortable at rest, 
but less than ordinary activity causes fatigue, palpitation, or 
dyspnea. 
Class IV (Severe) Unable to carry out any physical activity without discomfort. 
Symptoms of cardiac insufficiency at rest. If any physical 
activity is undertaken, discomfort is increased. 
 
An early phenomenon in the clinical course of HF is sympathetic overactivation. This 
occurs when there is an increase in nerve activity which is clearly detectable in patients 
of all four NYHA classes. Consequences of sympathetic overactivation include 
increased oxygen and metabolic demands on the myocardium, reduced oxygen supply in 
the myocardium, augmented sodium and water retention, decreased myocardial 
arrhythmogenic threshold and a direct necrotic effect on the myocardium (Floras 1993). 
These consequences contribute to the exercise intolerance commonly found in HF 
patients (Grassi & Mancia 1999). The prevailing model associated with sympathetic 
overactivation assumes that it begins with ventricular systolic dysfunction, which 
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increases the sympathetic outflow directed to all the vascular beds (Floras 2009). New 
knowledge however, such as the identification of a selective alteration in autonomic 
regulation with attenuation of HRV early in HF, amongst others, has prompted the 
proposal of a new contemporary model (ibid). The new contemporary model is an 
update on what mechanisms are responsible for sympathetic activation in HF. These 
mechanisms include 1) the impaired vagus nerve regulation of the arterial baroreceptor 
reflex; 2) muscle sympathetic nerve activity is blunted by conventional inhibitory 
ventricular baroreceptor reflex control; 3) elevated filling pressures may cause cardiac 
norepinephrine spillover by stimulating a cardiac-specific sympathoexcitatory reflex; 4) 
persistent pulmonary mechanoreceptor-mediated entrainment of sympathetic outflow; 
and 5) arterial baroreflex regulation of muscle sympathetic nerve activity modulates 
generalized sympathetic outflow and adjusts a centrally established set point for 
sympathetic outflow.  
 
2.2.3 Pump failure vs. sudden cardiac death 
Pump failure occurs when diminished cardiac output severely impairs the delivery of 
oxygen and nutrients to organs and tissues of the body. This is reflected by severe 
failure of the heart’s main chamber, the left ventricle. Sudden cardiac death is the result 
of a sequence of events produced by a lethal cardiac arrhythmia commonly ventricular 
tachycardia or fibrillation but could also be bradyarrhythmia or pulseless electrical 
activity (Tomaselli & Zipes 2004). In both cases the final pathway is the same, 
disruption to the electrical system causes the heart to stop beating, blood supply to the 
body is lost (particularly the brain) and the body dies. The prediction of sudden cardiac 
death appears more challenging because death in symptomatic CHF patients is often due 
to progressive pump failure (Brouwer et al. 1996). Sudden cardiac death does occur 
more often in less severe ambulatory CHF patients whose symptoms are less clear 
(Sandercock & Brodie 2006).  
 
2.2.4 Predictors of morbidity and mortality in heart failure 
HF has an unpredictable clinical path with a variety of individual factors relating to its 
outcome (Pocock et al. 2006). A number of models in HF have been reported as a means 
of refining and quantifying both individual and multiple factors together simultaneously 
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for their predictive ability. In these models older age (starting at 60 years of age), 
diabetes and lower left ventricular ejection fraction (beginning <45%) are the three most 
powerful predictors (ibid). Other independent predictors include higher NYHA class, 
male sex, higher body mass index (BMI), lower diastolic blood pressure, previous 
hospitalization due to HF and decreased autonomic function. Common symptoms 
identified within HF are low exercise tolerance, arrhythmias, cardiothoracic ratio, 
disturbances in autonomic activity, and increased heart rate at rest. HRV is a 
measurement of autonomic function and its use as a predictor of mortality in HF patients 
is ongoing in research and will be discussed in the next section.  
 
2.2.5 Heart rate variability in heart failure 
In a prospective study of HRV and mortality in CHF, a reduction in the SDNN 
identified patients at higher risk of death (Noland et al. 1998). This study also found the 
reduction in SDNN to be a better predictor of death due to progressive HF than other 
conventional clinical measurements. A reduced cardiac parasympathetic activity 
indicated by a reduced HRV was found in 42 male patients with CHF (Nolan et al. 
1992). This implies the importance of various HRV measurements in helping to 
diagnose or monitor high risks in the HF population.    
  
Quality of life was assessed in two major studies in the USA which determined that HF 
impaired self-reported quality of life more than any other common chronic medical 
disorder (Stewart & Blue 2001).  This suggests that the effect of HF on daily life is 
significant and needs to be addressed. HF can be complex and progressive, resulting in 
increased strain over time which can lead to hospital readmissions (Annema et al. 2009). 
Rates of readmission range between 25% and 50% within six months of the first 
hospitalization and are often seen as preventable in 23% to 31% of cases (Annema et al. 
2009). Intervention techniques such cardiac rehabilitation, daily monitoring of vital 
signs and weight monitoring can aid in preventing readmission by spotting deterioration 
before it is severe enough for readmission. 
 
The first study on HRV in HF was conducted by Saul et al. (1988) and sparked interest 
in the investigation of possible changes that occur in HRV in HF. The study explored 
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correlations between HRV and current clinical status (Chattipakorn et al. 2007). The 
autonomic nervous system in HF is characterized by dysfunction in sympathetic 
activation, parasympathetic withdrawal and peripheral organ non-responsiveness (Grassi 
et al. 1995). As HRV provides a non-invasive, indirect measurement of autonomic 
control of the heart, it is an ideal measurement to use in patients with HF. A good 
functioning autonomic nervous system should yield a high HRV, which implies a 
healthy individual (Sueta 2003).  In CHF patients, depressed HRV levels are regularly 
observed at all stages of systolic dysfunction (Fauchier et al. 1997). UK Heart was a 
significant prospective study conducted for more than a year on 433 patients with 
congestive heart failure (NYHA class’s I-III). It assessed the reduction of SDNN, 
creatinine, serum sodium, non-sustain ventricular tachycardia, cardiothoracic ratio and 
LV end diastolic diameter (Nolan et al. 1998). This study found that a reduced SDNN 
(<100ms) was the most powerful predictor of total mortality among a large number of 
clinical variables (Nolan et al. 1998).  
 
Conventional HRV measurements are related to systolic left ventricular function (Nolan 
et al. 1992) and NYHA functional classification (Casolo et al. 1995). The severity of left 
ventricular dysfunction relates to decreased HRV and therefore is connected with a poor 
prognosis (Wijbenga et al. 1998). Compared with post myocardial infarction patients, 
evidence of HRV in HF has not been as extensively investigated (Chattipakorn et al. 
2007). A continual progressive process of autonomic imbalance occurs in HF compared 
with myocardial infarction, where there is an impact of events followed by recovery of 
this imbalance (Chattipakorn et al. 2007). This makes finding the reference point to 
define the timing of HRV measurement in HF and comparison of different HF patients 
with similar clinical conditions difficult (Chattipakorn et al. 2007). A conclusive 
understanding of the pathophysiology of described alterations of HRV found in HF is 
lacking (Guzzetti et al. 2001). For HRV to be permitted for use as a clinical tool, more 
consistent data are required for understanding underlying mechanisms that induce the 
observed alterations in HRV in HF (Guzzetti et al. 2001).   
 
Impaired HRV measures are commonly identified risk factors in CHF, where sudden 
cardiac death has been used as a clinical end point (Sandercock & Brodie 2006). The 
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review paper by Sandercock and Brodie, (2006) found the best predictive HRV 
measures for all cause mortality were the global and/or slow oscillations in R-R 
intervals from both frequency and time domains. Sudden cardiac death was more 
difficult to predict because it occurs more often in lower NYHA class patients. Global 
HRV, along with NYHA class, patient age and Vo2 max can predict pump failure, which 
suggests that it is closely related to disease severity. In sudden cardiac death however, 
the best risk factors are LF power, and LF/HFr power ratio which reflect the short term 
fluctuations and sympathovagal interaction (ibid). Sandercock & Brodie (2006) also 
found that the most powerful risk factor in three out of four subject groups from 
independent studies was power in the LF band from both long and short-term 
recordings. HRV can be improved with exercise training; this has already been 
demonstrated in older patients with HF (Murad et al. 2012). Exercise training in patients 
with HF can be facilitated through a treatment programme of cardiac rehabilitation. 
Cardiac rehabilitation is an important part of HF treatment along with pharmacological 
methods (Authors/Task Force Members et al. 2012).  
 
2.3 Intervention: Cardiac Rehabilitation Programmes  
Cardiac rehabilitation (CR) is a medically supervised programme designed to improve 
the health and wellbeing of people with heart problems. CR programmes usually 
encompass an overall approach to helping the patient adjust back to an active life style 
following heart problems. The programme usually consists of healthy lifestyle education 
including diet, exercise and stress reduction. Rehabilitation teams are made up of 
different professionals, which may include doctors, nurses, exercise specialists, 
dieticians, psychologists, physical and occupational therapists. CR clinical guidelines 
such as the Scottish Intercollegiate Guidelines Network, (2002) focus on rehabilitation 
of myocardial infarction and revascularization but also address angina and HF.  
 
Patients with HF were originally cautioned against physical exercise until the late 1980s 
(Coats 2000). This was challenged and the benefit of exercise in patients with HF was 
demonstrated by Coats et al. (1990). An eight week training programme produced a 20-
25% increase in peak oxygen consumption, exercise tolerance and reduced 
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questionnaire-rated symptoms associated with their condition (Coats 1990). Participants 
in this study also found an increase in the ease and degree of performing daily activities 
(ibid). From the 1990s onwards the research in this area increased with larger and better 
designed studies in patients with HF, assessing the physiological benefits and increases 
in exercise capacity that are possible through CR (Coats 1999).  
 
A CR programme is defined by the American Heart Association as a comprehensive 
exercise, education and behavioural modification designed for HF patients for 
improvement of physical and emotional well-being. CR has demonstrated improvement 
in physical health and a decrease in subsequent morbidity and mortality. This is 
achieved through exercise, education, behaviour change, counselling and support 
strategies (Taylor et al. 2010).  
 
Increased morbidity from HF in developed countries is due to improved diagnosis and 
more successful treatment of acute illnesses including treatments such as CR (Neal 
2004). Optimal physical activity levels of those participating in CR have not been 
established (Taylor et al. 2010). Reasons for this have been cited as difficulties in 
attending regular sessions and a reluctance to take part in group-based sessions. There 
are two types of CR, home-based and centre-based. Home-based rehabilitation is a 
structured programme carried out in the patient’s home with clear objectives for 
participants that include monitoring, follow-up visits, telephone calls etc. Centre-based 
CR is a supervised group based programme that can be based in various settings such as 
the hospital physiotherapy department, community sports centre or University 
gymnasium (Dalal et al. 2010).  
 
2.3.1 UK cardiac rehabilitation guidelines 
European and UK guidelines for CR are provided by a number of sources. These include 
The National Institute for Health and Clinical Excellence (NICE), The British 
Association for Cardiac Rehabilitation (BACR), The European Society of Cardiology 
(ESC) and the Scottish Intercollegiate Guidelines Network (SIGN). BACR and SIGN 
release guidelines for CR as a whole, while NICE and ESC release guidelines for 
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specific disease states such as HF and myocardial infarction, and have the CR guidelines 
within that framework. 
 
The BACR released standards and core components in 2007. The core components 
listed were as follows: 
1. Lifestyle:  
I) Physical activity and exercise  
II) Diet and weight management 
III) Smoking cessation 
2. Education 
3. Risk factor management  
4. Psychosocial 
5. Cardio protective drug therapy and implantable devices 
6. Long-term management strategy 
 
Lifestyle should encompass risk stratification and baseline assessment to determine the 
appropriate exercise prescription, choice of venue (home/centre/community based) and 
appropriate staff and support structure for the patient. Dietary habits and anthropometric 
assessments should be used in diet and weight management. Counselling and 
pharmacological support should be given to each patient if smoking cessation is needed. 
 
Misconceptions surrounding cardiac illness can be eradicated through education. Other 
risk factors should be highlighted for the patient and recognition of decreasing 
symptoms is paramount for patient health.  Ensuring open communication with staff and 
counselling is appropriate to address problems such as sexual dysfunction, 
psychological issues or occupational factors. Close monitoring of risk factors such as 
blood pressure, lipid and glucose lowering are vital to ensure that patient health is not 
deteriorating. Psychological status should be monitored in patients to ensure anxiety and 
depression is not leading to a poor outcome. Psychological assessment through 
questionnaires and discussion should be used to monitor patient quality of life. Drug 
therapy such as ACE inhibitors, beta blockers and implantable devices are also 
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important parts of patient therapy and should be taken into consideration throughout the 
rehabilitation process. 
 
Long term management includes the patient’s responsibility to pursue a healthy lifestyle 
while ensuring they have the appropriate support to do so. Assessment over time will 
ensure that patients have appropriate support and encouragement (British Association 
for Cardiac Rehabilitation 2007). NICE provides guidelines for CR in patients with HF 
through reviews of the literature. Clinical evidence statements provide information on 
standard care vs. exercise rehabilitation and changes in NYHA class recorded in the 
literature from various experimental groups.  
 
The American Heart Association reported that CR programmes should consist of 
exercise training with multifaceted and multidisciplinary approaches to cardiovascular 
risk reduction (Balady et al. 2000). Every CR programme should include specific core 
components that aim to maximize the cardiovascular risk reduction by:  
1. Encouraging healthy behaviours 
2. Seeking ways to keep adherence to those behaviours 
3. Reducing any effects that may lead to disability  
4. Promoting an active lifestyle for patients with cardiovascular disease.   
 
2.3.2 Core components 
Core components of CR programmes include patient assessment, nutritional 
counselling, lipid management, hypertension management, smoking cessation, weight 
management, diabetes management, psychosocial management, physical activity 
counselling, and exercise training (Balady et al. 2000).  Each section is explained briefly 
in table 2.4. 
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Table 2.4 Description of core components of cardiac rehabilitation programmes  
Component Evaluation Interventions Expected Outcomes 
Patient Assessment Medical history, Physical 
examination, Testing  
Written record, feedback 
between patient and health care 
provider 
Improved quality of life, goals 
and strategies established, 
written summary of patient 
outcomes 
Nutritional Counselling Estimates of daily caloric 
intake, assess eating habits and 
make targets for areas of 
nutritional intervention 
Specific dietary modifications, 
diet plan, educate and counsel 
patient,  incorporate behaviour 
change model and compliance 
strategies 
Adherence to new diet, new 
understanding of good nutrition, 
plan in place to address eating 
behaviour 
Lipid Management Obtain fasting measures of lipid 
values, assess current treatment 
and compliance, add lipid 
lowering medication and assess 
at 6 weeks and 2 months 
Provide nutritional counselling 
to help reduce triglycerides 
through exercise, alcohol 
moderation, drug therapy etc., 
provide intervention to increase 
HDL through exercise, smoking 
cessation etc. 
Frequent assessment and 
modification of treatment, 
reduce LDL to <100 mg/dL, 
triglycerides to <200 mg/dL 
and HDL to >35 mg/dL 
Hypertension Management Measurement of resting BP on 
2 occasions, assess treatment 
compliance 
Provide lifestyle modifications 
such as exercise, sodium 
restriction, alcohol moderation, 
drug therapy 
Get BP values to systolic of 
<130 mm Hg and diastolic of 
<85 mm Hg  
Smoking Cessation Assess psychological issues, 
classify patient as non-smoker, 
former smoker, current smoker, 
determine readiness to change 
Provide education and 
counselling, encourage 
physician, staff, family support, 
provide relapse prevention 
Select quit date, facilitate goal 
setting, complete abstinence 




Weight Management Measure weight, height, waist 
circumference and calculate 
BMI 
Establish short-term and long-
term weight loss goals, develop 
combined diet, exercise 
behavioural program, aim for 
energy deficit of 500-1000 kcal 
Continued assessment, 
modification of interventions, 
monitor goal achievement, 
adherence to diet and exercise 
program to achieve weight loss 
goals 
Diabetes Management Identify diabetic patients 
through medical history, obtain 
fasting plasma glucose  
Develop diet plan, monitor 
glucose levels, develop regimen 
of healthy diet plus exercise, 
insulin therapy etc. 
Normalization of fasting blood 
glucose at 80-110 mg/dL 
Psychosocial Management Identify psychological distress 
through levels of depression 
and anxiety 
Education, self-help strategies, 
refer to mental health 
professional if deemed 
appropriate 
Develop plan for ongoing 




Physical Activity Counselling Assess current physical activity 
levels, evaluate activities 
relevant to gender, age etc. 
Provide advice, support and 
counselling, set goals to 
increase physical activity 
Increased participation in 
domestic, occupational and 
recreational activities, improved 
psychosocial well-being 
Exercise Training Obtain exercise test before 
participation begins 
Develop individualized exercise 
prescription, include warm-up, 
cool down and flexibility 
exercises 
Patient understanding of safety 
issues during exercise, lowered 
cardiovascular risk and 
improvement in overall 
outcomes  
Information in Table 2.4 is summarized from Balady et al. (2000). 
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A self-help manual called the Heart Manual is used in some UK home-based CR and 
other countries including Canada, Australia, Italy and New Zealand (Lewin 1998). The 
manual is a prescribed exercise rehabilitation method developed for cardiac event 
patients after hospital discharge using a cognitive-behavioural framework (Lewin 1998). 
The view of the amount of activity that a patient can undertake after a cardiac event has 
changed over time with research developments shifting the bases of HF treatment.  
Ground breaking work by Mæland, (1988) demonstrated the effect patients’ beliefs had 
on their health status. This psychological study highlighted that 67% of patients rated 
their health as high before the event, then down to 21% at discharge from the hospital, 
31% at six weeks and just 42% at 3-5 years (Mæland & Havik 1988). The patients 
perceived health status predicted their psychological recovery process, along with how 
soon then would return to work or had to be readmitted to the hospital. 
 
The Heart Manual involves some key features which make the programme a more 
holistic approach: a six-week programme which includes workbooks, audio and written 
materials to help monitor progress; elements of exercise, health education and 
psychological assessment; and finally a trained facilitator is used to help guide the 
patient and their family through the programme (Lewin 1998). The Heart Manual helps 
focus patient recovery and assists in answering questions and concerns. The structure 
allows for careful monitoring and patient feedback through the use of their facilitator 
and care management team. Despite this elaborate structure, uptake of the Heart Manual 
programme has been poorly supported (Taylor et al. 2007). Research into the use of the 
Heart Manual in other countries has begun in Canada, Australia, Italy and others (ibid).  
 
2.3.3 Cardiac rehabilitation in heart failure 
Exercise interventions can result in a number of positive outcomes for patients with HF.  
Documented benefits of CR consist of improvement in exercise tolerance, symptoms, 
blood lipid levels, and psychosocial well-being (Wenger 2008). Reductions in cigarette 
smoking, stress and mortality have also been demonstrated (ibid). Only two fatalities 
were reported for 1.5 million patient hours of supervised exercise, demonstrating the 
safety of CR (Wenger 2008). The benefits of exercise have been reported in various 
healthy and diseased populations emphasizing its importance to quality of life. The 
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following section will discuss exercise intervention studies conducted within the HF 
population. 
 
2.3.3.1 Exercise intervention publications 
Historically exercise was not recommended for patients with HF, and this was the case 
until the late 1980s (Coats 2000). The first publication on exercise training in HF was in 
1987 and compared an exercise group with a control group for 11 months (Lipchenko & 
Fomin 1987). The exercise included walking, cycling and exercise therapy; an increase 
in exercise capacity, reduced heart rate increment and a greater reduction in systemic 
peripheral resistance were demonstrated in the exercise group when compared with the 
control group. There are two major reviews that have assessed the effectiveness of CR 
in HF particularly, the Cochrane review by Davies et al, (2010) and ExTraMATCH 
Collaborative, (2004). The ExTraMATCH Collaborative, (2004), found a significant 
effect of exercise training on the reduction of mortality in HF patients; however re-
analysis of that trial data found there was no statistically significant difference of 
exercise training for HF patients when compared with controls (Davies et al. 2010; 
Gotzsche 2005). This was due to ExTraMATCH only using trials that reported survival 
data and the inclusion of unpublished data (Davies et al. 2010).  
 
Other factors to consider include medical therapy as that provides proven survival 
advantage (Shekelle et al. 2003). In the HF-ACTION trial 94% of patients were taking 
beta-blockers, angiotensin-receptor blockers or angiotensin-converting enzyme 
inhibitors while 45% had implantable cardioverter defibrillator (Whellan et al. 2007), all 
known to reduce the risk of mortality. Therefore assessment of CR programmes must 
also consider the affect of medical therapy when assessing outcomes. In 1990 the 
benefits of exercise training were reported in a controlled cross-over trial with a 20-25% 
increase in exercise tolerance, peak oxygen consumption and symptoms (Coats et al. 
1990). CR through exercise has been associated with a reduction in the debilitating 
symptoms caused by HF (ExTraMATCH Collaborative 2004).  
 
Exercise can affect symptoms such as breathlessness and fatigue, through the effects on 
both the cardiovascular and musculoskeletal systems (McKelvie et al. 2002). Symptoms 
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found in CHF patients have been linked to peripheral manifestations (Coats 2000).  
Localized or systemic forms of exercise therapy could benefit these peripheral 
manifestations and therefore modify symptoms and benefit patients, possibly affecting 
disease progression and survival (Coats 2000).  
 
Exercise training programmes produce positive outcomes such as delaying the onset of 
anaerobic metabolism, increasing vagal tone, reducing sympathetic drive and increasing 
aerobic capacity in patients with HF (Dracup et al. 2007). The majority of studies 
conducted in this area are randomised controlled trials that focus mostly on symptomatic 
benefits and substitute markers of prognosis such as HRV and peak oxygen 
consumption (ExTraMATCH Collaborative 2004). Exercise training improves survival 
time in patients with HF due to considerably improved left ventricular systolic function 
(ExTraMATCH Collaborative 2004). Exercise capacity assessed with or without 
metabolic measurements has proven a more powerful prognostic tool than other 
traditional risk factors such as smoking, hypertension and diabetes (Myers et al. 2002). 
Variability in heart rate suggests that exercise training may reduce adrenergic tone and 
increase vagal tone which can have a positive effect on the important neurohormonal 
and musculoskeletal abnormalities that occur in HF (ExTraMATCH Collaborative 
2004).   
 
Several explanations have been offered to suggest physiologically how exercise training 
benefits patients with HF. These include ventricular remodelling (Haykowsky et al. 
2007), improved myocardial contractility and diastolic filling (Belardinelli et al. 1999). 
In ischaemic patients particularly, improvement is by stimulating new vessel formation 
and dilating coronary vessels from improved myocardial perfusion which alleviates 
endothelial dysfunction (ExTraMATCH Collaborative 2004). Patients with HF 
demonstrate neurohormonal and musculoskeletal abnormalities (Davies et al. 2010; 
ExTraMATCH Collaborative 2004); measurements of HRV have shown that exercise 
training may increase vagal tone and reduce adrenergic tone (Coats et al. 1992; 
European Heart Failure Training Group 1998; Hepburn et al. 2005; Libonati 2013; 




With an aging population the prevalence of HF is increasing and will significantly affect 
costs in the public health system (Miche et al. 2009).  Finding ways to combat and treat 
this growing epidemic are important to ensure the health system can work at its best for 
years to come. Various exercise programmes may have different benefits for patients 
with HF. An increase in physical performance in elderly patients has been documented, 
however no clear recommendations on endurance versus muscle strengthening 
programmes have been published (Miche et al. 2009). A clear correlation has been 
established between peak Vo2 and performance in the six-minute walk test, providing 
easy measurement and evaluation of stress tolerance in CHF patients (Guyatt et al. 
1985). An increase in physical performance has been demonstrated in older patients (age 
74 ±3) where peak Vo2 and muscle strength significantly increased after six months 
(Miche et al. 2009).  Despite the benefits to CR, participation remains suboptimal (Dalal 
et al. 2010). 
 
2.3.3.2 Barriers to cardiac rehabilitation 
Gender differences have been documented in the literature. When considering women’s 
responses to CR, the effects are equivalent to those of men’s in Vo2 peak and cardiac 
mortality (Kavanagh et al. 2003). Elderly women are, however, less likely to be referred 
for CR and are less likely to attend compared to their male counterparts (Wenger 2008).  
 
A lower functional capacity at the time of admittance to CR tends to attain greater 
benefit. It is important to recognize what barriers may be preventing patients from 
participation in CR programmes. In other countries such as the USA, there are financial 
and ethnic barriers with non-white women being less likely to gain referral to CR 
programmes (Wenger 2008). A number of potentially modifiable factors predict 
attendance for CR programmes (Cooper et al. 2002). Indirect influences included 
gender, job status and health concerns; direct influences included lower income/greater 
deprivation, age, lack of belief in ability to influence the disease outcome (Cooper et al. 
2002).  
 
Qualitative studies which have researched the barriers and enablers which impact CR 
uptake have cited flexible services, transport, individual views, level of awareness or 
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understanding of services and intervention, religious and cultural issues, one-to-one 
care/group care, communication problems and the absence of services or long waiting 
lists (Lakhmana 2009). Drop-out rates in CR range from 20% in the first three months to 
50% in six months; women, smokers and patients who suffered more than one 
myocardial infarction were more likely to drop-out (Jolly et al. 2003). The uptake rate 
for those deemed medically suitable was 83%. Around 27% of patients referred did not, 
however, attend sessions due to reasons cited as ‘too ill’, ‘having further investigations’ 
or ‘physically incapacitated’ (NACR 2009).   
 
A review by Thompson & Clark (2009), which analysed why so many patients do not 
receive CR in the UK cited distance, transportation issues, lack of convenience, lack of 
referral by physicians, lack of funds, illness, lack of interest, denial of severity of illness, 
not believing it will work or is suitable for them and family or work obligations. 
Common themes appear throughout the literature and further investigation within the 
UK of barriers patients may face in their referral to rehabilitation, and how to combat 
them, could help to increase participation. It is also important to understand what will 
motivate patients to seek out CR and what factors may help maximize its benefits to 
their health. Excess weight and excess adipose tissue are risk factors for cardiovascular 
disease and could potentially be used to help motivate patients to exercise. Physical 
activity can result in decreased body fat, which can impact exercise performance and 
health. Body composition, a measurement of body fat, will be discussed in the following 
section to help assess what impact it may have on HRV and patients with HF. 
 
2.4 Body Composition 
Body composition is measured by models that divide body weight into two or more 
components. The most frequently used are two or four component models. Two 
component models (2-C) consist of fat mass and lean body mass; and assume a constant 
relative hydration value for lean body mass (73.8%). Assessment methods using this 
model include skinfold thickness, bioelectrical impedance analysis and 
hydrodensitometry. The 2-C models provide reasonable estimates of body fat 
percentage, however influences such as age, gender, ethnicity and physical activity 
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levels affect the proportions of water, mineral and protein within lean body mass, 
causing discrepancies in the measurement (Baumgartner et al. 1991; Deurenberg et al. 
1989; Wagner & Heyward 2001). Multi-component models [three component (3-C) and 
four component (4-C)] divide the body into fat, water and solids (protein and mineral). 
The 3-C assumes a constant for the protein-mineral ratio, while the 4-C model divides 
the body into fat, water, mineral and protein components. Assessment methods using 
this model include dual-energy x-ray absorptiometry (DEXA), and computed 
tomography (CT, CAT).   
 
2.4.1 Obesity 
The World Health Organization (WHO) defines overweight and obesity as excess 
amounts of body fat that presents a risk to health. Obesity has become a global 
epidemic, with over 1.4 billion adults diagnosed as overweight or obese in 2008 (World 
Health Organization 2010a). Globally obesity accounts for 44% of diabetes, 23% of 
ischaemic heart disease and 7-41% of certain cancers (ibid). In clinical practice, the 
purpose of body composition measurement is to evaluate clinical nutritional status 
through measuring fat mass (FM) and free fat mass (FFM) (Thibault et al. 2012). 
Obesity has been recognized as a risk factor for diabetes and cardiovascular disease, 
both of which are associated with autonomic dysfunction (Lindmark et al. 2005; 
Schroeder et al. 2005; Thayer et al. 2010). It has been hypothesized that insulin 
resistance and the development of obesity-associated diseases are mediated by 
autonomic dysfunction. The precise relationship however, between adiposity and insulin 
sensitivity is still unclear (Liao et al. 1996; Lindmark et al. 2005; Shibao et al. 2007; 
Thayer & Lane 2007).  It is recommended that nutritional status be measured on a 
regular basis in both hospitalised patients and those nutritionally at risk to reduce 
complications that result from poor nutritional status (Kondrup et al. 2003).  
 
Subtypes of obesity have been recognized to help characterize specific trends including 
metabolically healthy but obese and metabolically obese, normal weight (Karelis et al. 
2004). Metabolically healthy but obese are individuals who have elevated body fat but 
maintain a normal metabolic profile (i.e. favourable cardiovascular risk profiles and 
normal to high insulin sensitivity); metabolically obese, normal weight are lean 
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individuals with clustering of metabolic and cardiovascular risk factors including 
elevated fasting glucose, systematic inflammation and insulin resistance (ibid). 
Metabolically obese, normal weight women are reportedly at higher risk for 
cardiovascular mortality (Romero-Corral et al. 2008); anyone in this subtype of obesity 
are at increased risk of developing diseases associated with obesity (Shea et al. 2011). 
Those who are metabolically healthy obese are free from the metabolic disturbances 
associated with chronic disease, despite carrying excess fat mass (Bluher 2010; Primeau 
et al. 2011).  
 
2.4.2 Fat mass and fat free mass 
Fat mass constitutes all lipids from adipose and other tissues in the body. Adiposity is 
characterized by a high fat mass percentage caused by excessive storage of fat in 
adipose tissue (Deurenberg & Yap 1999). Fat mass functions as a thermal insulator, 
stores energy for periods of lower energy intake, produces hormones and protects 
certain organs against mechanical damage by surrounding them (ibid). Adipose tissue is 
essential for life; classifications of optimal amounts are determined by gender and age. 
Age-adjusted body fat % recommendations are displayed in Table 2.5 and 2.6. 
 
Table 2.5 Body-fat percentage recommendations for males 
Age Under fat Healthy Range Overweight Obese 
20-40 years Under 8 % 8-19 % 19-25 % Over 25 % 
41-60 years Under 11 % 11-22 % 22-27% Over 27 % 
61-79 years Under 13 % 13-25 % 25-30 % Over 30 % 
Source: Gallagher et al, (2000)  
 
Table 2.6 Body-fat percentage recommendations for females 
Age Under fat Healthy Range Overweight Obese 
20-40 years Under 21% 21-33 % 33-39 % Over 39 % 
41-60 years Under 23% 23-35 % 35-40 % Over 40 % 
61-79 years Under 24% 24-36 % 36-42 % Over 42 % 




Conversely, fat free mass consists of all lipid-free chemicals and tissues including water, 
muscle, bone, connective tissue and internal organs. Fat free mass and lean body mass 
are often used interchangeably, however there are slight differences between them. Lean 
body mass contains a small amount of essential lipids (Lohman 1992). In body 
composition analysis, water is separated into its own category as it comprises up to 63% 
of body mass (Armstrong et al. 1997), and therefore will be discussed in greater detail. 
 
2.4.3 Water 
Water is essential to life; humans cannot normally survive without water for more than a 
few days, whereas they can go without food for considerably longer (Benelam & 
Wyness 2010). Adequate hydration is necessary for the body to sustain normal 
physiological functioning such as the transportation of nutrients, waste removal and the 
regulation of body temperature. The human body consists of between 45% to 75% water 
by weight; lean tissue is made up of a higher percentage of water at 70% compared to 
just 20% of fat tissue (ibid). Water in the body is found in different compartments of 
inner and outer cells called the intracellular and extracellular cells. Intracellular cells 
account for 65% while 35% is found in extracellular cells (Sawka et al. 2005). There are 
two types of extracellular cells: interstitial fluid (the fluid present between cells) and 
plasma (the fluid in the blood that transports blood cells around the body) (ibid). 
 
In 2010, a study of 80 adults living in the UK reported average consumption of 2402 
ml/day for females and 2056 ml/day for males (Al-Jalali & Shirreffs 2010). This is 
comparably higher than the amounts reported in the National Diet and Nutrition Survey 
(NDNS), completed in 2000-2001. NDNS reported that total beverage consumption in 
males was 1988 ml per day and 1585 ml per day in females (Henderson et al. 2002). In 
both studies, UK males consumed below the recommended amount on average of 2500 
ml/day; females were over the average in Al-Jalali & Shirreffs, (2010) but below the 
average of 2000 ml/day in the NDNS survey (2000-2001).  
 
Water is an important component of the body’s natural structure, used for circulatory 
function, biochemical reactions, metabolism, substrate transport across cellular 
membranes, temperature regulation, and numerous other physiological processes 
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(Armstrong 2007). Fluid-electrolyte turnover and total body water (TBW) change 
constantly due to water gained from food, fluids, and water loss from the lungs, skin and 
kidneys (ibid). Water is vital for survival, and there is great interest in the advantages of 
good hydration for people to function well and to look and feel good (Benelam & 
Wyness 2010). Hydration levels will have different effects on the healthy population, 
athletes and clinical populations and the interaction with the environment is also an 
important factor to consider.   
 
Euhydration is the term used to describe normal body water content. This does not occur 
at a specific point but rather is represented by an average (Oppliger & Bartok 2002). 
Dehydration or hypohydration is the process of uncompensated water loss that results in 
total body water falling below the average basal value. This process occurs through 
sweat, respiratory vapour, urine or faeces (Armstrong 2007). Hyperhydration occurs 
when ingested fluid temporarily increases body water content over the average basal 
level (ibid). Levels of hydration change over time and this process is important for 
maintaining healthy body function. Clinical populations and athletes are special 
populations that need to consider their fluid status. Through various disease states or 
physical activity, both of these groups need to monitor their hydration levels to ensure 
optimal health and body function. 
 
2.4.4 The effects of hydration levels on clinical patients 
Chronic mild to moderate dehydration has been associated with several disease states 
including fatal coronary heart disease. The influence of hydration on cardiovascular 
reactivity during psychological stressors was examined and a positive relationship was 
found between TBW and the change in heart rate, diastolic blood pressure and total 
peripheral resistance during reactivity to posture change (Patterson 2002). The most 
common fluid and electrolyte imbalance in older people has been reported as 
dehydration. Among nursing home patients admitted to hospital for acute illness, 34% 
were dehydrated (Hodgkinson et al. 2001). Mortality rates among older people with 
dehydration have been reported as high as 46% (ibid). More research however is needed 
in this area, looking at understanding the underlying mechanisms and physiological 




2.4.5 Body composition measurement techniques 
Body composition can be measured using a variety of techniques which includes 
hydrodensitometry, air displacement plethysmography, hydrometry, dual-energy x-ray 
absorptiometry, skinfolds, bioelectrical impedance analysis and near-infrared 
interactance model. Each measure is defined in table 2.7. 
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Table 2.7 Definition of body composition measurement techniques 
Measure Definition 
Body circumferences [waist circumference 
(WC) or waist to hip ratio (WHR)] 
Prediction of body fat from measurements of the waist (WC) or the ration between 
the waist and hip (WHR). 
Body mass index (BMI) Weight to height index calculated by the equation (weight (kg)/ height (m)2) 
Hydrodensitometry (Underwater weighing) Measurement of body density (estimate of total body volume from the water 
displaced by the body when fully submerged). 
Air Displacement Plethysmography (ADP) Calculated from air displacement to estimate body volume 
Hydrometry Measurement of total body water (TBW) by dilution of isotopic tracers 
(concentration of hydrogen or oxygen isotopes is measured in saliva, plasma or urine 
to estimate TBW) 
Dual-Energy X-Ray Absorptiometry (DEXA) Measures bone mineral density by x-ray of an individual’s bones by two x-ray beams 
with different energy levels 
Skinfolds Indirect measure of the thickness of subcutaneous adipose tissue by measuring two 
layers of the skin and the underlying subcutaneous fat at selected sites.  These 
measures are then input into a prediction equation. 
Bioelectrical Impedance Analysis A current is applied at a given frequency (which may vary) and the higher 
conductivity of water compared to the other compartments is used to determine its 
volume 
Near-Infrared Interactance Model Estimation of body fat % from the reflectance of near-infrared light off the 
underlying tissue 
Computerized Tomography (CT) Medical imaging using computer processed x-rays to produce topographic images of 
specific areas of the body 





2.4.5.1 Bioelectrical impedance analysis 
Bioelectrical impedance analysis (BIA) is an easy technique to use in the 
determination of fat-free mass and TBW. BIA is a portable and relatively 
inexpensive, non-invasive measure (Kyle et al. 2004b). The results are reproducible 
and rapidly obtained and the use of BIA as a bedside method has increased (ibid).  
This suggests BIA is a beneficial tool for use with both healthy and clinical 
populations.   
 
BIA is also one of the ways hydration can be measured by using equations that 
convert reactance and resistance to estimate TBW. The term impedance arises from 
the combination between reactance (arising from cell membranes) and resistance 
(arising from extra and intracellular fluid) (Kyle et al. 2004a). BIA measurement 
generally takes approximately five minutes to perform. An undetectable current is 
passed through the body to determine resistance and reactance (Wilmore & Costill 
1999). Water and electrolyte distribution in the tissues determines the electrical 
conduction between the electrodes. Fat mass has a greater impedance, so it is more 
difficult for a current to flow through it when compared with free-fat mass.  Free-fat 
mass consists of all the body water and conducting electrolytes making conductivity 
much greater within this tissue (ibid).  
 
There are however several different methods of BIA. The following section briefly 
describes each method as reported by (Kyle et al. 2004a).  
• Single frequency BIA: measurement at 50Hz via surface electrodes placed on 
the hand and foot. Total body water (TBW) is technically not measured 
through this method as it does a weighted sum of extra-cellular water and 
intracellular water resistivities. It does however estimate fat –free mass and 
total body water but cannot determine differences in intracellular water.  
• Multi-frequency BIA: involved impedances at multiple frequencies ranging 
from 0 to 500 kHz which evaluate free-fat mass, TBW, ICW and ECW.  Poor 
reproducibility has been reported in frequencies above 200 Hz and below 5 
Hz especially for reactance measurements. 
• Bioelectrical spectroscopy (BIS): made up of mathematical models and 





biological variations already present in the normal population; leading to the 
lack in improvement of mixed theory analysis over empirical prediction.  
• Segmental-BIA: this method was developed to overcome inconsistencies that 
arise from resistance and body mass of the trunk.  This method uses a six-
electrode technique on peripheral electrode sites with new equations for fat 
weight based on fat distribution 
• Localized bioelectrical impedance analysis: this method focuses on well 
defined body segments which minimizes interference effects. 
• Bioelectrical impedance vector analysis (BIVA or vector BIA):  R and 
reactance (Xc) are standardized for height and plotted as point vectors in the 
R-Xc plane. The individual vector is then compared with references of 50%, 
75% and 95% tolerance ellipses calculated in the healthy population of the 
same gender and race. 
 
2.4.6 Body composition measurement limitations 
Body composition is affected by age, gender, physical activity level and disease. 
Densitometry and electrical impedance are detailed methods, which are known to 
yield accurate results but are based on hypotheses established in normal weight 
adults and therefore are not necessarily transferable to other populations (Rolland-
Cachera 1993). Skinfold thickness tests are affected by a number of factors, those 
that increase skin thickness such as exercise, oedema or dermatitis; and dehydration 
which reduces skin thickness (Wells & Fewtrell 2006). Skinfold measurement also 
needs a certain level of expertise by the technician (ibid). Limitations to 
hydrodensitometry include measurement of residual lung volume, variation in body 
mass, underwater weighing and water temperature (Lohman 1981). Air displacement 
plethysmography, computerized tomography, dual-energy x-ray absorptiometry and 
near infrared interactance models are expensive compared to other methods such as 
skinfold or BIA assessment (Wagner & Heyward 1999).  
 
The need for sample-specific impedance prediction models for BIA (particularly for 
single frequency measurements) has led to criticism of the method; especially 
because of proven differences in the body geometry and chemical composition of 
fat-free mass between ethnic groups (Ellis et al. 1999). A comparison between BIA 





found BIA a more useful method for use in epidemiologic health surveys because 
BIA explained more of the variance in estimated fat mass and fat-free mass (Lukaski 
1990).  
 
When considering TBW, 24-hour water deficit varies from person to person. In 
athletes the range is generally from 1.5 to 6.7 L, and in sedentary individuals it is 
generally from 1.1 to 3.1 L. This is primarily attributed to the size of the body and 
the activity. TBW balance is then only achieved if dietary and metabolic sources of 
water are sufficient (Board 2004). Next the volume and time of water consumption 
must be considered as it may alter measurement of hydration status. If a large 
quantity of pure water or hypotonic fluid (e.g. 1.2 L in five minutes) is ingested this 
would result in the water entering the blood and kidney function producing a large 
volume of dilute urine before the intracellular and extracellular fluid could 
equilibrate (Armstrong 2007).   
 
When considering hydration measurement, other conditions or complicating factors 
must be controlled or accounted for (Shirreffs 2003). Measurements of hydration 
should measure fluid volume and concentration in real time, have excellent 
precision, accuracy and reliability, be non-invasive, interpreted in concert with other 
hydration indices,  be portable, inexpensive, safe, and simple to use (Armstrong 
2007). The choice of hydration measurement should ultimately be determined by the 
sensitivity, accuracy, technical and time requirements and expense of the 
measurement device (Shirreffs 2003). 
 
2.4.7 Hydration and cardiovascular function 
Hydration status and exercise heat stress influence HRV independently (Carter III et 
al. 2005). The strong return of parasympathetic activity is thought to be the main 
mechanism underlying cardio-deceleration after exercise and the degree to which 
autonomic control of heart rate during recovery from exercise may be affected by 
hydration status (Carter III et al. 2005). Dehydration is associated with increased 
cardiovascular strain and dehydration alone negatively influences parasympathetic 






Cardiovascular function can be severely affected by dehydration. These effects 
include a decrease in orthostatic tolerance and a relative tachycardia at rest and 
during exercise (Charkoudian et al. 2003). Mild post-exercise dehydration of 
approximately 1% of body weight or more can lead to an increase in resting heart 
rate and/or decreased tolerance to lower body negative pressure which indicates 
impaired cardiovascular control (ibid). These affects have mostly been demonstrated 
through healthy subjects therefore experimentation on specific disease populations 
could help expand this area of research. 
 
NICE (National Clinical Guideline Centre 2010) state that fluid retention can occur 
with heart conditions for two main reasons: 
1. Fluid leaks into the lungs and/or veins due to blood flow from the body to the 
heart backing up 
2. Inadequate blood volume from the heart to the rest of the body resulting in 
the kidneys sensing a decrease in blood flow and compensating by retaining 
salt and water. 
 
Accurate fluid volume assessment is essential as the impact of therapeutic 
intervention is critical and differential diagnoses can be long and complicated 
(Peacock & Soto 2010). Blood volume analysis in patients with a history of CHF 
shows that increased blood volume is associated with increased risk of death or 
urgent cardiac transplant (Androne et al. 2004). Maintaining adequate hydration is 
important for all populations, but can have serious consequences for those more 
vulnerable due to circumstances or illness. More research is needed to determine the 
optimum non-invasive method for maintaining good levels of hydration in clinical 
population. 
 
2.4.8 Fat mass and cardiovascular function 
Excessive fat mass has an impact on the structure of the heart and its function 
(Poirier et al. 2006b). Excessive abdominal fat is a global risk factor for 
cardiovascular diseases (Yusuf et al. 2004); levels of risk vary among different 
gender and ethnicities (Poirier et al. 2006a). Reduced vascular endothelial function 
(general functional capacity of endothelial cells to synthesize and release nitric 





Hashimoto et al. 1998). Reduced arterial elasticity is also associated with increased 
adiposity (Christou et al. 2005).  Increased adiposity is linked to hypertension (Hall 
2003), with several clinical studies showing that a gain in fat mass predicts the 
development of hypertension (Hall 2000).  
 
Worsened sympathetic and parasympathetic function is associated with higher 
abdominal-to-peripheral fat distributions (Christou et al. 2004). Disturbances in 
cardiac structure have been linked to excessive fat mass (Lauer et al. 1991). Obese 
individuals tend to have larger chamber size, greater wall thickness and greater left 
ventricular mass (Hammond et al. 1988; Messerli et al. 1983). Left ventricular 
hypertrophy is a strong predictor of cardiovascular morbidity and mortality (Levy et 
al. 1990). Greater resting stroke volume and resting cardiac output are a result of 
increased cardiac mass and chamber dimensions found in those who are obese 
(Alpert & Alexander 1998). 
 
2.5 Conclusions: 
As a measure of autonomic function, HRV is potentially useful in both clinical and 
healthy populations. This review has discussed the prognostic value of HRV in 
clinical populations such as HF. HF is a complex disease, which affects millions of 
people in the UK and around the world. CR as a medical intervention in HF is 
underused and ways to improve uptake and completion of programmes are essential. 
The use of HRV in CR will be explored in the present thesis, using a novel device 
called Ithlete to take daily measurements. As obesity increases globally, access to 
different body composition techniques is essential in helping individuals monitor 
their risk. Cost, usability and access are important for any body composition device.  
The present thesis will explore novel devices for body composition and assess the 
relationship that may exist between HRV measured with the Ithlete application and 
body composition measured through BIA.  
 
Technological advances in microprocessors, wireless technology etc. allow the 
assessment of physical activity and energy expenditure using several different 
personalised body monitoring devices (Andre & Wolf 2007). These devices, 
including heart rate monitors, accelerometers, indirect calorimetry devices and 





a free-living environment (ibid). Nonetheless, it is recognized that accurate self 
monitoring can provide important feedback to the user (Dilley 1998; Schnoll & 
Zimmerman 2001; Wierenga, Browning & Mahn 1990), emphasizing the need to test 
and find accurate inexpensive devices.   
 
Using a new HRV analysis device called Ithlete software for the IPod touch 
measurements of HRV in both a healthy population and patients with HF, will be 
assessed and the following research questions will be asked: 
1. Is Ithlete a reliable HRV measurement? 
2. Can daily measurements of HRV (rMSSD) be collected using a new device 
(Ithlete) in participants both healthy participants and patients with heart 
failure?   
3. Is Ithlete an easy device to use daily?   
4. What is the normal range of HRV (rMSSD) in healthy participants and 
participants with heart failure using Ithlete software?   
5. Can Ithlete be used to help facilitate a cardiac rehabilitation programme post 
heart failure?  
 
The use BIA to test body composition will be assessed and compared in the healthy 
and heart failure populations and the following questions will be asked: 
6. Is BIA an appropriate measure for hydration status in healthy and/or heart 
failure patients? 
7. What is the difference in accuracy between various BIA devices? 
8. Is there a device that participants can use in their home daily to assess body 
composition? 
9. Are similar relationships present between Ithlete measurements of rMSSD 
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CHAPTER 3: COMPARISON OF HEART RATE AND HEART RATE 
VARIABILITY (rMSSD) ANALYSIS USING POLAR s810i AND ITHLETE 
 
The present study was conducted to compare the analysis of heart rate variability 
(HRV) root mean square of successive difference (rMSSD) in milliseconds (ms) and 
heart rate (HR) in beats per minute (bpm) obtained from the Polar s810i heart rate 
monitor (HRM) (Polar Electro Oy) with Ithlete software (HRV Fit Ltd, Hampshire, 
UK) for the iPod touch at rest. Four moderately active participants, two healthy (H) 
(29 ±2.8 years of age) and two heart failure (HF) patients (68.5 ± 7.8 years of age) 
performed seated measurements with each device simultaneously during which R-R 
intervals were recorded. Bias, limits of agreement (LoA), significant differences and 
interclass correlation coefficients (ICC) were calculated. 
 
High ICCs and narrow limits of agreement in the present study demonstrate good 
agreement between Polar heart rate monitor (HRM) and Ithlete devices. In addition, 
no significant differences were found between rMSSD measurements at p < 0.05 for 
three out of the four participants however, a significant difference between HR 
measurements was found between devices for all participants. Pearson correlations 
for HR in H participants were r = 0.81 and r = 0.92 (p < 0.001). HR Pearson 
correlations for HF participants were r = 0.92 (p < 0.001) and r = 0.30 (p < 0.05). 
Pearson correlations in H participants for rMSSD were r = 0.56 and r = 0.76 (p < 
0.001); and 0.87 and r = 0.90 (p < 0.001) for HF participants. 
 
When participants were grouped together as H or HF participants, Bland & Altman 
analysis demonstrated a bias for HRV of 2.0 ms for healthy and -2.75 ms for HF 
participants. LoA of -15.6 – 19.7 for healthy and -13.8 – 8.3 for HF were 
demonstrated between Polar HRM and Ithlete. Despite the larger bias and LoA, there 
were a limited number of outliers for HRV and HR (4.7% of HRV in healthy 
participants lying outside the LoA and 2.7% for HF participants; for HR 5.9% of 
differences lay outside of the LoA for both healthy and HF participants). ICCs were 
>0.85 in three out of four participants, suggesting that Ithlete and Polar HRV 






Therefore the Ithlete measurement system provides a new perspective for 
investigation of rMSSD and can be considered a good alternative device for short-




3.1.1 Heart rate  
Cardiovascular diseases (CVD) are increasing all over the world and have become 
the number one cause of death globally (World Health Organization 2011). Resting 
heart rate (HR) has been demonstrated as a strong predictor for morbidity and 
mortality in the general population (Kannel et al. 1987), and in chronic heart failure 
(CHF) (Lechat et al. 2001; Pocock et al. 2006). Risk factors which increase the 
chance of getting CVD include smoking, unhealthy diet, obesity and physical 
inactivity. In the UK it is recommended that adults do at least 150 minutes per week 
of moderate-intensity exercise. To monitor the intensity of exercise, reliable 
telemetry HR monitors can be used for immediate feedback and storage of HR data 
for further analysis at a later date (Gilman & Wells 1993; Macfarlane et al. 1989; 
Robinson et al. 1991).  
 
3.1.2 Heart rate variability 
Heart rate variability (HRV) was demonstrated as a reliable and reproducible 
technique for assessing autonomic activity in the late 90s (Noland et al. 1998). 
Different habitual levels of physical activity may cause changes in HRV (Nunan et 
al. 2009). Studies have demonstrated that CHF patients have decreased HRV, and 
this decrease can be used to predict cardiac events (Fauchier et al. 1997; Nolan et al. 
1998; Task Force. 1996). A good functioning autonomic nervous system should 
yield a high HRV, which implies a healthy individual (Sueta 2003). In CHF patients, 
depressed HRV levels are regularly observed at all stages of systolic dysfunction 
(Fauchier et al. 1997). 
 
Environmental conditions (i.e. temperature, humidity), mental stress and body 
position (i.e. standing vs. supine) strongly influence HRV (Ewing et al. 1991). There 
are various indices of HRV analysis (Task Force. 1996), which include time domain, 





time and frequency domain analysis (also known as spectral analysis) have been 
reported in several studies (Kautzner et al. 1995; Lord et al. 2001; Marks & 
Lightfoot 1999; Pardo et al. 1996; Pinna et al. 2007). The range of HRV 
measurement parameters can be analysed by several commercial devices. A brief 
explanation of measurement parameters will be discussed in the following section.  
 
3.1.2.1 Measurement indices of HRV 
Time domain measurements are determined by the heart rate at any given point in 
time or between successive normal complexes (Task force, 1996). Geometric 
measurements represent R-R intervals in geometric patterns, such as the triangular 
index and the triangular interpolation of NN. In the triangular index measure, the 
lengths of the R-R intervals are used to form the x-axis of the plot, and the number of 
each R-R interval length is used for the y-axis. The triangular interpolation measure 
provides the baseline width of the distribution, measured as a base of a triangle 
which approximates the NN interval distribution of HRV (Task force, 1996). 
Frequency domain analysis (spectral analysis) provides understanding of the effects 
of sympathetic and parasympathetic systems on HRV (Akselrod et al. 1981). Each 
method of analysis has advantages and disadvantages to consider. The cost of data 
collection may be significantly higher for some methods of HRV analysis, and 
reliability is dependent on appropriate statistical analysis. 
 
Time-domain measurements are commonly used and involve several different HRV 
measures; these include SDNN, SDANN, total power and ULF power, VLF power 
and LF power, rMSSD, pNN50 and HF power. A full review of these measures and 
their interrelation can be found elsewhere (Nunan et al. 2010). There are high 
correlations between time and frequency domain measures of vagal activity 
suggesting they can be used interchangeably (Bigger Jr et al. 1989). The root of the 
mean squared differences of successive heart periods (rMSSD) and the high 
frequency power of the normal R-R interval power spectrum have correlations as 











3.1.2.2 HRV measurement duration and position  
In the literature there is a large range in the recommended duration of HRV 
recordings. The duration can be as short as 30 seconds or as long as a 48-hour 
continuous recording (Task Force, 1996). Bigger et al. (1993) compared HRV 
measurement epochs of 2-15 minutes with 24-hour ambulatory recordings in patients 
with HF. Measurements of 2-15 minutes predicted death nearly as well as the same 
measures computed over a 24-hour period. The prediction of 2-15 minute recordings 
improved significantly when matched individually with each of the three best 
predictors of mortality (NYHA class, left ventricular ejection fraction, and crackling 
noises heard on auscultation of the lung) (ibid). A one-minute bedside deep 
breathing test of HRV in post-myocardial infarction patients also demonstrated that 
short-term measurements of HRV were good predictors of all cause mortality and 
sudden death (Katz et al. 1999).   
 
Sandercock et al. (2005) outlined advantages to short-term HRV measurements 
including speed of execution, and ease of analysis. Short-term HRV measurements 
can be edited manually in various software applications, as they contain a number of 
individual R-R intervals, can be recorded under controlled conditions, and can be 
supervised by a researcher to ensure standardisation. Short-term measurement 
reliability of multiple indices of HRV have been assessed in several studies (Aubert 
et al. 2001; Bigger et al. 1993; Choi et al. 2006; Koskinen et al. 2009; La Rovere et 
al. 2003; Nunan et al. 2009; Pinna et al. 2007; Tharion et al. 2009), all of which have 
found acceptable reliability. Between HRV measures, time-domain values 
demonstrate adequate homogeneity but spectral measures appear to be mainly 
heterogeneous (Sandercock 2007). Time domain (statistical) measures such as total 
power, ultra low frequency (ULF) power, very low frequency (VLF) power, low 
frequency (LF) power, rMSSD, and pNN50 are highly correlated with each other 
(Kleiger et al. 1991).  
 
HRV has been demonstrated as an effective measurement for 24-hour ambulant 
measurements (Furlan et al. 1990; Task Force. 1996), short term measurements 
(Bigger et al. 1993; Lucreziotti et al. 2000; Pagani et al. 1986) and very short term 





HRV indices. Spectral analysis requires recording periods of at least five minutes, 
and a signal which has stationarity (Task Force, 1996). These requirements may be 
more difficult to obtain outside of a laboratory, however a simpler measurement 
(rMSSD), can be measured over short R-R interval recordings. The rMSSD measure 
also does not require stationary signal like spectral measures. Therefore this thesis 
will utilize rMSSD.  
 
3.1.2.3 rMSSD 
rMSSD is a time domain measure of HRV which reflects parasympathetic activity 
without being dependent on heart trends (Stein et al. 1994).  rMSSD is independent 
of mean HR and considered robust against gradual trends over time (Hilz & Dütsch 
2006). rMSSD is sensitive to short term high frequency heart period fluctuations, 
and is often used in clinical cardiology (Porges & Byrne 1992).  There is a good 
correlation between rMSSD and frequency domain measures of high-frequency 
HRV (HFr) which reflects respiratory sinus arrhythmia (RSA) (Task Force, 1996). 
rMSSD is influenced by a variety of factors which include rate and depth of 
respiration, physiology of sinoatrial node, physical conditioning and age (Berntson et 
al. 2005). 
 
The rMSSD measure is reported to be less sensitive to variations in respiratory 
patterns and has been suggested as superior to spectral methods of HRV assessment 
due to its sensitivity to vagal cardiac control (Penttilä et al. 2001). In research 
assessing the reliability of ultra-short HRV measurements (10 s) rMSSD emerged 
with high correlations with the standard 5-minute short-term recording (Thong et al. 
2003). Nussinovitch et al, (2011) also found rMSSD to be a reliable parameter for 
assessing HRV from ultra-short 1-minute or 10-second resting ECG recordings. For 
experimental work, Pinna et al, (2007) recommended that research designs using 
HRV parameters for outcomes should be based on the parameters with the lowest 
variation, of which rMSSD was listed as one.  
 
The rMSSD measure has been suggested as superior to spectral methods due to its 
sensitivity as a measure of vagal cardiac control, and is less sensitive to variations in 
respiratory patterns (Penttilä et al. 2001). There is a high correlation between 





al. 2005). This suggests that rMSSD is perhaps useful as a time-domain index of 
vagal control of the heart (Berntson et al. 2005). There is typically a low-frequency 
cut off of 0.12 to 0.15 Hz in spectral estimates of vagal control due to limited 
sympathetic contribution to heart period variability beyond that frequency (Berntson 
et al. 1993). rMSSD has been demonstrated as an effective measure for effectively 
capturing respiratory sinus arrhythmia and a reliable assessment of cardiac vagal 
outflow (Penttilä et al. 2001).  
 
rMSSD values in HF patients have been recorded in the literature at 21.5 ± 12.3 in 
529 HF patients with a mean age of 62.0 ± 9.6 (Nolan et al. 1998). Another study 
documented rMSSD at 20 ± 2 in 59 HF patients (Brouwer et al. 1995), while a study 
looking at sudden cardiac death in HF found rMSSD values at 22.9 ± 14.9 (n=135) 
in survivors and 21.1 ± 13.2 (n=55) in non-survivors (Galinier et al. 2000). Other 
factors affecting HRV measurement must be considered for testing conditions; 
especially the duration of measurement and body position during measurement. 
Body positions have been tested on several occasions suggesting optimal testing 
protocol in athletic populations (Dantas et al. 2010; Porto & Junqueira Jr 2009; 
Reland et al. 2005). For athletes with a low resting HR, standing HRV measures are 
better because changes in parasympathetic activity may be harder to detect in the 
supine position (Kiviniemi et al. 2007). This should not be an issue for the present 
study’s population, as participants are all moderately active with resting HR’s above 
60 beats per minute (bpm).  
 
Average HRV values have been published in various studies in healthy (Nunan, 
Sandercock & Brodie 2010) and diseased (Brouwer et al. 1995; Nolan et al. 1998) 
populations. There are still no clear references or definitive figures for what 
appropriate HRV values should be within specific populations. Therefore, clinical 
use of HRV has not yet been solidified as common practice. 
 
3.1.2.4 Reproducibility of HRV  
The reproducibility of HRV has been highlighted throughout literature as an 
important area for further research (Leicht & Allen 2008; Sandercock et al. 2005; 
Task Force, 1996). For athletes, HRV testing in the upright (standing) position is 





the increase of sympathetic drive (Dantas et al. 2010). Research has demonstrated 
good reliability for both supine and orthostatic testing (Chen et al. 1999; 
Radhakrishna et al. 2000; Siebert et al. 2004).  Measurements cannot be compared in 
different positions i.e. supine vs. orthostatic. Reproducibility between devices is also 
necessary before they are used in a research capacity. Polar s810 models have been 
validated for HRV measurement against ECG, and Holter devices among some other 
HRM’s (Gamelin et al. 2006; Porto & Junqueira Jr 2009; Weippert et al. 2010).   
 
Measurement of HRV was originally undertaken using ECG equipment with a 
sampling rate of 1,000 Hz, providing accuracy at ±1 ms between R-R intervals.  
Reproducibility depends on the time interval between measurement, mental stress, 
local conditions (temperature, noise) and spontaneous or paced breathing (Pinna et 
al. 2007; Pitzalis et al. 1996; Sandercock et al. 2005).  Reproducibility of HRV 
increases when breathing periodicity is controlled in short-term recordings (5-10 
minutes) (Pitzalis et al. 1996). Elements of mood, alertness and mental activity affect 
intra-individual variability in HRV parameters because of intrinsic instability of 
HRV (Pinna et al. 2007). In clinical populations such as HF, this is very hard to 
control (Stein et al. 1995). However, it is not necessarily important how variable 
HRV is because it is so sensitive to change (Sandercock 2007). The significance lies 
in interpretation, both in terms of expected values at baseline, and the expected 
magnitude of change (ibid).  
 
3.1.2.5 HRV exercise and overtraining  
Changes to HRV occur during exercise, caused by an increase in sympathetic 
activity and a decrease in parasympathetic activity (Gladwell et al. 2010; Perini & 
Veicsteinas 2003). An initial decrease in HRV has been demonstrated within minutes 
or hours following exercise in several studies (Mourot et al. 2004b; Parekh & Lee 
2005; Terziotti et al. 2001). Furthermore, it appears to take longer to restore vagal 
tone following a high intensity bout of exercise (80% Vo2 peak) compared with 
moderate intensity exercise (50% Vo2 peak) (Mourot et al. 2004b; Parekh & Lee 
2005). Overtraining occurs when the volume and intensity of a person’s exercise 
exceeds their capacity to recover. During the early stages of overtraining, there is a 
typical shift towards sympathetic activation (and/or vagal withdrawal) (Halson & 





monitoring. Overtraining is thought to have a negative impact on autonomic 
cardiovascular control (Hedelin et al. 2000). When considering different fitness 
levels, overtraining has a stronger effect on HRV in untrained women compared with 
their trained counterparts (Winsley et al. 2005).  
 
Since HRV has been demonstrated as a non-invasive measurement of autonomic 
control (Task Force, 1996), this suggests that sudden and larger changes in workload 
will have a greater impact on recovery and HRV. Monitoring training for quantifying 
workload has been used by athletes since the 1970’s, and has been assessed in 
several studies (Banister & Calvert 1980; Earnest et al. 2004; Foster et al. 2001; 
Kiviniemi et al. 2010; Manzi et al. 2009; Stagno et al. 2007). HRV measurements 
have been demonstrated as good tools for use in the prevention of overtraining 
(Foster 1998; Hedelin et al. 2000; Hynynen et al. 2006; Mourot et al. 2004a; 
Uusitalo et al. 2000). By monitoring HRV levels frequently, individuals can make 
sure they do not progressively dip during an exercise training programme.  
 
3.1.2.6 HRV measurement devices 
There are many ongoing discussions about the use of different measurements, and 
which are the most accurate or best measures for a specific population. There are 
now several different HRV analysis systems on the market which include Polar, 
Nevrokard, Leadtek, Nerve Express. Polar machines measure HRV using various 
features of their heart rate monitor ranges, including the OwnIndex, Ownzone, and 
EnergyPointer. Nevrokard offer professional software tools and devices that can 
measure advanced HRV, blood pressure variability etc. Leadtek provides an 
autonomic system measuring time and frequency domain parameters and Nerve 
Express also provides autonomic system assessment via different modalities.  These 
devices however, have limitations. Because HRV is not displayed directly on the 
devices, it can only be derived after feeding measurements through a separate 
software tool.  These devices also need measurement durations of at least 5-minutes. 
 
Traditionally, HRV research was confined to ECG systems or Holter monitors which 
require trained personnel for operation, are expensive and time consuming (Nunan et 
al. 2009). The development of ECG telemetry on wireless HR monitoring systems 





ECG systems (Gamelin et al. 2006; Kingsley et al. 2005; Nunan et al. 2008; 
Vanderlei et al. 2008; Weippert et al. 2010) deeming HRV analysis from Polar s810 
HR monitor’s reliable.  
 
A new device, called Ithlete, was developed as a software application with a dongle 
that can be used with smartphones and the iPod touch (2nd generation or later). 
Ithlete is an ECG receiver that attaches to a mobile device and takes one-minute 
measurements of HRV (rMSSD) through the use of a standard HR monitor chest 
strap. As HRV can assess cardiac autonomic function, Ithlete measurements may 
provide a way to quantify the body’s autonomic response to exercise. Repeated inter-
individual assessment of HRV can be used to optimise the work-to-rest ratio (Manzi 
et al. 2009). Ithlete was developed as a tool for preventing overtraining in endurance 
athletes. Ithlete software for iPod touch is yet to be validated.  The device has great 
potential because of its short measurement time, low cost and accessibility of the 
device. Validation is necessary however, to ensure it is an appropriate device to use 
in both healthy and clinical populations.  
 
3.1.3 Aims 
The aim of the present study was therefore to validate HRV measurement on novel 
equipment called the Ithlete, specifically determining if Ithlete and Polar s810i are 
interchangeable for measurement of rMSSD and HR. The present study uses Polar as 
the ‘gold standard’, because it is the most popular field based assessment tool for 
HRV available. This study proposes to use just one measure, rMSSD, in one minute 
measurements to assess HRV. With high correlations between the time-domain 
measures, there is no need to measure all of them each time HRV analysis is 
undertaken. rMSSD has been demonstrated in the literature as a reliable 
measurement with high correlation to the others. For the purpose of this thesis, HRV 
(rMSSD) will be the main measurement assessed across the various chapters and 
therefore the most important measure being validated in this chapter.   
 
It is hypothesized that a good relationship will be demonstrated between HRV 







Four participants took validation measurements: two heart failure (HF) patients from 
a London based hospital, and two healthy (H) participants with no known 
cardiovascular disease. During HF clinics, a Consultant Cardiologist recruited two 
participants with HF in accordance with NHS Research Ethics Committee standards 
and expectations. Two healthy research students were recruited in accordance with 
Bucks New University ethics committee standards and expectations. Participants 
were given an information pack before agreeing to participate. This information pack 
included: 
1. An information sheet with details of the requirements for each participant  
2. An informed consent form 
3. An HRV measurement information package 
Participants were requested to read the information pack prior to meeting with the 
researcher. During the first meeting any questions or concerns were addressed. All 
procedures were approved by the local research ethics committee. Participants 
completed their consent form in front of the researcher, and the researcher 
countersigned the form.   
 
3.2.2 Experimental design 
Following informed consent, participants with HF were asked to visit the clinic at 
their hospital to meet with the researcher for a demonstration. Two Bucks New 
University students met with the researcher in the University sport science 
laboratory. All four participants took part in a demonstration on how to use both the 
Polar s810i heart rate monitor (HRM) (Polar Electro Oy, Kempele, Finland) and the 
Ithlete software (HRV Fit Ltd, Hampshire, UK) on the iPod touch. They were 
required to complete two measurements in the presence of a researcher before taking 
the device home. Each participant then took both devices home and recorded R-R 
intervals simultaneously with a Polar s810i HRM, and the Ithlete software on the 
iPod touch. The researcher requested each participant record at least 50 HRV/HR 





3.2.2.1 Data acquisition 
A standard analogue ECG chest strap was worn in the middle of the chest just under 
the sternum. Participants were instructed to undertake measurements in the seated 
position. Two indices (rMSSD in ms and HR in bpm) were recorded simultaneously 
via the Ithlete software (HRV Fit Ltd, Hampshire, UK) for the iPod touch (Ithlete 
2009) and the Polar s810i HRM (Polar Electro Oy, Kempele, Finland). Real time 
heart and lung animation on the iPod touch facilitated paced breathing during one-
minute Ithlete measurements, and the screen also indicated the reception of each 
heart beat from the analogue chest strap. Heart animation on the Polar HRM also 
signalled reception of each heart beat. First participants started the five minute 
measurement using the Polar s810i HRM, and within those five minutes were 
instructed to take a one-minute measurement using the Ithlete software. After each 
recording, measurements were saved to the respective device. The time was 
synchronized on both devices for each participant before measurement commenced.  
Measurements were matched by the time-stamp on each recording.  
 
Figure 3-1 Ithlete software on an iPod touch vs. Polar s810i HRM 
       
 
3.2.2.2 Data analysis 
Ithlete readings via Ithlete software enables recordings to be emailed and saved into 
an excel spreadsheet. Polar HRM recordings were transferred wirelessly using a 
USB-infrared transmitter into Polar Precision Performance software. All recordings 
were transferred to a password protected PC. Polar R-R interval data were exported 
into Kubios Heart Rate Variability Analysis (Biosignal Analysis and Medical 





Kuopio, Finland). After importing these R-R records into Excel 2007 (Microsoft 
Inc., USA) time series were graphically analyzed and manually edited to exclude 
aberrant beats. 
 
3.2.3 Statistical analysis 
Statistical analysis was carried out using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Data normality was tested by the Shapiro-Wilk test, and 
homogeneity of variance was verified by the Levene test. An independent-sample t-
test was then undertaken to detect the presence of a systematic difference in HRV 
and HR values calculated by both systems. To compare the two devices on HRV/HR 
measurements, intra-class correlation coefficients (ICC) and their 95% confidence 
intervals (CI) were calculated. In addition, Bland-Altman plots with modified limits 
of agreement (LoA) were used according to Bland & Altman (2007) to evaluate the 
inter-method discrepancies and their stability across a wider value range. 
 
Bland-Altman analysis involves a scatter plot, with the difference of the two 
measurements for each sample on the vertical axis and the average of the two 
measurements on the horizontal axis. Three horizontal reference lines represent the 
average difference between the measurements, along with lines to mark the upper 
and lower control limits of plus and minus 1.96 multiplied by sigma, respectively, 
where sigma is the standard deviation of the measurement differences. If the two 
methods are comparable, then differences should be small, and show no systematic 
variation with the mean of the two measurements ('Small' would be an amount that 
would be clinically insignificant for the factor being measured). 
 
3.3 Results 
The total number of recordings between all participants was 272. Twenty-three 
recordings had to be excluded due to large sequences of aberrant beats (error or 
noise) in the raw data. The two H participants, one male and one female, were aged 
27 and 31 respectively. The HF participants were also one male and one female, 
aged 74 and 63 respectively. The HF participants were diagnosed NYHA class II (a 
disease characterized by a shift toward sympathetic over activity). All participants 





longer than 60 minutes per session. Average HR (bpm) and rMSSD (ms) values for 
each participant are displayed in table 3.1 below.  
 
Table 3.1 Average values of heart rate variability (rMSSD) and heart rate (HR) for 
each healthy (H) and heart failure (HF) participant 




Polar          
rMSSD (ms) 
Ithlete        
rMSSD (ms) 
H participant 1 77.68 ± 8.14 74.47 ± 7.99 75.51 ± 13.07 78.29 ± 7.65 
H participant 2 76.56 ± 6.53 74.28 ± 7.14 67.95 ± 7.20 68.56 ± 5.96 
HF participant 1 83.24 ± 14.76 79.80 ± 12.83 55.16 ± 11.01 51.60 ± 10.51 
HF participant 2 97.28 ± 15.52 91.99 ± 11.05 50.60 ± 12.98 48.81 ± 12.62 
Repeated measures ANOVA revealed no significant differences in rMSSD 
measurements between Polar HRM and Ithlete in both H participants and one HF 
participant; the other HF participant had a significant difference. Details of the 
analysis can be found in table 3.2. Significant differences were found between 
devices in HR measurement. However, the standard error of the difference (SED) 
and mean difference (MD) were >2.5 bpm for HR and less than 2.5 ms for rMSSD. 
 
Table 3.2 Paired sample t-test results for rMSSD (ms) and HR (bpm) in healthy (H) 
and heart failure (HF) participants 
 p MD Lower CI Upper CI 
H participant 1 HR (bpm) 0.001 3.21 2.21 4.19 
H participant 2 HR (bpm) 0.001 2.27 1.44 3.10 
HF participant 1 HR (bpm) 0.001 3.44 1.73 5.14 
HF participant 2 HR (bpm) 0.03 5.28 0.66 9.91 
H participant 1 rMSSD (ms) 0.07 -2.77 -4.87 -0.68 
H participant 2 rMSSD (ms) 0.55 -0.60 -1.99 0.79 
HF participant 1 rMSSD (ms) 0.02 3.56 1.98 5.14 
HF participant 2 rMSSD (ms) 0.06 5.61 0.17 3.39 
 
Significantly high Pearson correlation coefficients were demonstrated between 
Ithlete and Polar HRM devices for both HR and rMSSD in both H and HF 





(p < 0.001). HR Pearson correlations for HF participants were r = 0.92 (p < 0.001) 
and r = 0.30 (p < 0.05). Pearson correlations in H participants for rMSSD were r = 
0.56 and r = 0.76 (p < 0.001); and 0.87 and r = 0.90 (p < 0.001) for HF participants. 
 
Analysis of all participant data showed high interclass correlation and high lower 
95% confidence intervals between Polar HRM and Ithlete for both HRV and HR in 
three out of four participants. Table 3.3 displays the ICC 95% CI for Polar HRM and 
Ithlete for the healthy and HF participants. The ICC 95% CI for HRV was >0.70 for 
three out of the four participants. 
 
Table 3.3 Interclass correlation coefficient and 95% confidence interval for each 
participant group for HRV and HR 
Participant Group ICC 95% CI 
Lower bound Upper bound 
H participant 1 HR (bpm) 0.93 0.71 0.97 
H participant 2 HR (bpm) 0.86 0.65 0.93 
HF participant 1 HR (bpm) 0.94 0.84 0.97 
HF participant 2 HR (bpm) 0.42 0.01 0.67 
H participant 1 rMSSD (ms) 0.85 0.74 0.92 
H participant 2 rMSSD (ms) 0.67 0.51 0.78 
HF participant 1 rMSSD (ms) 0.90 0.73 0.96 
HF participant 2 rMSSD (ms) 0.94 0.90 0.97 
 
Figures 3.1-3.4 are Bland & Altman plots of agreement for HR (bpm) and rMSSD 
(ms) recorded simultaneously via Polar and Ithlete systems. When considering Bland 
& Altman plots for each participant, there were narrow limits of agreement for HRV 






Figure 3-2 Bland-Altman plots of agreement and normally distributed differences 




Figure 3-3 Bland-Altman plots of agreement and normally distributed differences 












Figure 3-4 Bland-Altman plots of agreement and normally distributed differences 





Figure 3-5 Bland-Altman plots of agreement and normally distributed differences 




To allow for comparison with the literature, participants were grouped into H and HF 
participants. The ICC’s and Pearson correlations for each group were calculated and 
are displayed in Table 3.4. Figure 3.5 and 3.6 show Bland & Altman plots for 
participants grouped together as H and HF participants, first for HR and then for 







Table 3.4 Interclass correlation coefficient, 95% confidence interval and Pearson 
correlation for each participant group for rMSSD and HR 
Participant 
Group 
ICC 95% CI r 
Lower bound Upper bound 
H HR (bpm) 0.76 0.66 0.83 0.81  
HF HR (bpm) 0.79 0.67 0.87 0.70  
H rMSSD (ms) 0.87 0.75 0.93 0.66  
HF rMSSD (ms) 0.93 0.86 0.96 0.89  
Significant difference at p< 0.01 
 
 
Figure 3-6 Bland-Altman plots of agreement and normally distributed differences 




Figure 3.7 Bland-Altman plots of agreement and normally distributed differences 








The purpose of this study was to compare rMSSD (ms) and HR (bpm) derived from 
Polar s810i HRM (Polar Electro Oy, Kempele, Finland) and Ithlete (HRV Fit Ltd, 
Hampshire, UK) in both healthy and heart failure participants. High ICC’s and 
narrow limits of agreement in the present study demonstrate good agreement 
between Polar HRM and Ithlete devices. In addition, no significant differences were 
found between rMSSD measurements at p < 0.05 for three out of the four 
participants however, a significant difference between HR measurements was found 
between devices for all participants.   
 
HRV is an excellent tool for measurement of enhanced risk stratification, and may 
provide insight into physiological and pathological conditions (Task Force, 1996). In 
normal sedentary, athletic and clinical populations, HRV time and frequency domain 
measurements have been utilized for evaluating cardiac autonomic function and 
sympathovagal balance (Aubert et al. 2003; Dixon et al. 1992; Iellamo 2001; Kleiger 
et al. 2005; Pumprla et al. 2002). HRV has been recognised as an important and 
independent predictor of morbidity, mortality and risk of cardiovascular events (Task 
Force, Kleiger et al. 2005; Tsuji et al. 1996). For the purpose of this thesis, HRV 
(rMSSD) will be the main measurement assessed across the various chapters and 
therefore the most important measure being validated in this chapter.   
 
rMSSD is an ideal tool for monitoring how the body responds to exercise training 
and other stressors because of its sensitivity to vagal cardiac control, and is less 
sensitive to variations in respiratory patterns (Penttilä et al. 2001). Autonomic 
activity becomes altered during exercise; HR increases as a result of increased 
sympathetic activity during exercise, and heart rate recovery is mediated by vagal 
reactivation following exercise (Myers et al. 2007). Monitoring HRV daily has been 
demonstrated as a valuable tool in making exercise training more effective and 
preventing overtraining (Manzi et al. 2009). Ithlete is an easy device for users to 
monitor their resting HRV and HR. With an easy user-interface, and immediate 
feedback displaying HRV and HR values, Ithlete also compares the latest day’s HRV 
value with the moving average over the previous seven days. Comparing the 
difference in an individual’s HRV values over several days provides a unique, 






For accurate measurement of HRV, it is important to consider factors that influence 
HRV (i.e. body position, time of day). Better reproducibility of both time and 
frequency domain parameters of HRV have been reported in the standing position 
(Dantas et al. 2010). In healthy subjects, better reliability of HRV has been 
demonstrated in the upright position during measurement (Dantas et al. 2010; Reland 
et al. 2005). HRV measures in the standing position, also appear to be more sensitive 
to variations in sympathetic activity (Dantas et al. 2010). External factors such as 
mood, stress, sleep and anxiety may have less influence on HRV in the orthostatic 
position because of the increase in the sympathetic drive (ibid).  
 
The present study however, involves both clinical and healthy populations, and 
therefore the standing position was not always feasible for consistent measurement. 
After consulting with the Ithlete developer and a consultant cardiologist it was 
decided that seated measurement would be more appropriate than standing, to 
maintain continuity between H and HF participants. For this reason, participants 
were asked to do their measurements in the seated position, to ensure that both HF 
patients and H participants could stay upright comfortably for five minutes to take 
Polar HRM measurements and one minute Ithlete measurements.   
 
Various studies have validated the use of different Polar HRM models’ 
reproducibility and precision to measure HRV, when compared with Holter or ECG 
systems (Godsen et al. 1991; Leger & Thivierge 1992; Seaward et al. 1990); 
including the s810i used in the present study (Conraads et al. 2004; Gamelin et al. 
2006; Nunan et al. 2009; Wisløff et al. 2007). When comparing Ithlete with Polar 
s810i, acceptable agreement was confirmed.  Ithlete demonstrated high correlation 
coefficients (> 0.70) for both rMSSD and HR, in 75% of healthy and HF 
participants. Very little data are lost when using devices with Ithlete compared with 
Polar s810 HRM. HR and rMSSD average values are displayed directly on the 
screen of devices, immediately after measurement with Ithlete instead of having to 
input the data through external software on a PC. As both Polar and Ithlete use the 
same analogue chest strap for data acquisition, validation in the present study is more 
focused on software/data treatment as a source of variation. Therefore utilizing Polar 





have been demonstrated as effective in other studies (Åhs et al. 2009; Bricout et al. 
2010; Tarvainen et al. 2009).   
 
To facilitate comparison to other studies, participants were also grouped as H and HF 
participants for Bland & Altman analysis. The results from the present study have a 
larger bias and LoA for HRV, when compared with Kingsley et al. (2005) and 
Weippert et al, (2010).  Kingley et al, (2005) demonstrated a bias of < 0.10ms and 
LoA of less than 10ms between Polar HRM and an ECG.  Weippert et al, (2010) 
demonstrated a bias of <0.50ms and LoA of -15.1 – 14.3 between Polar HRM and an 
ECG.  The present study demonstrated a bias for HRV of 2.0 ms for healthy and -
2.75 ms for HF participants with LoA of -15.6 – 19.7 and -13.8 – 8.3 respectively 
between Polar HRM and Ithlete. Despite the larger bias and LoA, there were a 
limited number of outliers for HRV and HR (4.7% of HRV in healthy participants 
lying outside the LoA and 2.7% for HF participants; for HR 5.9% of differences lay 
outside of the LoA for both healthy and HF participants). ICC’s were >0.85 in three 
out of four participants, suggesting that Ithlete and Polar HRV (rMSSD) readings 
have good agreement.  
 
According to Lee et al. (2004), measurement devices for HRV can be considered 
interchangeable if the lower ICC 95% CI value exceeds 0.70. The present study 
found high interclass correlation and high lower 95% confidence intervals between 
Polar HRM and Ithlete for both HRV and HR in three out of four participants. This 
suggests that Ithlete and Polar measurements may not be interchangeable but are 
good enough because of the distinct advantages Ithlete provides. Short duration 
measurements are more susceptible to noise or erroneous beats (Vybiral et al. 1990). 
Therefore the presence of any erroneous beats could have a large impact in the 
results.   
 
Ithlete measurements are short and convenient compared with other commercially 
available HRMs. Other HRMs are valid measurement devices for HRV (Nunan et al. 
2009); however, there remains the need for users to lay supine for up to ten minutes 
to capture HRV. The measurements must then be stored to the device and transferred 
to a PC for data analysis. Through the use of a smartphone or iPod touch, Ithlete 





comparison to previous measurements. Therefore users can make sure the 
measurement is near enough, and if not, because Ithlete measurement duration is so 
short, repeat it.  If that large difference remains, then the user can be confident it is 
due to their physiological response, and not device error.  
 
As reported by Radespiel-Troger et al. (2003) and Gamelin et al. (2006), the present 
study found good correlations between HRV (rMSSD) and HR (bpm) in both H and 
HF participants from Polar HRM and Ithlete. Significant correlations were 
demonstrated for all participants in both rMSSD and HR measures. Overall, HRV 
measurements from the present study suggest good agreement between Ithlete and 
Polar HRM measurements.  
 
3.5 Conclusions 
HRV based on R-R interval analysis obtained by automated acquisition from Ithlete 
for iPod touch with a standard HRM chest strap, was reliable and feasible in both 
healthy and heart failure participants. Ithlete measurements are a simple and easy 
technique for HRV analysis. High ICCs in three out of four participants, for both 
rMSSD and HR suggest good agreement between devices. High Pearson correlation 
coefficients suggest Ithlete is a valid measure for rMSSD. Ithlete and Polar 
measurements may not be interchangeable but are good enough because of the 
distinct advantages Ithlete provides. Therefore the Ithlete measurement system can 
be considered a good alternative device for short-term rMSSD measurement in both 
healthy and heart failure populations. The Ithlete measurement system provides a 
new perspective for investigation of HRV in various populations in both sport 
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CHAPTER 4: MEASUREMENT OPTIONS FOR BODY COMPOSITION 
USING BIOELECTRICAL IMPEDANCE ANALYSIS DEVICES 
Bioelectrical impedance analysis (BIA) is a widespread method used in both healthy 
and patient populations to measure body composition. Several initiatives, i.e. weight 
loss programmes and athletics have resulted in an increase in the demand for user-
friendly devices. BIA devices are practical, convenient and potentially inexpensive. 
In the literature, BIA is shown to be valid in assessing body composition for adults 
when compared with the gold standard of underwater weighing. The purpose of this 
study was to compare six different BIA devices, ranging in price, to see if there is a 
sufficient level of agreement between them.  
 
Sixty-one participants completed BIA measurements with all six devices; there was 
no statistically significant difference between BIA devices in the measurement of 
weight, body fat, basal metabolic rate and body mass index as determined by one-
way analysis of variance (ANOVA). A significant difference was found in 
measurements of muscle mass between the BIA 101 and Homedics devices. Five 
devices had no significant difference in measurement of total body water (TBW) or 
body fat percentage between them. 
 
The present study found good relative agreement in body composition measurements 
between five BIA devices, which suggests that it is acceptable to use any of the BIA 








The energy stores in the body play a vital role in physiological function. Nutritional 
status, diet, exercise etc. have an impact on those energy stores. Measurement of 
these energy stores can be undertaken using body composition, which involve 
models that divide body weight into two or more components including fat, muscle, 
water, bone and mineral. Excess body fat puts individuals at higher risk for 
cardiovascular diseases, type 2 diabetes, cancer and other health disorders 
(Department of Health 2011). Adequate amounts of water are necessary for the body 
to sustain normal physiological functioning i.e. the transportation of nutrients, waste 
removal and the regulation of body temperature. In certain conditions, however, 
excessive water retention can be an indicator of pathophysiological conditions. Due 
to the necessity of body water balance, it is important to be able to measure this 
important variable.  
 
In clinical practice, the purpose of body composition measurement is to evaluate 
clinical nutritional status though measuring fat mass (FM) and free fat mass (FFM) 
(Thibault et al. 2012). Numerous methods for body composition measurement exist; 
they include skin-fold thickness, waist-circumference, waist-stature ratio, dual-
energy x-ray absorptiometry (DEXA), and bioelectrical impedance analysis (BIA). 
BIA was chosen for the present study because is it one of the most widely used 
techniques (Sun et al. 2005).  
 
4.1.1 Bioelectrical impedance analysis 
BIA is a method for estimating body composition. It operates by sending a small 
electrical current through the body and measuring impedance, which is the 
opposition to the current. As a consequence of homecare and weight loss therapy, 
there has been an increase in the demand for bioelectrical impedance analysis (BIA) 
consumer devices (Bosy-Westphal et al. 2008). In the literature, BIA is shown to be 
valid in assessing body composition for adults when compared with the gold 
standard of underwater weighing (Reilly et al. 1994; Segal et al. 1985). These 
consumer devices are relatively inexpensive and easy to use for indirect 






There are a variety of BIA measurement techniques which include single frequency 
and multi-frequency systems. Single frequency systems infer total body water 
(TBW) from whole-body resistance to conductance of a current of 50 kHz. Multi-
frequency devices measure at different frequencies ranging between 0 and 500 kHz. 
Single frequency BIA has been demonstrated as a valid and reliable means of 
measuring body composition in healthy populations with stable water and electrolyte 
balance (Pateyjohns et al. 2006).  
 
BIA devices offer a variety of measurements which can include TBW, free fat mass 
(FFM), fat mass (FM), body mass index (BMI) and basal metabolic rate (BMR). The 
main principle involved in BIA is that an electrical current will flow more rapidly 
through tissues with higher water and electrolyte concentration than through tissue 
less hydrated (Nichols et al. 2006). Therefore resistance to the electric current 
directly relates to the amount of free fat mass (FFM). Fat mass (FM) can then be 
calculated by subtracting the amount of FFM from the total body mass. Fluid-
electrolyte turnover and TBW change constantly due to water gained from food, 
fluids, and water loss from the lungs, skin and kidneys (Armstrong 2007). BIA 
analysis for the estimation of TBW is based on the electrophysical model where 
impedance is measured at a fixed frequency of 50 kHz and height is used as a 
substitute for conductor length. The use of BIA in a clinical setting is under debate. 
Within the NHS it is still not a recommended tool as a substitute for BMI according 
to NICE guidelines (National Institute for Health and Clinical Excellence 2006), 
however this has been questioned (Neville et al. 2006; Ode et al. 2007; Prentice & 
Jebb. 2001).  
 
Sustaining normal physiological functions, like transportation of nutrients, regulation 
of body temperature or waste removal, require adequate hydration (Berdanier 2000). 
A decrease in orthostatic tolerance and a relative tachycardia at rest and during 
exercise, are a consequence of dehydration and its effect on cardiovascular function 
(Charkoudian et al. 2003). Dehydration has also been cited to cause a decrease in 
blood volume which then decreases stroke volume due to the increase in heart rate 
and decrease in filling time (Turkevich et al. 1988). Chronic mild to moderate 
dehydration is associated with several disease states including coronary heart disease 





increased physiological strain, occurred due to increased heart rate, decreased stroke 
volume, thermoregulatory strain and stress response, among other factors (Casa et al. 
2010). Patterson (2002) examined the influence of hydration on cardiovascular 
reactivity during psychological stressors and found positive relationships between 
total body water and the change in heart rate, diastolic blood pressure and total 
peripheral resistance during reactivity to posture change. All these effects are 
significant and can cause serious complications if not remedied.   
 
The present study aims to validate several low-cost BIA devices, for the purpose of 
using them in clinical populations such as heart failure. It would be a great advantage 
to have the ability to measure hydration status in different settings (i.e. hospital, GP 
surgery, on the field of play) to ensure people have optimal hydration whether they 
are athletes or patients. Measuring hydration status with just TBW however, has its 
limitations. TBW is a measure of the quantity of water in all tissues in the body and 
therefore is affected by hyperhydration, obesity and other cofactors (Tzamaloukas & 
Murata 1995; Tzamaloukas et al. 1998).  Bioelectrical impedance vector analysis 
(BIVA) uses impedance measurements to create a pattern analysis which is plotted 
as a vector coordinated system (Bosy-Westphal et al. 2005). BIVA analysis is 
independent of hydration status, and therefore is a complimentary control measure 
for correct interpretation of BIA.  
 
More research is needed in this area, to understand the underlying mechanisms and 
physiological implications of hydration status while taking into consideration various 
health risks. BIA is one of the ways hydration can be measured by using equations 
that convert reactance and resistance to estimate the TBW. However as stated above, 
this has its limitations. Body composition assessment for information on nutritional 
status through BIA is an undervalued technique in clinical practice (Walter-Kroker et 
al. 2011). There are many devices on the market that range in price from 
approximately fifteen pounds to over a thousand pounds, making it difficult to 
decide which devices to use.  
 
4.1.2 Aims 
The aim of the present study was to compare six different BIA devices, ranging in 





benefit of this would then be economical purchase of the required number of devices 
for experimental use. This would especially apply if the BIA device was to be used 
in the home, as access to a large number of devices would mean that more 
participants could use them concurrently.  
 
4.2 Methods 
4.2.1 Recruitment of participants 
Staff and students of Buckinghamshire New University were invited by internal 
advertisement on notice boards and through emails. Each participant was recruited in 
accordance with University ethics committee standards and expectations. 
Participants responded via email or phone and were sent an information pack before 
agreeing to participate which included: 
1. An information sheet with detail of the requirements for each participant 
during the laboratory visit 
2. An informed consent form 
3. A detailed demographic information sheet 
Participants were requested to read the information pack prior to attending the 
laboratory and any questions or concerns were addressed.  All participants were free 
from any serious medical conditions. All procedures were approved by the local 
research ethics committee. 
 
4.2.2 Participants 
Volunteers from 18 to 65 years of age were included. Any pregnant women or 
persons with a demand pacemaker or any other implanted automatically controlled 
electronic device were excluded. Participants completed a written consent form in 
front of a trained researcher who then countersigned the form. 
 
4.2.3 Instrumentation and data acquisition 
Six bioelectrical impedance analysis devices were used in each laboratory session for 
data acquisition. Two devices involved measurement in the supine position, four 
devices involved measurement in the standing position. At the beginning of each 
testing session, height was measured with a stadiometer (Leicester height 
measurement, Seca, UK). Weight was measured on a standard weight scale 





circumference (WC) was taken with a tape measure (Myotape body tape measure, 
AccuFitness, Greenwood). 
 
Previous research using the Tanita analyser has demonstrated good correlations 
between Tanita scales and the gold standard of dual energy x-ray absorptiometry 
(DEXA) (Frisard et al. 2005; Sung et al. 2001; Thomson et al. 2007). Hydrasite, is 
however a relatively new, non-invasive method for the classification of hydration in 
clinical outcomes. Hydrasite is based on the same resistance (R) and reactance (Xc) 
principles as the other devices, however it also uses bi-variate distribution (BIVA). 
This plots resistance and reactance over height using Xc/height against R/height for 
both men and women, yielding a phase angle with relevant confidence and tolerance 
limits or norms which can then be compared (Piccoli et al. 1995). This allows a more 
sensitive and specific classification of hydration state. 
 
The BIA devices vary in which measurements they perform.  The following is a list 
of all possible measurements: 
• Weight (W)    
• Total Body Water (TBW) 
• Hydration level (HL)   
• Body Fat % (BF) 
• Muscle Mass (MM)   
• Basal Metabolic Rate (BMR)  
• Body Mass Index (BMI) 
• Free Fat Mass (FFM) 
 






















Tanita ✔ ✔ ✔ ✔  ✔  ✔ 
Salter ✔  ✔ ✔     
Homedics ✔ ✔ ✔ ✔  ✔ ✔  
Hanson ✔  ✔ ✔     
Hydrasite     ✔    
BIA 101  ✔ ✔ ✔  ✔ ✔ ✔ 
 
 
4.2.4 Experimental design 
4.2.4.1 Supine measurements 
Participants were asked to lay down in a comfortable position with legs and arms 
slightly spread so as not to have contact with each other or with their trunk. 
Participants had to lie in a supine position for approximately five minutes pre-test to 
allow an even distribution of body fluids. Resistance and reactance measurements 
were then recorded via BIA 101 (Akern; Florence, Italy) and CardioEFG Hydrasite 
Technology device (Akern; Florence, Italy).  
 
BIA 101 
Four electrodes were placed on the same side of the body. One electrode on the 
bisecting line of the hand and wrist, one just below the fingers on the back of the 
hand, one on the bisecting line of the leg and the foot (on the front of the leg at ankle 
level), and another just below the toes on the top of the foot. Recording was executed 
allowing at least three reading cycles before inputting measurements into the 
Bodygram software (Akern; Florence, Italy). Bodygram software then computed 
body composition measurements including BMI, body fat %, fat free mass %, 
intracellular water, and extracellular water for each participant and stored it in the 





CardioEFG Hydrasite technology device 
This device used two electrodes for measurement. One electrode was placed on the 
bisecting line of the hand and wrist, the other was placed on the bisecting line of the 
leg and ankle. TBW percentage was computed through resistance, reactance and 
phase angle measurements inputted into the Cardiogram software (Akern; Florence, 
Italy). Hydrasite performs estimates of hydration through measurement of TBW, 
extra cellular water (ECW) and intracellular water (ICW) together and supplies the 
percent content of water in the lean tissue. Therefore the other devices measure the 
quantity of water in the body, compared with Hydrasite which measures actual 
hydration state from the percent content of water in the lean tissue.  
 
4.2.4.2 Standing measurements 
Tanita Scale BC-418MA III  
The weight of each participant’s clothes (usually 1-2 kg) was entered into each 
instrument- along with characteristics (standard or athletic, male or female). Then 
age and height (cm) were entered and the participant stood on the Tanita scale with 
their bare feet. Once in a stable condition, participants picked up the grips at the side 
in each hand and BIA took place.  
 
For the remaining three devices (HoMedics 9116 Black Glass Platform Body Fat 
Analyser Scale, Hanson HFA Liner Body fat Analyser and Body Water Graduation, 
Salter 9106 WH3R Glass Body Analyser & Scale) participants stood on each scale 
with their bare feet for the measurement. Participant information such as age, height 
and fitness level (if necessary for that device) was entered into each machine before 
measurement took place.  A stadiometer (Seca 213, United Kingdom) was used for 
height measurements. 
 
4.2.5 Statistical analysis 
All statistical analysis was analysed using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Values are reported in the text as mean ± standard deviation. 
Differences between individual values obtained from each BIA device were assessed 
using one-way analysis of variance (ANOVA). If ANOVA displayed a statistically 
significant main effect, differences among means were assessed with Tukey’s 





level of relative agreement between different BIA devices. A P-value of <0.05 was 
considered statistically significant. The CardioEFG Hydrasite Technology device 
(Akern; Florence, Italy) was not included in all statistical analysis tests because its 
measurement of hydration is not directly comparable to the other devices used in the 
present study.  
 
Bland-Altman analysis was used to determine absolute limits of agreement between 
all BIA devices, with the Tanita scale serving as the criterion measure.  
 
4.3 Results 
Sixty-one people participated in the present study. Average participant 
characteristics are displayed in Table 4.2 below.  
 
Table 4.2 Subject characteristics 
Characteristic Mean &  
Standard Deviation 
Range 
Age (years) 39.1 ± 13.1 19-65 
Weight (kg) 71.8 ± 14.8 40-108 
Height (cm) 168.4 ± 9.7 147-190 







Table 4.3 Mean Body mass index (BMI), Body fat (%), Total body water (TBW), 






TBW (%) BMR 
(kcal/day) 
MM (%) 
Tanita 25.2 ± 4.6 27.8 ± 9.5 54.2 ± 9.0 1542 ± 309 _________ 
Salter 25.9 ± 4.6 28.0 ± 7.4 52.5 ± 5.3 __________ _________ 
Homedics _________ 27.5 ± 8.3 51.0 ± 8.3 1573 ± 233 35.6 ± 5.4  
Hanson _________ 29.9 ± 11.0 50.2 ± 6.7 __________ _________ 
Hydrasite _________ _________ 67.3 ± 6.9  __________ _________ 
BIA 101 25.3 ± 4.5 28.5 ± 9.3 52.6 ± 6.9 1551 ± 190 47.6 ± 8.0  
  Significant difference at p< 0.01 
 
There was no statistically significant difference between BIA devices in 
measurement of weight (F (4,305) = 0.441, p = 0.779) or body fat (%) (F (4,304) = 
0.709, p = 0.587).  Neither were their differences in basal metabolic rate (F (2,182) = 
0.251, p = 0.779), nor BMI (F (2,182) = 0.471, p = 0.625).  
 
A significant difference was found between TBW and MM measurements using one-
way ANOVA where (F (4,291) = 53.913, p <.001) and (F (1,121) = 95.360, p = 
.000) respectively.  
 
Analysis based on Bland and Altman, (2007) revealed good relative agreement with 
wide limits of agreement between the Tanita scale and four out of the five other BIA 
devices for TBW. Salter was r2= 0.75 (7.24 to -6.47), Hanson was r2= 0.52 (12.47 to 
-7.13), Homedics was r2= 0.89 (7.57 to -3.87) and BIA101 was r2= 0.77 (6.95 to -
6.33).  The only device that had poor agreement on this occasion was the Hydrasite 







Figure 4-1 Bland-Altman plots comparing Tanita TBW (%) with TBW (%) from 







There was good relative agreement between Tanita and the other devices when 
considering body fat percentage with wide limits of agreement. For Salter r2= 0.75 
with limits of agreement (9.13 to -9.64) percentage points, Homedics was r2= 0.83 
(7.99 to -7.41), Hanson was r2= 0.65 (10.51 to -14.89) and BIA101 was r2= 0.75 







Figure 4-2 Bland-Altman plots comparing Tanita BF% with BF% from Salter (A), 








Body composition measurement is a useful tool for determining the ratio between 
body compartments such as body fat, free fat mass and total body water and 
measurements can be an indicator of disease. There are many commercially available 
devices representing a range in price (£15 to >£1000). The aim of the present study 
was to compare six different BIA devices, varying in price and complexity, to see if 
there was an acceptable level of agreement between them. The primary finding of 
this study was that four BIA devices assessed produced relative agreement with the 
reference instrument- the Tanita analyser. The remaining device produced 
measurements with unacceptably wide limits of agreement in absolute terms. For the 





systematic bias and random error (LoA) will be discussed and interpreted in terms of 
clinical acceptability.  
 
All devices except for Hydrasite underestimated TBW when compared with the 
Tanita analyser, while BIA 101 and Homedics slightly overestimated BF. The 
average range of BF% found was between 27.5 and 29.9% which is within the 
acceptable range.  The prediction error for BIA devices should be no more than 4% 
(Heyward 1991). Table 4.3 demonstrates that there were significant differences 
between devices in two measurements, TBW and MM. After excluding Hydrasite 
because of its different measurement output, there was no significant difference in 
TBW between the other five BIA devices.  
 
The Tanita analyser and BIA 101 are the only devices within this study to already 
have been validated against the gold standard of underwater weighing. Comparing 
the Akern BIA 101 and underwater weighting Deurenberg et al, (1991) produced a 
good correlation between the two devices and equations predicted from this study are 
used throughout the literature indicating the significance of that work.  That study, 
along with others, demonstrates the value of BIA evaluation of body composition 
(Erceg et al. 2010; Houtkooper et al. 1996; Khan et al. 2005; Kyle et al. 2004; 
Lukaski & Siders 2003; Pichard et al. 2000; Sun et al. 2003). Further research using 
BIA 101 has found it to be an accurate and reliable device when correlated with 
densitometry (Baumgartner et al. 1991) and dual-energy x-ray absorptiometry 
(Kanellakis et al. 2010). 
 
The Tanita analyser demonstrated significant correlations between this device and 
underwater weighing in > 200 subjects, measurements obtained by the Tanita 
analyser correlated at (r= 0.89) with % fat determined by underwater weighing and 
at (r=0.89) with the same measure obtained by dual-energy x-ray absorptiometry 
(Nuñez et al. 1997). Ritchie et al, (2005) reported a correlation between 
measurement of body fat percentage obtained from the Tanita analyser and 
underwater weighing of r= 0.76 among men with cardiovascular disease. Based on 
this and other previous research it appears the Tanita foot-to-foot analyser is an 





In the present study the Tanita analyser produced strong correlations with four other 
BIA devices. Despite strong correlation coefficients indicating good relative 
agreement, correlation alone is inadequate as a method to identify the degree of 
coincidence between the methods (Bland & Altman 1986). The correlations in this 
study were generally good, with the highest correlations demonstrated between 
Tanita and Homedics (r2= 0.83 CI 7.99 to -7.41), Salter (r2= 0.75 CI 9.13 to -9.64) 
and BIA 101 (r2= 0.75 CI 8.59 to -10.30). The lowest correlation was demonstrated 
between Tanita and Hanson at r2= 0.65 CI (10.51 to -14.89). These values are 
consistent with other studies (Bolanowski & Nilsson 2001; Lukaski & Siders 2003; 
Ravaglia et al. 1999; Shafer et al. 2009; Sun et al. 2003), which concluded that the 
method works but we wanted better so we also compared the cost of each device to 
determine if expense is in line with accuracy of measurement. 
 
In the present study, the Homedics scale had both the highest relative agreement and 
the narrowest limits of agreement making it the most accurate when compared with 
the Tanita scale. As cited earlier in the discussion, the Tanita, when compared with 
the gold standard of underwater weighing was found to have similar relative 
agreement and limits of agreement. This would suggest that use of the Homedics 
scale in future research would be valid, and due to its low cost could be 
advantageous in a wide variety of settings.  
 
Higher TBW and extracellular water measurements are reported in obese subjects 
compared with normal-weight subjects (Steijaert et al. 1997). BIA devices should 
take into account characterization (age, height, weight, BMI and ethnicity) of the 
sample population on which its equations are based (Bosy-Westphal et al. 2008). The 
user also must consider the impact inappropriate characterization would have on the 
accuracy of body fat prediction from the device; to ensure they are getting the best 
possible result. In each of the devices used in the present study, age, gender and in 
some cases physical activity level was entered into the machine before measurement. 
Population specific equations could confirm this method as the best for clinical 
practice. Commercially available values varied between machines; a Which? study 
(Which ?. 2006), observed that useful results can be obtained by using the same 
device consistently. Devices that can produce measurements within <4% error are 





machine, and not necessarily the calibre of the machine. Considering that high levels 
of agreement have been shown between several devices in the present study, it seems 
acceptable to focus on the change in measurements instead of the absolute figure that 
is given by the machine. This measurement when taken outside of the laboratory 
should be taken as a guide, especially considering that usage in the home setting will 
not necessarily be achieved using appropriate test conditions such as monitoring 
food and fluid intake before the test. Users should simply focus on using the machine 
at roughly the same time of day for repeat testing under as similar conditions as 
possible. The key is to look at the relative change from day-to-day to get an accurate 
picture. When thinking about the cost of the machine vs. its performance, the user 
must keep this is mind.  
 
There are several publications citing the significance of dehydration in healthy 
people and recommended amounts of water intake. A number of adverse effects have 
been documented in the literature, including a decrease in orthostatic tolerance 
(Charkoudian et al. 2003). Other studies have found an increase in resting heart rate 
and decreased tolerance to lower body negative pressure (Davis & Fortney 1997); 
decreased orthostatic tolerance has also been linked to diuretic use (Frey et al. 1994) 
and prolonged bed rest (Kamiya et al. 1999). Dehydration is prevalent in both 
healthy populations and diseased populations, and is often related to a large number 
of hospital admissions and large expenditure (Ritz et al. 2008).   
 
Progressively the propensity of body composition to cardiovascular disease, diabetes 
mellitus, cancer, osteoporosis and arthritis has been explored (Zeng et al. 2008). This 
makes accurate determination of body composition clinically useful in these 
populations to ensure therapy is optimised (ibid).  Fluid balance is important in heart 
failure because inadequate fluid levels can result in cardiac or renal dysfunction. In 
particular dehydration and electrolyte imbalances can lead to cognitive impairment 
(Vogels et al. 2007). BIA can be used to monitor fluid balance in heart failure 
patients to ensure fluid imbalance is caught early enough to avoid organ dysfunction. 
 
The cost of a BIA device will always be a substantial part of the decision making 
process for choosing a machine. With such a wide range in cost for devices it is not 





devices, all varying in cost, were used. Three of the devices assessed cost less than 
£20: HoMedics 9116 Black Glass Platform Body Fat Analyser Scale cost £15.98, 
Hanson HFA Liner Body fat Analyser and Body Water Graduation cost £19.40 and 
Salter 9106 WH3R Glass Body Analyser & Scale cost £19.99. The other three 
devices: Tanita Scale BC-418MA III, Akern BIA 101and Akern Hydrasite cost 
£1240, £899 and £6125 respectively. The cost was not related to the devices 
agreement with the reference device in this study.   
 
The best agreement between the Tanita scale and another device was found with the 
HoMedics 9116 Black Glass Platform Body Fat Analyser Scale which cost £15.98. 
This suggests that consumers should not necessarily equate expense with accuracy. It 
is important to like the present study, test the devices with scrutiny in controlled 
settings to obtain definitive results on agreement between them. The level of 
agreement found in the present study is comparable with other studies comparing 
body composition measurement between different techniques and devices. The 
appropriate level of agreement depends on what is required from the device, hence 
the use of the Bland & Altman method. The purpose of the LoA is to provide 
generalizable values enabling researchers to determine whether two different assays 
agree to the point where they are interchangeable. 
 
BIA offers a great opportunity for non-invasive assessment of human body 
composition in the clinical setting and other patient care options (Lukaski 1999).  
BIA is easy to use, non-invasive in nature, has a high degree of reproducibility at a 
relatively low cost (ibid). BIA absolute values of TBW are well correlated with the 
gold standard of isotope dilution and hydrostatic weighing (Kushner et al. 1992; 
Lukaski et al. 1986; Lukaski et al. 1985). When compared with other methods of 
body composition analysis such as skinfold thickness and dual-energy x-ray 
absorptiometry, BIA is easier machinery to use without the need for special 
technicians for operation.   
 
When purchasing a BIA device, it is important to check what the device offers to see 
if it meets all needs. Some low cost devices do not offer as many measurements as 
other devices (i.e. basal metabolic rate, free fat mass). However they can still provide 





water. Studies investigating what value changes in body composition could have 
with specific diseased populations could provide more evidence for the benefits of 
BIA in practice.  
 
The impact of hydration on disease has been documented in the literature 
investigating risk factors caused by environmental and lifestyle influences on 
different disease states (Manz 2007). Mild to severe levels of dehydration or 
euhydration may also account for different morbidity (ibid). Future research should 
look into daily measurements to test sensitivity of the devices. BIA is easy to use but 
is thought to generally lack the precision and accuracy necessary for hydration 
monitoring (Oppliger & Bartok 2002). Studies combining BIA sensitivity testing 
with longitudinal data on people with varying hydration levels could help to solidify 
the use of BIA in clinical and field settings and enhance what we already know about 
the importance of optimal hydration levels. BIA device measurements need to be 
within the limits of agreement to deem them accurate enough for use instead of the 
criterion measurement device in determining body composition. How far apart 
measurements from different BIA devices can be without causing difficulties is a 
question of judgement. A high correlation would be considered anything from 0.7 
and upward and has been used in literature when comparing body composition 
measurement techniques (Bracco et al. 1996; Newton et al. 2005; 
Wattanapenpaiboon et al. 1998). 
 
A limitation to this study is the lack of control over what participants ate or drank 
before participating in measurements, however this gives the experiment external 
validity as this is what ‘real-world’ monitoring is like. The primary focus of this 
study however, was to compare measurements taken at the same time from different 
devices so this should not have had much impact.  
 
4.5 Conclusions 
Numerous measures can be used for body composition analysis in laboratory 
conditions including densitometry, dual energy x-ray absorptiometry, BIA and 
magnetic resonance imaging. Out of these devices BIA is a quick and simple 
method, which is non-invasive and takes reliable measurements with minimal intra- 





immediately, is portable and reproducible within <1% error on repeated 
measurements (Segal et al. 1991), making it the most appealing of the devices listed 
above. This study found no significant difference between five BIA devices in 
measures of TBW and BF. The agreement between the various BIA devices was 
strong which suggests that either of the different BIA devices could be used both at 
home and in the clinical setting. BIA is a fairly inexpensive, non-invasive technique 
which has a good correlation with the gold standard of under water-weighing. The 
difference between devices was not significant, indicating that price may not be an 
important factor in deciding on a BIA device.  This means that in large scale surveys, 
where cost becomes a major factor, it could be acceptable to use low cost devices to 
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CHAPTER 5: THE RELATIONSHIP BETWEEN ITHLETE 
MEASUREMENTS AND BODY COMPOSITION ASSESSED BY 
BIOELECTRICAL IMPEDANCE ANALYSIS 
Heart rate variability (HRV) is the physiological phenomenon of variation in the 
time interval between heartbeats. There are several factors that influence HRV, 
including chronic factors such as gender, age, ethnicity, level of physical fitness and 
body composition, or acute factors such as postural changes, time of day, and drug 
therapy. The relationship between HRV, heart rate (HR) and fat mass (FM) has been 
documented in the literature where large amounts of body fat were associated with a 
depressed HRV and increased HR, both of which are associated with worse health 
status.  
 
The aim of the present study was to try to expand the understanding of the 
relationship between HRV and body composition measurements. The present study 
proposes to use just one measure, rMSSD, in one minute measurements to assess 
HRV using novel equipment and software called Ithlete. With high correlations 
between HRV measures, there is no need to measure all time-domain indices each 
time HRV analysis is undertaken. The rMSSD measure has been demonstrated in the 
literature as a reliable measurement with high correlation to several other HRV 
measures. The aim of this study was to establish if there is any relationship between 
HRV and body composition measurements of weight, body fat percentage, total 
body water, basal metabolic rate and muscle mass using bioelectrical impedance 
analysis (BIA).     
 
In the present study, significant differences between genders were observed for 
height, weight, body fat, muscle mass, basal metabolic rate, alcohol consumption, 
rMSSD, HR and total body water (TBW). Significant ethnic differences were only 
observed for age, HR and alcohol consumption. When comparing groups by body 
mass index (obese/overweight to healthy), significant differences were demonstrated 
in HR, BF, TBW and muscle mass. Smokers had significantly lower rMSSD and 
alcohol consumption. Different daily physical activity levels yielded significant 
differences in HR, BF, muscle mass and alcohol consumption. The present study 
furthered the knowledge of the relationships that exist between body composition 





activity level and smoking status. BIA and Ithlete are both quick and simple 
methods, which are non-invasive and take reliable measurements. The use of these 
devices in clinical populations may benefit patient care and help provide valuable 




Overweight or obese individuals are at a higher risk of cardiovascular diseases such 
as type 2 diabetes, cancer and other health disorders (Department of Health 2011). In 
the last 25 years, the prevalence of obesity has more than tripled with 62.8% of 
adults in the UK (aged 16 or over) classified as overweight or obese in 2010 (ibid). 
Body  mass index (BMI) is the most common method used for measuring obesity at 
the population level (Department of Health 2011); the measure is however limited, 
because it fails to discriminate between percent fat mass and lean mass (Romero-
Corral et al. 2008). Body fat % can also be measured through a number of other 
methods, including skin-fold thickness, waist-circumference, waist-to-hip ratio, dual-
energy x-ray absorptiometry (DEXA), and bioelectrical impedance analysis (BIA). 
BIA was chosen for the present study because it is a potentially inexpensive, direct 
measure of body fat (BF). BIA is a widespread method used in healthy and clinical 
populations to measure body composition (Buchholz, Bartok & Schoeller 2004), and 
has similar advantages to other field techniques as it is safe, quick, and needs 
minimal operator training (Kushner 1992).  
 
5.1.1 Bioelectrical impedance analysis 
BIA estimates body composition by sending a small imperceptible electrical current 
through the body and measuring impedance (the opposition to current) (Pateyjohns 
et al. 2006). BIA devices typically measure total body water (TBW), free fat mass 
(FFM), fat mass (FM)/ BF %, body mass index (BMI) and basal metabolic rate 
(BMR). Electrical current will flow more rapidly through tissues with higher water 
and electrolyte concentrations (Nichols et al. 2006). Therefore, resistance to the 
electric current directly relates to the amount of FFM.  FM can then be calculated by 








The increased prevalence of obesity in the population has occurred across both sexes 
and particularly among ethnic minorities in the UK (Department of Health 2011). 
Ethnic differences in anthropometric values such as BMI, waist-to-hip ratio and 
waist circumference have been reported (Brancati et al. 2000; Carroll et al. 2008; 
Flegal et al. 2010; Hedley et al. 2004). Estimates in adult obesity prevalence among 
various ethnicities vary based on the measurement criteria. Chinese men and women 
have the lowest reported obesity prevalence in the UK (Gatineau & Mathrani 2011), 
compared with White British individuals. Pakistani’s, Bangladeshi and Black-
Caribbean’s have reported poorer health (Department of Health 2010). African-
Americans tend to have higher rates of hypertension, atherosclerosis, obesity and 
insulin resistance when compared with Caucasians (Hoffman 2009). 
 
When considering gender, men are classified as overweight when their BF % is 
between 19-30% (with age-adjusted range recommendations), and obese when BF % 
exceeds 25-30% (Gallagher et al. 2000). Women are classified as overweight when 
their BF % is between 33-38% (with age-adjusted range recommendations), and 
obese when BF % exceeds 39-42% (Gallagher et al. 2000).  The pathophysiology of 
obesity has been linked with the autonomic nervous system (ANS) (Laederach-
Hofmann, Mussgay & Ruddel 2000). Heart rate variability (HRV) is a non-invasive 
electrocardiographic measure that examines the sympathetic and vagal components 
of the ANS (von Borell et al. 2007). The ANS makes itself visible through HRV, 
indicating how the body is trying to preserve its equilibrium.   
 
5.1.3 Heart rate variability and Ithlete 
HRV is the physiological phenomenon of variation in the time interval between 
heartbeats. Measurement of HRV is non-invasive, and examines one aspect of 
autonomic nervous function. There are a number of fundamental physiological acute 
and chronic factors that can have an effect on HRV. Traditionally, HRV research 
was confined to ECG systems or Holter monitors, which require trained personnel 
for operation, are expensive and time consuming (Nunan et al. 2009). The 
development of ECG telemetry on wireless heart-rate monitoring systems allows 
field-based assessment. A new device called Ithlete was developed as a software 





Ithlete is an ECG receiver that attaches to a mobile device and takes one-minute 
measurements of HRV (rMSSD) through the use of a standard heart rate monitor 
chest strap.  
 
5.1.4 Acute factors affecting HRV 
Acute factors influencing HRV include postural changes and time of day (Burger et 
al. 1999). Conflicting results have been published about the affects of several acute 
factors. Various drug therapies including beta-blockers (Chattipakorn et al. 2007) 
have also been reported to affect autonomic function. Research has demonstrated 
that beta-blockers have a positive effect on HRV (Aronson & Burger 2001; Malfatto 
et al. 1998). Caffeine has also been demonstrated to have an effect in both healthy 
participants and diabetic patients (Richardson et al. 2004). Studies on the effects of 
caffeine on HRV analysis are inconclusive (Rauh et al. 2006). Research into the 
assessment of short- and long-term reproducibility of HRV in supine and standing 
positions found that HRV indices are mostly independent of body position 
(Kowalewski & Urban 2004). Conversely, there are also chronic factors affecting 
HRV which will be discussed next. 
 
5.1.5 Chronic factors affecting HRV 
Chronic factors which affect HRV include gender, age, level of physical fitness and 
body composition. The influences of age, aerobic fitness exercise, and overtraining 
on HRV have been reported in several studies (De Meersman & Stein 2007; Hautala, 
Kiviniemi & Tulppo 2009; Hedelin et al. 2000). Gender is an important determinant 
of HRV in healthy subjects (Antelmi et al. 2004). A progressive decrease in HRV is 
associated with age, and can be predictive of mortality in different clinical 
populations (Zulfiqar et al. 2010). People that exercise regularly will generally 
demonstrate an increased parasympathetic activity and lower heart rate when 
compared with sedentary people; this is especially noticeable at rest (Dixon et al. 
1992).   
 
When considering the effect of ethnicity on HRV, differences have been 
demonstrated in the literature. Ethnic differences in HRV have been studied 
predominantly in Afro-Caribbean vs. Caucasian populations, and studies have been 





drive in Afro-Caribbean’s when compared with age-matched Caucasians (Guzzetti et 
al. 2000; Liao et al. 1995). Decreased sympathetic tone was also found in Afro-
Caribbean adolescents compared with their Caucasian counterparts in a study that 
compared HRV with high and low blood pressure (Urbina et al. 1998).  Conflicting 
results were then published in 2003, which found that Afro-Caribbean adolescents 
displayed a greater sympathetic contribution to total power when compared with 
age-matched Caucasian adolescents (Faulkner et al. 2003). 
 
A comparison of Asian and Caucasian children found significantly elevated LF:HFr 
power in the Asian children which supports previous investigations of Afro-
Caribbean vs. Caucasian differences (Reed et al. 2006). Independent studies of HRV 
in the Asian population demonstrated lower HRV in children born in Asia compared 
with Caucasian children living in North America (Kikuchi et al. 2003; Nagai et al. 
2004).  
 
The ANS has an influence on the function of the cardiovascular system and energy 
balance (Laederach-Hofmann et al. 2000). The relationship between HRV and 
adiposity is unclear, as results from previous research have been inconsistent. 
Zahorska et al, (1993) found that obese subjects had relatively poor HRV profiles, 
while only weak associations were found between HRV and adiposity by Peterson et 
al. (1988). Several studies, however, have linked an alteration in both sympathetic 
and parasympathetic activity to increased adiposity (Laederach-Hofmann et al. 2000; 
Peterson et al. 1988; Sztajzel et al. 2009). Decreased sympathetic responsiveness has 
also been associated with increased adiposity (Piccirillo et al. 1996; Piccirillo et al. 
1998).  There are several acute and chronic factors known to influence HRV. Such 
differences may be of importance due to the well-documented associations between 
HRV and health. These influences need to be considered when assessing the 
relationship between adiposity and HRV; they will now be briefly discussed.  
 
5.1.6 Implications of reduced HRV 
Reduced HRV indicates low levels of parasympathetic activity. Low levels of HRV 
are associated with several disease states, including diabetes and heart failure 
(Aronson et al. 2004; Kataoka et al. 2004). Reduced HRV is a powerful predictor of 





disease (CHD) (Liao et al. 1997).  HRV is lower in those with chronic heart failure 
(Sandercock & Brodie 2006), type 2 diabetes (Schroeder et al. 2005) and those who 
die (Zulfiqar et al. 2010). Reduced HRV is related to gender; HRV has been reported 
as much as 21% higher in males compared with females (Sookan & McKune 2012). 
HRV is known to reduce with age, with correlations such as r= -0.67 in males, and 
r=-0.45 in females (Yukishita et al. 2010). The correlation between HRV and obesity 
r=-0.39, demonstrated that with increased obesity, HRV decreases (Ramaekers et al. 
1998). The established link between obesity and increased risk of cardiovascular 
disease, type II diabetes, hypertension, and certain cancers (Poirier et al. 2006), is 
similar to the risks associated with reduced HRV (CV disease, type II diabetes and 
insulin resistance) (Algra et al. 1993; Tsuji et al. 1994).  
 
Reduced HRV has also been linked to several cognitive disorders such as depression 
(Thayer et al. 1998), generalized anxiety disorder (Thayer et al. 1996), and panic 
disorder (Friedman & Thayer 1998). However, the causal direction of these 
associations is still unclear (Su et al. 2010). Ingjaldsson et al, (2003) reported 
reduced HRV levels in alcoholic vs. non-alcoholic subjects and a positive association 
was seen between HRV and positive mood (ibid).   
 
In healthy populations, reduced HRV is associated with a 32-45% increased risk of a 
first cardiovascular event (Hillebrand et al. 2013). In a study of 41 healthy 
participants, obesity indices including fat mass, percentage fat content, and waist-to-
hip ratio were negatively associated with HRV at r=-0.33, r=-0.35 and r=--0.38 
respectively (Kim et al. 2005). Weight reduction resulting in reduced adiposity is 
associated with improved ANS function (Arone et al. 1995; Ito et al. 2001; Karason 
et al. 1999).  
 
5.1.7 Aims 
The aim of the present study was therefore to examine if Ithlete measurements of 
HRV/HR demonstrate the same associations with cardiovascular risk factors as those 
already reported. Ithlete measurements will be compared with body composition 
measurements obtained by BIA (i.e. body fat %, muscle mass %, body mass index 
(BMI), total body water (TBW) and basal metabolic rate (BMR)). Lifestyle factors 





considered. Gender and ethnic comparisons will also be made to determine if 
patterns emerge in particular groups. 
 
It is hypothesized that there will be a relationship demonstrated between HRV 
rMSSD (ms)/HR (bpm) measurement of HRV from Ithlete with BF % measured by 
BIA. In practical terms, low (optimal: within recommendations for age and gender) 




5.2.1 Recruitment of participants 
Staff and students of Buckinghamshire New University were invited to take part in 
the study through internal advertisement on notice boards and emails. Each 
participant was recruited in accordance with University ethics committee standards 
and expectations. Participants responded via email or phone and were sent an 
information pack before agreeing to participate. This information pack included: 
1. An information sheet with details of the requirements for each participant and 
instructions for use of the equipment at home; 
2. An informed consent form; 
3. A detailed demographic information sheet. 
Participants were requested to read the information pack, and during the first 
meeting any questions or concerns were addressed.  All participants were free from 




Seventy-eight participants were tested, of which 35 were male and 43 were female.  
Participant age ranged from 22 to 48 years. All participants were defined as healthy 
(free from any serious illness at the time of testing), and none of the participants was 
known to have any cardiovascular problems or to be taking any medication that 
would have influenced the experimental procedures.  
The participants were asked to state their ethnicity and were then split into three 





background), Afro-Caribbean (Black Caribbean, Black African or any other Black 
background), and Other, including South Asian (Indian, Pakistani, Bangladeshi or 
any other South Asian background), East Asian (Chinese, Japanese, Korean or any 
other East Asian background) and Turkish, Arab, or Mixed (Mixed White and Black, 
Mixed Black and Asian, mixed Asian and White, any other Mixed background). 
There were three physical activity (PA) groups; group A: <30 minutes of exercise 
per day, group B: 30-60 minutes of exercise per day and group C: >60 minutes of 
exercise per day. 
All the equipment used was calibrated according to the manufacturers’ 
recommendations before each device was given out to participants.   
 
5.2.3 Experimental design 
Following appropriate ethical approval and informed consent, participants were 
trained by the researcher on how to use the devices at home.  A demonstration was 
given by the researcher and then participants undertook a trial measurement 
themselves. Following the demonstration, participants completed a consent form and 
demographics form, kept by the researcher; an information sheet and measurement 
sheet were included in the package given to patients with the device. 
 
5.2.3.1 Heart rate variability analysis 
Heart rate variability measurements were taken using an iPod touch with the Ithlete 
application (Ithlete 2009). For the HRV measurement, a standard analogue ECG 
chest strap was worn in the middle of the chest just under the sternum. Using the 
Ithlete software for the iPod touch, participants measured HRV for one minute, three 
times in succession in a seated position. Participants were given one minute between 
each HRV recording.  
 
Real time heart and lung animation on the iPod touch facilitated paced breathing 
during measurements, and the screen also indicated the reception of each heart beat 
from the analogue chest strap. After one minute of recording, measurements were 
saved to the device. HRV (rMSSD in ms) and HR (bpm) were recorded via the 
Ithlete software for the iPod touch (Ithlete 2009).  The breathing frequency was set at 





When the one minute measurement was complete, the HR (bpm) and HRV (rMSSD 
in ms) were displayed on the screen and saved to the device. Ithlete recordings were 
transferred to a password protected PC via Ithlete software, which enabled 
recordings to be emailed and saved into an excel document. 
 
5.2.3.2 Bioelectrical impedance analysis 
The HoMedics 9116 Black Glass Platform Body Fat Analyser Scale was used by 
participants first thing in the morning when they woke up. The device was placed on 
a flat surface and participants stood on the scale with their bare feet for the 
measurement. Participants’ gender, age, and height were entered into the machine 
before measurement took place.  Participants were asked to take the measurement 3 
times in a row and record all the measurements.  
 
5.2.4 Statistical analysis  
All statistical analysis was undertaken using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Independent sample t-tests were performed to examine if 
differences occur in gender or smoking status. Analysis of variance (ANOVA) was 
performed to examine relationships between ethnic groups and physical activity 
levels. Pearson correlation analysis was used to evaluate the relationships between 
rMSSD, HR and various body composition analysis measurements, including body 
fat %, free fat mass % and total body water (TBW). Analysis of covariance 
(ANCOVA) was then performed to determine if age or gender were determining 
factors in differences between ethnic or physical activity groups. A P-value of ≤ 0.05 








Average participant characteristics by gender are displayed in Table 5.1. Ethnic 
differences were evaluated for all of the measurements; averages for each ethnic 
group are displayed in Table 5.2.   
 
Table 5.1 Subject characteristics 
Characteristic Males (n = 35) Females (n = 43) 
rMSSD(ms) 73.3 ± 12.1 67.2 ± 13.1* 
HR (bpm) 69.1 ± 12.9 75.9 ± 13.2* 
Age (years) 33.9 ± 13.0 32.9 ± 10.5 
Height (cm) 178.5 ± 8.5 165.5 ± 8.0  
Weight (kg) 77.7 ± 11.5 67.6 ± 11.6  
Body fat (%) 20.8 ± 6.9 30.5 ± 9.3  
Total body water (%) 53.6 ± 6.3 50.2 ± 6.7* 
Muscle (%) 39.7 ± 3.8 35.3 ± 4.8  
Basal Metabolic Rate 
(kcal) 
1796 ± 214 1469 ± 154  
Desk Job (%)  30.7 37.2 
Smoker (%)  7.7 11.5  
Alcohol (units/week) 8.1 ± 7.7 3.0 ± 4.6  
*Significant difference at p<0.05 









Table 5.2 Subject Characteristics by Ethnicity 
Characteristic Caucasian 
(n = 40) 
Afro-
Caribbean 
(n = 17) 
Other 
(n = 20) 
rMSSD(ms) 71.1 ± 13.7 65.2 ± 12.7 71.4 ± 11.3 
HR (bpm) 69.2 ± 12.2* 79.4 ± 13.3* 75.3 ± 13.7 
Age (years) 32.8 ± 10.9 34.1 ± 13.0* 32.0 ± 9.4* 
Height (cm) 173.9 ± 10.5 173.1 ± 8.8 168.5 ± 11.0 
Weight (kg) 73.9 ± 11.3 74.8 ± 13.3 67.0 ± 13.4 
Body fat (%) 24.2 ± 7.2 29.6 ± 9.0 27.0 ± 12.8 
Total body 
water (%) 
52.1 ± 5.5 49.9 ± 6.9 52.5 ± 8.8 




1692 ± 258 1571 ± 266 1776 ± 219 
Desk Job (%) 39.7  13.0 15.6 
Smoker (%) 7.8  3.9 7.8  
Alcohol 
(units/week) 
8.1 ± 7.6  1.8 ± 4.2  2.3 ± 3.7  
*Significant difference at p<0.05 
Significant difference at p<0.01 
→ One participant did not disclose their ethnic group 
 
Significant differences were demonstrated between the Caucasian and the Afro-
Caribbean group in HR. Age was significantly different between the Afro-Caribbean 
group and the ‘Other’ ethnic group. A significant difference was also demonstrated 
in alcohol consumption between the Caucasian group and the other two ethnic 
groups.  There was no significant difference in alcohol consumption between the 
Afro-Caribbean group and the ‘Other’ ethnic group. Average participant 





Table 5.3 Subject characteristics by physical activity (PA) level 
Characteristic (A)<30 
mins/day 
(n = 23) 
(B)30-60 
mins/day 
(n = 38) 
(C)>60 
mins/day 
(n = 17) 
rMSSD at 
rest (ms) 
65.4 ± 11.0* 73.3 ± 13.1* 68.3 ± 13.5 
HR at rest 
(bpm) 
81.0 ± 11.2 68.2 ± 13.3  72.1 ±14.8* 
Age (years) 32.2 ± 12.3 30.8 ± 7.6  40.7 ± 15.1* 
Height (cm) 170.7 ± 12.3 172.0 ± 9.9 174.1 ± 10.3 
Weight (kg) 73.8 ± 12.1 70.8 ± 14.1 72.9 ± 9.2 
Body fat (%) 30.6 ± 11.5  23.1 ± 6.3  26.8 ± 10.1 
Total body 
water (%) 
49.5 ± 6.9* 53.6 ± 5.9* 50.7 ± 7.5 




1811 ± 1127 1640 ± 270 1601 ± 291 
Desk Job (%) 19.2  35.9  12.8 
Smoker (%) 6.4 9.0 3.8 
Alcohol 
(units/week) 
2.5 ± 5.2* 6.5 ± 6.3* 6.5 ± 8.4* 
*Significant difference at p< 0.05 
Significant difference at p< 0.01 
 
Significant differences in rMSSD were demonstrated between groups A and B (p < 
0.05). Significant differences in HR were demonstrated between groups A and B (p 
< 0.01), and groups A and C (p < 0.05). A significant difference between group A 
and B was shown in TBW and alcohol consumption at p < 0.05, and BF at p < 0.01. 
Significant differences between groups A and C were demonstrated for age and 
alcohol consumption at p < 0.05. Significant differences in muscle (p< 0.05) and age 
(p < 0.01) were demonstrated between groups B and C. The average participant 





Table 5.4 Subject characteristics by smoking status 
Characteristic Non-Smoker (n = 63) Smoker (n = 15) 
rMSSD at rest (ms) 71.9 ± 11.2 61.8 ± 16.6  
HR at rest (bpm) 71.9 ± 12.3 76.7 ± 17.6 
Age (years) 34.7 ± 12.4 27.7 ± 4.1 
Height (cm) 173.3 ± 9.9 167.5 ± 11.8 
Weight (kg) 73.1 ± 12.2 68.2 ± 13.3 
Body fat (%) 26.6 ± 9.7 24.1 ± 8.3 
Total body water (%) 51.2 ± 6.3 54.2 ± 8.0 
Muscle (%) 36.8 ± 4.8 39.1 ± 5.0 
Basal Metabolic Rate 
(kcal) 
1708 ± 716 1571 ± 263 
BMI 24.5 ± 3.6 23.8 ± 4.3 
Desk Job (%)  17.9  50.0 * 
Alcohol (units/week) 4.6 ± 6.2 8.5 ± 8.0* 
*Significant difference at p< 0.05 







Table 5.5 Pearson’s correlation for rMSSD/HR correlated with other measurement 
variables 








rMSSD  _ _ -0.62 0.001  
Height 0.05 0.68 -0.01 0.95 
Weight 0.07 0.54 0.02 0.84 
Body Fat -0.07 0.54 0.17 0.13 
TBW -0.03 0.79 -0.03 0.79 
Muscle mass 0.03 0.77 -0.11 0.36 
BMR -0.01 0.92 0.001 0.98 
Age 0.02 0.87 -0.26 0.02* 
Alcohol 
units/week 
0.07 0.52 -0.17 0.15 
BMI 0.09 0.48 0.02 0.89 
PA 0.11 0.33 -0.27 0.02* 
*Significant difference at p< 0.05 
Significant difference at p< 0.01 
 
 
5.3.1 Partial correlations 
Partial correlations were undertaken to explore the relationships between rMSSD, 
HR and lifestyle factors.  Physical activity (PA) level, smoking, and alcohol 
consumption were assessed, while controlling for chronic factors (gender and age). 
There was a strong negative partial correlation between rMSSD and HR which 
remained when age and gender were controlled at r = -0.632 (p < 0.001). HR was 
still significantly negatively correlated with age at r = -0.26 (p < 0.05) when 
controlled for gender.  HR was significantly negatively correlated with PA which 
remained when controlling for age (r = -0.22 p < 0.05) and gender (r = -0.24 p < 
0.05) separately. However when gender and age were controlled for together, there 
was no longer a significant correlation between HR and PA at r = -0.19 p = 0.10. It is 





probability.  These low correlations will still leave a large proportion of unexplained 
variances. 
 
5.3.2 Analysis of covariance 
Analysis of covariance (ANCOVA) was performed to explore the relationships 
between categorical variables (ethnicity, gender and smoking), with characteristics 
where significant differences were found between groups.  Chronic factors (age and 
gender) were controlled for to see if they had an impact on the significant differences 
demonstrated.  Despite controlling for age, significant differences remained between 
genders in BF, BMR, TBW and muscle mass at p < 0.01.  The significant difference 
between genders in rMSSD was no longer significant when controlled for age (p = 
0.11).  
 
Ethnic differences in HR remained significant at p < 0.05 when gender and age were 
controlled. Significant ethnic differences (p < 0.01) in alcohol consumption also 
remained when gender and age were controlled.  
 
A significant difference in HR remained between PA groups when age and gender 
were controlled at p < 0.01. Significant differences in age between PA groups also 
remained when gender was controlled at p < 0.01. When controlled for age, 
significant differences remained between PA groups in BF, muscle and alcohol 
consumption at p < 0.05. When controlled for gender, there was no longer a 
significant difference between PA groups in BF, muscle and alcohol consumption. 
When controlled for age and gender together, there were also no longer significant 
differences between PA groups for BF, muscle and alcohol consumption. 
 
Significant differences between smokers and non-smokers in rMSSD at p < 0.01 
remained when controlled for age and gender. Significant differences in alcohol 
consumption (p < 0.05) between smokers and non-smokers remained when 









The aim of the present study was to examine if Ithlete measurements of rMSSD 
(ms)/HR (bpm) demonstrated the same associations with cardiovascular risk factors 
as those already reported in the literature. Lifestyle factors such as alcohol intake, 
physical activity level, and smoking were also considered. Statistical analysis was 
undertaken to control for gender and age, to see if their influence caused the 
significant differences or correlations between groups. Ithlete measurements 
demonstrated relationships between physical activity levels, smoking and alcohol 
consumption; however in the present study, no relationships were shown between 
rMSSD/HR and body composition measurements. Resting HRV (rMSSD) analyses 
taken with the Ithlete software were easy and convenient; participants reported no 
problems using the device. HR and rMSSD were significantly negatively correlated 
at p < 0.01). This correlation remained when controlled for gender and age. 
 
5.4.1 Gender 
In the present study rMSSD was significantly higher in the male population. There 
was no significant difference in age between genders, so that did not play a role in 
this result. There were slightly more female participants (n=43) compared with 
males (n=35), but this also does not explain this result. Gender differences in HRV 
have been reported throughout the literature (Antelmi et al. 2004; Carter et al. 2003; 
Evans et al. 2001; Gregoire et al. 1996). Reported gender differences in HRV have 
been inconclusive, with some studies suggesting females have a higher resting HRV 
(Evans et al. 2001; Koskinen et al. 2009), and other studies suggesting males have a 
higher resting HRV (Bonnemeier et al. 2003; Umetani et al. 1998). In adult studies, 
there is a slight majority demonstrating that women possess a higher vagal influence 
than men (Antelmi et al. 2004; Gregoire et al. 1996; Liao et al. 1995).  In contrast, 
studies looking at gender differences in children have found girls to have a lower 
HRV compared to boys (Faulkner et al. 2003; Umetani et al. 1998), signifying that 
the effect of gender may be modulated by age.  
 
When controlled for age, there were no longer gender differences in rMSSD, 
suggesting that age had more impact on rMSSD than age in the present study. 
Measurements of rMSSD may have been higher in the male population within this 





measures.  Umetani et al. (1998) reported differences in the specific time-domain 
indices where age related decreases in HRV occurred at different times. The SDNN 
index demonstrated a significantly steeper decline in HRV in females at >50 years 
when compared with their counterparts at >30 years. In comparison rMSSD and 
pNN50 demonstrated a decline in both genders at >30 years, but the rate of decline 
in females was slower (Umetani et al. 1998).  
 
Typical resting measurements of HR should be between 60 and 100 bpm for the 
average sedentary adult. The mean for both male and female participants in this 
study were well within that range at 72.3 ± 13.4 and 67.2 ± 13.8 respectively. The 
mean rMSSD in the present study for male and female participants were similar to 
those systematically reviewed recently (Nunan et al. 2010). The relationship between 
HRV/HR and FM has been discussed throughout the literature. Few studies however, 
have looked at individual indices of body composition such as muscle mass, body fat 
percentage and total body water compared specifically with HRV and HR. When 
controlled for gender, HR and age were still significantly positively correlated.  This 
confirms that resting HR increases with age in both males and females. HR and PA 
remained negatively correlated when controlled for gender and age separately, 
however when controlled for together the correlation was no longer significant. 
Physical activity is known to decrease resting HR (Katona et al. 1982; Smith et al. 
1989; Wilmore et al. 1996). The results of the present study suggest that age and 
gender however, also affect these changes. PA level has an impact on body 
composition (Andreacci et al. 2008; Slentz Ca et al. 2004), and both these factors 
influence HRV measurements.  
 
The present study found no correlations between HRV/HR and body composition 
measurements of muscle mass, BF, TBW or BMR. This is in contrast to other studies 
who have reported associations. Sztajzel et al, (2009) reported large amounts of body 
fat were associated with a depressed HRV and increased HR. Higher body weight 
was related to decreasing time domain parameters, including rMSSD and SDNN in 
adolescent obese subjects (Rabbia et al. 2003; Sztajzel et al. 2009). Decreased HRV 
indices have been associated with total body FM (Christou et al. 2004). Lower levels 
of rMSSD were associated with high levels of total body fat mass and fat free mass 





HRV in women where a higher BMI had reduced parasympathetic control and 
elevated sympathovagal modulation (Pai et al. 2011). Partial correlations were 
assessed to control for gender and age, however significant correlations were still not 
found between HRV/HR and body composition variables.  
 
Due to biological differences between males and females, significant gender 
differences observed in height and weight within the present study were as expected. 
Generally in England, males are reported on average to be taller and heavier than 
females (Department of Health 2010). Females had a higher average body fat 
percentage; lower average muscle mass and BMR which were also to be expected as 
previous research have also demonstrated these gender differences (Buchholz et al. 
2001; Gallagher & Heymsfield 1998; Gallagher et al. 1997; Kim 2012). Alcohol 
consumption, as demonstrated in literature, was also significantly higher in males 
compared with females (Ely et al. 1999; Wilsnack et al. 2000). In the present study, 
gender differences remained between BF, BMR, TBW and muscle (p < 0.01) when 
controlled for age. Gender differences in rMSSD were no longer significant when 
controlled for age; suggesting that age has a significant influence on the difference 
found in the present study’s population. 
 
Desk jobs are associated with long periods of sedentary time which has been 
associated with increased risk of obesity, diabetes, heart disease, certain types of 
cancer, and death (Wilmot et al. 2012).  In the present study no significant difference 
was found in occupation between men and women, which differs from Shauman 
(2006), who reported differences in the choice of occupation between women and 
men despite the same level and education. The present study only used two 
categories for occupation which may account for this; dividing into more specific 
occupational groups may show greater differences. 
 
5.4.2 Ethnicity 
In the present study, ethnic differences were only observed for age, HR, PA (p<0.05) 
and alcohol consumption (p<0.01). No significant differences were observed in 
rMSSD between ethnic groups. This is in contrast to the literature, as several studies 
have reported differences (Faulkner et al. 2003; Guzzetti et al. 2000; Liao et al. 





Afro-Caribbean populations found both decreased sympathetic activity in Afro-
Caribbean’s (Guzzetti et al. 2000; Liao et al. 1995; Urbina et al. 1998), and greater 
sympathetic contribution in Afro-Caribbean’s (Faulkner et al. 2003). Similarly, 
studies examining HRV in Caucasian and Asian children are inconsistent. Kikuchi et 
al (2003) reported lower HRV in Asian children when compared with their 
Caucasian counterparts; but Reed et al (2006) found higher frequency domain 
indices in Asian children. The present study placed participants into three categories: 
Caucasian, Afro-Caribbean and other. There were notably more Caucasian 
participants (n=40) compared with the other two groups (Black n=17 and other 
n=20), which may have impacted results.  
 
Bathula et al. (2008) reported higher HR in South Asian men when compared with 
their Caucasian counterparts. Higher average resting HR was also reported among 
South Asian children (Whincup et al. 2002).  Lower resting HR’s were reported in 
participants of European descent in an eight year follow-up study, examining the 
association between resting HR, cardiovascular, cancer and all-cause mortality 
(Kristal-Boneh et al. 2000). Results of resting HR from the present study follow the 
same pattern as the literature, with Caucasians demonstrating the lowest resting HR 
(69.2 ± 12.2 bpm), followed by Others (75.3 ± 13.7 bpm) and then Afro-Caribbeans 
(79.4 ± 13.3 bpm).  Higher resting HR is associated with low physical fitness and 
increased risk of mortality (Kristal-Boneh et al. 2000). Ethnic minorities are at 
higher risk of heart disease. South Asians are known to have a higher prevalence of 
hypertension (Lane & Lip 2001) and are at increased risk of coronary heart disease 
(Balarajan 1991). Also, Afro-Caribbeans have a higher incidence of stroke (Saxena 
et al. 2004; Stewart et al. 1999). When controlling for gender and age, ethnic 
differences in HR still remained. This suggests that ethnic differences in HR can 
occur at various ages and in both men and women.  
 
In the present study, significant ethnic differences were observed in alcohol 
consumption. Caucasian participants averaged more than three-times the amount of 
alcohol consumption per week than the other two ethnic groups. This is in line with 
the literature, as a review examining alcohol consumption in the UK found that most 
studies reported lower drinking levels in most ethnic minority groups when 





and amount of drinking have both been reported higher in Caucasian populations 
compared with ethnic minority groups (Afro-Caribbean, South Asian, Chinese), with 
36% of Caucasians reporting to drink at least three-times-per-week compared with 
17% in Afro-Caribbeans (Cochrane 1999). Twenty-five percent of Caucasians 
regularly drink two or more times a week compared with just two percent in South 
Asians (Denscombe 1995). Nazroo (1997) assessed alcohol consumption once a 
week or more by ethnicity and gender, and reported Caucasians at 69% for males 
and 46% for females, compared with Afro-Caribbeans at 50% for males and 23% for 
females, South Asians at 25% for males and 4% for females, and Chinese at 32% for 
males and 11% for females. These findings are similar to those reported in the 
present study, where significant differences in alcohol consumption were found in 
both gender and ethnicity. When age and gender were controlled, significant ethnic 
differences in alcohol consumption remained; suggesting that alcohol consumption 
differs between gender and ethnic groups at various ages. 
  
5.4.3 Physical activity levels 
There were some surprising results when participants were split into PA levels. 
There was a significant difference in age, with those stating they were the most 
physically active also having the highest average age. This is in contrast with the 
literature where PA tends to decline with age (Droomers et al. 2001; Jackson et al. 
2009; Sallis 2000). When controlled for gender, age was still significantly different 
at p < 0.01. Significant differences with respect to PA level were also found in HR, 
BF, muscle mass and alcohol consumption. There were three groups; group A: <30 
minutes of exercise per day, group B: 30-60 minutes of exercise per day and group 
C: >60 minutes of exercise per day. Group B had the lowest resting HR and body fat 
percentage. Group C would be expected to have the lowest resting HR, because 
literature has shown an association between resting HR and fitness level (Aubert et 
al. 2001; Dixon et al. 1992; Loimaala et al. 2000; Pichot et al. 2000). Those who do 
more daily exercise would presumably be the most fit. When controlled for gender 
and age, HR was still significantly different at p < 0.01 between PA groups. This 







Body fat percentage was lowest in group B but this could be due to group C having a 
higher average age, as body fat increases with age (Gallagher et al. 2000). The same 
relationship was demonstrated with muscle mass; with Group C demonstrating lower 
muscle mass than group B but this again may be attributed to age. When controlled 
for age, BF and muscle remained significantly different at p < 0.05. When controlled 
for gender however, they were no longer significantly different; suggesting that 
gender had a greater effect in the present study’s population than age. When 
controlled for both gender and age together, BF and muscle were no longer 
significantly different. Alcohol consumption was significantly lower in group A 
compared with group B and C, but there does not appear to be any attributable 
reason for this, as no other factor associated with alcohol was significantly higher in 
group A. When controlled for age, alcohol remained significantly different (p < 0.05) 
between PA groups. When controlled for gender alcohol was no longer significant, 
again suggesting that gender has more impact within this population. When 
controlled for gender and age together, alcohol was also no longer significantly 
different between PA groups.  
 
5.4.4 Smoking  
Increased sympathetic nervous activity has been associated with cigarette smoking 
(Barutcu et al. 2005). Second-hand smoke has been associated with cardiac 
autonomic dysregulation (Felber Dietrich et al. 2007; Tsuji et al. 1996). Within the 
present study, significant differences between smokers and non-smokers were found 
in rMSSD and alcohol consumption. Smokers had significantly lower rMSSD. This 
is in accordance with the literature, which has reported lower HRV in those exposed 
to environmental tobacco smoke at home and at work (Dekker et al. 1997; Felber 
Dietrich et al. 2007; Pope et al. 2001). When controlled for gender and age 
significant differences in rMSSD between smokers and non-smokers remained. 
When controlled for alcohol consumption the difference in rMSSD between smokers 
also remained significant. This suggests that despite the known association between 
smoking and alcohol, rMSSD is still affected by just smoking.  
 
In the present study, a difference in alcohol consumption was demonstrated between 
smokers and non-smokers. When controlled for age and gender, the difference 





with alcohol abuse (de Vries et al. 2008; Keenan et al. 1990; Ma et al. 2000). 
Therefore higher alcohol consumption in the smoking population is in accordance 
with the literature. There is, however, a large difference in the amount of smoking 
compared with non-smoking participants within this study, which reduces the 
significance of these results. 
 
None of the significant differences between genders observed in the present study 
were surprising or unexpected. The absence of a difference between genders in the 
amount of smokers, and those having desk jobs, is on the other hand intriguing. 
Historically, men smoke more than women. However, in European countries 
especially, there has been a sharp decrease in smoking prevalence amongst men 
(WHO 2005).  In England, there are contradictory views about smoking cessation. 
Brose et al (2011) reported women as less successful than men in quitting smoking 
through an NHS smoking cessation service, while other research reported no clear 
evidence for overall sex differences in cessation of smoking (Jarvis 1984; Jarvis et 
al. 2012). A strong correlation has been found between the level of economic 
development and the prevalence of smoking among men and women (Hitchman & 
Fong 2011). All of this may be contributing to women smoking at nearly the same 
rate as men in Australia, Canada, USA and most of Western Europe (WHO 2008).  
 
5.4.5 Limitations 
Limitations to this study involve the method of obtaining participants. Self selection 
naturally occurred through the recruitment of participants. Those who are involved in 
this study were those that wanted to participate, and therefore are not necessarily 
representative of the population.   
 
Participants took measurements at home first thing in the morning, without the 
presence of the researcher, and therefore the researcher cannot be absolutely sure 
that participants followed the instructions for optimal measurement completely. 
Participants were encouraged to not eat or drink before taking measurements and to 
ensure that their resting HRV/HR was taken first thing before moving around too 







The present research study was unique in its use of a novel HRV measurement 
device (Ithlete). Gender differences were demonstrated in rMSSD, HR, alcohol 
consumption and body composition measurements; these differences remained in all 
except rMSSD when controlled for age. Ethnic differences were demonstrated in HR 
and alcohol consumption, and remained when controlled for gender and age. This 
suggests that ethnic differences in rMSSD are present in both genders and at various 
ages. Gender differences in rMSSD however, are modulated by age. In the present 
study, no significant correlations were demonstrated between rMSSD/HR obtained 
from Ithlete and body composition measurements. This is in contrast to the literature, 
suggesting that Ithlete measurements may not demonstrate the same correlations. 
More research is needed using the Ithlete device in a larger cohort to determine this 
definitively.  
 
Future research should expand this research by increasing the participant base in 
both numbers and different ethnic groups. Ithlete is an easily accessible application 
for iPod touch (2nd generation or later) or a smartphone, which can be used to 
measure HR and rMSSD. Future research should focus on utilizing Ithlete for 
measurement in special populations who are known to be at increased risk to further 
explore the relationships that exist between HRV/HR and other cardiovascular risks 
factors such as body composition. Knowledge of these relationships may lead to 
establishing increased risk factors, which in turn can lead to improvement in both 
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CHAPTER 6: HEART RATE VARIABILITY IN HEALTHY CAUCASIAN 
AND SOUTH ASIAN PARTICIPANTS  
 
Cardiovascular disease (CVD) is the leading cause of premature death in the UK. 
The health of the cardiovascular system is influenced by both modifiable and non-
modifiable CVD risk factors. The link between ethnicity and health is well 
established. Ethnic minorities such as Black African/Caribbean or South Asians tend 
to have higher rates of risk factors for CVD (i.e. hypertension, atherosclerosis, 
obesity and insulin resistance) when compared with Caucasians. Higher rates of 
ischaemic heart disease and diabetes are found among the British South Asian 
community. Heart rate variability (HRV) is the phenomenon of the difference in time 
between heart beats, which is influenced by the autonomic nervous system (ANS). 
The ANS has an influence on the function of the cardiovascular system and energy 
balance. A reduced level of HRV has been demonstrated to be a significant predictor 
of a cardiac event, morbidity and mortality. There is no consensus on the effect of 
ethnicity on HRV, with studies demonstrating both higher and lower HRV in ethnic 
minorities.  
 
The aims of the present study were two-fold; first to explore ethnic differences in 
HRV between healthy Caucasian and South Asian participants, while estimating the 
normal pattern for HRV in this population. The secondary aim was to determine the 
feasibility of HRV measurements, using a new personal heart rate variability monitor 
(Ithlete).  
 
No significant difference was found in HRV or heart rate (HR) between South Asian 
and Caucasian participants. There were also no significant differences in HRV and 
HR when controlled for gender and age. No significant difference in resting HRV 
between South Asian and Caucasian or male and female participants when matched 
for age were found in the present study.  This is despite indications that autonomic 
function is related to both cardiovascular diseases and diabetes. Ethnic differences 
demonstrated in this study were inconclusive; however future research in a larger 
cohort of participants could explain the natural differences that may cause increased 






The link between ethnicity and health is well established and there are numerous 
ethnic differences in health risks including hypertension, diabetes and the risk of 
cardiovascular events. The human body is a complex system that has several 
subsystems interacting within it to keep the system operational. One of those 
subsystems is the cardiovascular system which involves the health of the heart and 
circulatory system. Problems with the cardiovascular system result in cardiovascular 
disease (CVD) which is currently the leading cause of death worldwide with an 
estimated 17.1 million people dying from CVD each year (World Health 
Organization 2011). Furthermore, CVD is the leading cause of death and premature 
death in the UK, with approximately 20% of men and almost 15% of women in the 
UK dying from complications related to CVD (British Heart Foundation 2008). 
CVD accounts for approximately 198,000 deaths per year in the UK, despite death 
rates falling due to improvements in treatment, secondary prevention, and a 
reduction in major risk factors (ibid). Coronary heart disease (CHD) and stroke are 
the most common forms of CVD, accounting for 48% of all deaths related to CVD. 
CHD alone costs the UK economy approximately £7 billion pounds per year (British 
Heart Foundation 2008). Several risk factors increase the likelihood of developing 
CVD, which are now discussed.  
 
6.1.1 Risk factors 
The health of the cardiovascular system is influenced by both modifiable and non-
modifiable CVD risk factors. Modifiable or ‘lifestyle’ risk factors include: a lack of 
exercise, diet, smoking, alcohol use and obesity. External or environmental factors 
are associated with increased CVD, most probably via differences in such risk 
factors. For instance, deprivation is positively correlated with deaths from circulatory 
diseases in England and Wales (British Heart Foundation 2008). The difference in 
CHD prevalence among different socioeconomic groups across the UK is attributed 
to modifiable factors including diet, smoking and alcohol (ibid). Mortality is 60% 
higher in smokers, and in 2001 27% of the population over 16 years of age smoked 
cigarettes (Doll et al. 2004). Poor diet increases the risk of CHD, particularly diets 
high in saturated fat, sodium and sugar (World Health Organization 2003). Physical 
inactivity is estimated to account for 20% of CHD in developed countries (ibid). 





stress, and lack of social support all increase the risk of CHD (Brezinka & Kittel 
1996). While modifiable risk factors are important for public health, it should also be 
noted that they interact with a number of non-modifiable factors. Knowledge of 
these factors can help target health education and healthcare more effectively. Non-
modifiable CVD risk factors include: family history, gender, age and ethnicity. A 
first-degree relative of someone with premature myocardial infarction (MI) is 50% 
more likely to have an MI themselves (Chow et al. 2007). The risk of CVD is also 
higher in some ethnic groups; specific examples will be discussed below.  
 
6.1.2 Ethnic differences 
There are ethnic differences in anthropometric values, including BMI, waist-to-hip 
ratio and waist circumference (Brancati et al. 2000; Carroll et al. 2008; Flegal et al. 
2010; Hedley et al. 2004). Estimates of adult obesity prevalence among different 
ethnicities vary based on the measurement criteria. Chinese men and women appear 
to have the lowest obesity prevalence compared to other ethnicities (Gatineau & 
Mathrani 2011). African-Americans tend to have higher rates of hypertension, 
atherosclerosis, obesity and insulin resistance when compared with Caucasians 
(Hoffman 2009). In the UK, South Asians from India, Pakistan and Bangladesh have 
a higher prevalence of mortality from coronary heart disease (Balarajan 1995; Wild 
& Mckeigue 1997).  
 
Ethnic differences in HRV have been studied predominantly in Black vs. White 
studies and have been so far inconclusive (Guzzetti et al. 2000). Ethnic differences in 
health vary from one condition to the next, as Black and minority ethnic groups tend 
to have higher rates of cardiovascular disease but lower rates of cancer (Bhopal 
2007). Larger numbers of cardiovascular disease and stroke have been found in 
black and other ethnic minority groups (Lip et al. 2007). Black men born in the 
Caribbean are 50% more likely to die of stroke than the rest of the general 
population (Department of Health 2010). To break down ethnicity further, in 
England, surveys commonly show that Indian, East African, Asian and Blacks report 
the same health as White British participants; while Chinese report better health 
(Department of Health 2004). Statistically however, Pakistani’s, Bangladeshi and 






6.1.2.2 White vs. South Asian 
Higher body fat percentage, abdominal obesity and higher liver fat content have been 
reported in the Asian population when compared with their Caucasian counterparts 
of the same BMI (Lovegrove 2007). Increased body fat is an independent risk factor 
for diabetes, hypertension and cardiovascular disease (Wulan et al. 2010). There is a 
higher premature death rate in the South Asian population of the UK which is 46% 
higher in men and 51% higher in women (British Heart Foundation 2008). Men born 
in South Asia are 50% more likely to have angina or a heart attack compared with 
the general population in the UK (Department of Health 2010). The South Asian 
population is five-times more likely to suffer from diabetes mellitus when compared 
with the general population (Department of Health 1999), and have the highest 
prevalence of ischaemic heart disease (Department of Health 2004). 
 
6.1.3 Heart rate variability 
Heart rate variability (HRV) is a physiological phenomenon where the time interval 
between heart beats is measured through various techniques. Measurement of HRV 
is non-invasive, and examines one aspect of autonomic nervous function. The 
autonomic nervous system (ANS) controls visceral functions and functions 
predominantly below the consciousness level. The ANS affects heart rate, 
respiration, perspiration etc. The ANS makes itself visible through HRV indicating 
how the body is trying to preserve its equilibrium. rMSSD is an HRV measure of 
vagal tone which has been associated with health and disease. Thus HRV has the 
potential to monitor the autonomic response to exercise volume on a daily basis. 
HRV has been demonstrated as a reliable and reproducible technique for assessing 
autonomic activity (Noland et al. 1998). There are various parameters for HRV 
analysis (Task force, 1996) which include time domain, frequency domain and non-
linear methods.  
 
Good correlations (as high as 0.90) have been demonstrated between the time 
frequency measurement rMSSD and frequency domain measures of high-frequency 
HRV (HFr) (Task force, 1996). The present study will focus on one measure in 
particular, the root of the mean squared differences of successive heart periods 
(rMSSD). A full review of these measures and their interrelation can be found in 






rMSSD is a time domain measure of HRV which reflects parasympathetic activity 
without being dependent on heart trends (Stein et al. 1994).  rMSSD is independent 
of mean heart rate and considered robust against gradual trends over time (Hilz & 
Dütsch 2006). rMSSD is influenced by a variety of factors which include rate and 
depth of respiration, physiology of sinoatrial node, physical conditioning and age 
(Berntson et al. 2005). The prognostic value of HRV at rest has been demonstrated in 
healthy subjects (Ramirez-Villegas et al. 2011; Zulfiqar et al. 2010). The rMSSD 
measure has been suggested as superior to spectral methods due to its sensitivity to 
vagal cardiac control and its reduced sensitivity to variations in respiratory patterns 
(Penttilä et al. 2001).  
 
6.1.3.2 HRV and ethnicity 
When considering the effect of ethnicity on HRV, differences have been 
demonstrated in the literature. Blacks have a lower sympathetic drive when 
compared with age-matched whites (Guzzetti et al. 2000; Liao et al. 1995a). 
Decreased sympathetic tone was also found in black adolescents compared with their 
white counterparts in a study that compared HRV with high and low blood pressure 
(Urbina et al. 1998). Conflicting results were then published in 2003, which found 
that black adolescents displayed a greater sympathetic contribution to total power 
when compared with age-matched white adolescents (Faulkner et al. 2003). 
 
A comparison of Asian and Caucasian children found significantly elevated ration of 
low frequency and high frequency power (LF:HFr) in the Asian children, which 
supports previous investigations of black-white differences (Reed et al. 2006). 
Independent studies of HRV in the Asian population propose that racial differences 
in time and frequency domain measures of HRV occur where Asian children living 
in Asia display a lower HRV than Caucasian children living in North America 
(Kikuchi et al. 2003; Nagai et al. 2004).  
 
6.1.3.3 HRV measurement devices 
HRV can be measured through a number of devices. Holter tapes are known as the 
standard measurement of ECG records for 24-hour ambulatory recordings (Task 





models and Suunto t6 with excellent agreement found with an ambulatory ECG 
system (Weippert et al. 2010). A novel short-term HRV measurement device called 
Ithlete was launched on the market in 2009. Ithlete is an ECG receiver that attaches 
to smartphones or iPod touch (2nd generation or later). The device is used with a 
regular analogue (5.4 kHz) heart rate monitor chest strap and takes a one-minute 
measurement of both HR and HRV. The Ithlete application uses a paced breathing 
frequency, and has lung and heart animation displayed on the screen during 
measurement. This new device has great potential because of its simplicity and low 
cost, and will be used in the present study. 
 
6.1.4 Aims 
This research study will focus on expanding the understanding of HRV 
measurements in two different ethnic groups. As discussed above there are various 
HRV measures that are used with high correlation between them. The present study 
proposes to use just one measure, rMSSD in one minute measurements to assess 
HRV. With high correlations between the measures, there is no need to measure all 
of them each time HRV analysis is undertaken.  rMSSD has been demonstrated in 
the literature as a reliable measurement with high correlation to the others (Berntson 
et al. 2005; Task force, 1996). 
 
The aims of the present study were two-fold: first to demonstrate any ethnic 
differences in rMSSD between healthy Caucasian and South Asian participants, 
while also trying to ascertain the normal range for rMSSD in this population. The 
secondary aim was to demonstrate ethnic differences in HRV measurements using a 
single measure of HRV (rMSSD) from a new, simple HRV device (Ithlete).  
   
It is hypothesized that Ithlete software for measurement of rMSSD will demonstrate 








6.2.1 Recruitment of participants 
Staff and students of Buckinghamshire New University were invited to take part in 
the study through internal advertisement on notice boards and emails. Each 
participant was recruited in accordance with University ethics committee standards 
and expectations. Participants responded via email or phone and were sent an 
information pack before agreeing to participate. The information pack included: 
1. An information sheet with detail of the requirements for each participant 
before and during the laboratory visit 
2. An informed consent form 
3. A physical activity readiness questionnaire (PAR-Q) 
4. A detailed demographic information sheet 
Participants were requested to read the information pack prior to attending the 
laboratory. Any questions or concerns were addressed during the initial meeting with 
the researcher. All participants were free from any serious medical conditions and 
contraindications to exercise as indicated by the PAR-Q. All procedures were 
approved by the local research ethics committee. 
 
6.2.2 Participants 
Caucasians were classified as White’s from European decent. South Asian 
participants were classified as those descending from India, Pakistan or Bangladesh 
(United Nations Statistics Division 2012). Fifty-nine participants were tested, of 
which 29 were Caucasian (13 male) and 30 were South Asian (15 male).  Participant 
age ranged from 22 to 65 years. All participants were defined as healthy (free from 
any serious illness at the time of testing), and none of the participants was known to 
have any cardiovascular problems, or to be taking any medication that would have 
influenced the experimental procedures.  
 
Participants completed a PAR-Q; those who answered ‘yes’ to any of the conditions 
mentioned in the PAR-Q were excluded.  Participants completed their consent form 






6.2.3 Experimental design 
Following appropriate ethical approval and informed consent, participants were 
asked to visit the cardiovascular research lab at Bucks New University, Uxbridge. 
Prior to the test, participants were asked to avoid caffeine, heavy physical activity, 
smoking, and alcohol intake for the 10 hours preceding their lab visit.  Participants 
were also encouraged not to eat at least two hours prior to the test. All the equipment 
used was calibrated before each test according to the manufacturers’ 
recommendations.   
 
6.2.3.1 Heart rate variability analysis 
Two measures (rMSSD in ms, and HR in bpm) were recorded via the Ithlete 
software for the iPod touch (Ithlete 2009).  A standard analogue ECG chest strap was 
worn in the middle of the chest just under the sternum. Real time heart and lung 
animation on the iPod touch facilitated paced breathing during measurements, and 
the screen also indicated the reception of each heart beat from the analogue chest 
strap. Participants measured rMSSD for one- minute, three times in succession in a 
seated position. Participants were given one-minute between each rMSSD recording.  
After each one-minute recording, measurements were saved to the device. 
 
The breathing frequency was set at 7.5 breaths per minute, designed to maximize 
RSA response (Brown et al. 1993). When the one minute measurement was complete 
the HR (bpm) and RMSSD in ms were displayed on the screen and saved to the 
device. Ithlete recordings were transferred to a password protected PC via Ithlete 
software, which enabled recordings to be emailed and saved into an excel document. 
 
Examinations took place in the research lab, which was maintained at a comfortable 
temperature with limited distractions. Experimental procedures were described to 
participants in advance. All procedures carried out during the examination were 
considered non-invasive. 
 
6.2.3.2 Bioelectrical impedance analysis 
Body composition measurements involved participants lying in a supine position for 
testing allowing at least five minutes for even body fluid distribution before 





of each participant, one on the bisecting line of the wrist/ankle and the other 
proximal to the fingers/toes. Once ready for measurement an undetectable current 
was passed through the distal electrodes on the hand and foot and the proximal 
electrodes on the wrist and ankle receive the current flow (Wilmore & Costill 1999).  
Water and electrolyte distribution in the tissues determines the electrical conduction 
between the electrodes. Fat mass has a greater impedance as it is more difficult for a 
current to flow through it when compared with free-fat mass.  Free-fat mass consists 
of all the body water and conducting electrolytes making conductivity much greater 
within this tissue (ibid).  
 
Using the BIA 101 and Bodygram software (Akern; Florence, Italy), small wires 
were connected for measurement and a recording was executed allowing at least 
three reading cycles before inputting measurements into the Bodygram software. 
Bodygram software then computed body composition measurements including BMI, 
body fat %, fat free mass %, intracellular water, extracellular water for each 
participant and stored in the Bodygram software program. BIA measurements take 
approximately five minutes to perform.  
 
6.2.4 Statistical analysis 
All statistical analysis was undertaken using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Differences between ethnicity and gender were assessed using 
analysis of covariance (ANCOVA). Owing to the established relationship with HRV, 
analysis was undertaken which controlled for gender and age. A p-value of < 0.05 
was considered statistically significant. 
 
6.3 Results 
6.3.1 Participant characteristics 
Anthropometric, HRV and HR characteristics for each group are represented in 
Table 6.1 displaying ethnicity (Asian and Caucasian) and gender (male and female). 
Student t-tests found a significant difference between the South Asian and Caucasian 
participants in age and weight (p ≤ 0.05). A significant difference was also found 
between genders in weight. The other participant characteristics recorded were 
similar in both groups. Body composition characteristics for each group are 





(male and female). Student t-tests found a significant difference between the South 
Asian and Caucasian participants in BMI (p < 0.05), TBW and BMR (p< 0.01). 
 
Table 6.1 Mean and SD for anthropometric characteristics, rMSSD and HR of the 
participants 
Ethnicity Caucasian (n=29) South Asian (n=30) 
Gender Male  
(n= 13) 
Female 
(n = 16) 
Male  
(n = 15) 
Female  
(n =15 ) 
rMSSD (ms) 67.4 ± 12.8 68.4 ± 8.2 69.2  ± 7.0 73.1  ± 6.8 
HR (bpm) 79.4 ± 13.1 82.3 ± 11.1 83.9  ± 12.9 79.8  ± 7.3 
Age (years) 38.4 ± 13.0  34.6 ± 12.1* 24.9 ± 3.6  26.6  ± 3.5*  
Height (cm) 173.4 ± 9.5  163.9 ± 5.1  171.5  ± 5.6  161.7  ± 4.7  




89.4 ± 10.9  80.2 ± 13.9* 83.3 ± 6.8  75.1  ± 10.5*  
*Significant difference at p< 0.05 
Significant difference at p< 0.01 
 
Significant differences in age were demonstrated between Caucasian and South 
Asian males (p < 0.01), and Caucasian males and South Asian females (p < 0.01). 
Significant differences in age were demonstrated between Caucasian females and 
South Asian females (p < 0.05), and Caucasian females and South Asian males (p < 
0.01). There was no significant difference demonstrated between Caucasian males 
and females in age. In height, significant differences were demonstrated between 
Caucasian males and females (p < 0.01), Caucasian males and South Asian females 
(p < 0.01). No significant difference was demonstrated between Caucasian males and 
South Asian males. A significant difference in height was demonstrated between 
Caucasian females and South Asian males (p < 0.01), and between South Asian 
males and females (p < 0.01).  
 
Significant differences in weight were demonstrated between Caucasian males and 
females, and Caucasian males and South Asian females at p < 0.01. A significant 
difference in weight was demonstrated between Caucasian and South Asian males at 
p < 0.05. Significant differences were also found between South Asian males and 





differences in WC were demonstrated between Caucasian males and females (p < 
0.05), and Caucasian males and South Asian females (p < 0.01). A significant 
difference in WC was also demonstrated between South Asian males and females (p 
< 0.01). 
 
Table 6.2 Mean (SD) body composition characteristics of the participants 
Ethnicity Caucasian (n=29) South Asian (n=30) 
Gender Male  
(n= 13) 
Female 
(n = 16) 
Male  
(n = 15) 
Female  
(n =15 ) 
BMI 26.3 ± 3.9  24.9 ± 5.0 23.8 ± 3.2 22.0  ± 3.6  
Body fat (%) 23.8 ± 9.6 26.6 ± 11.9 27.4  ± 6.8 28.7  ± 9.2 
Total body water 
(%) 
44.6 ± 8.6  35.3 ± 6.2*  37.0  ± 5.0  29.4  ± 2.6*  
Basal metabolic 
rate  (kcal) 
1784 ± 250  1478 ± 174  1570 ± 187  1378  ± 111  
Free fat mass (%) 76.2 ± 9.6 73.4 ± 11.9 72.6  ± 6.8 71.3  ± 9.2 
Muscle mass (%) 54.8 ± 11.9* 47.2 ± 10.2 49.5  ± 8.4 47.3  ± 9.1* 
Exercise time (min) 13.6 ± 3.0 13.7 ± 2.1 14.3 ± 3.1 13.9 ± 1.4 
V02max  
(kg.ml.min-1) 
29.2 ± 6.6* 27.5 ± 5.7 29.0 ± 6.0 24.8 ± 4.2* 
*Significant difference at p< 0.05 
Significant difference at p< 0.01 
 
Significant differences in BMI were demonstrated between Caucasian males and 
South Asian females (p < 0.01). Significant differences in TBW were demonstrated 
between Caucasian males and all other groups at p < 0.01. Significant differences in 
TBW were also demonstrated between South Asian males and females (p < 0.01) 
and between Caucasian and South Asian females (p < 0.05). Significant differences 
in BMR were demonstrated between Caucasian males and all other groups at p < 
0.01. A significant difference in BMR was also demonstrated between South Asian 
males and females at p < 0.01. Significant differences between Caucasian males and 
South Asian females were demonstrated in both MM and Vo2 max at p < 0.05. 
 
6.3.2 Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) 
ANOVA showed no significant differences between Caucasian and South Asian 





anthropometric characteristics there were significant ethnic differences in age, 
weight and waist circumference; a significant gender difference in height was also 
demonstrated. Significant ethnic differences were found for BMI (p < 0.05), TBW (p 
< 0.01) and BMR (p < 0.01).  
 
ANCOVA revealed no significant ethnic difference (p = 0.33) for HRV or HR (p = 
0.08), when controlled for age and gender. When presented graphically, 
approximately the same difference between parallel lines appeared between gender 
and ethnicity in covariate analysis of HRV and HR. When controlled for gender and 
age, significant ethnic differences remained at p < 0.05 for BMI, and p < 0.01 for 
TBW, WC, BMR, height, and weight.  Significant differences emerged between 
South Asian and Caucasian participants in exercise time (p < 0.01) and relative 
V02max (p < 0.01) during ANCOVA analysis. 
 
6.4 Discussion 
6.4.1 Ethnic comparison 
One factor noted in the evolution of CVD is autonomic dysfunction, but the few 
comparisons of autonomic system function made between ethnic groups are 
inconsistent. Ethnic differences in autonomic function are important, because 
research has shown that there is a relationship between HRV and diseases such as 
diabetes mellitus (Liao et al. 1995b; Schroeder et al. 2005), stroke (Robinson et al. 
1999) and hypertension (Schroeder et al. 2003; Singh et al. 1998). In the UK, 
diabetes mellitus and CVD are more prevalent in ethnic minorities (South Asians, 
Black African/Caribbean) (Department of Health 2010). Within the present study, no 
significant differences were found in HRV or HR between South Asian and 
Caucasian participants. There were also no significant differences in HRV and HR 
when controlled for gender and age. Similar results were found with obese black and 
white youths with no significant difference in HRV (Gutin et al. 2000).    
 
Ethnic differences in parasympathetic modulation have been reported in adults, with 
blacks having higher parasympathetic modulation than whites (Liao et al. 1995a). 
However, similar research undertaken with a smaller sample size in youths found 
different results (Franke et al. 2004; Urbina et al. 1998). A recent study in Pakistan 





volunteers from a foreign population, and found increased rMSSD in the Pakistani 
population (Khan et al. 2010). Ethnic differences have been reported in diseases such 
as hypertension, diabetes and heart disease.  Some ethnic groups are at an increased 
risk compared with others in different disease states, and it is important to promote 
prevention within these groups. Ethnic differences in cardiovascular risk profiles 
(Whincup et al. 2002) imply that ethnic differences in HRV could occur. When 
considering South Asians and cardiovascular disease specifically, genetic and 
environmental factors are likely to play a role (Bhatnagar et al. 1995; Williams 
1995). Moreover, these factors also affect other ethnic groups (i.e. African, Chinese, 
Malay) (Lee et al. 2001; Marijon et al. 2007).   
 
The average values obtained in the present study for rMSSD from Ithlete were 
similar to results in several other studies (Khan et al. 2010; Quintana et al. 1997; 
Ramaekers et al. 1998).  Khan et al, (2010) compared healthy Pakistani subjects with 
a healthy foreign population and found higher rMSSD values in the Pakistani 
population. This is similar to the present study where South Asians also had a 
slightly higher rMSSD value, although this was not a significant difference. This 
suggests that Ithlete is a viable option for rMSSD measurement, and is an 
improvement in measurement technique considering its ease of use, short 
measurement duration and low cost.  
 
Ethnic differences found in the literature regarding HRV are sparse and inconclusive 
(Choi et al. 2006), and tend to focus more on Caucasian and Afro Caribbean 
comparisons. When considering other cardiac measurement indicators such as 
hypertension, ethnic differences have been found between Caucasians and South 
Asians in the UK (Lane & Lip 2001). Most of the literature has demonstrated a 
higher prevalence of hypertension in South Asians and Afro Caribbeans (ibid). The 
present study found similar values of resting rMSSD with no significant difference 
between the two populations with a mean rMSSD of 71.1 ms in South Asians 
compared with 68.0 ms in Caucasians. Ethnic differences in HRV have been 
associated with a higher resting heart rate, and lower levels of both energy 
expenditure and physical activity (Eyre et al. 2013). The present study found no 
significant difference in resting rMSSD between South Asian and Caucasian, or male 





minorities living in the UK have lower uptake rates of health service provision in 
coronary artery disease (Ford & Cooper 1995), and diabetes clinics (Hawthorne 
1994). Higher rates of ischaemic heart disease and diabetes are found among the 
British South Asian community (Chandola 2001). This emphasizes the importance of 
defining ethnic differences in physiological measurements and promoting awareness 
of increased risk factors in these populations.  
 
When considering ethnicity, there may be different degrees of body fatness in 
different populations (i.e. ethnicity) due to diverse body proportions which will have 
an impact on BMI (World Health Organization 2006). There has been increased 
attention placed upon the possible need for the development of different BMI cut-
offs due to mounting evidence that the associations between percentage body fat, 
body fat distribution and BMI differ across populations (WHO expert consultation 
2004). The National Institute for Clinical Excellence (NICE) released a new BMI 
and waist circumference guideline in the UK for black and minority ethnic groups in 
July 2013. This may help to increase the awareness within those communities to 
make them aware of when they become at higher risk of cardiovascular disease, 
hypertension and/or type-2 diabetes (ibid). 
 
Analysis of variance revealed significant ethnic differences in age, weight and WC. 
The relationship between age and HRV has been documented in literature (Liao et al. 
1995a; Pomeranz et al. 1985; Stein et al. 1997) and therefore ANCOVA analysis was 
used to control for age. Weight and WC differences were also expected, with other 
studies reporting ethnic differences in both variables (National Institute for Health 
and Clinical Excellence (NICE) 2006; Sisson et al. 2009; Staiano & Katzmarzyk 
2012). Excess body fat is a contributing factor to common diseases including 58% of 
type 2 diabetes and 21% of heart disease (Department of Health 1999). The fat level 
at which this becomes higher risk differs between ethnic groups (ibid), resulting in 
the necessity for specific WC thresholds for various ethnic groups (Zhu et al. 2005).  
 
Significant differences emerged between South Asian and Caucasian participants in 
exercise time (p< 0.01) and relative Vo2 max (p <0.01) during ANCOVA analysis. 
Levels of physical activity and body composition have been associated with Vo2 max 





differences in body composition found in the present study may contribute to this, 
because of the established relationship cited in literature between body composition 
and Vo2 max (Jackson et al. 1995; Jackson et al. 1990; Jackson et al. 1996). 
Furthermore, lower physical activity levels have been reported in the UK in the 
South Asian population, for both children (Eyre et al. 2013) and adults (Babakus & 
Thompson 2012; Fischbacher et al. 2004; Hayes et al. 2002), when compared with 
their White counterparts.  
 
6.4.2 Gender comparison 
A significant gender difference in height was also demonstrated; this was expected 
as on average, males in the UK tend to be taller than females (Office for National 
Statistics 2005). For body composition measurements, significant ethnic differences 
were found for BMI, TBW and BMR. These results are in accordance with literature 
where differences in body composition between ethnic groups have been 
demonstrated (Ama et al. 1986a; Ama et al. 1986b; Schutte et al. 1984). Strong 
associations between BMI and HRV have been reported in younger populations 
(Fagard et al. 1999; Felber Dietrich et al. 2006; Vallejo et al. 2005).   
 
Gender comparisons are important to consider due to inherent physiological (i.e. 
hormonal) and anthropometric (i.e. body fat percentage) differences between genders 
which may impact on HRV. The impact of these factors has been assessed in several 
studies (Fagard et al. 1999; Matsukawa et al. 1998; Vallejo et al. 2005). Genetic 
influence may also account for up to 65% of the variance in HRV measurements 
(Kupper et al. 2004; Singh et al. 1999; Snieder et al. 1997). Women have been 
reported to have higher cardiac parasympathetic modulation compared to that of men 
(Evans et al. 2001). Gender differences have been controversial with studies 
suggesting females have a higher resting HRV (Cowan et al. 1994; Evans et al. 
2001; Huikuri et al. 1996; Koskinen et al. 2009; Ryan et al. 1994), and other studies 
suggesting that males have a higher resting HRV (Bigger et al. 1995; Bonnemeier et 
al. 2003; Ingall et al. 1990; Saleem et al. 2012; Umetani et al. 1998).   
 
The present study found no significant differences between male and female 
participants when controlled for age. This is in line with two other studies which 





activity (Moodithaya & Avadhany 2012; Ramaekers et al. 1998). Both gender and 
ethnic differences in resting HRV have been reported in the literature, however few 
studies indicate which ethnicity the gender differences were found in. Those that 
have assessed ethnicity and gender together, reported lower sympathetic activity in 
both young and older women in the Caucasian population (Hogarth et al. 2007; 
Narkiewicz et al. 2005), and healthy Pakistani subjects (Saleem et al. 2012). 
 
6.4.3 Limitations 
Limitations to this study involve the method of obtaining participants.  Self selection 
naturally occurred through the recruitment of participants.  Those who are involved 
in this study were those that wanted to participate, and therefore are not necessarily 
representative of the population. A percentage of the students within the present 
study were international South Asian students who were recent inhabitants of the UK 
within the last 6 months, making the comparison between ethnicities multifaceted.   
Studies in the literature of this nature have directly compared ethnicity based on 
populations inhabiting the same environment (Reed et al. 2006; Urbina et al. 1998). 
A comparison of the same ethnicity in different environments, i.e. South Asian 
participants born and raised in South Asia compared to those born and raised in the 
UK, might have demonstrated differences between both South Asians and also White 
British.      
 
6.5 Recommendations 
Future research should examine the differences that exist between different 
ethnicities in a large range of physiological characteristics. In future, a large 
longitudinal study could provide insight into the natural occurring differences 
between ethnicities, however the logistics and expense of such a study could be 
challenging. Better information about ethnic differences could help to promote 
awareness about common conditions found in certain ethnic groups, and perhaps in 
certain age ranges. This could lead to prevention strategies that may establish a 
healthier population and cost the NHS less money in the long term. The UK is home 
to many different ethnicities which could be researched. With a growing ethnic 
population (Department of Health 2010), it is important that considerations are made 
for those deemed to be at higher risk due to their genetic/ethnic background or other 






The present study provides unique ethnic comparisons, and argues for more research 
into the environment and physiology interaction that may naturally occur.  No ethnic 
differences in rMSSD or HR measures between South Asian and Caucasian 
participants were found in the present study; however differences did emerge in 
several body composition measurements. Ethnic differences demonstrated in this 
study were inconclusive, however questions were raised regarding the difference 
between ethnic minorities born and raised in the UK versus those who immigrate in 
later life. Resting rMSSD analyses taken with the Ithlete software were easy and 
convenient; participants reported no problems using the device. The low cost, ease-
of-use and great accessibility of Ithlete make it an excellent potential device for 
prospective research.  
 
Future research in a larger cohort of participants with varying degrees of time spent 
living in the UK could explain the ethnic differences that occur. The notion that 
some ethnic groups are potentially at higher risk with certain characteristics, may 
have an effect on the way people live their lives, and consequently on their health. 
This insight into ethnic differences could lead to advances in prevention techniques. 
Better screening in the future for certain diseases that are found to be high risk in 
those specific populations, could reduce mortality and save the NHS money and 
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CHAPTER 7: THE RELATIONSHIP BETWEEN HEART RATE VARIABILITY, 
BODY COMPOSITION AND AEROBIC CAPACITY IN HEALTHY 
PARTICIPANTS WITH VARYING PHYSICAL ACTIVITY LEVELS 
Heart rate variability (HRV) is a non-invasive measure of autonomic function that 
has been demonstrated as a powerful predictor of mortality in the general population. 
Exercise capacity has also been associated with the risk of mortality. Body 
composition measurements are increasingly used along with body mass index (BMI) 
to assess increased risk of disease. Associations between these measurements have 
been demonstrated in the literature. The aim of the present study was to expand the 
understanding of heart rate variability measurements using a novel software 
application called Ithlete. This study will try to reproduce basic correlations seen 
between vagal HRV and other measures, including aerobic capacity and body 
composition, with the Ithlete device.  
 
Fifty-nine healthy participants were tested, of which 28 were male and 31 were 
female. Participant ages ranged from 22 to 65 years. Participants completed a 
modified Bruce protocol incremental exercise test on a motorized treadmill. Body 
composition measurements were undertaken using a bioelectrical impedance analysis 
device and HRV and heart rate (HR) measurements were completed using the Ithlete 
for iPod touch.  The present study found no significant gender differences in root 
mean square successive difference (rMSSD). Significant negative correlations at p< 
0.01 were demonstrated between resting rMSSD measurements and HR, weight and 
BMI. rMSSD was also negatively correlated with waist circumference (WC) (p 
<0.05) and positively correlated with Vo2 peak (p <0.05). 
 
The rMSSD measure obtained from the Ithlete device showed the same relationships 
with descriptive characteristics that other vagal measures did in previous studies. 
This suggests that Ithlete is an acceptable alternative measurement device to others 









The health of the population is an increasing concern. Public health campaigns have 
become a regular occurrence cautioning against health risks such as obesity, 
smoking, diet and lack of exercise. Such campaigns aim both to raise the awareness 
of the general population and encourage healthier lifestyles. Exercise capacity in 
itself has been expressed as the best predictor of mortality (Blair & Haskell 2006; 
Myers et al. 2002; Palatini et al. 2002; Pate et al. 1995).  Exercise capacity is related 
to many health outcomes, one of which is heart rate variability (HRV) (Galetta et al. 
2005; Levy et al. 1998; Perini et al. 2002). HRV is a non-invasive measure that has 
also been demonstrated as a powerful predictor of mortality in the general population 
(Rennie et al. 2003; Tsuji et al. 1996).  Decreased HRV is an independent risk factor 
for morbidity and mortality and will therefore be discussed in more detail below. 
 
7.1.1 Heart rate variability 
Heart rate variability (HRV) is a non-invasive electrocardiographic measure that 
examines the sympathetic and vagal components of autonomic nervous function. The 
autonomic nervous system makes itself visible through HRV indicating how the 
body is trying to preserve its equilibrium. Thus HRV has the potential to monitor the 
autonomic response to exercise volume on a daily basis.  HRV has emerged as a 
reliable and reproducible technique for assessing autonomic activity (Noland et al. 
1998). Key determinants in healthy longevity depend on preservation of autonomic 
function, particularly HRV-parasympathetic function (Zulfiqar et al. 2010).  
 
There are various parameters for HRV analysis (Task Force, 1996), which include 
time domain, frequency domain and non-linear methods. Time domain (statistical) 
measures such as the mean of the standard deviations of all normal R-R intervals 
(SDNN), the standard deviation of the average NN intervals calculated over short 
periods (SDANN), total power and ultra low frequency (ULF) power, very low 
frequency (VLF) power and low frequency (LF) power, root mean square of the 
successive difference (rMSSD), the percentage of adjacent R-R intervals that varied 
by more than 50 ms (pNN50) and high frequency (HFr) power are highly correlated 





which mainly reflects vagally mediated fluctuations of HR (Akselrod et al. 1981; 
Tulppo et al. 1996).   
 
rMSSD is a time domain measure of HRV which reflects parasympathetic activity 
without being dependent on heart trends (Stein et al. 1994).  High correlations have 
been found between time and frequency domain measures of vagal activity. This 
suggests that they can be used interchangeably (Bigger Jr et al. 1989).  The rMSSD 
measure has been suggested as superior to spectral methods due to its sensitivity as a 
measure of vagal cardiac control and is less sensitive to variations in respiratory 
patterns (Penttilä et al. 2001). In this chapter rMSSD and HFr will be discussed 
analogous to one another because they demonstrate the same vagal physiological 
phenomenon. rMSSD and the HFr power of the normal R-R interval power spectrum 
have correlations as high as (>0.90) (ibid). In research assessing the reliability of 
ultra-short (i.e. 10 second) HRV measurements, rMSSD values emerged with high 
correlations, with the standard 5-minute short-term recording (Thong et al. 2003). 
Nussinovitch et al, (2011) also found rMSSD to be a reliable parameter for assessing 
HRV from ultra-short 1-minute or 10-second resting ECG recordings. For 
experimental work, Pinna et al, (2007) recommended that research designs using 
HRV parameters for outcomes should be based on the parameters with the lowest 
variation, of which rMSSD was listed as one. Due to the number of publications with 
favourable results using rMSSD, this study will focus on rMSSD in particular. 
 
7.1.2 Clinical importance of HRV 
Cardiovascular disease (CVD) is the leading cause of death and premature death in 
the UK (British Heart Foundation 2008).  Increased cardiovascular risk is associated 
with a low HRV and high HR (Taylor 2010). HRV can be used to assess disease, 
autonomic imbalances, and mortality (Thayer et al. 2010). Increased cardiovascular 
deaths are associated with diabetes mellitus, which can cause cardiovascular 
autonomic neuropathy (Kudat et al. 2006). Cardiac autonomic neuropathy is a 
serious frequent complication of diabetes mellitus (Vinik et al. 2003). There is also 
an association between low HRV and the prevalence of diabetes (Gerritsen et al. 






When considering specific populations, impaired autonomic function (measured 
through HRV) is known to predict death, especially in chronic heart failure patients 
(Marijon et al. 2010). Early detection of critical changes in patients’ vital signs such 
as HRV can help in the identification of worsening heart failure and prevent 
rehospitalisation and other outcomes (Cleland et al. 2005). Reduced HRV is also 
associated with systemic hypertension (Singh et al. 1998). Continued health and 
longevity is dependent on the preservation of autonomic function over time (Zulfiqar 
et al. 2010). High HRV is a measure of good health, and a high level of physical 
fitness. Different habitual levels of physical activity may cause changes in HRV 
(Nunan et al. 2009). In the healthy population, HRV can be a valuable tool for 
monitoring the effects of stress on the body (Pieper et al. 2010; Thayer et al. 2012). 
Given the importance of HRV in clinical measures, the following will highlight the 
use of HRV in non clinical measures. 
 
7.1.3 Non-clinical determinants of HRV 
Chronic factors which affect HRV include gender, age, level of physical fitness, and 
body composition. Gender is an important determinant of HRV in healthy subjects 
(Antelmi et al. 2004). The majority of research looking at gender differences in 
adults shows that women possess higher vagal activity than men (Antelmi et al. 
2004; Gregoire et al. 1996; Liao et al. 1995a).  In contrast studies looking at gender 
differences in children show girls to have a lower HRV compared to boys (Faulkner 
et al. 2003; Umetani et al. 1998). This signifies that the effect of gender may be 
modulated by age. 
 
There is an inverse relationship between age and HRV, as age increases HRV 
decreases (Koskinen et al. 2009; Nunan et al. 2010b). A progressive decrease in 
HRV is associated with age, and can predict mortality in different clinical 
populations (Zulfiqar et al. 2010). People that exercise regularly generally 
demonstrate an increased parasympathetic activity, and lower heart rate when 
compared with sedentary people; this is especially noticeable at rest (Dixon et al. 
1992). A high HRV at rest improves the capacity for adaptation to varying or 
unpredictable stimuli (Goldberger 1991). Athletes have a higher HRV at rest (this 
reflects a parasympathetic predominance) than sedentary people (Aubert et al. 2003; 





Acute factors such as time of day and postural changes can also have an effect on 
HRV (Pagani et al. 1986). Research into the effect of time of day on HRV is 
conflicting. In a study that analysed HRV measurements at three different times of 
day (morning, afternoon, evening) there was significant variation found and low 
reproducibility (Lord et al. 2001). Vagal modulation in normal subjects did not 
reflect any changes due to different body positions (Avbelj et al. 2003). In a study of 
autonomic cardiovascular function in healthy young adults, autonomic activity was 
not significantly different in varying body positions. However HRV parameters 
within this study indicated sympathetic dominance during sitting (Watanabe et al. 
2007). Due to the number of factors that affect HRV, it is important to ensure they 
are considered when HRV is used as a research outcome.  
 
7.1.4 Body composition: body fat and total body water 
Excess body fat is associated with a number of health problems including 
cardiovascular disease, type II diabetes, and many cancers making it a major health 
issue worldwide (Haslam & James 2005; Kopelman 2000). Body composition 
outlines how much of body mass is made up of fat, fluid (mostly water), and muscle.  
Those with a body composition that contains more fat are more likely to have 
decreased HRV (Byrne et al. 1996). Healthy body fat ranges have been published for 
each gender in specific age ranges. The healthy body fat percentage range for 20-39 
year old females is between 21-33% and 8-20% for males (Gallagher et al. 2000). 
For 40-59 year old females the healthy body fat percentage range is 23-34% and 11-
22% for males of the same age (ibid).  
 
The relationship between obesity and autonomic function has been explored by 
several researchers, with two contradictory opinions on how results should be 
interpreted. The first opinion assumes the obese have higher sympathetic tone 
verified by elevated catecholamine levels (Troisi et al. 1991). The other assumes that 
the obese have a lower sympathetic tone, as demonstrated by lower recorded low 
frequency (LF) component of HRV (Spraul et al. 1993). Despite these contradictory 
opinions, it is agreed that the autonomic nervous system contributes to regulation of 
energy expenditure and body fat content (Nagai et al. 2004). The extent to which 






Water is essential to life; humans cannot survive without water for more than a few 
days whereas they can go without food considerably longer (Benelam & Wyness 
2010). The human body consists of between 45% to 75% water by weight; lean 
tissue is made up of a higher percentage of water at 70% compared to just 20% of fat 
tissue (ibid). Water is an important component of the body’s natural structure, used 
for circulatory function, biochemical reactions, metabolism, substrate transport 
across cellular membranes, temperature regulation, and numerous other 
physiological processes (Armstrong 2007). Fluid-electrolyte turnover and total body 
water change constantly due to water gained from food, fluids, and water loss from 
the lungs, skin and kidneys (ibid).  
 
Bioelectrical impedance analysis (BIA) determines fat-free mass and total body 
water by using equations that convert reactance and resistance to estimate the total 
body water.  The term impedance arises from the combination between reactance 
(arising from cell membranes) and resistance (arising from extra and intracellular 
fluid) (Kyle et al. 2004). The average TBW percentage ranges for a healthy adult 
female is 45-60% and 50-65% for a male (Maughan & Griffin 2001). Hydration 
status in humans effects cardiovascular function both at rest and during exercise 
(Charkoudian et al. 2003).  Dehydration induces an increase in sympathetic outflow, 
which in turn may have an impact on sympatho-vagal balance and consequently 
HRV (Princi et al. 2005).  
 
7.1.5 Exercise capacity 
Exercise capacity has been demonstrated as a strong predictor of morbidity and 
mortality (Blair et al. 1996; Gulati et al. 2003; Kokkinos et al. 2008; Rognmo et al. 
2004).  The exercise test has become a valuable clinical tool due to it being relatively 
inexpensive, non-invasive and provides several clinically relevant diagnostic and 
prognostic pieces of information (Froelicher & Myers 2000; Gibbons et al. 1997). 
The influence of exercise on HRV has been demonstrated throughout literature (al-
Ani et al. 1996; Gladwell et al. 2010; Hautala et al. 2001; Manzi et al. 2009; Ogoh et 
al. 2002; Raven et al. 2006). The relationship between exercise capacity, aerobic 
exercise and enhanced vagal modulation of the heart in healthy populations has been 
demonstrated (Billman 2002; Carter et al. 2003b; Hautala et al. 2009). This may be 





decrease in sympathetic outflow and an increase in cardiac modulation of heart rate 
(Billman 2002). Changes to HRV occur during exercise, caused by an increase in 
sympathetic activity and a decrease in parasympathetic activity (Gladwell et al. 
2010; Perini & Veicsteinas 2003). Over time, exercise improves HRV in both 
healthy and clinical populations (Billman & Kukielka 2006; Kaikkonen et al. 2008; 
Levy et al. 1998; Mandigout et al. 2002).  
 
7.1.6 Aims 
The present study aims to expand the understanding of HRV measurements using 
novel equipment and software called Ithlete. This study proposes to use just one 
measure, rMSSD in one minute measurements to assess HRV. With high 
correlations between the measures, there is little need to measure all of them each 
time HRV analysis is undertaken.  rMSSD has been demonstrated in the literature as 
a reliable measurement with high correlation to the others. The aim of this study was 
to reproduce basic correlations seen between vagal HRV and other measures 
including aerobic capacity and body composition, but with a new device (Ithlete). 
Establishing these relationships with the Ithlete device could provide a new 
monitoring tool for athletes, coaches and clinical populations. Because Ithlete is 
inexpensive compared with other medical devices, has a short measurement time and 
is user-friendly, it is an ideal tool for different populations to use outside the 
laboratory setting. 
 
Given that the literature suggests that there is a close relationship between various 
HRV indices and measures such as aerobic capacity and body fat, it is hypothesized 
that there will be a significant relationship between aerobic capacity measured by 
Vo2 peak, body composition measured by BIA and the rMSSD (ms) measurement of 
HRV from Ithlete. High rMSSD measurements will correspond to high aerobic 
capacity, lower body fat percentage and euhydration. Assessment by partial 
correlation will improve on the relationship established in the literature because 
chronic factors such as age and gender will be controlled for, taking away the effect 








7.2.1 Recruitment of participants 
Staff and students of Buckinghamshire New University were invited by internal 
advertisement on notice boards and through emails. Each participant was recruited in 
accordance with University ethics committee standards and expectations. 
Participants responded via email or phone and were sent an information pack before 
agreeing to participate which included: 
1. An information sheet with detail of the requirements for each participant 
before and during the laboratory visit 
2. An informed consent form 
3. A physical activity readiness questionnaire (PAR-Q) 
4. A detailed demographic information sheet 
Participants were requested to read the information pack prior to attending the 
laboratory and any questions or concerns were addressed.  All participants were free 
from any serious medical conditions and contraindications to exercise as indicated 
by the PAR-Q. All procedures were approved by the local research ethics committee. 
 
7.2.2 Participants 
Fifty-nine participants were tested, of which 28 were male and 31 were female.  
Participant ages ranged from 22 to 65 years of age. All participants were defined as 
healthy (free from any serious illness at the time of testing) and none of the 
participants was known to have any cardiovascular problems or be taking any 
medication that would have influenced the experimental procedures.  
Participants completed physical activity readiness questionnaires (PAR-Q); those 
who answered ‘yes’ to any of the conditions mentioned in the PAR-Q were 
excluded.  Participants completed their consent form in front of the researcher and 
the researcher countersigned the form. 
7.2.3 Experimental design 
Following appropriate ethical approval and informed consent, participants were 
asked to visit the cardiovascular research lab at Bucks New University, Uxbridge. 
Prior to the test participants were asked to avoid caffeine, heavy physical activity, 





were also encouraged not to eat at least two hours prior to the test. All the equipment 
used was calibrated before each test according to the manufacturers’ 
recommendations.   
 
7.2.3.1 Heart rate variability analysis 
Two measures (rMSSD in ms and HR in bpm) were recorded via the Ithlete software 
for the iPod touch (Ithlete 2009).  A standard analogue ECG chest strap was worn in 
the middle of the chest just under the sternum. Real time heart and lung animation on 
the iPod touch facilitated paced breathing during measurements and the screen also 
indicated the reception of each heart beat from the analogue chest strap. Participants 
measured rMSSD for one- minute, three times in succession in a seated position. 
Participants were given one-minute between each rMSSD recording.  After each 
one-minute recording, measurements were saved to the device. 
 
The breathing frequency was set at 7.5 breaths per minute, designed to maximize 
RSA response (Brown et al. 1993). When the one minute measurement was complete 
the HR (bpm) and rMSSD in ms were displayed on the screen and saved to the 
device. Ithlete recordings were transferred to a password protected PC via Ithlete 
software which enables recordings to be emailed and saved into an excel document. 
 
7.2.3.2 Bioelectrical impedance analysis 
Body composition measurements involved participants lying in a supine position for 
testing allowing at least five minutes for even body fluid distribution before 
measurements were recorded.  Two electrodes were placed on both the hand and foot 
of each participant, one on the bisecting line of the wrist/ankle and the other 
proximal to the fingers/toes. Once ready for measurement an undetectable current 
was passed through the distal electrodes on the hand and foot and the proximal 
electrodes on the wrist and ankle receive the current flow (Wilmore & Costill 1999).  
Water and electrolyte distribution in the tissues determines the electrical conduction 
between the electrodes. Fat mass has a greater impedance as it is more difficult for a 
current to flow through it when compared with free-fat mass.  Free-fat mass consists 
of all the body water and conducting electrolytes making conductivity much greater 






Using the BIA 101 and Bodygram software (Akern; Florence, Italy), small wires 
were connected for measurement and a recording was executed allowing at least 
three reading cycles before inputting measurements into the Bodygram software. 
Bodygram software then computed body composition measurements including BMI, 
body fat %, fat free mass %, intracellular water, extracellular water for each 
participant and stored in the Bodygram software program. BIA measurements take 
approximately five minutes to perform.  
 
7.2.3.3 Cardio-respiratory capacity analysis 
Participants were attached to a 12-lead ECG and facemask; five minutes of resting 
heart rate and gas measurements were then undertaken. After resting recordings, 
participants performed an incremental exercise test using the Bruce protocol on a 
motorized treadmill with online breath-by-breath analysis (Medical Graphics Cardio 
Control analysis system (MG) (Medical Graphics Corporation, St. Paul Minnesota, 
USA). The system was calibrated for each test using known reference and calibration 
gas concentrations. 
 
Each stage of the incremental exercise test lasted three minutes, with the endpoint 
when participants reached 90% of their predicted maximum heart rate or voluntary 
cessation due to fatigue. Directly following the exercise test participants were seated 
and a five-minute recovery period was measured. 
 
Examinations took place in the research lab maintained at a comfortable temperature 
with limited distractions. Experimental procedures were described to participants in 
advance. All procedures carried out during the examination were considered non-
invasive. 
  
7.2.4 Statistical analysis  
All statistical analysis was undertaken using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Owing to their established relationships with HRV, aerobic 
fitness (Bruce protocol treadmill test) and gender were controlled for. Student t-tests 
were undertaken to measure differences. Pearson correlation analysis was used to 





various body composition analysis measurements including BMI, body fat % and 
total body water (TBW). A P-value of ≤ 0.05 was considered statistically significant.  
 
7.3 Results 
7.3.1 Participant characteristics 
Participant characteristics for each gender are displayed in Table 7.1. Student t-tests 
found a significant difference in weight. The other participant characteristics 
recorded were similar in both groups.  
 
Table 7.1 Mean and SD for anthropometric and body composition characteristics of 
the participants 
Characteristic Male  
(n = 28) 
Female  
n = 31) 
Age (years) 30.6 ± 11.3 32.0  ± 9.8 
Height (cm) 173.5  ± 7.2 162.8  ± 5.4  




86.5  ± 9.5 78.7  ± 12.6* 
Body Fat (%) 24.5  ± 7.5 29.2  ± 11.2 
Body Mass Index 
(BMI) (kg/m2) 
24.9  ± 3.4 24.4  ± 6.1 
Total body water 
(%) 
41.6  ± 7.6 32.3  ± 5.3  
*Significant difference at p< 0.05 






7.3.2 HRV/HR, aerobic capacity and physical activity characteristics 
HRV (rMSSD) and HR at rest are represented in Table 7.2 along with aerobic 
capacity characteristics (respiratory ratio (RR), respiratory exchange ratio (RER), 
maximal oxygen uptake (Vo2 peak), unit of energy (METS) for each gender. Student 
independent t-tests revealed significant differences in Vo2 peak and Borg scale 
between genders. Table 7.3 displays the average amount of physical activity 
completed per day for each gender. 
 
Table 7.2 Mean and SD of rMSSD, HR and aerobic capacity characteristics of the 
participants 
Characteristic Male 
(n = 28) 
Female 
(n = 31) 
rMSSD (ms) 68.1 ± 10.2 70.8 ± 7.7 
HR (bpm) 82.6 ± 12.7 79.3 ± 9.4 
RR 
(breaths/min) 
34.4 ± 6.7 33.6 ± 6.6 
RER 1.1 ± 0.1 1.0 ± 0.1 
Vo2 peak  
(ml·kg-1·min-1) 
29.5 ± 6.9 25.7 ± 4.9* 
Borg Scale 15.3 ± 2.6 13.3 ± 3.8* 
Exercise Time 
(min) 
13.9 ± 3.1 13.7 ± 1.6 
METS 8.2 ± 1.9 7.34 ± 1.4 
*Significant difference at p< 0.05 
 
 
Table 7.3 Reported physical activity levels for male and female participants 
Physical Activity Level Male (n=27) Female (n=30) 
None 33.3 % 6.7 %  
< 30 minutes/day 37.1 % 33.3 % 
30-60 minutes/day 14.8 % 46.7 %  
> 60 minutes/day 14.8 % 13.3 % 
Significant difference at p< 0.01 
 
7.3.3 Analysis of covariance (ANCOVA)  
There were no significant r gender differences observed for HRV, F (1, 52) = 1.342; 
heart rate, F (1, 49) = 0.78 or Vo2 peak F (1, 49) = 1.045. When presented 
graphically roughly the same difference between parallel lines appeared between 





7.3.4 Correlations: Resting HRV/HR, aerobic capacity and physiological 
characteristics between genders 
Correlations are displayed in table 7.4. Resting rMSSD measurements were 
correlated with Vo2 peak at r= 0.302 and HR at r= -0.552 both at p<0.05. Body 
composition measurements of waist circumference, weight and BMI were also 
correlated with resting HRV at r= -0.297(p<0.05), r=-0.363(p<0.01) and r= -0.334 
(p<0.05) respectively.  Resting HR was correlated only with age at a level of r= -
0.258 (p<0.05). Vo2 peak correlated with age at r= -0.346 (p<0.01) and fat free mass 
at r= 0.449 (p<0.01). 
 
7.3.5 Correlations: Anaerobic threshold and physiological characteristic between 
genders 
Speed, RER, METS, RR and VE at anaerobic threshold were analysed through 
bivariate correlation analysis.  Notable correlations were found between speed at 
anaerobic threshold and TBW (r= 0.300 p< 0.05), age (r= -0.351 p<0.01), and height 
(r= 0.277 p< 0.05). METS were correlated at anaerobic threshold with BF (r= -0.276 
p< 0.05) and FFM (r= 0.276 p< 0.05); RR was correlated with resting HR (r= 0.298 
p< 0.05). VE was correlated with BMI (r= 0.316 p< 0.05), TBW (r= 0.622 p< 0.01), 
height (r= 0.486 p< 0.01), weight (r= 0.532 p< 0.01), WC (r= 0.414 p< 0.01) and 
BMR (r= 0.540 p< 0.01).  
 
7.3.6 Partial correlations: Resting HRV/HR, aerobic capacity and physiological 
characteristics 
Partial correlations were used to explore the relationships between HRV, HR, 
aerobic capacity and physiological characteristics while controlling for participant’s 
gender and age. There was a strong negative partial correlation between HRV and 
HR at r= -0.60, (p< 0.01) with high levels of HRV being associated with low levels 
of HR. An inspection of the zero order correlation suggests that controlling for 
gender and age has little effect on the HRV/HR relationship.  Partial correlations 
controlling for age and gender were also explored between HRV, aerobic capacity, 
waist circumference, weight and BMI. These partial correlations demonstrated 
negative correlations between HRV and waist circumference (r= -0.23, which was 






Table 7.4 demonstrates correlations between physiological characteristics, aerobic 
capacity and body composition. Significant correlations for rMSSD and HR obtained 
from the Ithlete device with the other characteristics are highlighted in red because 
the present study is particularly interested in correlations between Ithlete 
measurements and other correlates. 
 
It is recognized that because of numbers, some low correlations will yield a 
significant probability. Therefore significant but low correlations will still leave a 






Table 7.4 Correlations between physiological characteristics, aerobic capacity and body composition measurements 
 rMSSD HR Age H W WC BF FFM BMI TBW Vo2 
peak 
VE ET Borg METS RER RR 
rMSSD -- -0.55  -0.11 -0.07 -0.36  -0.30* -0.19 0.19 -0.33* -0.20 0.30* -0.12 0.23 -0.16 0.24 -0.19 -0.04 
HR -- -- -0.26* 0.07 0.39  0.43  -0.37  0.02 -0.08 0.00 -0.22 -0.09 -0.18 0.00 -0.18 0.05 0.11 
Age -- -- -- -0.05 0.39  0.43 0.17 -0.17 0.45  0.25 -0.35  0.00 -0.47  0.14 -0.38  0.31* -0.33* 
H -- -- -- -- 0.43  0.31* -0.37  0.37  -0.06 0.72  0.31* 0.51  -0.03 0.15 0.23 0.15 0.08 
W -- -- -- -- -- 0.90  0.36  -0.36  0.87  0.73  -0.17 0.55  -0.26* 0.34* -0.23 0.19 -0.09 
WC -- -- -- -- -- -- 0.41  -0.41  0.81  0.61  -0.28* 0.40  -0.37  0.34* -0.35  0.14 -0.05 
BF -- -- -- -- -- -- -- -1.00  0.60  -0.35  -0.50  -0.06 0.24 -0.03 -0.45  -0.03 -0.09 
FFM -- -- -- -- -- -- -- -- -0.60  0.35  -0.50  0.06 0.24 0.03 0.45  0.03 0.09 
BMI -- -- -- -- -- -- -- -- -- 0.41  -0.35  0.36  -0.26 0.39  -0.37  0.15 -0.16 
TBW -- -- -- -- -- -- -- -- -- -- 0.18 0.54  -0.09 0.37  0.07 0.23 -0.09 
Vo2 
peak 
-- -- -- -- -- -- -- -- -- -- -- 0.61  0.63  0.13 0.99  0.37  0.18 
VE -- -- -- -- -- -- -- -- -- -- -- -- 0.43  0.37  0.61  0.64  0.23 
ET -- -- -- -- -- -- -- -- -- -- -- -- -- 0.15 0.71  0.53  0.19 
Borg -- -- -- -- -- -- -- -- -- -- -- -- -- -- 0.14 0.30* 0.17 
METS -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 0.46  0.23 
RER -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 0.16 
RR -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 





Table 7.4 on the previous page is a correlation matrix displaying the correlations 
found between physiological characteristics and other variables including exercise 
capacity measurements including Exercise Time (ET), Body Mass Index (BMI), 
Borg Scale (Borg), Height (H), Respiratory Exchange Ratio (RER), Body Fat 
Percentage (BF), Respiratory Rate (RR), Total Body Water (TBW), Waist 
Circumference (WC), Free Fat Mass (FFM), Minute Ventilation (VE), Weight (W). 
 
7.4 Discussion 
The present research study sought to explore the relationships that exist between 
HRV (rMSSD), aerobic capacity and body composition while also reproducing basic 
correlations seen between vagal HR and other measures with a new HRV 
measurement tool (Ithlete). The present study found no significant gender 
differences in rMSSD. Significant negative correlations at p< 0.01 were 
demonstrated between resting rMSSD measurements and HR, weight and BMI.  
rMSSD was also negatively correlated with WC (p <0.05) and positively correlated 
with Vo2 peak (p <0.05). Since rMSSD reflects parasympathetic activity without 
being dependent on heart trends (Stein et al. 1994), these correlations demonstrate 
the effect of parasympathetic tone on those variables. Resting rMSSD analyses taken 
with the Ithlete software were easy and convenient; participants reported no 
problems using the device.   
 
7.4.1 rMSSD and heart rate 
Gender differences in resting HRV have been reported in the literature. Gender 
differences have been controversial with studies suggesting females have a higher 
resting HRV (Evans et al. 2001; Koskinen et al. 2009), and other studies suggesting 
males have a higher resting HRV (Bonnemeier et al. 2003; Umetani et al. 1998).  
Within this study, females had a slightly higher resting HRV than males but this was 
not significantly different (p<0.05).  
 
The present study found resting HR was negatively correlated with age (p <0.05). 
Several studies have looked at the relationship between physical activity levels and 
HR (Aubert et al. 2003; Carter et al. 2003a; Nunan et al. 2010a; Sandercock et al. 





becomes altered during exercise; HR increases as a result of increased sympathetic 
activity during exercise, and heart rate recovery is mediated by vagal reactivation 
following exercise (Myers et al. 2007). The interaction between the sympathetic and 
parasympathetic branches of the autonomic nervous system influences results in the 
autonomic state known as sympathovagal balance (Goldberger 1999). 
Sympathovagal tone assessed by HRV has been directly associated with BMI, body 
fat percentage and skeletal muscle in young healthy males and females (Duncker R. 
et al. 2011). This research study is unique due to its use of an innovative 
commercially available device called Ithlete which measures both HR and HRV. 
Ithlete is innovative because it takes one-minute measurements of rMSSD and HR, 
displaying the measurement directly on the screen instead of having to input raw 
data into external software. 
 
The present study aimed to reproduce basic correlations seen between vagal HRV 
and other measures including aerobic capacity and body composition (specifically 
hydration) with the Ithlete device to see if a lower cost device can be used in healthy 
and clinical populations. Resting measurements of HR should be between 60 and 
100 bpm (Kossmann 1953), the mean for both male and female participants in this 
study was well within that range. The mean rMSSD for male and female participants 
were found to be similar to other studies discussed in a systematic review completed 
in 2010 (Nunan et al. 2010).  The relationship between rMSSD, HR and FM is well 
documented. Larger percentages of body fat were associated with reduced HRV and 
increased HR (Sztajzel et al. 2009). An increase in body weight was related to 
decreased time domain parameters including rMSSD and SDNN in adolescent obese 
subjects (Rabbia et al. 2003; Sztajzel et al. 2009). Decreased HRV indices have 
recently been associated with total body FM (Christou et al. 2004). Lower levels of 
rMSSD were associated with high levels of total body fat mass and fat free mass in 
obese children (Gutin et al. 2000). A relationship was found between BMI and HRV 
in women where a higher BMI had reduced parasympathetic control and elevated 
sympathovagal modulation (Pai et al. 2011), therefore lower HRV. HRV has also 
been associated with exercise capacity, where a higher exercise capacity corresponds 
to higher HRV (De Meersman 1993; Galetta et al. 2005; Melanson & Freedson 






7.4.2 Body composition 
BMI cut-offs have been criticised in recent years due to their inability to demonstrate 
a higher risk of adverse events in individuals classed as overweight (BMI 25-29 
kg·m2) when compared with normal weight counterparts (Lopez-Jimenez 2009; 
Romero-Corral et al. 2006).  This is because BMI cannot differentiate between body 
fat from lean mass in various populations (ibid). A systematic review in 2010 
suggests that when defining obesity based on the amount of body fat, the normal 
(healthy) cut-off level for BMI should actually fall between 25-30 kg·m2 
(Okorodudu et al. 2010).  
 
Current guidelines in the UK state that a healthy BMI should be between 18.5-24.9 
(National Institute for Health and Clinical Excellence (NICE) 2006). In this study the 
female average fell within this range at the upper limit while the male average fell 
just outside at 25 suggesting that half of the participants were in the overweight 
range of BMI. In the UK waist circumference is cited as an increased risk at ≥ 94 cm 
for males and ≥ 80cm for females (National Institute for Clinical Excellence 2007). 
In this study the average waist circumference was below both cut-offs at 86 ± 10 for 
males and 79 ± 13 for females, although the female average was only one point 
below the cut-off suggesting that about half of the female participants were above 
that cut-off. When BMI is less than 35, waist circumference is a valid measurement 
of abdominal fat mass and is suggested for use in indentifying disease risk (ibid).  
With this in mind, both males and females in this study could be considered at higher 
risk based on both BMI and WC measurements.  
 
While there are some obvious drawbacks to the use of BMI including the inability to 
account for muscle, measures of body fat are better because BMI does not 
differentiate between adipose tissue and lean mass in intermediate BMI ranges 
(Frankenfield et al. 2001; Piers et al. 2000; Romero-Corral et al. 2007). The average 
body fat percentage for males and females in the present study were within the 
normal ranges when broken down into the age related body fat recommendations.  
The healthy body fat percentage range for 20-39 year old females is between 21-33% 
and 8-20% for males (Gallagher et al. 2000).  For 40-59 year old females the healthy 
body fat percentage range is 23-34% and 11-22% for males of the same age (ibid). In 





and 28.1 ± 10.1 for females. For 40-59 year olds the average for males was 24.6 ± 
8.4 and females was 32.1 ± 14.0. This suggests that participants in this study had 
relatively healthy body fat percentages. Body composition measurement in the 
present study was derived from bioelectrical impedance analysis (BIA), where fat 
measurements are derived from prediction models to estimate total body water and 
free fat mass (Chumlea & Guo 1994; Guo et al. 1989).  
 
Maughan & Griffin, (2001) report that the normal healthy range for TBW percentage 
for a healthy adult female should be between 45-60%, and 50-65% for a male. In the 
present study the average TBW for both male and female participants were below 
those averages. However there are many factors that could affect this. TBW levels 
change naturally throughout the day and will also fluctuate based on food and water 
consumption throughout the day. If a large quantity of pure water or hypotonic fluid 
(e.g. 1.2L in 5 minutes) is ingested this would result in the water entering the blood 
and kidney function producing a large volume of dilute urine before the intracellular 
and extracellular fluid could equilibrate (Armstrong 2007).  In this case that would 
suggest that using urine indices would be invalid because the urine values would 
reflect the volume of liquid consumed instead of the change in TBW (Kovacs, 
Senden & Brouns 1998). Water and food consumption before the test were not 
controlled within the present study, therefore these daily fluctuations could have 
affected the results marginally.  
 
7.4.3 Vo2 peak 
The average Vo2 peak for a sedentary male is approximately 45 ml·kg-1·min-1 and 38 
ml·kg-1·min-1for sedentary females (Geddes 2007). The mean for both male (29.5 ± 
6.9 ml·kg-1·min-1) and female (25.7 ± 4.9 ml·kg-1·min-1) in this study was much 
lower than that, suggesting that the fitness level of the participants within this study 
was not very high. When broken down into age specific groups, established 
guidelines for Vo2 peak (ml·kg-1·min-1) for healthy non-athletic males and females 
are shown in table 7.5 (Wilmore & Costill 2005). Vo2 peak for both males and 
females were all found to be lower in this study except for one group. Female 
participants (30-39) were the only group mean within the average non-athlete range. 
There could be many reasons for this which includes genetics, current state of health 





activity is dependent mostly on lifestyle; most of the South Asian participants had 
recently arrived in England and did not report high levels of physical activity. The 
levels of physical activity reported from this cohort of participants were low, with 
70.4% of males reporting their physical activity levels as < 30 min per day; 40% of 
females reported physical activity as < 30 minutes per day. Adults (18 – 65 years of 
age) should undertake a minimum of 30 minutes of moderate-intensity aerobic 
(endurance) exercise five days a week or vigorous-intensity aerobic exercise for a 
minimum of 20 minutes three times per week (Haskell et al. 2007). These low levels 
of physical activity help to explain the lower Vo2 peak values found in the present 
study, along with the use of the modified Bruce protocol for testing. 
 
Table 7.5: Recommended Male and Female Vo2 peak values (ml·kg-1·min-1) 
Age Male Female 
 Non Athlete 
Average 
This Study Non Athlete 
Average 
This Study 
20-29 43-52 24.2 ± 10.3 (17) 33-42 29 ± 9.2 (19) 
30-39 39-48 22.9 ± 2.2 (5) 30-38 23 ± 14 (5) 
40-49 36-44 26.1 ± 5,2 (5) 26-35 33.7 ± 3.3 (2) 
50-59 34-41 15.7 ± 11 (4) 24-33 22.2 ± 5.7 (3) 
*Non-Athlete average accessed from (Wilmore & Costill 2005) 
( ) Denotes the number of participants in each age group  
 
Testing was carried out using the modified Bruce protocol, the test was stopped 
when participants reached 90% of their maximum heart rate (as predicted by 220- 
age) or if they could not keep up the pace on the treadmill. True Vo2 max is 
dependent on maximal effort (Howley et al. 1995), however some participants did 
not appear to be at complete exhaustion but opted to end the test as they did not feel 
that they could continue. Different perceptions of exhaustion within this participant 
cohort suggests that a discrepancy existed which may not just be attributed to their 
physical performance. Other factors may have been their perceived level of their 
own athleticism, or their low self efficacy which many participants stated before the 
test.  Some participants felt that they were not athletic and therefore would not be 
able to do well on the test.  Some participants had also never used a treadmill, and 





The lower Vo2 peak averages demonstrated in the present study may be due to the 
use of the modified Bruce protocol. Submaximal exercise tests are practical in a 
range of settings, require less time to execute and are usually safer than maximal 
exercise tests. Standard prediction equations are used for submaximal exercise 
testing to determine maximal oxygen uptake (Vo2 max) (Noonan & Dean 2000); 
high reliability of predicted Vo2 max when compared with measured Vo2 max was 
reported at (r=0.96) for the general equation (ibid); suggesting submaximal tests are 
a useful measurement tool. Within the present study, participants may not have 
pushed themselves to their maximum as several volitionally stopped the test 
considerably below their maximum heart rate. Several participants had also never 
used a treadmill before and therefore found it hard to adjust to.  The use of treadmills 
in submaximal testing provides benefits because treadmills are often used as a 
training modality and they are regularly found in fitness facilities and laboratories 
(Vehrs et al. 2007). 
 
Gender differences were also considered in the present study, a significant difference 
between males (29.52 ml·kg-1·min-1) and females (25.68 ml·kg-1·min-1) for Vo2 peak 
was demonstrated. Vo2 peak decreases with age and decreases more in males than in 
females when matched for age (Buskirk & Hodgson 1987; Hossack & Bruce 1982).  
The present study also had males and females matched for age. Body composition 
measurements are also associated with Vo2 peak in both males and females (Toth et 
al. 1994).  Another gender difference observed in this study is the RER, a numeric 
index of carbohydrate and fat utilization. The present study found a lower RER on 
average in females (1.02 ± 0.07) compared with males (1.06 ± 0.11). Gender 
differences in RER have been reported by Tarnopolsky (1990) who found 
significantly lower RER values in females compared with males which indicated an 
increased reliance on fats as fuel (Vella & Kravitz 2002). Between gender 
differences in metabolism and storage of fat occur with women having an increase in 
the proportion of energy derived from fat during low to moderate intensity exercise 
when compared with men (Vella & Kravitz 2002). In the present study RER was 







7.4.4 Cardiorespiratory correlations 
Correlations between resting HRV measurements and Vo2 max have been 
documented in the literature but are inconsistent (Grant et al. 2009). Either no 
correlation or significant correlations have been reported between the same HRV 
measurements and Vo2 peak; however this could be attributed to differences between 
the participants investigated (ibid). This study did find a significant correlation 
between HRV and Vo2 peak at r= 0.302 (p<0.05). However the sample size is 
slightly smaller compared with the literature, which reported the same findings and 
up to 91% of the variance is unaccounted for. There were significant correlations 
between anthropometric variables and exercise test measurements. Notably 
correlations found between age, height, weight, waist circumference and total body 
water with exercise test measurements strongly suggests the importance of each 
variable.  
 
7.4.4.1 Partial correlations 
Univariate correlations do not necessarily denote cause and effect and are 
problematic because they are limited to linear relationships between variables 
(Coppack 1990). Partial correlations have the advantage of facilitating correlation 
between two variables while removing the influence of another variable(s) 
(Stanovich 2007). In the present study a strong negative partial correlation was 
demonstrated between HRV and HR controlling for gender and age; other studies 
have also found high levels of HR associated with low levels of HRV (Ramaekers et 
al. 1998b; Tsuji et al. 1994).  Controlling for gender and age is important because of 
the established interrelationships between these measurements (Agelink et al. 2001; 
Cowan et al. 1994; Stein et al. 1997; Umetani et al. 1998). Ramaekers et al, (1998b) 
also completed partial correlation analysis finding the same result as the present 
study; however these correlations rarely appear in the literature despite their 
importance. The effect age has on HRV has been extensively analysed and widely 
reported therefore it must be controlled for when analysing differences in HRV 
between groups. This finding is consistent with the literature, as sympathetic 
activation is known to result in an increase in HR and decrease in overall HRV 






A negative correlation was demonstrated between 24-hour HR and rMSSD in 
healthy men and women between the ages of 18 and 71 (Ramaekers et al. 1998a), 
however when sub-analysed for age group this relationship was lost as participants’ 
age increased. Partial correlations controlling for age and gender were also explored 
between HRV, aerobic capacity, waist circumference, weight and BMI. These partial 
correlations demonstrated a negative relationship between HRV and three 
measurements: weight, waist circumference and BMI. This concurs with previous 
research showing that lower levels of HRV are commonly seen in people with higher 
weight (Hirsch et al. 1991; Sjoberg et al. 2011). Research on overweight and obese 
adults found a correlation between another HRV time-domain measure (low 
frequency power) and changes in WC (Sjoberg et al. 2011). BMI has been negatively 
associated with HRV in middle-aged and elderly subjects (Sajadieh et al. 2004), type 
1 diabetes patients and the general population (Colhoun et al. 2001). 
 
7.4.5 Limitations 
Limitations to this study involve the method of obtaining participants.  Self selection 
naturally occurred through the recruitment of participants. Those who are involved in 
this study were those that wanted to participate and therefore are not necessarily 
representative of the population. A percentage of the participants were international 
students who were recent inhabitants of the UK within the last 6 months; therefore 




The rMSSD measure from the Ithlete device shares the same relationships with 
aerobic capacity and body composition measures as other vagal measurements in the 
literature. The present study demonstrated negative relationships between rMSSD 
and HR, weight, WC and BMI. A positive relationship was demonstrated between 
rMSSD and Vo2 peak. Further research is warranted for the use of Ithlete in clinical 
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CHAPTER 8: HEART RATE VARIABILITY MEASUREMENT IN 
HEALTHY SUBJECTS WITH VARYING PHYSICAL ACTIVITY LEVELS 
USING ITHLETE SOFTWARE 
 
Heart rate variability (HRV) is the phenomenon of the difference in time between 
heart beats, which is influenced by the autonomic nervous system. The root mean 
squared successive differences (rMSSD) of heart periods is a time-domain measure 
of HRV which is sensitive to vagal cardiac control, and is less sensitive to variations 
in respiratory patterns. High HRV is an indication of good adaptability, which 
implies a healthy individual with a good working autonomic nervous system. The 
influence of exercise on HRV has been demonstrated throughout the literature, and 
rMSSD or the high-frequency (HFr) range are the most widely used methods for 
quantifying parasympathetic activation after cessation of exercise. Following a major 
bout of prolonged high intensity exercise, a decrease occurs in cardiac vagal outflow. 
This decrease in cardiac vagal flow can be measured through HRV. A change in 
HRV demonstrates that the exercise intensity was enough to cause physiological 
adaptations; these adaptations can lead to improved cardio-respiratory health. Ithlete 
is an HRV measurement tool designed to monitor the body’s autonomic response to 
exercise.  
 
Twenty-four subjects successfully completed the study. Ithlete measurements were 
assessed 24 and 48-hours following exercise, and a decrease in HRV following 
exercise was found in 37.5%, and 58.3% of participants respectively. Those 
participants who did at least 30 minutes of exercise, three or more times a week had 
a lower resting average heart rate and a higher resting average HRV. In total, 86% of 
the participants completed Ithlete measurements for one-month. When assessing 
HRV 24-hours following exercise, 38.1% of participants were coded as dippers 
(those who demonstrated a decrease in HRV). Forty-eight hours following exercise, 
58.3% of participants were coded as dippers. This suggests that changes in cardiac 
autonomic regulation may last for more than 24-hours. Ithlete appears to be an easy 
device to use for HRV assessment at rest in the healthy population. Ithlete provides 
easily interpreted, immediate feedback to the user which can be utilized to gauge 
how the body has responded to exercise. The range for rMSSD obtained from Ithlete 






8.1.1 Description of HRV 
Heart rate variability (HRV) is the phenomenon of the difference in time between 
heart beats, caused by the influence from the autonomic nervous system (ANS). The 
sympathetic and parasympathetic branches of the ANS influence the SA node which 
is the pacemaker of the heart. Several other influences have been proposed to affect 
the SA node, which include autonomic failure, changes in the autonomic nervous 
system throughout the day, and age-related or seasonal changes (Tulen et al. 1991).  
 
Traditionally, measurement of HRV required a high-quality electrocardiogram 
(ECG) with a sampling rate above 250 Hz and an accurate algorithm to detect the 
QRS complex (Task Force, 1996). There is a large range in the recommended 
duration of recording throughout the literature. The duration can be as short as 30 
seconds or as long as a 48-hour continuous recording. There are several modes of 
analysis that can be used for HRV measurement, including time domain, frequency 
domain, non-linear measurements. These modes were discussed in detail in the 
literature review (Chapter 2). High correlations have been demonstrated between 
time and frequency domain measures of vagal activity to suggest that they can be 
used interchangeably (Bigger Jr et al. 1989).  rMSSD and the high frequency power 
of the normal R-R interval power spectrum have correlations with each other as high 
as (>0.90) (ibid). The present study will focus on one measure in particular, rMSSD. 
 
8.1.1.1 rMSSD 
The square root of the mean squared differences of successive heart periods 
(rMSSD) is a time-domain measure which is often included in analytical systems for 
measuring HRV (Berntson et al. 2005). rMSSD is a frequently used index in clinical 
cardiology (Task Force, 1996), and is known for its sensitivity to short-term, high 
frequency heart period fluctuations (Porges & Byrne 1992; Task Force, 1996). The 
rMSSD measure has been suggested as superior to spectral methods due to its 
sensitivity to vagal cardiac control, and it is less sensitive to variations in respiratory 
patterns (Penttilä et al. 2001). There is a high correlation between absolute values of 





suggests that rMSSD is perhaps useful as a time-domain index of vagal control of 
the heart (Berntson et al. 2005).  
 
8.1.1.2 What is a healthy HRV measurement? 
High HRV is an indication of good adaptability, which implies a healthy individual 
with well functioning autonomic control mechanisms (Yerdelen et al. 2010). The 
typical resting heart rate (HR) for adults between the ages of eighteen to sixty is 60-
100 beats/min. HRV does not have a similar well-known figure which constitutes a 
healthy range. HRV is thought to be a very individual measure, which can vary a 
great deal from person to person. The relationship between aerobic capacity, aerobic 
exercise, and enhanced vagal modulation of the heart in healthy populations has been 
demonstrated (Billman 2002; Carter et al. 2003b; Hautala et al. 2009). A reason for 
this might be that aerobic training protects the heart against harmful cardiac events, 
through a decrease in sympathetic outflow and an increase in cardiac modulation of 
HR (Billman 2002). 
 
8.1.2 HRV and exercise   
The influence of exercise on HRV has been demonstrated throughout literature (al-
Ani et al. 1996; Gladwell et al. 2010; Hautala et al. 2001; Manzi et al. 2009; Ogoh et 
al. 2002; Raven et al. 2006). In a review of athletes and sedentary individuals, higher 
HRV values of rMSSD were found between both aerobically and anaerobically 
trained athletes (Aubert et al. 2003). A lower resting HR in endurance trained 
athletes was also demonstrated in several studies, suggesting enhanced vagal tone in 
athletes (ibid).  Endurance training results in decreased sympathetic activity, 
increased parasympathetic activity and increased HRV at rest (Carter et al. 2003b). 
Higher HRV values are produced by a healthy well-rested body, but factors affecting 
HRV must also be considered. 
 
Acute exercise responses and chronic adaptations to exercise have been considered 
(Ekblom et al. 1968; Nottin et al. 2002; Stratton et al. 1994), and are difficult to view 
in isolation (Thompson et al. 2001). The immediate responses that occur during 
exercise are known as acute responses, these include increased HR, increased 





long-term adaptations range from decreased resting HR, an increase in lung volume, 
cardiac hypertrophy, and changes in body composition.   
 
Autonomic activity becomes altered during exercise; this is signified by an increase 
in sympathetic activity and a decrease in parasympathetic activity (Gladwell et al. 
2010; Perini & Veicsteinas 2003). HR increases as a result of increased sympathetic 
activity during exercise, and heart rate recovery is mediated by vagal reactivation 
following exercise (Myers et al. 2007). The effects of gender (Huikuri et al. 1996; 
Kuo et al. 1999; Ryan et al. 1994) and age (Carter et al. 2003a; Lakatta 1993; Stein 
et al. 1997) on the ANS play a part in both acute and chronic adaptations to exercise; 
as do intensity and volume of exercise performed. Haskell et al, (2007) suggested 
that in order to see a health benefit, a minimum of 20-minutes of vigorous activity at 
least three times a week is necessary.  
 
Examining HRV following exercise provides an indication of alterations to vagal 
ANS activity (Pagani et al. 1986). Post-exercise recovery in relation to HRV has 
been examined in previous studies with various intensities and durations (Javorka et 
al. 2002; Mourot et al. 2004b; Pober et al. 2004). An initial decrease in HRV has 
been demonstrated within minutes or hours following exercise in several studies 
(Mourot et al. 2004b; Parekh & Lee 2005; Terziotti et al. 2001). Furthermore, it 
appears to take longer to restore vagal tone following a high intensity bout of 
exercise (80% Vo2 peak) compared with moderate intensity exercise (50% Vo2 peak) 
(Mourot et al. 2004b; Parekh & Lee 2005). Following a major bout of prolonged 
high intensity exercise, a decrease occurs in cardiac vagal outflow, and was observed 
for several hours after the cessation of exercise (Hautala et al. 2001). On the second 
day, following prolonged high intensity exercise, an accentuated rebound 
phenomenon with enhanced vagal regulation was observed with large inter-
individual variations of reduced vagal outflow at the time of recovery (ibid). The 
interaction between intensity, duration and HRV has become a tool in preventing 
staleness, overreaching or overtraining. These states are thought to develop as a 
result of excessive training loads, without adequate recovery in between. Several 
symptoms have been linked to overtraining, including changes in autonomic function 






Overtraining occurs when the volume and intensity (or TRIMP: to be explained in 
the next section) of a person’s exercise exceeds their capacity to recover. Symptoms 
can manifest as one or more behavioural, emotional and/or physical conditions. 
Overtraining most often manifests as pronounced fatigue, illness or reduced 
performance. An ANS disturbance is suggested as a possible cause for these 
symptoms (Hedelin et al. 2000). Overtraining is also thought to have a negative 
impact on autonomic cardiovascular control (Hedelin et al. 2000). When looking at 
the literature pertaining to athletes, a relationship between a drop in HRV and 
increased risk of illness was found in national level swimmers (Hellard et al. 2011). 
Cipryan et al. (2007) demonstrated a strong correlation between HRV and 
performance in male hockey players. Contrary to these studies, Uusitalo (1998) 
demonstrated that in female endurance athletes, an increased training load and 
overtraining did not cause significant changes to cardiac autonomic modulation or 
intrinsic HR.   
 
When considering different fitness levels, overtraining has a stronger effect on HRV 
in untrained women, compared with their trained counterparts (Winsley et al. 2005). 
This suggests that those who are less fit will find it more difficult to overcome the 
symptoms of overtraining. Abrupt changes in workload also appear to signal changes 
in autonomic control, compared with a progressively increasing workload, which 
triggers cardiovascular adaptation effects (Baumert et al. 2006). This implies that 
sudden and larger changes in workload will have a greater impact on recovery and 
HRV. Therefore measurements of HRV are good tools to use in the prevention of 
overtraining because by monitoring HRV levels, individuals can make sure they do 
not progressively dip during an exercise training programme. While monitoring 
HRV, monitoring the dose-response relationship for exercise training load is also 
important. The dose-response relationship between physical activity and 
performance has been quantified using the TRIMP method in endurance and team 
sport athletes (Foster et al. 2005; Padilla et al. 2000; Padilla et al. 2008; Rodríguez-
Marroyo et al. 2009; Stagno et al. 2007).  This method shall be discussed in detail in 








TRaining IMPulse (TRIMP) is defined as the training volume (total training 
duration) multiplied by the training intensity (average heart rate in beats per minute 
during exercise). TRIMP was developed by Dr. E. Bannister in the mid seventies to 
quantify training/exercise sessions. Quantifying training can be important for 
assessing how much impact training/exercise has on the body. The original TRIMP 
calculation was useful as a monitoring tool to assess progress and adherence to 
training; however the main drawback was that it did not distinguish between 
different levels of training. Exercise done at 60% of maximum HR (HRmax) is less 
demanding than exercise done at 85% HRmax, and therefore this needs to be 
accounted for. New calculations by Foster et al. (2001) devised five training zones 
(expressed as a % of HRmax) using heart rate zones to determine intensity. Athletes 
use this method to help define how hard to train at different periods of their season, 
and several studies analysing HRV have also used TRIMP (Earnest et al. 2004; 
Kiviniemi et al. 2010; Manzi et al. 2009). 
 
The new equation including the training zones now accounted for variation in 
intensity. For the purpose of the present study however, this was still not suitable 
because the dependent variable being assessed is HRV. By using HR within the 
TRIMP equation in the present study, the independent and dependent variables 
would be too closely related. Therefore, within the present study, TRIMP was 
calculated with intensity multiplied by duration. For simplification, intensity was 
classified into three categories (low, moderate, high). Low-intensity aerobic 
activity was described as not working hard enough to raise your HR or break a 
sweat. Moderate-intensity aerobic activity was described as working hard enough to 
raise your HR and break a sweat, yet still being able to carry on a conversation. 
High-intensity aerobic activity was defined as breathing hard and fast, with a sharp 
increase in HR. Aerobic activity at this level, resulted in not being able to say more 
than a few words without needing to pause for a breath. When used effectively, 
TRIMP can provide athletes and coaches with a gauge to prevent them from 
overworking the body. Overworking the body can result in inadequate recovery, 
which if not dealt with effectively, leads to overtraining. Because measurement of 





together with TRIMP has the potential to enhance training programmes and 
consequently performance.  
 
8.1.5 Measurement options for HRV 
Ultra-short measurements of as little as 10 seconds have been reported as reliable in 
certain time-domain parameters (Nussinovitch et al. 2011). A new measurement tool 
called Ithlete has been launched on the market which takes short measurements (one-
minute recordings), and is at a similar cost to Polar at approximately £200 per 
measurement kit. This is a much lower cost when compared with ECG systems. For 
the purpose of the present study, Ithlete was used because of its short measurement 
time, cost and accessibility of the device. 
 
8.1.5.1 Ithlete 
Ithlete was developed as a software package with a dongle that can be used with 
smartphones and the iPod touch. Ithlete takes one-minute measurements of HRV 
through the use of a standard HR monitor chest strap. Ithlete measurements should 
be taken first thing in the morning when the body is at rest. Measurements of HRV 
are used to help people monitor how their body is responding to exercise and stress.  
HRV is thought to decrease when the body is put under stress. As HRV can assess 
cardiac autonomic function, Ithlete measurements may provide a way to quantify the 
body’s autonomic response. Ithlete was developed as a tool for preventing 
overtraining in endurance athletes. For the purpose of this study however, Ithlete is 
used to quantify the body’s response to variation in exercise in a range of fitness 
levels. The creator of Ithlete modified its measurement output of rMSSD to make for 
an easily interpretable figure for non-expert users.  The value displayed by the 
application is the natural log transformed rMSSD, multiplied by 20 (lnrMSSDx20). 
The ease and convenience of short-term rMSSD measurements from the Ithlete 
application should provide a good platform for maximum compliance from 
participants.  
 
Several studies have analysed the effects of training on HRV using ECG readings 
which need to be converted from analogue to digital, and analysed through a 
software package (Aubert et al. 2003; Iellamo et al. 2002; Mourot et al. 2004a). 





Vanderlei et al. 2008), which need to be inputted into software on a computer and 
converted into HRV measurements. The present study is the first to use Ithlete 
measurements in healthy participants to assess their response to exercise. Ithlete 
rMSSD readings are displayed directly on the measurement device screen (i.e. iPod 
touch or smartphone). Measurements are displayed immediately following a 
recording, instead of having to input raw data into a software package on a PC for 
analysis. Comparisons are made between previous measurements of rMSSD taken 
within the last month on that device. This provides each user with a unique pattern 
that corresponds to their own specific autonomic response to stress’ such as exercise. 
 
8.1.6 Aims 
The aims of the present study were to: (i) assess the ability of Ithlete software to 
measure HRV daily for one month in healthy participants, (ii)  assess the relationship 
between physical activity, smoking, and alcohol with HRV and HR, (iii) assess 
Ithlete measurements for 24 and 48-hours following exercise to see if a decrease 
(dip) in HRV occurs. 
  
8.2 Methods 
8.2.1 Recruitment of participants 
Staff and students of Buckinghamshire New University were invited to take part in 
the study through internal advertisement on notice boards and emails. Each 
participant was recruited in accordance with University ethics committee standards 
and expectations. Participants responded in person, via email or phone and were sent 
an information pack before agreeing to participate. The information pack included: 
1. An information sheet with details of the requirements for each participant; 
2. An informed consent form; 
3. HRV measurement information package; 
4. Physical activity diary; 
5. A detailed demographic information sheet. 
Participants were requested to read the information pack, and during the first 
meeting any questions or concerns were addressed. All participants were free from 








Twenty-eight participants were tested, of which 13 were male and 15 were female. 
Participant ages ranged from 25 to 64 years. All participants were defined as healthy 
(free from any serious illness at the time of testing), and none of the participants 
were known to have any cardiovascular problems, or to be taking any medication 
that would have influenced the experimental procedures.  
Details of the study were explained when participants met with the researcher. The 
Ithlete software was demonstrated and the physical activity diary was also explained.  
Participants completed their consent form in front of the researcher, and the 
researcher countersigned the form. 
8.2.3 Experimental design 
Following appropriate ethical approval and informed consent, participants were 
asked to visit the cardiovascular research lab at Bucks New University, Uxbridge. 
Each participant was given a demonstration of how to use the Ithlete software on the 
iPod touch and required to complete two measurements in the presence of a 
researcher before taking the device home. Then each participant was required to take 
an HRV measurement daily, first thing when they woke up, for one month. Each day 
participants also recorded the following items in a physical activity diary: 
1. What (if any) exercise was performed the day before; 
2. Duration of that exercise; 
3. Intensity of that exercise (Low/Moderate/High); 
4. Daily scale of how they felt on a scale of 0-100% (100% being the best). 
 
For the purpose of the present study, duration and intensity were used to calculate 
TRIMP. TRIMP was used to determine if subjects engaged in a sufficient amount of 
exercise on a given day to cause a change in HRV. The median-split method was 
used to determine if subjects exercised or not. If subjects did more than 50% of their 
mean daily exercise, this was then deemed an exercise/training session. This 
information will be used to assess the relationship between exercise and Ithlete 
rMSSD measurements. Additionally, participants were classified as dippers if their 
rMSSD reading was lower than the previous reading. Athlete’s systematically 
overload in order to improve their performance and therefore may cause dramatic 





average individual however, will not systematically overload and therefore will not 
necessarily demonstrate dramatic decreases in rMSSD. Controls may have 
completed enough exercise to cause dramatic dips; however patients with heart 
failure often have low exercise tolerance and therefore are unlikely to demonstrate 
dramatic dips in rMSSD. Therefore in the present study, any dip in rMSSD was 
considered a training dip in order to keep consistency between controls and 
participants with heart failure in the following chapters.   
 
8.2.3.1 Heart rate variability analysis 
Heart rate variability measurements were taken using an iPod touch with the Ithlete 
application (Ithlete 2009). For HRV measurement, a standard analogue ECG chest 
strap was worn in the middle of the chest just under the sternum. Using the Ithlete 
software for the iPod touch, participants measured HRV in a seated position, for one 
minute when they woke up.  
 
Real time heart and lung animation via the Ithlete application was displayed on the 
iPod touch. This facilitated paced breathing during measurements and indicated 
reception of each heart beat from the analogue chest strap. Participants followed a 
breathing frequency of 7.5 breaths per minute, designed to maximize RSA response 
(Brown et al. 1993). When the one minute measurement was complete, the HR 
(bpm) and HRV (rMSSD) were displayed on the screen and saved to the device. At 
the end of the one month recording period, Ithlete recordings were transferred to a 
password protected PC via the Ithlete software which enables recordings to be 
emailed and saved into an excel document.  
 
8.2.4 Statistical analysis 
All statistical analysis was undertaken using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Values are reported in the text as mean ± standard deviation. 
The median-split method was used with the HRV data to split each participant’s 
values into two data sets (days when exercise was reported vs. days when no 
exercise was reported). Exercise was coded as 1 and corresponded to everything 
above and equal to the median. Anything below the median corresponded to no 
exercise reported and was subsequently coded 0. The median-split method was used 





each participant. The change in HRV from day-to-day was then calculated for each 
participant by subtracting the HRV value from the day before (HRV-day-2 minus 
HRV-day-1 etc.). Examining the change in HRV was also undertaken to allow 
objective comparison between subjects by disregarding absolute HRV values, as 
these can vary widely between subjects. Independent t-tests were then used to test 
differences in mean deviation of the change in HRV from day-to-day. Participant 
cases were weighted based on the number of recordings taken for each participant. 
From these data, participants were coded as dippers (those who showed a lower 
HRV following exercise) or non-dippers (no dip in HRV following exercise).  
 
The general linear model was used to quantify the relationship between training and 
rMSSD. Univariate analysis was performed on the change in rMSSD 24-hours 
following exercise reported/not-reported and 48-hours following exercise 
reported/not-reported. Participants were grouped into those who had a dip in rMSSD 
the day following exercise (dippers) vs. those who did not have a dip in rMSSD the 
day following exercise (non-dippers). Participants were classified as dippers if their 
rMSSD reading was lower than the previous reading. Finally, binary logistic 
regression was used to predict the presence or absence of exercise. A p-value of 
<0.05 was considered statistically significant.    
 
8.3 Results 
Average participant characteristics are displayed in table 8.1. Of the twenty-eight 
participants, four did not complete the physical activity diary or Ithlete 
measurements correctly, and therefore their TRIMP data were excluded from 
analysis. Four participants reported minor issues with the equipment, but overall 
participants were all happy with the device and found it easy to use. Table 8.1 
displays participant information including average HR, average rMSSD, average 








Table 8.1 Participant total mean characteristics 




Age (years) 37 ± 13 33 ± 13 
rMSSD (ms) 72.4 ± 7.4 69.3 ± 7.7 
HR  at rest (bpm) 67.5 ± 6.5 77.0 ± 7.0 
Physical Activity (%) 
<30 minutes/day 
41.2    58.8 
Smokers (%) 17.6 19.0 
Average alcohol units 
(n) 
3.7 ± 2.3 3.5 ± 2.1 
 
Table 8.2 displays average components for participants grouped by ethnicity (white 
or other), physical activity (less than 30 minutes per day, and 30 minutes or more per 
day), smoker or non-smoker and alcohol units (above or below the recommended 
intake per week of 21 units for men and 14 units for women).  
 
Table 8.2 Mean rMSSD, HR, age by group 



















70.6 74.1 66.5 73.9 72.9 71.0 69.6 72.1 
HR 
(bpm) 
72.1 68.8 78.9 67.4 65.4 73.3 69.6 71.8 
Age 
(years) 





































1 No 27 0.53 3.60 No 0.43 4.40 
2 Yes 35 -0.65 6.40 No 0.56 6.86 
3 Yes 28 -2.18 6.13 Yes -0.32 6.68 
4 No 21 0.41 9.17 Yes -0.85 7.32 
5 No 29 0.80 6.17 No 0.02 5.19 
6 No 35 0.65 5.76 No 1.22 5.38 
7 No 33 0.96 10.14 Yes -0.51 11.18 
8 No 33 0.70 8.00 No 1.79 7.04 
9 Yes 36 -0.58 10.39 Yes -0.15 10.68 
10 Yes 28 -4.35 14.29 Yes -2.98 13.30 
11 No 28 3.86 11.79 No 2.10 10.66 
12 No 24 7.61 18.97 No 7.25 16.65 
13 No 38 0.42 4.88 Yes -1.27 6.27 
14 No 26 7.50 10.41 Yes -0.25 7.76 
15 No 19 9.25 15.10 No 1.67 19.96 
16 No 31 0.26 30.45 No 5.19 20.04 
17 No 34 -0.60 7.44 Yes -0.73 9.33 
18 No 29 0.20 9.34 Yes -0.44 7.97 
19 Yes 25 -3.85 20.15 Yes -5.15 20.46 
20 Yes 29 -1.59 9.14 No 1.14 9.36 
21 No 23 2.44 8.08 No 0.57 9.86 
22 Yes 26 -0.69 8.61 Yes -2.65 10.38 
23 No 34 0.79 7.21 No 1.10 7.85 
24 Yes 33 -0.36 4.55 No 0.08 3.04 
* Number of recordings refers to the amount of recordings which had corresponding 
measurements at 24 and 48 hours following reported exercise.  Any recordings that 







8.3.1 General linear model: Univariate analysis 
Univariate analysis revealed that rMSSD 24-hours later was not significantly 
affected by exercise (p=0.12). The F value for rMSSD 24-hours after exercise was 
2.44. rMSSD 48-hours after exercise was also not significantly affected (p= 0.30), 
with an F value of 1.68. 
 
When participants did not exercise, the overall mean difference in rMSSD after 24-
hours was -0.67 ± 9.67 (CI -1.729, 0.388) (N= 384). When participant did exercise, 
the overall mean difference in rMSSD 24-hours later was 0.578 ± 11.54 (CI -0.581, 
1.737) (N= 320). The overall mean difference in rMSSD 48-hours after no reported 
exercise was 0.28 ± 0.56 (CI -0.814, 1.379) (N= 371), and when exercise was 
reported -0.57 ± 11.13 (CI -1.175, 0.628) (N= 309).  
 
When participants were grouped into those who had a dip in HRV 24-hours 
following exercise (dippers) vs. those who did not have a dip in HRV 24-hours 
following exercise (non-dippers) the mean differences were -6.91 ± 8.47 for dippers 
and 6.51 ± 7.88 for non dippers. Forty-eight hours following exercise, participants 
were again grouped as dippers and non-dippers with a mean difference of -7.43 ± 
9.24 for dippers and 6.98 ± 7.96 for non-dippers. A dip in HRV following exercise 
was expected; however, the magnitude of that dip is what indicates fatigue (i.e. if the 
dip in HRV is more that 1xSD, this would suggest the beginning of overreaching, 
and if this persisted, burnout would occur). 
 
8.3.2 Binary logistic regression 
Binary logistic regression was performed to access the impact of exercise on 
rMSSD.  The first model was set to assess the effects of exercise on rMSSD, 24-
hours following exercise, where the odds ratio was 1.056 (CI 0.784, 1.422) (p= 
0.72).  The second model looked at the effects of exercise on rMSSD, 48-hours 
following exercise, where the odds ratio was 1.219 (CI 0.901, 1.649) (p= 0.20). This 
suggests that a dip in rMSSD was more likely to occur 48-hours following exercise, 








The present study assessed the use of daily Ithlete rMSSD measurements, to gauge 
how the body responded to exercise. Ithlete measurements were measured daily for 
at least 28-days by 86% of the participants. A decrease in rMSSD following exercise 
was assessed at 24 and 48-hours. A dip in rMSSD was demonstrated in 37.5% of 
participants 24-hours following exercise, and 58.3% 48-hours following exercise. 
Because HRV is a valuable indicator for monitoring the status of the ANS (Acharya 
et al. 2006), the prognostic value of HRV is a useful indicator of autonomic 
imbalance. An autonomic imbalance is thought to be a precursor to overtraining, 
caused by excessive exercise. Prognostic measurements of HRV are also useful in 
various disease states, such as depression (Birkhofer et al. 2006; Kemp et al. 2012), 
cardiovascular diseases (Carney et al. 2001; Gehi et al. 2005; Taylor 2010) and 
diabetes (Malpas & Maling 1990; Pagkalos et al. 2008; Schroeder et al. 2005) 
 
The present study also assessed the relationship between rMSSD/HR and lifestyle 
factors (i.e. smoking, physical activity level). Smoking, low levels of physical 
activity and excessive alcohol consumption are known risk factors for cardiovascular 
disease (British Heart Foundation 2008; World Health Organization 2003). Some 
ethnic groups (Black, South Asian) are found to be at higher risk of acquiring 
diseases, such as diabetes and cardiovascular disease, when compared to the 
Caucasian population (Hoffman 2009; Lip et al. 2007; Wulan et al. 2010). Therefore 
the present study explored those relationships and the findings were compared with 
those already reported in the literature. 
 
8.4.1 Ethnicity and lifestyle characteristics 
When participants were grouped by ethnicity in the present study, (White vs. Other 
(Black, South Asian)), in the White population, the average rMSSD (ms) was found 
to be lower, while HR (bpm) was higher. These results are similar but somewhat 
conflicting with the two other healthy populations assessed within this thesis. In 
chapter five, rMSSD was very similar between the White and Other ethnic group, 
but higher in the South Asian population. In that same chapter, HR was significantly 
lower in the White group compared to the other groups. In chapter six, the White 
group had a lower rMSSD and HR. These results are therefore not surprising, as 





HRV. Both a lower sympathetic drive (high HRV) has been reported in Black 
participants when compared with age-matched Whites (Guzzetti et al. 2000; Liao et 
al. 1995) and a higher sympathetic contribution to total power (lower HRV) when 
compared with age-matched White adolescents (Faulkner et al. 2003).   
 
Smokers had a higher average rMSSD when compared with non-smokers and a 
lower average HR (bpm), which would be expected to be the other way around 
because smoking puts people at a higher risk of disease.  The difference between the 
groups however was not significant, and for rMSSD especially, the margin between 
the two groups was very small. Both the number of smokers (n=7) vs. non-smokers 
(n=20) and age may have played a role in these results. The average age of non-
smokers was higher by 5 years and age is known to have an effect on HRV (Liao et 
al. 1995; Reardon & Malik 1996; Ryan et al. 1994; Stein et al. 1997; Yeragani et al. 
1997). However, the documented age differences in HRV tend to be compared either 
by decade (Bigger et al. 1995) or young vs. old (Bitsios et al. 1996; Stein et al. 
1997). But in the present study, both averages would be classified within the same 
decade or age group, making the studies incomparable. When considering alcohol 
intake, participants who on average had less than the recommended intake per week 
had a higher average rMSSD but demonstrated a higher resting HR. A higher resting 
HRV and a lower resting HR are associated with better health. Those who average 
below the recommended weekly alcohol intake should exhibit those averages. Again 
the numbers in these groups were not even, which may have affected these results. 
 
Participants were grouped into those who did at least 30 minutes of physical activity 
a day (n=17) vs. those who did less than 30 minutes of physical activity per day 
(n=7). Resting rMSSD was significantly higher (p < 0.01) in the group that did at 
least 30 minutes of exercise. Resting HR was also significantly lower (p < 0.05) in 
this group. These results are similar to those already found in other participants 
within the present thesis. This result was to be expected as the effect of exercise on 





8.4.2 Changes in HRV following exercise 
To aid statistical analysis, the median split technique was used in the present study, 
because it facilitated a comparison between participants who reported exercise vs. 
non-exercise days. As each subject’s physical fitness varied, the median split 
technique allowed for a quantifiable comparison between participants. The median-
split technique resulted in two groups of equal size for each subject, making 
comparison between the two groups more statistically appropriate. The general linear 
model was used to allow for greater statistical analysis, exploring the interactions 
among both continuous and categorical variables. This model was used to decipher if 
there was a relationship between the independent variable (exercise training) with 
the dependent variable (a decrease in HRV), and if there was a relationship, to 
quantify that relationship. 
 
Eighty-six percent of participants completed HRV measurements for at least 28 days 
and filled in their daily physical activity diary. Physical activity levels were 
important to consider as a relationship has been demonstrated between resting HRV 
and HR in several studies (Buchheit et al. 2004; Carter et al. 2003b; Furlan et al. 
1993; Grossman et al. 2004; Melanson & Freedson 2001; Sandercock et al. 2005; 
Stein et al. 1999). The present study found that those who averaged at least 30-
minutes of exercise per day at least three-times per week had a lower resting HR. 
This is in accordance with the literature, where those who are more physically active 
are found to have a lower resting HR (Goldsmith et al. 1992; Katona et al. 1982; 
Kingwell et al. 1996; Melanson & Freedson 2001), and higher HRV (De Meersman 
1993; Dixon et al. 1992; Goldsmith et al. 1992; Jurca et al. 2004; Schuit et al. 1999). 
 
When looking at rMSSD 24-hours after exercise was reported, 38% of participants 
were coded as dippers. Forty-eight hours following exercise 58% of participants 
were coded as dippers. This suggests that the change in rMSSD is best monitored 48-
hours following training, as this is where the most significant changes were 
demonstrated. This is in contrast to what has been reported in the literature; however, 
the effect of a single bout of exercise on resting HRV has not been explored at great 
length. The benefits of a single bout of exercise that have been reported to include 
increased insulin sensitivity, lower blood pressure and decreased low density blood 





time these benefits last has not been reported. Long-term improvements in resting 
HRV following chronic exercise training have however, been demonstrated (Iellamo 
et al. 2000; Melanson & Freedson 2001; Seals & Chase 1989).   
 
The majority of studies that have explored the effect of the changes in HRV after a 
bout of sub-maximal exercise, only measured for relatively short periods of 15-180 
minutes following exercise (Brenner et al. 1997; Gladwell et al. 2010; Oida et al. 
1997; Terziotti et al. 2001). A limited number of studies have measured HRV for 
more than 24-hours, Furlan et al, (1993) observed increased sympathetic activity for 
more than 24-hours after heavy physical work. Pober et al, (2004) reported an 
increase in a couple of markers for vagal activity (pNN50 and HF normalised units) 
for up to 22-hours following exercise. Like the present study, Gladwell et al. (2010) 
demonstrated a decrease in rMSSD post-exercise, but this was only at 30-minutes. 
By 65-minutes post-exercise, they reported an increase in rMSSD over baseline of 
13.9 ± 74.3%.  
 
An initial decrease in HRV following a single bout of exercise has been 
demonstrated (James et al. 2002; Javorka et al. 2002). This might be explained by 
inhibitory affects from sympathetic blood hormones (Miyamoto et al. 2003), or the 
accumulation of waste products during exercise which activates metabolic receptors 
(O'Leary 1993). The combination of sympathetic activation and parasympathetic 
withdrawal are thought to be the cause of the rise in HR during exercise (Arai et al. 
1989). Reactivation of the parasympathetic nervous system following exercise is 
then thought to cause a decrease in heart rate (Imai et al. 1994). Baroreflex action 
and insulin sensitivity have been suggested as the physiological reasons for the 
observed changes in HRV, because both have been linked to exercise and HR 
(Kirwan et al. 1991; Laitinen et al. 1999; Seals & Chase 1989).  In healthy subjects 
this physiological response is culpable for changes observed in HRV, however in 
patients with heart failure, both baroreflex and insulin sensitivity are abnormal (La 
Rovere et al. 2009; Mortara et al. 1997). Therefore in these two populations, there 
may be something different happening physiologically to cause the decrease in HRV 
following exercise. In chapter ten, the results of the present study will be compared 





patients with heart failure, future research should further explore the physiological 
causes for this decrease. 
 
Changes to HRV during and following exercise may be as a result of changes in 
plasma volume, changes in sympathetic nerve outflow, increased baroreflex 
sensitivity, or changes in the levels of vasoactive substances in the circulation 
(Kirwan et al. 1991; Laitinen et al. 1999; Pober et al. 2004; Seals & Chase 1989). 
Evidence to explain what happens physiologically when changes in HRV occur 
during and following exercise have not yet been demonstrated sufficiently in the 
literature (Pober et al. 2004).  More research is also needed for determining how long 
it takes for changes in HRV to return back to baseline. Hayashi et al. (1992) 
suggested that recovery of cardiac autonomic regulation following moderate to high 
intensity exercise occurs later than recovery of peripheral circulation or oxygen 
uptake. The present study contributes to the debate on when changes in HRV return 
back to baseline. More detailed follow-up in both healthy and clinical populations 
are necessary to determine how long these changes occur, and what may cause them. 
 
In healthy adults there is an expected adaptational increase in maximal oxygen 
consumption in response to exercise training, which is also associated with longer 
term indexes of HRV. This presumed relationship is largely based on cross-sectional 
investigations, comparing athletes with sedentary individuals (Stein et al. 1999). 
Several studies have demonstrated modifications in HRV following an aerobic 
training programme (De Meersman 1993; Goldsmith et al. 1992; Schuit et al. 1999).  
Evidence suggests that HRV can be used for optimising individual training, and 
measurement of HRV overnight is a better tool for assessing accumulated fatigue 
when compared with resting HR alone (Earnest et al. 2004; Pichot et al. 2000). The 
present study had participants with varying levels of physical activity, none of which 
were participating in a specific training programme. After 48-hours, over 50% of 
participants still demonstrated a dip in rMSSD following exercise. This suggests that 
adaptations can still occur without being on a prolonged training programme. The 
present study did not assess if HRV improved over time in these participants because 
no exercise intervention was imposed on this group. This adaptation would not be 
expected in this population because they were not necessarily engaging in exercise 





8.4.3 Overtraining and HRV 
The body’s ability to repair muscle, tissues and replenish energy stores is essential in 
the process of maximizing physiological adaptation. This is accomplished by 
ensuring that the body has enough time to recover adequately before the next bout of 
exercise. The balance between sleep, nutrition and other circumstances will also 
have a major impact on how well and how swiftly the body can recover. Reduced 
supine HRV has been reported in overtrained athletes when compared with trained 
athletes and untrained control subjects (Mourot et al. 2004a). Reduced 
parasympathetic HR control after wakening was observed in 12 overtrained athletes 
(Hynynen et al. 2006). Hedelin et al. (2000) found no significant changes in HRV in 
overtrained canoe athletes following a training camp, and Bosquet et al. (2003) 
reported no significant changes in HRV in nine endurance athletes both during, and 
two weeks following overtraining. In contrast to these studies, the present study’s 
participants had various fitness levels (no participants reported heavy training 
regimes), and none were considered to be overtrained. Ithlete rMSSD measurements 
did demonstrate a dip in several participants. This dip did not last longer than seven 
consecutive days in any participant, suggesting that none were overtrained.  
 
8.4.4 Limitations 
In the present study, participants were asked to record their exercise activity daily on 
a physical activity diary. Participants had to choose a zone for the rate of intensity at 
low/moderate/high and this was a very subjective measure. It is hard to gauge how 
well they adhered to the described intensity zones within one work-out. However, 
they were asked to record the zone within which they thought they were within most 
throughout the workout. Conversely, the large range of activity levels within the 
participants in the present study, helped to counter that effect.   
 
Median split is one of the techniques used to make continuous variables into 
categorical variables. This is done by finding the median of the continuous variable 
and placing any value below the median into the ‘low’ group and every value equal 
to and higher into the ‘high’ group. It must be acknowledged that the median split 
method has some disadvantages. Making continuous variables into categorical ones 
does reduce statistical power primarily because of the reduction in the inherent 





how a median split is done, there is always a loss of power. Another issue resulting 
from the median split is that every value above the median and below the median are 
considered equal despite the fact that there may be a large variation between them. In 
the present study, several participants had very low activity levels. This therefore 
resulted in very small bouts of exercise being considered training, along with larger 
bouts of exercise.  In these cases, this may have slightly skewed the results.    
 
The median split technique was used within this study because it allowed for a 
comparison between subjects to dictate whether exercise occurred or not. Because 
each subjects’ physical fitness varied, the median split technique allowed for 
comparison between subjects by characterizing their own training regime into two 
groups, where exercise training was relative to each subject. This technique is not 
perfect, but was best for comparisons within this thesis.   
 
8.5 Conclusions 
Ithlete measurements of rMSSD and HR were undertaken on a consistent basis by 
86% of participants for one-month. A dip in HRV was demonstrated in more than 
50% of participants when exercise was reported 48-hours earlier. Ithlete appears to 
be an easy device to use for daily HRV assessment. It is also cost efficient when 
compared to other medical devices, and provides feedback to the user which can be 
easily interpreted without the use of inputting raw data into a software package. 
Future research should focus on the effects of exercise on HRV over various time 
periods with a large cohort of participants; especially monitoring HRV directly 
following exercise for up to 72-hours afterwards. This could be very beneficial in the 
assessment of the effect of exercise on the body over time, and the effect of intensity 
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CHAPTER 9: HEART RATE VARIABILITY MEASUREMENT IN 
PATIENTS WITH HEART FAILURE WITH VARYING PHYSICAL 
ACTIVITY LEVELS USING ITHLETE SOFTWARE 
Heart rate variability (HRV) is a non-invasive electrocardiographic measure that 
examines the sympathetic and vagal components of autonomic nervous function.  
There are various parameters for HRV analysis which include time domain, 
frequency domain and geometric methods. Conventional HRV analysis tends to 
produce all of these measures through measurement software; several of these 
measurements such as rMSSD and the high frequency power (HFr) of the normal R-
R interval power spectrum are highly correlated with one another. With that in mind, 
the present study will focus on one of those measurements, the root of the mean 
squared differences of successive heart periods (rMSSD). There does not appear to 
be a need to compare several different measurements with such high correlations. 
The present study aimed to assess the ability of Ithlete software to measure HRV 
daily for one month in participants with heart failure (HF), while assessing if a 
decrease (dip) in rMSSD occurred following exercise.  
 
One hundred and three participants with HF were recruited from three London 
hospital sites, and agreed to participate in the present study. Seventy participants 
were male and 33 were female; participant ages ranged from 24 to 87 years. 
 
A dip in rMSSD, 24-hours following reported exercise was demonstrated in 46.5% 
of HF patients. Forty-eight hours after reported exercise, 65.1% demonstrated a dip 
in rMSSD. When patients did not report exercise, a dip in rMSSD was found in 
55.8% of participants after 24-hours, and 53.5% 48-hours after. These results suggest 
that a dip in rMSSD may be more likely to occur at 48-hours after exercise was 
reported, however a dip was also observed in approximately 50% of participants 
when exercise was not reported. Approximately 50% of participants completed all 
the Ithlete measurements for at least 28 consecutive days. Participants reported good 
usability on a daily basis suggesting Ithlete to be an acceptable measurement device 
in this population. Effective daily use of the Ithlete HRV measurement device for 
gauging exercise response was demonstrated in patients with HF. Patients stated that 
using the device was simple, convenient and an effective use of time and 






9.1.1 Heart rate variability and heart failure 
Heart failure (HF) can be defined as a condition in which a structural or functional 
abnormality impairs the pumping ability of the heart. Despite normal filling 
pressures, these abnormalities weaken the heart’s pumping action and lead to 
difficulties in the metabolizing tissues receiving enough blood, and therefore enough 
oxygen (Dickstein et al. 2008). Impaired autonomic function is recognized as a 
consequence of chronic heart failure (CHF) (Nolan et al. 1992). Heart rate variability 
(HRV) is a non-invasive electrocardiographic measure that examines the 
sympathetic and vagal components of autonomic nervous function. The autonomic 
nervous system makes itself visible through HRV, indicating how the body is trying 
to preserve its equilibrium. A good functioning autonomic nervous system should 
yield a high HRV, which implies a healthy individual (Sueta 2003). As HRV 
provides an indirect, non-invasive measurement of autonomic control of the heart, it 
is an ideal measurement to use in patients with heart failure.  
 
The first study on HRV in HF was conducted by Saul et al, (1988) and sparked 
interest in the investigation of possible changes that occur in HRV in HF, seeking 
correlations between HRV and current clinical status (Chattipakorn et al. 2007). 
Other studies have demonstrated that as a result of CHF, patients have decreased 
HRV and this decrease can be used to predict cardiac events (Fauchier et al. 1997; 
Nolan et al. 1998; Task Force. 1996). 
 
HRV has been demonstrated as an effective measurement for 24-hour ambulant 
measurements (Furlan et al. 1990; Task Force, 1996), short-term measurements 
(Bigger et al. 1993; Lucreziotti et al. 2000; Pagani et al. 1986) and very short term 
measurements (Thong et al. 2003). Bigger et al. (1993) compared HRV measurement 
epochs of 2-15 minutes with 24-hour ambulatory recordings in HF patients. This 
study found that measurements of 2-15 minutes predicted death nearly as well as the 
same measures computed over a 24-hour period. When matched individually with 
each of the three best predictors of mortality (NYHA class, left ventricular ejection 
fraction and crackling noises heard on auscultation of the lung) they significantly 
improved the prediction (ibid). A one-minute bedside deep breathing test of HRV in 





of HRV were good predictors of all cause mortality and sudden death (Katz et al. 
1999).   
 
The present study will use the root mean squared of successive differences of heart 
periods (rMSSD). rMSSD is a time domain measure of HRV which reflects 
parasympathetic activity without being dependent on heart trends (Stein et al. 1994). 
rMSSD has been suggested as superior to spectral methods due to its sensitivity to 
vagal cardiac control and is less sensitive to variations in respiratory patterns 
(Penttilä et al. 2001). rMSSD has been demonstrated as an effective measure for 
capturing respiratory sinus arrhythmia and a reliable assessment of cardiac vagal 
outflow (Penttilä et al. 2001).  
 
In patients with HF, the autonomic nervous system is characterized by dysfunction in 
sympathetic activation, parasympathetic withdrawal and peripheral organ non-
responsiveness (Grassi et al. 1995). CHF may result in depressed HRV levels, which 
are regularly observed at all stages of systolic dysfunction (Fauchier et al. 1997). A 
research project called UK Heart was a substantial prospective study which followed 
patients for more than a year, it was conducted with 433 congestive HF patients 
(NYHA classes I-III), with a mean ejection fraction of 0.41 ± 0.17 L. UK Heart 
found a reduction in several clinical variables including SDNN, creatinine, serum 
sodium, non-sustain ventricular tachycardia, cardiothoracic ratio and LV end 
diastolic diameter (Nolan et al. 1998). An SDNN of <100ms was the most powerful 
predictor of total mortality among a large number of clinical variables (Nolan et al. 
1998).  
 
Conventional HRV measurements are related to systolic left ventricular function 
(Nolan et al. 1992) and functional classification (Casolo et al. 1995). The severity of 
left ventricular dysfunction correlates with decreased HRV and, therefore, poor 
prognosis (Wijbenga et al. 1998). Reduced HRV is an established risk factor for 
sudden cardiac death in CHF patients (Sandercock & Brodie 2006). The best 
predictive HRV measures for all cause mortality are the global and/or slow 
oscillations in R-R intervals from both frequency and time domains (ibid). Given this 
relationship, it is important to identify interventions which are able to increase HRV 





9.1.2 Exercise and heart failure 
Patients with HF were originally cautioned against physical exercise until treatment 
changed in the late 1980s (Coats 2000). Coats et al, (1990) challenged this practice, 
and the benefit of exercise in patients with HF was demonstrated in an 8-week 
training programme. The programme produced a 20-25% increase in peak oxygen 
consumption, increased exercise tolerance and reduced questionnaire-rated 
symptoms associated with their condition (Coats et al. 1990). Participants in this 
study also found an increase in the ease and degree of performing daily activities 
(ibid). From the 90s onwards the research in this area increased with larger and 
better designed studies in patients with HF looking at the physiological benefits and 
increases in exercise capacity that are possible through cardiac rehabilitation (Coats 
1999). 
  
The American Heart Association defines a cardiac rehabilitation as a comprehensive 
exercise, education and behavioural modification programme designed for patients 
with heart disease to improve physical and emotional well-being. Cardiac 
rehabilitation has demonstrated improvement in physical health and a decrease in 
subsequent morbidity and mortality, achieved through exercise, education, behaviour 
change, counselling and support strategies (Taylor et al. 2010).  
 
Exercise training programmes produce positive outcomes such as delaying the onset 
of anaerobic metabolism, increasing vagal tone, reducing sympathetic drive and 
increasing aerobic capacity in patients with HF (Dracup et al. 2007). The majority of 
studies conducted in this area are randomised controlled trials that focus mostly on 
symptomatic benefits and substitute markers of prognosis such as HRV and peak 
oxygen consumption (Belardinelli et al. 1999; Dubach et al. 1997; Giannuzzi et al. 
1997; Hambrecht et al. 1995; Kiilavuori et al. 2000; McKelvie et al. 2002; Wielenga 
et al. 1999; Willenheimer et al. 1998). Exercise training considerably improves 
survival time in patients with HF due to improved left ventricular systolic function 
(ExTraMATCH Collaborative 2004). Exercise capacity assessed with or without 
metabolic measurements has proven a more powerful prognostic tool than other 
traditional risk factors such as smoking, hypertension and diabetes (Myers et al. 
2002). Variability in heart rate suggests that exercise training may reduce adrenergic 





neurohormonal and musculoskeletal abnormalities that occur in heart failure 
(ExTraMATCH Collaborative 2004).  
 
TRaining IMPulse (TRIMP) is defined as the training volume (total training 
duration) multiplied by the training intensity (average heart rate in beats per minute 
during exercise). Exercise done at 60% of maximum HR (HRmax) is less demanding 
than exercise done at 85% HRmax, and therefore this needs to be accounted for. 
New calculations by Foster et al. (2001) devised five training zones (expressed as a 
% of HRmax) using heart rate zones to determine intensity. The new equation 
including the training zones now accounted for variation in intensity. For the purpose 
of the present study however, this was still not suitable because the dependent 
variable being assessed is HRV. By using HR within the TRIMP equation in the 
present study, the independent and dependent variables would be the same. 
Therefore, within the present study, TRIMP was calculated with intensity multiplied 
by duration. 
 
Measurements of HRV are used to help people monitor how the body is responding 
to exercise and stress.  HRV is thought to decrease when the body is put under stress. 
Increases in resting HRV following a exercise training in patients with HF have been 
documented in several studies (Kiilavuori et al. 1995; Kubinyi et al. 2003; Malfatto 
et al. 2002; Murad et al. 2012; Selig et al. 2004). However, an initial decrease in 
HRV in the minutes or hours following exercise is known to occur (Mourot et al. 
2004b; Parekh & Lee 2005; Terziotti et al. 2001). As HRV is known to assess 
autonomic function, Ithlete measurements provide a way to quantify autonomic 
response. Ithlete was developed as a tool for preventing overtraining in endurance 
athletes. For the purpose of the present study however, Ithlete was used with heart 
failure patients with a range of fitness levels, to quantify the body’s response to 
variation in exercise. 
 
9.1.3 Aims 
Thus the aims of the present study were: (i) to assess the ability of Ithlete software to 
measure HRV daily for one month in participants with heart failure, (ii) to assess 
Ithlete measurements over 24 and 48-hours following reported exercise to see if a 





It is hypothesized that Ithlete software will be a feasible measurement device for 
capturing daily HRV in participants with HF. In accordance with the literature, a dip 
in HRV following exercise is expected to occur.  
 
9.2 Methods 
9.2.1 Recruitment of participants 
The researcher attended clinics with either a Consultant Cardiologist or Heart Failure 
Nurse Specialist at three London hospital sites. Each participant was recruited in 
accordance with NHS Research Ethics Committee standards and expectations. 
Participants responded in clinic or by phone and were sent an information pack 
before agreeing to participate. The information pack included: 
1. An information sheet with detail of the requirements for each participant 
before and during the laboratory visit; 
2. An informed consent form; 
3. HRV measurement information package; 
4. A detailed demographic information sheet. 
Participants were requested to read the information pack prior to attending the clinic 
to meet with the researcher and any questions or concerns were addressed. All 
procedures were approved by the local research ethics committee. 
 
9.2.2 Participants 
A total of n=103 participants responded within the clinics and agreed to participate 
in the study of which n=70 were male and n=33 were female. Participant ages ranged 
from 24 to 87 years. All participants were defined as suffering from heart failure 
with varying levels of impairment but all were deemed suitable by the medical team 
at the hospital they attended. 
Inclusion criteria: The participants were recruited from three hospitals in the London 
area. The participants were heart failure patients within the New York Heart 
Association classifications of I, II & III aged at least 18 years of age. Heart failure 
treatment was under the control of the participant's consultant cardiologist.  
Exclusion criteria: Participants were excluded if they had any of the following 
conditions: Consistent atrial fibrillation, unstable coronary artery disease with 





heart valve surgery or planned transplantation, uncontrolled arterial hypertension, 
acute myocarditis, worsening clinical condition, inability to read the display of a 
handheld device or deemed unable to comply with home telemonitoring; inadequate 
understanding of English; any visual or cognitive impairment sufficient to interfere 
with the participant's ability to use the device (Cleland et al. 2005; Dar et al. 2009; 
Scherr et al. 2009).  
Participants completed their consent form in front of the researcher and the 
researcher countersigned the form. 
9.2.3 Experimental design 
Following appropriate ethical approval from the NHS Southwest Research Ethics 
Committee and informed consent, participants were asked to visit the clinic at their 
hospital to meet with the researcher for a demonstration. Each participant was given 
a demonstration of how to use the Ithlete software on the iPod touch and required to 
complete two measurements in the presence of a researcher before taking the device 
home. Then each participant was required to take an HRV measurement once every 
morning when they woke up for 1 month in succession. Each day participants also 
recorded on a calendar: 
1. What (if any) exercise was performed the day before; 
2. Duration of that exercise; 
3. Intensity of that exercise (Low/Moderate/High); 
4. Daily scale of how they felt on a scale of 0-100% (100% being the best). 
 
For the purpose of the present study, duration and intensity were used to calculate 
TRIMP. TRIMP was used to determine if subjects engaged in a sufficient amount of 
exercise on a given day to cause a change in HRV. The median-split method was 
used to determine if subjects exercised or not. If subjects did more than 50% of their 
usual daily exercise, this was then deemed an exercise/training session. This 
information will be used to assess the relationship between exercise and Ithlete 
rMSSD measurements. Additionally, participants were classified as dippers if their 
rMSSD reading was lower than the previous reading. Athlete’s systematically 
overload in order to improve their performance and therefore may cause dramatic 
decreases in rMSSD (equivalent to one or two standard deviations or more). The 





necessarily demonstrate dramatic decreases in rMSSD. Controls may have 
completed enough exercise to cause dramatic dips; however patients with heart 
failure often have low exercise tolerance and therefore are unlikely to demonstrate 
dramatic dips in rMSSD. Therefore in the present study, any dip in rMSSD was 
considered a training dip in order to keep consistency between controls and 
participants with heart failure.   
 
9.2.3.1 Heart rate variability analysis 
Heart rate variability measurements were taken using an iPod touch with the Ithlete 
application (Ithlete 2009). For HRV measurement, a standard analogue ECG chest 
strap was worn in the middle of the chest just under the sternum. Using the Ithlete 
software for the iPod touch, participants measured HRV in a seated position, for one 
minute when they woke up.  
 
Real time heart and lung animation via the Ithlete application was displayed on the 
iPod touch. This facilitated paced breathing during measurements and indicated 
reception of each heart beat from the analogue chest strap. Participants followed a 
breathing frequency of 7.5 breaths per minute, designed to maximize RSA response 
(Brown et al. 1993). Ithlete software provides an indication of how the body has 
responded to exercise by displaying a colour behind the change in HRV as displayed 
below on an Iphone beside daily and weekly change. These indications are displayed 
in the table as an average number which corresponds to one of the four colour 
indications (1-1.5=Blue for normal recovery, 1.5-2.5=Green for good recovery, 2.5-
3.5=Amber for not the best recovery, 3.5-4=Red for bad recovery). TRIMP is 
displayed as an average of intensity of exercise multiplied by the duration of exercise 
and Day Scale (how patients felt on a scale of 0-100, 100 being the best and 1 being 
the worst) is displayed as a percentage. More specifically, amber represents the first 
day when HRV is more than 1 x SD (standard deviation of natural log transformed 
rMSSD) below the moving average of the previous seven days (so excluding the 
most recent recorded value); red represents the second day when this condition is 
true (i.e. two successive days when the current value is more than 1x SD below the 
moving average blue line) and green represents a rise of more than 2 x SD compared 
to the previous day. Green is intended to indicate good recovery and signifies that 





When the one minute measurement was complete, the HR (bpm) and HRV (rMSSD) 
were displayed on the screen and saved to the device. At the end of the one month 
recording period, Ithlete recordings were transferred to a password protected PC via 
the Ithlete software which enables recordings to be emailed and saved into an excel 
document. 
 
9.2.4 Statistical analysis 
All statistical analysis was undertaken using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Values are reported in the text as mean ± standard deviation. 
The median-split method was used with the HRV data to split each participant’s 
values into two data sets (days when exercise was reported vs. days when no 
exercise was reported). Exercise was coded as 1 and corresponded to everything 
above and equal to the median, anything below the median corresponded to no 
reported exercise and was subsequently coded 0. The median-split method was used 
to allow comparison between subjects objectively by making HRV values relative to 
each participant. The change in HRV from day-to-day was then calculated for each 
participant by subtracting the HRV value from the day before (HRV-day-2 minus 
HRV-day-1 etc.). Independent t-tests were then used to generate mean and standard 
deviation of the change in HRV from day-to-day.  Participant cases were then 
weighted based on the number of recordings taken for each participant. From these 
data, participants were coded as dippers (those who showed a lower HRV following 
training) or non-dippers (no dip in HRV following training).  
 
The general linear model was then used to quantify the relationship between training 
and HRV. Univariate analysis was performed on the change in HRV 24-hours 
following exercise reported/exercise not reported and 48-hours following exercise 
reported/exercise not reported. Participants were then grouped into those who had a 
dip in HRV 24-hours following exercise (dippers) vs. those who did not have a dip 
in HRV 24-hours following exercise (non-dippers). Binary logistic regression was 
then used to predict the presence or absence of exercise. A P-value of <0.05 was 







In total forty-six participants completed measurements for a one-month period 
without missing two consecutive measurements. Participants have been placed into 
NYHA classes by the Consultant Cardiologist or Heart Failure Specialist Nurse; 
throughout section 9.3, results will either be displayed within those NYHA 
classifications, by gender or on an individual basis. In table 9.1 participants are 
divided into NYHA classes and average values for each class are displayed for age, 
rMSSD, heart rate and ejection fraction. Table 9.2 displays gender averages for 
rMSSD, HR, indication, TRIMP and day scale.  
 
Table 9.1 Mean participant values for age, rMSSD, HR and EF by NYHA class.  






Age (years) 64.6 ± 12.5 57.2 ± 19.1 63.3 ± 12.5 
rMSSD (ms) 81.4 ± 10.2 75.9 ± 7.3 75.4 ± 12.3 
HR at rest 
(bpm) 
81.5 ± 10.2 82.2 ± 13.2 84.7 ± 6.1 
Ejection 
Fraction (%) 
41.5 ± 9.0 38.9 ± 11.3 31.3 ± 11.7 
TRIMP 149.6 ± 56.7 135.38 ± 94.4 110.55 ± 82.6 
 
 
Table 9.2 Mean rMSSD, HR, Indication, TRIMP and Day Scale for each participant 
by gender 
Age Gender rMSSD HR Indication TRIMP Day Scale 
63 ± 12 M 77.4 ± 10.5 82.4 ± 9.7 1.5 ± 0.9 116.2 ± 89.7 61.2 ± 12.8 
59 ± 14.5 F 75.2 ± 7.2 86.9 ± 14.4 1.4 ± 0.8 111.5 ± 63.1 68.5 ± 17.2 
For the above table, HRV, i.e. rMSSD is measured in milliseconds (ms), HR in beats per 
minute (bpm). Indication corresponds to the number allocated by Ithlete software to indicate 
how the body has responded to exercise (based on the difference between the rolling average 
of the previous seven days and the current measurement). TRIMP (corresponds to volume in 
minutes multiplied by an intensity number where low = 1, medium = 2 and high = 3) and 
day scale corresponds to the patients rating of how they feel on a scale from 1-100 (1 being 






Table 9.3 Change in rMSSD 24 and 48-hours after training  





























1 No 52 2.94 10.22 Yes -2.29 9.14 
2 No 34 1.52 8.77 Yes -2.11 12.70 
3 No 27 1.69 8.31 Yes -0.42 7.98 
4 Yes 14 -0.36 5.56 Yes -0.55 5.79 
5 Yes 35 -0.79 9.54 No 0.05 9.29 
6 Yes 18 -0.94 6.11 Yes -2.50 5.82 
7 Yes 17 -0.88 9.05 No 0.61 10.69 
8 No 21 1.77 14.03 Yes -2.25 18.25 
9 Yes 24 -0.95 11.53 No 2.44 8.04 
10 No 31 0.48 13.69 No 1.97 12.81 
11 No 18 14.60 20.82 Yes -13.63 14.26 
12 Yes 32 -3.02 11.28 No 1.55 13.39 
13 No 27 2.52 10.85 Yes -2.63 15.14 
14 No 30 0.25 7.23 Yes -2.76 8.41 
15 No 32 16.80 37.74 Yes -5.63 69.52 
16 No 21 0.30 8.11 Yes -0.57 6.94 
17 Yes 37 -0.44 11.05 No 1.14 12.79 
18 No 25 0.77 13.86 Yes -0.41 12.86 
19 Yes 28 -1.91 9.13 Yes -0.13 7.68 
20 No 32 0.63 12.38 Yes -0.12 11.47 
21 Yes 19 -15.86 34.34 Yes -1.18 5.75 
22 No 25 3.65 6.38 Yes -1.71 6.75 
23 Yes 40 -2.08 22.74 Yes -0.38 22.77 
24 Yes 29 -14.46 42.22 No 6.94 34.72 
25 No 15 5.83 5.52 Yes -6.45 9.97 
26 Yes 35 -0.42 22.36 Yes -4.83 16.39 
27 No 16 0.79 13.14 Yes -1.54 19.70 
28 No 27 2.54 15.09 No 0.18 11.71 
29 Yes 42 -2.19 14.77 Yes -1.08 16.97 
30 Yes 32 -0.32 10.06 No 1.13 9.57 
31 No 35 2.70 10.92 Yes -4.53 12.07 
32 No 35 0.394 8.64 No 0.31 9.88 
33 Yes 37 -0.592 13.26 No 0.68 14.07 
34 No 23 0.381 7.55 No 0.63 8.20 
35 Yes 30 -3.61 12.32 Yes -0.94 16.93 
36 Yes 24 -1.96 17.11 Yes -0.41 28.86 
37 No 16 1.29 19.65 Yes -3.03 22.71 
38 No 26 2.45 40.84 No 3.91 41.13 
39 No 23 0.66 19.52 No 1.86 19.77 
40 Yes 31 -1.02 17.65 Yes -3.32 17.30 
41 Yes 26 -12.58 19.82 No 20.67 20.93 
42 No 34 -0.59 10.46 Yes -0.63 8.30 
43 Yes 17 -1.36 5.59 Yes -0.66 5.49 
44 No 21 0.45 11.1 No 0.48 10.59 
45 No 29 0.49 6.1 No 0.08 8.51 
46 No 21 1.8 37.8 No 6.35 40.89 
* Number of recordings refers to the amount of recordings which had corresponding measurements at 
24 and 48 hours following reported exercise.  Any recordings that did not have both follow-up 
recordings were excluded. 





Univariate analysis revealed that after 24-hours rMSSD was not significantly 
affected by exercise (p= 0.70).  The F value for rMSSD 24-hours following exercise 
was 0.137. The rMSSD 48-hours after exercise was also not significantly affected 
(p= 0.06) with an F value of 1.978. 
 
The overall mean change of rMSSD 24-hours after no reported exercise was -0.232 ± 
0.845 (CI -1.889, 1.426) (n= 583) and 24-hours following reported exercise was -
0.032 ± 0.813 (CI -1.628, 1.564) (n= 609). The overall mean change of HRV 
(rMSSD) 48-hours after no reported exercise was -0.492 ± 0.89 (CI -2.245, 1.262) 
(n=567) and 48-hours after reported exercise was -0.525 ± 0.492 (CI -2.255, 1.205) 
(n= 581). When participants were grouped into those who had a dip in HRV 24-
hours following exercise (dippers) vs. those who did not have a dip in HRV 24-hours 
following exercise (non-dippers) the mean changes were -11.57 ± 13.51(rMSSD) for 
dippers and 10.12 ± 12.7 (rMSSD) for non-dippers. Forty-eight hours following 
exercise participants were again grouped as dippers and non-dippers with a mean 
change of -11.59 ± 13.52 (rMSSD) for dippers and 10.73 ± 12.94 (rMSSD) for non-
dippers.  
 
9.3.2 Binary logistic regression 
Binary logistic regression was performed to assess the likelihood of exercise being 
associated with a decline in HRV. First, the effect of exercise on HRV (rMSSD) at 
24 and 48-hours following reported exercise was assessed. At 24-hours after exercise 
the odds ratio was 1.007 (CI 0.802, 1.264) (p= 0.95).  Forty-eight hours following 
exercise the odds ratio was 0.976 (CI 0.774, 1.230) (p= 0.84). This suggests that 
there was no greater likelihood of a decline in HRV (rMSSD) at 24 or 48-hours 
following exercise. Ratios so close to one indicate that there was no significant 
difference in HRV between days following exercise being reported vs. not reported.  
 
9.3.3 Coefficient of variation 
Table 9.4 below displays the coefficient of variation (CV) of HRV, HR, training 
impulse (TRIMP) and day scale (DS) by NYHA class. Table 9.5 displays the CV of 
HRV, HR, TRIMP and DS by gender, and Table 9.6 by exercise group (calculated 





Table 9.4 CV for rMSSD and HR, TRIMP and DS for each NYHA class 
NYHA Class CV for 
rMSSD (ms) 




CV for DS 
(%) 
I 20.7  7.4 94.4 22.5 
II 17.5  6.8 77.9 19.8 
III 36.9  6.6 88.1 47.6 
 
Table 9.5 CV for rMSSD and HR, TRIMP and DS by gender 
Gender CV for 
rMSSD (ms) 




CV for DS 
(%) 
Male 26.6 6.8 89.0 30.0 
Female 13.7 7.1 60.8 27.8 
 













23.7 6.4  78.2 30.6 
Not regular 
exercise 
26.5 7.4  93.5 28.8 
 Significant difference at p < 0.01 
The CV rMSSD for all the HF participants was 25.1%. No significant differences 
were demonstrated between genders or exercise group for rMSSD, HR, TRIMP or 
DS.  A significant difference was demonstrated between day scale groups HR at p = 
0.003.  A significant difference was also found between NYHA class II and III in the 








The present study aimed to assess the ability of Ithlete software to measure HRV 
daily for one month in participants with HF. This study also assessed the use of 
Ithlete HRV measurement daily to gauge how HF patients responded to exercise. 
Ithlete measurements were assessed 24 and 48-hours following exercise. Patients 
were encouraged to take measurements at rest, first thing in the morning before 
moving around too much or having any caffeine. In all, 103 HF patients agreed to 
participate in the present study. Of those, 45% completed all of the required 
measurements including the physical activity diary and Ithlete measurements for a 
one-month period without missing two consecutive measurements. A further 23% 
completed measurements with the device, but did not complete the required amount. 
Those that did not complete all the measurements cited reasons such as not enough 
time in the morning, difficulty saving the readings all the time, the device was too 
difficult to use, or they didn’t like using touch screen devices. Despite less than half 
completing all the required measurements, overall patients reported the device was 
simple and easy to use. Assessment of patients’ feelings toward the device will be 
explored further in chapter ten. 
 
The overall coefficient of variation for rMSSD in HF patients within the present 
study was 25.1, with a larger variation found in male participants when compared 
with females. There were a significantly larger number of male participants, which 
almost certainly caused the greater variation in male vs. female participants. The 
greater the number of participants with differing values, it follows on that the greater 
the variation will become. A significant difference in rMSSD was found between 
NYHA classes II and III; this cannot be explained by numbers, because the groups 
had a similar number of participants. A larger variation was demonstrated in NYHA 
class III, which, is the group with the most severe symptoms. Impaired autonomic 
function in this group should be more severe, however the impact on HRV is not 
clear. Due to the inherent variation in dysfunction amongst participants, a large 
variation in rMSSD could be expected. Alternatively this group could also have 
demonstrated less variation in rMSSD, due to everyone having very poor function. 
Further investigation is needed to determine what affect specific symptoms may 
have on rMSSD. However more variation could occur because of different 






A dip in rMSSD was found in 46.5% of HF patient’s 24-hours after reported 
exercise; 48-hours following exercise 65.1% demonstrated a dip in rMSSD. When 
patients didn’t report exercise, a dip in rMSSD was found in 55.8% of patients after 
24-hours, and 53.5% after 48-hours. This suggests that the dip in rMSSD was not 
necessarily related to exercise in this patient group, and other stressors such as 
comorbidities may have played a role. Measurements of HRV in HF patients have 
previously been used as a measurement of cardiovascular status, implicating those at 
higher risk of mortality (Brouwer et al. 1996; Nolan et al. 1998). HRV 
measurements have also been associated with overtraining (Lehmann et al. 1993; 
Mourot et al. 2004a; Uusitalo 1998), which occurs when there is not a sufficient 
amount of rest/recovery time between exercise bouts. Monitoring HRV in patients 
with HF has several benefits, making Ithlete an attractive option as it can facilitate 
quick and easy measurements on a daily basis. Ithlete can be used to gauge a 
patient’s risk of mortality as well as monitoring the effect of an exercise training 
programme by helping patients recognize when and how hard to exercise. These 
functions will be explored further in chapter eleven where Ithlete was used to help 
facilitate cardiac rehabilitation.    
 
The benefits of exercise in patients with HF has been documented in the literature 
(Davies et al. 2010; ExTraMATCH Collaborative 2004; Selig et al. 2004; Wielenga 
et al. 1999; Willenheimer et al. 1998), however exercise prescription should be 
clinician directed. The first publication on exercise training in post myocardial 
infarction patients with HF was in 1987 and compared an exercise group with a 
control group for 11 months (Lipchenko & Fomin 1987). The exercises included 
walking, cycling and exercise therapy; an increase in exercise capacity, reduced HR 
increment and a greater reduction in systemic peripheral resistance were 
demonstrated in the exercise group when compared with the control group (ibid). 
The benefits of exercise training were demonstrated in a controlled cross-over trial 
with a 20-25% increase in exercise tolerance, peak oxygen consumption and 
symptoms (Coats et al. 1990). Cardiac rehabilitation through exercise has been 
associated with a reduction in the debilitating symptoms caused by HF 






Participating in exercise can have a positive effect on HF symptoms such as 
breathlessness, fatigue, palpitations and quality of life through effects on both the 
cardiovascular and musculoskeletal systems (McKelvie et al. 2002). Following 
participation in an exercise programme, studies have demonstrated improvements in 
various symptoms including fatigue (Coats et al. 1992; Kavanagh et al. 1996; Oka et 
al. 2000; Shephard et al. 1998); breathlessness (Coats et al. 1992; Kavanagh et al. 
1996; Tyni-Lenne et al. 1999); and quality of life (Belardinelli et al. 1999; 
Willenheimer et al. 1998). Localized or systemic forms of exercise therapy could 
modify symptoms and benefit patients, possibly affecting disease progression and 
survival (Coats 2000). Monitoring patients responses to exercise can help patients 
get the most out of their exercise programme; monitoring autonomic function is a 
good way to facilitate this. 
 
Participants with HF were coded as dippers (those who showed a lower rMSSD 
following exercise) and non-dippers (no dip in rMSSD following exercise). Twenty 
participants were coded as dippers 24-hours following reported exercise. Forty-eight 
hours following reported exercise, 28 participants were coded as dippers. This 
suggests that the change in rMSSD is best monitored 48-hours following training, as 
this is where the most significant changes were found with over half of the 
participants showing a dip in rMSSD. The effect of a single bout of exercise on 
resting HRV has not been explored at great length; however improvements in resting 
HRV following chronic exercise training have been demonstrated (Iellamo et al. 
2000; Melanson & Freedson 2001; Seals & Chase 1989). An initial decrease in HRV 
following a single bout of exercise has been reported in healthy subjects (James et al. 
2002; Javorka et al. 2002). Gladwell et al, (2010) demonstrated a decrease in rMSSD 
post-exercise, but this was only at 30-minutes. However Pober et al, (2004) 
demonstrated autonomic changes in healthy young males persisted for at least 22 
hours following the termination of exercise. The present study has identified that HF 
patients, like their healthy counterparts, may also display a dip in HRV on the days 
following exercise training. The dip in rMSSD was only demonstrated in 
approximately 50% of participants. These results are therefore inconclusive; the 
absence of a dip in some participants may be explained by a lack of enough exercise 
intensity, as these patients were not involved in a structured exercise programme. 





autonomic changes persist following exercise by measuring continuously for at least 
48-hours to gauge when these changes occur and determine what intensity of 
exercise is necessary in order to elicit these changes. 
 
Exercise training load is the cumulative amount of stress placed on an individual 
during an exercise bout. TRIMP was developed by Banister et al, (1980) to provide a 
quantifiable measurement of exercise training volume and intensity in a single term.  
Periodization is the organization of phases of training at specific periods by 
alternating training to its peak. A decrease in HRV has been associated with the 
intense phase of periodization, also known as overreaching (Kuipers 1998). Uusitalo 
et al, (1998) suggested that normal training compared with excessive training may 
cause different changes in HRV and a decreased HRV may be a sign of fatigue. That 
study found a decrease in HRV in the first four weeks of intense training (seven days 
a week at 70-90% of Vo2 max) compared with a control group.  
 
In elite rowers, changes in cardiovascular autonomic modulation involving a switch 
from vagal to sympathetic predominance has been observed when going from lower 
to higher intensities (Iellamo et al. 2002; Iellamo et al. 2004). Pichot et al (2002), 
demonstrated that HRV reflects recovery status in untrained athletes, male rowers 
from the Italian national team (Iellamo et al. 2004) and elite Olympic weightlifters 
(Chen et al. 2011). Exercise at moderate-to-high intensity is associated with a 
significant delay in post-exercise recovery of HRV when compared with low-to-
moderate exercise (Buchheit et al. 2007; Kaikkonen et al. 2007; Kaikkonen et al. 
2008). Participants within the present study were encouraged to keep to their regular 
routine during the 28 measurement days. Most participants reported low-moderate 
exercise patterns, and therefore may not have undertaken enough exercise to cause a 
significant decrease in rMSSD following exercise. 
 
Vagal related indexes such as rMSSD or the power density in the high-frequency 
range (HFr) obtained by spectral analysis are the most widely used methods for 
quantifying parasympathetic activation following bouts of exercise (Task Force, 
1996). After 20-minutes of short-term exercise Arai et al, (1989) proposed that 
recovery of autonomic regulation occurs a few minutes following exercise. 





outflow was demonstrated for several hours (Hautala et al. 2001). On the second day 
following prolonged heavy exercise an accentuated rebound phenomenon with 
enhanced vagal regulation was observed with large inter-individual variations of 
reduced vagal outflow at the time of recovery (ibid). This was characterized by a 
quicker recovery of altered autonomic function in those with better cardio-
respiratory fitness when compared with those of poorer fitness. This suggests that the 
fitness level, intensity and duration of exercise have an effect on the amount of 
decrease observed in HRV following exercise, and how long it takes to return to pre-
exercise levels.  
 
Odds ratios demonstrated in the present study suggested that 24-hours after exercise 
was reported, participants were 1.007 times more likely to have a dip in rMSSD. 
After 48-hours participants were 0.976 times more likely to have a dip in rMSSD 
following exercise. This suggests that within the present study, there was no 
difference in the likelihood of a dip from one day to the other. To my knowledge, no 
other research has looked at the dip in HRV following exercise in HF patients. An 
initial decrease in HRV has been demonstrated within minutes or hours following 
exercise in several studies (Mourot et al. 2004b; Parekh & Lee 2005; Terziotti et al. 
2001). Furthermore, it appears to take longer to restore vagal tone following a high 
intensity bout of exercise (80% Vo2 peak) compared with moderate intensity 
exercise (50% Vo2 peak) (Mourot et al. 2004b; Parekh & Lee 2005). This may begin 
to explain the findings of the present study. HF patients may start off with a lower 
HRV initially due to their condition. Lower baseline HRV may affect their capacity 
to recover, as this suggests they have a low cardiorespiratory fitness. 
Cardiorespiratory fitness has been demonstrated as a factor affecting recovery of 
HRV to pre-exercise values. Another factor was HF patients’ physical activity was 
undertaken at what they considered low intensity suggesting they did not perform 
enough exercise to cause any autonomic modulation. If participants with HF had 
completed high intensity exercise, greater autonomic modulation would be expected.  
 
A markedly reduced HRV is an established symptom of HF and predicts poor 
prognosis (Bilchick et al. 2002; Nolan et al. 1992). Participants from all three NYHA 
classes included in the present study had an average HRV within the normal range 





often occurs with HF patients, and is displayed through a reduced HRV (Task Force, 
1996).  Elderly patients with HF are thought to have even more impaired HRV due 
to age-related autonomic dysfunction (Reardon & Malik 1996) and associated co- 
morbidities such as diabetes, hypertension and inflammatory conditions (Task Force, 
1996) 
 
With an aging population the prevalence of HF is increasing and will significantly 
affect costs in the public health system (Miche et al. 2009).  Finding ways to combat 
and treat this growing epidemic are important to ensuring the health system can work 
at its best for years to come. Various exercise programmes may have different 
benefits for patients with HF. An increase in physical performance in elderly patients 
has been documented, however no clear recommendations on endurance versus 
muscle strengthening programmes have been outlined (Miche et al. 2009). There is a 
clear correlation between Vo2 peak and performance in the six-minute walk test 
providing easy measurement and evaluation of stress tolerance in CHF patients 
(Guyatt et al. 1985). An increase in physical performance has been demonstrated in 
older patients (age 74 ±3) where after six months, peak Vo2 and muscle strength 
significantly increased (Miche et al. 2009). Despite the benefits to cardiac 
rehabilitation, participation remains suboptimal (Dalal et al. 2010).  In chapter eleven 
the effect of exercise measured by HRV (Ithlete) will be explored through a 
moderate walking rehabilitation programme.  
 
9.4.1 Limitations 
Within the present study there was a wide age range within the participants. Some 
participants had concerns about using the touch screen on the iPod device and 
despite practicing with the researcher were still not comfortable when they took the 
measuring kit home. This may have accounted for errors in taking and saving 
measurements.  Participants were also asked to record their exercise activity daily in 
a physical activity diary. Participants had to choose a zone for the rate of intensity at 
low/moderate/high and this was a very subjective measure. For some patients this 
concept was hard to grasp as they did not have much energy to carry out their daily 
activities. They cited that everything they did felt like it was at high intensity 
because it took so much effort to carry out and this could have an affect on 





Quantifying the level of exercise with percent Vo2 max or maximum HR could have 
provided more accuracy; however you would then need participants to measure their 
HR during each bout of exercise. This would be quite tedious for participants as they 
would need to wear a heart rate monitor for potentially most of everyday. This was 
seen as too intrusive for the present research study, and therefore the intensity zones 
were used instead. It is difficult to gauge how well participants adhered to the 
described intensity zones within one exercise, therefore, they were asked to pick the 
zone within which they thought they were exercising within most during each 
exercise bout. There was however a large range of activity levels within the 
participants which helped to counter that effect.   
 
9.5 Conclusions 
Ithlete measurements of rMSSD and HR in HF patients were undertaken on a 
consistent basis for one-month for 46 patients.  Of those 46 participants most 
reported that the device was easy to use and most did not have any trouble taking 
measurements on a daily basis. The remaining participants took no measurements or 
part measurements, where they either just did Ithlete recordings or only filled in the 
calendar. A dip in rMSSD following reported exercise was found in more than 60% 
of participants after 48-hours; 24-hours after reported exercise a dip was found in 
less than 50%. These results were somewhat inconclusive; however a lack of 
sufficient exercise intensity most likely played a role. Future research on the effects 
of exercise on HRV over various time periods with a large cohort of participants 
could be very beneficial in the assessment of the effect of exercise on the body over 
time.  For patients with HF, this device can be explored for use in the clinical setting 
to provide patients and clinical staff with feedback on autonomic function. Ithlete 
appears to be an easy device to use for HRV assessment.  Ithlete is also cost efficient 
when compared to other medical devices and provides feedback to the user which 
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CHAPTER 10: ADHERENCE, REFERENCE VALUES AND USER 
ASSESSMENT OF ITHLETE HEART RATE VARIABILITY (HRV) 
MEASURES FOR PATIENTS WITH HEART FAILURE 
Short-term heart rate variability (HRV) measurements are the type most commonly 
used to non-invasively investigate cardiac autonomic function and provide as much 
information as long-term measurements. Impaired autonomic function, characterized 
by decreased HRV has been demonstrated in clinical populations when compared 
with healthy counterparts. Telemonitoring is a new diagnostic modality which 
records physiological data (i.e. HRV, blood pressure), and is used as a tool to 
monitor patients in their home. Telemonitoring is commonly used in the heart failure 
population for early detection of worsening heart failure (HF) symptoms and to help 
reduce rehospitalisation. The ease of use for a telemonitoring device is important to 
ensure that subjects can use the device consistently and supply reproducible results. 
Ithlete is a novel telemonitoring application for HRV measurement on a smartphone 
or Apple iPod touch. 
 
The aims of the present study were to (i) assess the adherence of HF patients to daily 
measurement of HRV root mean of square successive difference (rMSSD) and heart 
rate (HR) in beats per minute (bpm) using Ithlete software (ii) establish reference 
values for patients with HF. User assessment through questionnaires was also 
completed to examine how patients felt about using the device daily. HRV values 
were also analyzed by looking at covariates such as comorbidities and medication to 
see what effect, if any, they had on adherence and HRV measurements. 
 
Ninety percent of HF participants using Ithlete for daily measurement reported that 
they were able to use the device without any major issues. Ithlete measurements in 
HF patients were undertaken on a consistent basis for at least twenty-eight days for 
forty-six patients (44.6%). Males were no more likely than females to comply with 
the study protocol. Patients with comorbidities such as ischaemic heart disease or 
dilated cardiomyopathy were statistically no more or less likely to complete 
measurements. The average rMSSD for HF patients was marginally lower than those 
reported for healthy participants in chapter eight. The coefficient of variation for 
healthy participants was 10.9, compared with 25.1 for patients with HF; the 





patients reported Ithlete was easy to use, an efficient use of time and recommended 
its use for other patients. The touch screen was reported as easy to use and getting in 
and out of the measurement application was also easy. The Ithlete device is cost 
efficient when compared to other medical devices; providing immediate feedback to 





The effective use of HRV to monitor how the body responds to exercise has been 
demonstrated (Kiviniemi et al. 2007; Kiviniemi et al. 2010). Measurement time has 
varied throughout the years; however research has demonstrated that short term 
measurements are found to be as valid as long term measurements (Nunan et al. 
2009; Task Force. 1996). There are several devices on the market that can be used 
for short-term HRV measurements including Polar, Suunto, Biopac HRV, and most 
recently Ithlete. Of the devices, Ithlete is unique because it is compatible with 
smartphones, tablet PCs and the Apple iPod touch by attaching an ECG dongle into 
the headphones jack of those devices. Ithlete is a software application designed to 
measure heart rate variability (HRV) as root mean square of successive difference 
(rMSSD) (ms) and heart rate (HR) in beats per minute (bpm). Measurements take 
one minute and are advised to be taken first thing in the morning.  
 
The rMSSD measure has been suggested as superior to spectral methods of HRV 
assessment due to its sensitivity to vagal cardiac control (Penttilä et al. 2001); and is 
less sensitive to variations in respiratory patterns (ibid). The mean rMSSD value for 
529 heart failure (HF) patients was reported as 21.5 ± 12.3 with a mean age of 62.0 ± 
9.6 (Nolan et al. 1998). Another study reported mean rMSSD as 20 ± 2 in 59 HF 
patients (Brouwer et al. 1995), while a study looking at sudden cardiac death in HF 
found rMSSD values at 22.9 ± 14.9 (n=135) in survivors and 21.1 ± 13.2 (n=55) 
non-survivors (Galinier et al. 2000).  
 
Validity of a measurement is the extent to which the variable measures what it is 
intended to. Several studies have assessed the validity of HRV on several heart rate 





Junqueira Jr 2009; Weippert et al. 2010). HRV was declared a reliable and 
reproducible technique for assessing autonomic activity by Nolan et al, (1998); but 
the reproducibility of HRV has been highlighted throughout literature as an 
important area for further research (Leicht & Allen 2008; Sandercock et al. 2005; 
Task Force. 1996). Reproducibility has been studied in both adults and children with 
intriguing results. In children, one study found the reproducibility of HRV was poor 
with a low coefficient of variation (Winsley et al. 2003); while other studies found 
significant differences in HRV when comparing children by age (Goto et al. 1997), 
and exercise (Mandigout et al. 2002). In adults however, good reproducibility of 
HRV has been demonstrated in several different measurement durations including 
24-hours (Pinna et al. 2007), 48-hours (Amara & Wolfe 1998), 1-2 weeks (Schroeder 
et al. 2004), and 2-6 months (Kowalewski & Urban 2004). Traditionally, HRV 
research was confined to ECG systems or Holter monitors, which require trained 
personnel for operation, are expensive and time consuming (Nunan et al. 2009). The 
development of ECG telemetry on wireless heart-rate monitoring systems allows for 
field-based assessment. In patients with HF, improving the follow-up of patients care 
at home could reduce the amount of acute hospitalizations (Maggioni et al. 2010).  
 
10.1.2 Telemonitoring 
Telemonitoring is a new diagnostic modality which records physiological data (i.e. 
blood pressure, body weight, HR, HRV), and has been shown as beneficial for 
patients with HF (Clark et al. 2007; Clarke et al. 2011). Data is transmitted remotely 
using a computer, mobile phone or telephone line for review by a clinician or 
research staff (Giamouzis et al. 2012). Telemonitoring can also be regular structured 
telephone calls, with or without the transfer of physiological data, between patients 
and clinicians (McAlister et al. 2004). Telemonitoring in chronic heart failure (CHF) 
patients has been reviewed by several studies (Chaudhry et al. 2007b; Clark et al. 
2007; Clarke et al. 2011; Giamouzis et al. 2012). Overall telemonitoring appears to 
be a favourable intervention in patients with CHF (Giamouzis et al. 2012); with all 
studies reporting improved quality of life for patients. There are however some 
conflicting results published; two large multicentre studies concluded that 
telemonitoring did not have a significant effect on death or rehospitalisation rates 
(Chaudhry et al. 2010; Koehler et al. 2011). Telemonitoring has also been linked 





2008). Three factors have been suggested as necessary criteria for telemonitoring to 
work. The first involves efficient transmission of physiological variables which 
would reflect early phases of decompensation (Mortara 2012). Second, data received 
should be translated into specific recommendations and third, patients must 
implement the recommended interventions (ibid). For successful telemonitoring, 
patient implementation can be coupled with their ability to continuously adhere to 
those recommendations over a specific period of time.  
 
10.1.3 Adherence to telemonitoring in heart failure patients 
Adherence is defined as the amount to which an individual’s behaviour complies 
with the healthcare providers recommendations i.e. medication, lifestyle changes etc. 
(World Health Organization 2003). Three categories to evaluate adherence to a 
prescribed therapeutic regimen were suggested for measuring the adherence to 
hypertensive medication (Cramer et al. 2008; World Health Organization 2003); and 
can be used on a wider scale for other therapeutic interventions such as exercise 
(Conraads et al. 2012). Patients who adhere to at least 80% of the prescribed regimen 
are the first category; patients who adhere to <20% of the prescribed regimen are the 
second category; and the third category consists of those patients in-between (ibid).  
Conflicting results have been published regarding adherence rates to telemonitoring 
in patients with HF. Low adherence rates were demonstrated in a large scale study of 
(n=1653) HF patients, where 14% never used the telemonitoring system and 55% 
used the system at least three times/week by the final week of the trial (Chaudhry et 
al. 2007a). Scherr et al, (2009) reported high adherence rates among HF patients in 
the telemonitoring group at 95%. In a more recent study on telemonitoring using 
mobile phones with HF patients, 89% of patients took measurements at least three 
times/week (Seto et al. 2012). 
 
10.1.4 Establishing reference values for HRV   
To ensure HRV measurements are reliable it is important to maintain consistency in 
data collection methods, data treatment and study population (Sandercock et al. 
2005). Studies that look at reliability demonstrate reduced reliability in clinical 
populations when compared to healthy subjects (Sandercock et al. 2005). Good 





by ensuring the measurement has been validated in that population in previous 
literature (Sandercock 2007a).  
 
A measurement is considered reliable when there is a small degree of change in the 
measure at separate occasions, under the same conditions (Nunan et al. 2009).  
Despite the use of HRV by thousands of authors globally, there is no adequate 
consensus on concurrent retest reliability (Sandercock 2007b). Reliability and 
reference values of HRV have been assessed in several previous studies (Amara & 
Wolfe 1998; Guijt et al. 2007; McNarry & Lewis 2012; Nunan et al. 2010; Pinna et 
al. 2007; Sandercock et al. 2005; Schroeder et al. 2004; Sinnreich et al. 1998; 
Winsley et al. 2003); however there is still no consensus on what changes in HRV 
are of clinical significance (Pinna et al. 2007). There is also a need to establish what 
represents a normal value of HRV in different populations on which sample size 
estimates can be based on for future research (Sandercock 2007b). What has been 
demonstrated is that HRV indices (especially spectral measurements) appear to have 
a large inter-subject variation, and due to a variety of interventions, demonstrate very 
large effect sizes (ibid). This suggests that HRV indices are not very reliable but are 
very changeable, making them suitable for serial measurement particularly within 
individuals (Sandercock 2007b).  
 
Short-term HRV measurements provide as much information as long-term 
measurements (Bigger et al. 1993). Short-term measurements of HRV are the type 
most commonly used when investigating cardiac autonomic function non-invasively 
(Pinna et al. 2007). When comparing different HRV measures, time-domain values 
demonstrate adequate homogeneity but spectral measures appear to be mainly 
heterogeneous (Sandercock 2007a). Random variation represented a small 
proportion of the between subject variability for most HRV parameters, and sample 
size determination for experimental work was recommend to be based on the 
parameters with the lowest variation, of which rMSSD was listed as one (Pinna et al. 
2007). There is an expected level of variation as short-term parameters of HRV are 
subject to day-to-day random variations (ibid). Between subject variability is not 
caused entirely by random error, but instead represents the differences in each 





same subject provides us with a within-subject coefficient of variation, and provides 
better reliability. 
 
Respiratory sinus arrhythmia is the natural occurring variation in HR that takes place 
during the breathing cycle. The use of paced breathing within the Ithlete 
measurement tool is designed to assist participants by providing a breathing pattern 
for them to follow on screen which maximizes their RSA response. The relationship 
between HR and respiration has been studied for several years (Kobayashi 2009). 
Both the depth and frequency of respiration have an impact on RSA. Research has 
also focused on the relationship between HRV and paced breathing and found 
differing results. Kobayashi (2009) found that it provides limited improvement in the 
reproducibility of HRV and suggested that simply reminding participants to avoid 
irregular inspiration during measurement was enough. Synchronizing breathing 
rhythm is known as paced breathing and has been undertaken in research studies 
using a metronome. Changing someone’s breathing pattern may not be optimal for 
measurement. Those who are not used to it may feel uncomfortable and therefore 
this may have a negative effect on measurement. Several studies have tried to 
identify the best breathing pattern for optimal heart rate variability measurements 
(Bernardi et al. 2000; Fang et al. 2008; Guzik et al. 2007; Hirsch & Bishop 1981; 
Kobayashi 2009; Kox et al. 2011; Maestri et al. 2010; Pinna et al. 2006) with 
conflicting results. Paced breathing may (Bernardi et al. 2000; Driscoll & Dicicco 
2000; Pinna et al. 2007) or may not (Hirsch & Bishop 1981; Kobayashi 2009; Kox et 
al. 2011; Maestri et al. 2010) increase reproducibility of HRV measurements. It is 
therefore essential to strike a balance.  
 
Evidently the best way to obtain totally reproducible methods is to control 
everything within a laboratory for several hours; however in most circumstances this 
is not practical. Finding innovative ways to perform short-term measurements in the 
comfort of the participant’s home using the same or similar circumstances such as 
measurements taken first thing in the morning before they have had anything to eat 
or drink and under the same breathing pattern can go a long way to ensuring 
reproducibility. For measurements to be completed regularly in the clinical 
population they need to be realistic and practical, trying to ensure as little 





with daily result charting, short one-minute measurements, a fixed breathing pattern 
to maximize RSA and an easy to use interface. 
 
10.1.5 Aims 
The primary aims of the present study were to (i) assess the adherence of HF patients 
to daily measurement of HRV (rMSSD) and HR (bpm) using Ithlete software; (ii) to 
establish reference values for rMSSD in patients with HF using the Ithlete software. 
User assessment was also undertaken to examine how patients felt about using the 
device daily and what impact it had on their care if any. HRV values were also 
analyzed by looking at covariates such as comorbidities and medication to see what 
effect, if any, they had on adherence, rMSSD, and HR measurements. Consistent 
HRV Ithlete measurements and positive patient feedback would demonstrate the 
usability of Ithlete within clinical populations.   
 
10.2 Methods 
10.2.1 Recruitment of participants 
The researcher attended clinics with either a Consultant Cardiologist or Heart Failure 
Nurse Specialist at three London hospital sites. Each participant was recruited in 
accordance with NHS Research Ethics Committee standards and expectations. 
Participants responded in the clinic or by phone and were sent an information pack 
before agreeing to participate. The information pack included: 
1. An information sheet with detail of the requirements for each participant 
before and during the laboratory visit 
2. An informed consent form 
3. HRV measurement information package 
4. A detailed demographic information sheet 
Participants were requested to read the information pack prior to attending the clinic 
to meet with the researcher and any questions or concerns were addressed. All 







One hundred and three participants responded within the clinics and agreed to 
participate in the study of which n=70 were male and n=33 were female. Participant 
ages ranged from 24 to 87 years with an average of 62.7 ± 17.9. All participants 
were defined as heart failure patients with varying levels of impairment but all were 
deemed suitable for the study by the medical team at the hospital they attended. 
Inclusion Criteria: The participants were heart failure patients within the New York 
Heart Association classifications of I, II & III aged at least 18 years of age. Heart 
failure treatment was under the control of the participant's consultant cardiologist.  
Exclusion Criteria: Participants were excluded if they had any of the following 
conditions: Consistent atrial fibrillation, unstable coronary artery disease with 
revascularization within the last 6 months or planned revascularization, planned 
heart valve surgery or planned transplantation, uncontrolled arterial hypertension, 
acute myocarditis, worsening clinical condition, inability to read the display of a 
handheld device or deemed unable to comply with home telemonitoring; inadequate 
understanding of English; any visual or cognitive impairment sufficient to interfere 
with the participant's ability to use the device (Cleland et al. 2005; Dar et al. 2009; 
Scherr et al. 2009). Participants completed their consent form in front of the 
researcher and the researcher countersigned the form. 
10.2.3 Instrumentation and data acquisition 
HRV (rMSSD in ms) and HR (bpm) were recorded via the Ithlete software for the 
iPod touch (Ithlete 2009).  The breathing frequency was set at 7.5 breaths per 
minute, designed to maximize RSA response (Brown et al. 1993). Each measurement 
took 1-minute, when this was complete the HR (bpm) and HRV (rMSSD in ms) 
were displayed on the screen and saved to the device. Ithlete recordings were 
transferred to a password protected PC via Ithlete software which enables recordings 
to be emailed and saved into an excel document. 
 
Patients were asked to record for one minute and the readings should be taken first 
thing in the morning. After using the device for at least 28 days (to provide within-
subject coefficients of variation), participants were asked to fill in a questionnaire 





questionnaire with the researcher posing the questions or by them filling it out 
themselves in the clinic room.  A picture of the measurement screen is displayed 
below in figure 10-1. 
 
Figure 10-1 Screen shot of Ithlete software on an iPod touch  
 
 
10.2.4 Experimental design 
Following appropriate ethical approval from the NHS Southwest Research Ethics 
Committee and informed consent, participants were asked to visit the clinic at their 
hospital to meet with the researcher for a demonstration. Each participant was given 
a demonstration of how to use the Ithlete software on the iPod touch and required to 
complete two measurements in the presence of a researcher before taking the device 
home. Then each participant was required to take an HRV measurement once every 
morning when they woke up for one month (at least 28 days). Each day participants 
were asked to fill in a physical activity calendar where they were asked to record the 
following: 
1. What (if any) exercise was performed the day before 
2. Duration of that exercise 
3. Intensity of that exercise (Low/Moderate/High) 
4. Daily scale of how you are feeling on a scale of 0-100% (100% being the 
best) 
Low-intensity aerobic activity was described as not working hard enough to raise 
your heart rate or break a sweat. Moderate-intensity aerobic activity was described as 
working hard enough to raise your heart rate and break a sweat, yet still being able to 





hard and fast, heart rate increasing substantially. At this intensity, participants would 
not be able to say more than a few words without pausing for a breath.  
 
10.2.5 Heart rate variability analysis 
Heart rate variability measurements were taken using an iPod touch with the Ithlete 
application (Ithlete 2009). For HRV measurement a standard analogue ECG chest 
strap was worn in the middle of the chest just under the sternum. Using the Ithlete 
software for the iPod touch, participants measured HRV for one minute each 
morning when they woke up. 
 
Real time heart and lung animation on the iPod touch facilitated paced breathing 
during measurements and indicated reception of each heart beat from the analogue 
chest strap.  Participants followed a breathing frequency of 7.5 breaths per minute, 
designed to maximize RSA response (Brown et al. 1993). When the one minute 
measurement was complete the HR (bpm) and HRV (rMSSD) were displayed on the 
screen and saved to the device. 
 
10.2.6 Statistical analysis 
All statistical analysis was completed using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Values are reported in the text as mean ± standard deviation.  
Chi-square analysis was completed to determine patient adherence to the study 
protocol. The coefficient of variation was calculated and used to determine variation 
in HRV/HR by gender and NYHA class and which medications should be covariates 
for binary logistic analysis. Univariate analysis was used to quantify the relationship 
between patient characteristics such as comorbidities and medications with their 
measurement results. Binary logistic regression was then performed on the change in 
HRV on the day immediately following training/non-training and two days 
following exercise/non-exercise with analysis controlling for comorbidities and 
different HF medications. A P-value of <0.05 was considered statistically significant.  
 
10.3 Results 
Forty-six out of 103 participants completed measurements successfully for at least 
one-month, of which eight were female and 38 were male (28% of the total female 





participants who completed HRV Ithlete measurements and their physical activity 
calendar was 64 ± 13.8 for males and 59 ± 26.1 for females. Participants’ 
measurements were deemed unsuccessful if they had less than half of the recordings 
complete for the amount of time that they had the device, with no more than two 
days in a row of HRV measurements missing. The average age of those who did not 
complete measurements was 67.0 ± 13.7 for males and 73.4 ± 13.7 for females.  For 
both genders, the average age was higher in those who did not complete 
measurements. This however was not a statistically significant difference (p= 0.286).  
 
10.3.1 Questionnaires 
Questionnaires were completed by patients when they returned the device back to the 







Table 10.1 Questionnaire answers (n=87 of 103 patients) 
Questions: Use of the Device Yes No Undecided 
1. Did you find the touch screen buttons easy to 
use? 
85% 15% - 
2. Did you have any trouble turning the device 
on? 
0% 100% - 
3. Did you have any trouble getting into the 
Ithlete application? 
15% 85% - 
4. Did you have any trouble starting the 
measurement phase? 
25% 75% - 
5. Did you have any trouble saving the 
measurements? 
35% 65% - 
6. Were you able to flip between screens to see 
if your measurement saved? 
70% 30% - 
Questions: Use of the Chest Strap  Yes No Undecided 
1. Did the chest strap fit appropriately? 95% 5% - 
2. Did you have any problems connecting the 
strap? 
85% 15% - 
3. Did you need to wet the sensors in order for 
it to register your heart rate? 
90% 10% - 
Questions: Charging the Device Yes No Undecided 
1. Did you have any problems charging the 
device? 
2.8% 97.2% - 
2. Approximately how often did you need to 
charge it? 
3.8 ± 3.2 times/month 
Questions: Overall Use Yes No Undecided 
1. Did you enjoy using the device? 89.5% 5.2% 5.2% 
2. Would you recommend use to other patients? 100% - - 
3. Did you find the measurements too time 
consuming? 
5.8% 94.2% - 
4. Is there anything about the device that you 
would recommend changing? 
See comments below 
Patients expressed a few comments regarding the Ithlete device.  Most enjoyed using 
the device and found the feedback helpful. Some issues cited were as follows: 
• Better strap needed, contact was on and off so had to wet it several times in 
order to get a recording 
• Ithlete dongle came loose at times (n=2) 
• Saving measurements should be automatic (n=7) 
• Sometimes no measurement came up after the minute was completed, or the 





• Should just have one application on the main screen so as not to confuse 
users 
• Not enough time to use it in the morning, would be better if measurements 
could be taken at any time of day (n=4) 
• Moving between screens could be confusing 
• I’m old fashioned so using a touch screen is hard to get the hang of 
• Touching the screen softly helps get the device working easier 
• Not good for mornings because I have young children 
• Good feedback to patients 
• Should input exercises into the iPod touch as well as one programme 
• Screen was hard to see first thing in the morning as I’m old 
• Easier strap, easier buttons on the device 
• Device may be too hard to use for older people because you need to have 
steady hands 
• Too complicated for an old man who lives alone 
10.3.2 NYHA classifications and comorbidities 
The percentage of HF participants with different comorbidities can be found in 
appendix III. Forty-six out of 103 participants completed the HRV Ithlete 
measurements and completed a calendar for one month. Table 10.2 displays the raw 
mean rMSSD, HR and TRIMP for each NYHA class, along with the mean age for 
each group and gender breakdown. As a whole, the mean age of those patients who 
completed measurements were 59.4 ± 18.5 compared with 66.3 ± 16.6 for those who 
















I M- (8) 
F- (3) 
64.6 ± 12.5 81.4 ± 10.2 81.5 ± 10.2 
 
94.6 ± 56.7 
II M- (16) 
F- (4) 
60.5 ± 12.1 72.4 ± 11.3 82.2 ± 13.2 
 
135.38 ± 94.4 
III M- (15) 
F- (0) 
63.3 ± 12.5 75.4 ± 12.3 84.7 ± 6.1 
 
110.55 ± 82.6 
 
Chi-square analysis results for patient adherence to Ithlete measurements for at least 
28 days are displayed in Table 10.3. Table 10.4 displays the amount of patients 
assigned to the three suggested adherence categories discussed in the introduction. 
Of the patients that did complete measurements 39.5% have dilated cardiomyopathy, 
37.2% have ischaemic heart disease, 23.3% have hypertension, and 9.3% have 
diabetes mellitus. Those comorbidities were controlled for with binary logistic 
regression analysis to examine if they had any significant association with HRV. For 
those patients who failed to complete measurements, 32.8% have cardiomyopathy, 
38.8% have ischaemic heart disease, 21.0% have hypertension and 9.0% have 
diabetes mellitus. These percentages are very similar to those of the patients who 
completed measurements. A chi-square test demonstrated no significant differences 
between the two groups at X2 (1, n=103) = 0.42, p= 0.52 for cardiomyopathy; X2 (1, 
n=103) = 0.11, p= 0.74 for ischaemic heart disease, X2 (1, n=103) = 0.10, p= 0.75 for 
hypertension and X2 (1, n=103) = 2.36, p= 0.13 for diabetes. This demonstrates that 
nearly 50% of patients had ischaemic heart disease, cardiomyopathy or both and that 
having comorbidities made patients no more or less likely to complete 
measurements.  
 
Table 10.3 Number of patients who adhered to the study protocol 
Gender Completed Not completed 
Male 41 34 






Table 10.4 Patient adherence groups for each gender 






Completed < 20% 
of measurements 
(%) 
Male 64.1 26.6 9.3 
Female 25.1 28.5 46.4 
 
Chi square analysis revealed that males were no more likely than females to comply 
with the study protocol X2 (1, n=103) = 0.56, p= 0.46. A one-way ANCOVA was 
then performed to evaluate the differences in raw rMSSD values between NYHA 
classes while controlling for age and gender. The homogeneity of regression 
assumption was tested first to evaluate the interaction between the covariates (age 
and gender) with NYHA class in the prediction of rMSSD. This interaction was not 
significant F (3, 35) p=0.607. The results of the one-way ANCOVA F (2, 38) = 1.49, 
p=0.24 showed that the differences in raw rMSSD values between NYHA classes 
were not statistically significant. There was no statistically significant difference 
between the amount of exercise (TRIMP) between NYHA classes as determined by 
one-way ANOVA (F (2, 43) = 0.932, p = 0.402).   
 
10.3.3 Coefficient of variation 
Table 10.5 displays the coefficient of variation (CV) of rMSSD, HR, TRIMP and DS 
for each gender. Table 10.6 displays the CV for rMSSD, HR, TRIMP and DS for 
each NYHA class. Levene’s F test determined significant differences in rMSSD 
between males and females, and NYHA classes II and III at p=0.01 and p=0.05 
respectively. There were no female participants classified as NYHA class III, 
suggesting that gender did not have an impact on the difference between NYHA 
classes. 
 
Table 10.5 Coefficient of variation for rMSSD, HR, TRIMP and day scale for each 
gender 
Gender rMSSD HR TRIMP Day Scale 
Males 26.6* 6.8 89.0 30.0 
Females 13.7* 7.1 60.8 27.8 





Table 10.6 Coefficient of variation for rMSSD and HR for each NYHA class with 





CV for HR CV for 
TRIMP 
CV of DS 
I 20.7 7.4 94.4 22.5 
II 17.5* 6.8 77.9 19.8 
III 36.9* 6.6 88.1 47.6 
*Significant difference at F <0.05 
 
The CV for rMSSD classified in groups by various HF medications and any 
comorbidity present in at least 10% of the current study’s patient population can be 
found in appendix II. No significant differences were demonstrated between patients 
on any medication versus those who were not. There were also no significant 
differences demonstrated in rMSSD between those with dilated cardiomyopathy, 
hypertension, ischaemic heart disease or diabetes mellitus versus those who did not.  
 
10.3.4 General linear model: Univariate analysis and Analysis of covariance 
(ANCOVA) 
Univariate analysis revealed that after 24-hours rMSSD in patients with HF were not 
significantly affected by training (p=0.70). The F value for rMSSD on the day after 
training was 0.137. The rMSSD 48-hours after training was also not significantly 
affected (p= 0.06) with an F value of 1.978. ANCOVA controlled first for NYHA 
class (p= 0.70), then for age (p= 0.98) and then finally for gender (p= 0.92) 
demonstrated no significant differences in rMSSD following training. ANCOVA 
controlling for all three variables also demonstrated no significant difference (p= 
0.98) in rMSSD following training.  
 
10.4 Discussion 
The aim of the present study was to assess the adherence of HF patients to daily 
measurement of HRV (rMSSD) and HR using Ithlete software, while also 
establishing reference values. Patients answered questionnaires, which assessed how 
patients felt about using the device daily and what impact they felt it had on their 





analysis of covariance to see what effect, if any, they had on adherence, rMSSD, and 
HR measurements.  
 
10.4.1 HF patient’s adherence to the study protocol 
In the present study, 45% of 103 participants complied with the study protocol by 
taking daily Ithlete measurements for one month. When separated into the three 
suggested adherence groups, 40 patients completed over 80% of measurements 
(38.8% of total participants). Twenty-five percent of the female patients recruited 
completed over 80% of the measurements, compared with 44% of male patients 
recruited. Chi square analysis revealed that males were no more likely than females 
to comply with the study protocol X2 (1, n=103) = 0.56, p= 0.46. The reported 
general adherence of HF patients to medication ranges from 10% (Monane et al. 
1994) to 98.6% (van der Wal et al. 2006). This is compared with only 35% 
compliance with regular weighing (at least three times a week or daily) (van der Wal 
et al. 2006) and low compliance reported by several other studies (Artinian et al. 
2003; De Geest et al. 2003; Ni et al. 1999; Strömberg et al. 2003). Compliance to 
exercise has also been reported as low in several studies (Artinian et al. 2003; 
Evangelista et al. 2003; Ni et al. 1999; van der Wal et al. 2006), suggesting that 
patients adhere well to some aspects of their care better than others.   
 
Previous studies with similar telemonitoring, involving the use of an electronic 
machine at home recorded higher results; 95% adherence of 120 patients doing daily 
measurements of blood pressure, heart rate and body weight (Scherr et al. 2009), 461 
patients completed 81% of vital signs transmissions and 95% of cardiorespiratory 
readings (Mortara et al. 2009), and 70% of 50 telemonitoring patients completed at 
least 80% of required recordings (Seto et al. 2012).  Therefore for the present study, 
a higher compliance was expected. Poor completion results were discussed with the 
medical teams at each hospital; possible reasons suggested included the lack of 
automatic save for the first portion of the study, diminishing resources through the 
NHS budget for supporting patients with HF (specifically the lack of an established 
cardiac rehabilitation programme at the main hospital site), language barriers (large 
population of foreign participants) and lack of patient contact. In other 
telemonitoring studies, patients send information directly to the clinicians who 





were only collected once a month, possibly affecting results. Data collection at 
shorter intervals may have motivated more patients to keep up with the 
measurements. Alternatively, patients did not have to send data in regularly (weekly) 
via the internet, sparing them the need to learn how to transmit data. The researcher 
initially thought this would be easier for the patient, however some patients reported 
that they would have liked sending the information and thought it would be more 
encouraging for them to take measurements daily knowing it would be transmitted 
each week. Other telemonitoring studies demonstrate conflicting results when 
comparing age, gender and ethnicity, with no difference in use of daily monitoring 
between those groups (Dar et al. 2009). In the present study significantly more males 
participated, statistical analysis was completed to control for gender and age and will 
be discussed in the following paragraph; ethnicity data were not collected in this 
cohort of participants. 
 
Reasons cited by patients for not complying with the study protocol predominantly 
related to time or incorrect use of the device (especially not saving measurements 
correctly). After the first 11 months of the study, the developer introduced an 
automatic save feature which prompted users to save at the end of each 
measurement. This was as a direct result of the feedback that the researcher received 
from questionnaires as this appeared to be the main barrier cited by patients who had 
not achieved correct measurements. Despite clear verbal and written instructions, 
many users were under the impression that they had saved the measurement but 
when the device came back there were no recordings or only a select few despite 
patients stating that they had taken measurements each day.   
 
More males were recruited than females, and so consequently more males completed 
measurements. This is not unusual because there is a higher prevalence of heart 
failure in males (Mehta & Cowie 2006; Stromberg & Martensson 2003); at two 
London hospitals, the Heart Failure Specialist Nurses clinics are thought to be 
composed of more male patients than females (approximately 80/20%), which 
accounts for why more males were recruited. Chi-square analysis revealed that males 
were no more likely than females to comply with the study protocol. Overall males 
did however appear to be more open to participating in the research study when 





patients tended to be older and already retired, therefore potentially had more free 
time, they also took to the device quicker during demonstration and seemed 
generally more interested in trying out an iPod touch. After discussing this with the 
Consultant Cardiologist and Heart Failure Specialist Nurse, they both thought this 
was related to the rapport with the clinician or the patient’s previous experiences of 
research in healthcare.   
 
10.4.2 User assessment of usability 
There were significantly less female participants in the study. Many female patients 
who were asked to participate in the study did not agree to take part compared with 
men when asked. Some women cited that they were too busy with their family or 
work to do measurements every morning (mainly women who had children to take 
care of in the morning before other obligations like work). Patients were reassured 
that the requirement was only approximately 2-5 minutes each morning. Some 
would then see the device demonstration but still would not commit to participating. 
Others said that they were not comfortable using the technology and did not want to 
try it. Of the men that did not want to participate they were also either apprehensive 
about the time commitment or did not think they could handle the technology.  
Despite being reassured by both the researcher and the heart failure nurse, many 
chose not to even try taking the device home, because they did not think they could 
use it appropriately. Patients were offered a demonstration and given the opportunity 
to try using Ithlete on an Apple iPod touch themselves. However many did not try 
taking the device home. This process was frustrating and not an expected outcome.  
In future further emphasis on the benefits of daily measurement and the impact it 
could have on clinical care by both the researcher and the clinician may help to 
convince patients to try out the device before making judgments. Perhaps explaining 
the prognostic value of HRV in HF might help convince patients of its importance 
and potential to help them improve their disease state.  
 
Just under half of the patients (44.7%) did not fill in the physical activity diary 
(PAD) completely, citing reasons such as it was too time consuming or too tedious. 
Some took the device home, took measurements but returned it without the PAD. In 
these cases patients were asked why they did not fill in the PAD and some of the 





they often forgot to fill it in for a few days and then were unable to recall what 
physical activity they had completed. Some patients brought the PAD back 
incomplete but had filled in certain days that they remembered. These diaries were 
still used if the participants took at least 10 days of readings with corresponding 
physical activity information. Some patients mentioned that they had trouble 
choosing which activity to put down each day.   
 
Participants were asked to write down one exercise a day, whatever they thought was 
the most strenuous on the body. Participants were asked to fill in the PAD daily 
(recording the information for the day before each morning when taking an Ithlete 
measurement). On the PAD for each day there was a space to record the highest 
intensity exercise, duration of the exercise and day scale. Intensity was classified as 
low/moderate/high and day scale was how the patient felt generally throughout the 
day on a scale of 0-100. To try to improve PAD compliance and reduce subjectivity, 
patients discussed an average week of activities with the researcher and assigned 
intensity numbers to those activities to help facilitate their understanding of the 
different levels.  
 
The number of patients who completed the PAD was also less than expected, but this 
may be due to the use of a paper exercise diary, instead of inputting their exercise 
into the device. Fukuoka et al, (2011) assessed compliance with a mobile-phone 
based PAD with pedometer use and found that 88.3% of participants completed 
diary entries. Poor accuracy of recall and poor real-time compliance of patients with 
diaries mean there is a potential lack of confidence in validity (Stone et al. 2003). 
Within the present study 55.3% of patients completed their PAD. However this did 
not comply with the number of Ithlete measurements taken. This is a similar finding 
to Stone et al, (2002) where compliance with paper diaries were examined with an 
electronic diary. Reported entries into the paper diary suggested 90% adherence 
compared with actual compliance which was recorded by the electronic diary at only 
11%. A centre-based cardiac rehabilitation (CR) programme would prove 
advantageous as clinicians could observe and monitor first-hand patient exercise 
adherence, intensity of exercise and duration. CR programmes typically run for 
approximately eight weeks, following that patients are encouraged to keep exercising 





monitor their own exercise and recovery while providing feedback on their recovery 
from exercise. Following a CR programme where Ithlete was utilised, patients could 
track their progress and feed it back to clinicians. This could also help encourage 
patients to keep active by providing accountability to the clinical team. In the 
absence of a centre-based CR programme, Ithlete could be utilised for home-based 
programmes by providing feedback to both the patient and clinician on how the 
patient is responding to the programme. With the decreasing amount of NHS 
resources in real terms however, programmes such as this are unlikely and therefore 
alternative ways must be found and utilized. The problem is that preventative work 
like this is hard to justify economically when budgets need to be cut because you 
cannot quantify the savings, only predict what the potential savings could be.  
 
Standardizing measurement conditions as much as possible are imperative for 
ensuring usability and reproducible measurements. With Ithlete measurements 
specifically, participants were asked to take measurements first thing when they 
woke up daily, in a seated position. Ninety percent of HF participants using Ithlete 
for daily measurement reported that they were able to use the device without any 
major issues. Participants reported that the device was easy to use and not too time 
consuming. The touch screen was reported as easy to use and getting in and out of 
the measurement application was also easy. Patients were encouraged to take a 
second measurement if the HRV or HR looks drastically different to their normal 
readings. The device reports when more than one measurement is taken in one day, 
which allowed the researcher to remove some outliers if patients took more than one 
measurement.  
 
Overall 89.5% of patients reported that they enjoyed using the device, 100% of 
patients said they would recommend the device to other patients and 94% stated that 
the measurements were not too time-consuming. This is despite just over half of 
these patients not taking complete correct measurements (this includes not taking 
any measurements, not taking enough measurements or not completing the physical 
activity diary). Overall that is a very positive outlook and bodes well for the use of 
Ithlete in future clinical practice. The issue remains that there was a lower 
completion rate than expected regardless of the positive feedback received and ease 





speculate it is partially due to the older population used within the present study. The 
device is gaining popularity with athletes looking to improve performance and 
inhibit overtraining; perhaps the patient population needed more information about 
the potential benefit to their health and lifestyle.  
 
The device is both easy to use and cost effective when compared to other medical 
devices of the same nature. The cost of the Ithlete kit (iPod touch + charger, Ithlete 
dongle, ECG chest strap) is approximately £230. This is considerably cheaper than 
other measurement devices typically used within the HF population for home 
telemonitoring; e.g. Honeywell HomMed Sentry system has been used in various 
studies (Alaoui et al. 2003; Dar et al. 2009; Levine et al. 2006; Martínez et al. 2006; 
Riley & Cowie 2009), with an approximate cost of $899 (£550). 
 
10.4.3 Reference values for HRV in heart failure 
Measurement length does not affect vagal HRV measurements such as rMSSD in the 
supine position (Grant et al. 2011), which is why it is such a good measure. In 
research assessing the reliability of ultra-short HRV measurements (10 s) rMSSD 
emerged with high correlations with the standard 5-minute short-term recording 
(Thong et al. 2003). Nussinovitch et al, (2011) also found rMSSD to be a reliable 
parameter for assessing HRV from ultra-short 1-minute or 10-second resting ECG 
recordings. Therefore on principle, Ithlete one minute measurements can be 
considered a reliable parameter for assessing rMSSD. There is a big influence of age 
on short-term HRV measurements (Nunan et al. 2010).  rMSSD values of heart rate 
variability would be expected to be lower in heart failure patients when compared 
with values cited in literature for the healthy population because HRV depends on 
the activity of the autonomic nervous system, particularly sympathetic activation and 
reduced vagal tone which are known to be characteristic in chronic heart failure 
patients (Sztajzel 2004). HRV can be used as a marker for predicting sudden cardiac 
death or progressive LV dysfunction in heart failure patients (Nolan et al. 1998).   
 
Reference values for rMSSD of healthy subjects compared with certain diseased 
populations have been compared in the literature. Sztajzel et al, (2004) reported 
rMSSD values of 27 ± 12 ms for healthy subjects vs. 24 ± 12 ms for patients with a 





chronic heart failure within that study at 21.5 ± 12.3 ms.  Ithlete rMSSD values are 
different from those in literature because the values displayed are the natural log 
transformed rMSSD multiplied by 20. In chapter nine of this thesis, mean rMSSD in 
healthy participants using Ithlete was 76.3 ± 6.2 ms. Within the present study the 
average rMSSD value for heart failure patients was 74.8 ± 10.4 ms. The mean 
rMSSD would expectedly be lower in patients with HF however the mean of 74.8 ms 
is above the averages cited in the literature for patients with HF. The difference 
between the two averages is not statistically significant. This may imply that 
participants in the present study were only in mild HF.  
 
The CV for healthy participants was 10.9, compared with 25.1 for patients with HF; 
the difference between them is statistically significant at p = 0.014. A larger CV was 
expected in the healthy population to demonstrate large variation in their rMSSD, 
however that was not the case. A larger number of participants would increase the 
statistical power of these tests. There was a larger number of HF patients in the 
cohort (n= 46) compared with healthy participants (n= 24), which could have 
affected the amount of variation. The larger amount of variation in the patients with 
HF, also suggests that the HF participants in the present study were only potentially 
in mild HF. 
 
When divided into NYHA classes and controlled for gender and age NYHA class I 
demonstrated a higher average rMSSD than NYHA classes II and III comparatively 
which would be expected because of the physical capabilities of each class. The 
averages for rMSSD were NYHA I 58.6 ms (95%CI (42.5-85.3) ms, NYHA II 44.5 
(95%CI 29.74-49.57) ms, and NYHA III 43.4 (95%CI 30.24-55.33) ms. The 
difference between the groups however was not significant (p=0.34), likely due to 
the small number of participants. Symptomatically, NYHA class III are said to be 
comfortable at rest however have marked symptoms during physical activity 
including fatigue, palpitations and dyspnea, compared with NYHA class I with no 
symptoms at rest or during physical activity. The difference between class II and III 
was comparatively small; a bigger difference in average rMSSD between the two 
might have been expected. NYHA class II has slight limitation of physical activity 
compared with marked limitation for NYHA class III suggesting a marked difference 





Considering the relationship between HRV and risk of mortality in patients with HF 
(La Rovere et al. 2003; Nolan et al. 1998), bigger differences in HRV between 
NYHA classes would be expected, especially considering the link between HRV and 
physical activity (Lai et al. 2011; Murad et al. 2012; Routledge et al. 2010). Within 
the present study, NYHA class II had the highest TRIMP values (135.38 ± 94.4) 
suggesting that they did the most exercise on average, followed by NYHA class III 
(110.55 ± 82.6) and then NYHA class I (94.6 ± 56.7). NYHA class II also had the 
lowest CV for HRV indicating the smallest amount of dispersion in the variable 
compared with NYHA class I and then NYHA class III. This is contrary to the CV 
for HR where the lowest CV was in NYHA class III, then NYHA class I followed by 
NYHA class II.  HRV and HR are known to be negatively correlated (Javorka et al. 
2003; Migliaro et al. 2001), and therefore this difference is to be expected.  
 
10.4.4 Differences in HRV according to medication and comorbidities 
Drug treatment in heart failure has an effect on HRV. There are several classes of 
heart failure drugs which were controlled for in statistical analysis. These drugs were 
controlled for because of their potential effect on HRV. Beta blockers and anti-
arrhythmic drugs are administrated to reduce HR, directly impacting HRV. ACE 
inhibitors, diuretics and aldosterone antagonists are administered to reduce blood 
pressure (to reduce the amount of force needed to eject blood from the heart) 
(National Institute for Health and Clinical Excellence 2010).  This initially would not 
necessarily impact on HRV, however as the heart adjusts to the reduced pressure, 
heart rate may be altered over time. When not controlling for any heart failure 
medication, the odds ratio for a dip in HRV was 1.007 (95%CI 0.802 - 1.264) (p= 
0.95). Beta blockers did not have a large effect on the odds ratio which went from 
1.007 to 0.996. In patients with chronic heart failure beta blockers are reported to 
restore autonomic imbalance. ACE inhibitors affect HRV by increasing 
parasympathetic activity in patients with chronic heart failure (Tuininga et al. 1994). 
Some of these medications will affect HRV in HF patients as they are meant to 
directly act on HR to help the patient cope with their symptoms.  
 
All HF patients were taking at least one type of medication, and several patients 
were on multiple medications. When examining coefficients of variation of rMSSD, 





more variation among patients who were on those medications compared with those 
who were not. Beta blockers are known to act directly on HR while the others reduce 
blood pressure, thus less variation would be expected with the use of beta blockers 
but not necessarily the others. In the present study, the CV for patients on beta 
blockers was 13.1 compared with 12.1 for those not on beta blockers. This difference 
was not statistically significant. Angiotensin II receptors, nitrates, digoxin, diabetic 
medication and amiodarone showed more variability with patients who were not 
taking them; the differences were not significant. Considering the action of the 
drugs, it would be expected that there would be less variation on those who were 
taking amiodarone, nitrates, or digoxin because these drugs act directly on HR. In the 
present study, there were no significant differences demonstrated in the coefficient of 
variation between groups on those medications vs. those who were not.  The CV for 
patients on amiodarone, nitrates and digoxin were lower compared with those 
patients not taking them.   
 
The effect of beta blockers on HRV was assessed by Cook et al, (1991) who found 
significant increases in HF power, rMSSD and pNN50 with the use of atenolol and 
propranolol, however the effects may differ with certain beta blockers. The 
suggested influence of ACE inhibitors on HRV is an increase in parasympathetic 
activity through the reduction of angiotensin II levels which removes cardiac vagal 
inhibitory activity (Clemson et al. 1994). Digoxin is thought to increase vagal 
modulation of R-R intervals but not cause a significant change in the mean value of 
R-R intervals (Kaufman et al. 1993).  
 
Significant differences were however found in the CV in regards to comorbidities.  
There was a significant difference in the CV between those with ischaemic heart 
disease, hypertension and diabetes compared with patients who did not have these 
conditions. Lower values of HRV in patients with diabetes (Kataoka et al. 2004; 
Kudat et al. 2006; Liao et al. 1995; Liao et al. 1998); ischaemic heart disease 
(Dekker et al. 2000; Liao et al. 1997; Tsuji et al. 1996) and hypertension (Gerritsen 
et al. 2001; Huikuri et al. 1996; Langewitz et al. 1994; Singh et al. 1998) have been 
demonstrated in the literature. In patients with coronary heart disease low values of 
HRV are strong predictors of mortality reflecting excessive sympathetic or 





study no significant differences were demonstrated in HRV between patients on 
heart failure medication compared with those who were not; this may be due to the 
small population size within the study. 
 
10.4.5 Limitations: 
The recruitment process for patients was undertaken through the Consultant 
Cardiologist or the Heart Failure Nurse specialist at each hospital. Bias may have 
occurred in the selection of participants. The Consultant Cardiologist or Heart 
Failure Nurse would decide which patients to approach or not, so even if some 
patients met the criteria, some patients were not recruited because the consultant or 
nurse did not think they would be appropriate. This made recruitment slightly 
subjective. Some of the reasons cited were patient anxiety or stress associated with 
their condition, comorbidities that made them unsuitable even though they were 
within the inclusion criteria, attitude of the patient, or capabilities of the patient.  
 
When sitting in on clinics, the researcher could only observe; it was up to the Nurse 
or Cardiologist to approach the patient about participation in the study. This may 
have created some bias as some suitable patients may not have been asked because 
of external factors. The clinician often made a judgement call based on what they 
thought the patient could handle, without necessarily asking the patient first. The 
clinicians stated that this was done because they did not want to upset the patient or 
cause them any unnecessary duress. Despite the validity of these external factors, all 
patients who met the inclusion criteria should have been approached and given the 
opportunity to accept or decline. Patient care is a priority within the NHS; 
appropriate ethical decisions must be made to ensure the well-being of the patient 
always comes first. This can be a complex process and balance is essential, and 
despite its impact on study recruitment it is necessary for best clinical practice.     
 
Within this study there was a wide age range within the participants with very small 
numbers of participants at the younger end (20-35) and the older end (75+) which 
could skew the average HRV results; the prevalence of heart failure increases with 
age therefore the HRV average results within this study might be higher than those 
that would generally be observed in the overall heart failure population.  Age was 





Some participants had concerns about using the touch screen on the iPod device and 
despite practicing with the researcher were still not comfortable when they took it 
home.  This may have accounted for errors in taking and saving measurements.  
Participants were also asked to record their exercise activity daily in calendars 
provided. Participants had to choose a zone for the rate of intensity at 
low/moderate/high and this was a very subjective measure. For some patients this 
concept was hard to grasp as they did not have much energy to carry out their daily 
activities. For some patients, walking for longer than five minutes was reported as 
high intensity compared with other patients who reported cycling or jogging for 
thirty minutes as high intensity. Some patients reported climbing the stairs as high 
intensity while others reported it as low. They cited that everything they did felt like 
it was at high intensity because it took so much effort to carry out and this could 
have an effect on comparisons between participants due to the subjectivity of the 
measurement. It is hard to gauge how well participants adhered to the described 
intensity zones within one exercise and this, again, could be highly subjective. They 
were asked to pick the zone within which they thought they were within most during 
the exercise. This is a common limitation within HF patients especially because the 
overall range of intensity is low due to functional capacity. Patients with heart failure 
with low functional capacity will have a low range of activities, leading to limited 
options for TRIMP resulting in poor statistical power. There was however a large 
range of activity levels within the participants which helped to counter that effect.   
 
10.5 Conclusion 
Ithlete measurements of HRV (rMSSD) and HR in patients with HF were completed 
on a consistent basis for one-month for forty-six patients (44.6% overall). Of those 
forty-six participants most reported that the device was easy to use and most did not 
have any trouble taking measurements on a daily basis. The remaining fifty-seven 
participants either took no measurements at all, took incomplete sets of 
measurements where they did Ithlete recordings (but not a sufficient amount) or only 
completed the physical activity diary. The use of and iPod touch for telemonitoring 
provides easy access to potential medical equipment however may have a slight age 
effect due to the use of a electronic touch-screen device. Some patients had 
reservations about using the device before even trying it, simply because it appeared 





were familiar with the use of a Smartphone for example were much more 
comfortable with the idea, thus perhaps identifying an experience effect. 
 
Generally patients were satisfied with measurement time and Ithlete usability. The 
majority would recommend the use of Ithlete to other patients. This was despite 
some of these patients not completing measurements correctly themselves. Overall 
that is a very positive outlook and lends well to the use of Ithlete in future clinical 
practice. The device is both easy to use and cost effective when compared to other 
medical devices of the same nature. Despite the lower than expected success rate for 
complying with the study protocol, future research should focus on using the device 
with larger populations, with varying age range. To improve outcomes, the device 
should be used in conjunction with an established cardiac rehabilitation programme 
to provide greater support and guidance for patients. There was more variation in 
rMSSD among patients who were on beta blockers, ACE inhibitors, diuretics, and 
aldosterone antagonists compared with those who were not. Statistically significant 
differences in the CV of rMSSD were demonstrated among patients with ischaemic 
heart disease, hypertension and diabetes compared with patients who did not have 
these conditions. 
 
For patients with HF, this device can be explored for use in the clinical setting to aid 
cardiac rehabilitation and provide patients and clinical staff with feedback on 
autonomic function. Overall Ithlete appears to be an easy device to use for HRV 
assessment in this population due to its usability, immediate easy to interpret 
feedback for the user and cost efficiency when compared to other medical devices. 
Due to large interpersonal variation of HRV, emphasized importance should be 
placed on daily measurement over a period of at least one month to ensure enough 
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CHAPTER 11: IMPLEMENTATION AND EVALUATION OF A HEART RATE 
VARIABILITY (HRV) GUIDED CARDIAC REHABILITATION PROGRAMME 
WITH HEART FAILURE PATIENTS USING THE ITHLETE  
Heart failure occurs when the pumping ability of the heart is impaired. The 
prevalence of chronic heart failure (CHF) is increasing. CHF is usually characterized 
by breathlessness on exertion, persistent fatigue, and/or signs of fluid retention. The 
New York Heart Association (NYHA) established functional stages to clarify the 
extent of heart failure (HF) from no limit to physical activity to severe limitation. 
Patients with HF have depressed HRV levels and this is a commonly identified risk 
factor for sudden cardiac death. Cardiac rehabilitation (CR) is a medically supervised 
programme designed to improve the health and wellbeing of people with heart 
conditions such as HF. Its benefits include improvement in exercise tolerance, 
improvement in symptoms, improvement in psychosocial well-being and reduction 
of stress. HRV measurements daily have the potential to gauge how HF patients are 
responding to exercise and stress during a CR programme.   
 
The purpose of the present study was to determine if a home-based CR programme 
using Ithlete as a biofeedback tool would be beneficial.  This study also examined 
whether or not patients demonstrated a dip in HRV following exercise. A six-minute 
walk test (6MWT), HRV daily measurements from the Ithlete device and patient 
feedback via a questionnaire were used to assess the benefits. 
 
The 6MWT demonstrated improvements in each NYHA class in the overall distance 
patients were able to cover in the test after the CR programme. A dip in HRV 24-
hours following exercise was found in 78.9% of HF patients, and 68.4% 
demonstrated a dip 48-hours following exercise. This is in contrast to HF patients 
not involved in a CR programme, where a dip was demonstrated in 46.5% of 
participants at 24-hours after exercise and 65.1% 48-hours after exercise. This 
suggests that different physiological adaptations occurred as a result of the CR 
programme. Patients stated that Ithlete was an easy device to use, and enjoyed 
receiving regular feedback. Other benefits included regular feedback for the 






11.1.1 Heart failure 
The prevalence of heart failure (HF) is increasing due to improved secondary 
prevention, aging populations, and improved survival following coronary events.  
Acute symptoms of cardiac insufficiency include undue fatigue, palpitations and 
shortness of breath. Depending on the severity of HF, acute symptoms worsen when 
physical activity is undertaken. HF is a multisystem condition with complex 
aetiology. It is commonly characterised by chronic autonomic dysfunction which can 
affect heart rate, blood pressure, sweating etc. and is important because it may have a 
large impact on a person’s quality of life (Stubendorff et al. 2012; Van Gestel et al. 
2011). Chronic autonomic dysfunction can be measured invasively by muscle 
sympathetic nerve activity (Furlan et al. 2000; Pagani et al. 1997), noradrenalin 
spillover (Coats et al. 1992; Kingwell et al. 1994) or non-invasively through 
measurements such of heart rate variability (HRV) (Bigger et al. 1988; Guzzetti et al. 
1988; Lombardi et al. 1987; Sztajzel 2004; von Borell et al. 2007). The importance 
of autonomic dysfunction in heart failure is described below. 
 
11.1.1.1 Autonomic dysfunction in heart failure 
Parasympathetic dysfunction in HF is characterized by increased firing of the 
sympathetic afferent cardiac fibres when the heart dilates, leading to tonic and reflex 
inhibition of cardiac vagal efferent activity (Schwartz & De Ferrari 2011). A 
reduction in vagal activity is most likely caused by systolic dysfunction (impaired 
ventricular contraction). The mechanisms involved in reduced vagal activity in 
diastolic dysfunction (where the heart does not dilate) have not been fully explained 
(Kishi 2012). Sympathetic dysfunction in HF is characterized by reduced sensitivity 
of various sympathoinhibitory reflexes such as baroreflex and cardiopulmonary 
reflexes (Zucker et al. 2009). Activation of the sympathetic nervous system in HF 
has been linked with sympathoexcitation and abnormal cardiovascular reflex 
functions (Zucker et al. 2007). A reduction in parasympathetic activity (Casolo et al. 
1989) and sympathetic activation (Kienzle et al. 1992), indicated through time 
domain and spectral HRV measurements, reflect the influence of the autonomic 
nervous system on cardiovascular function in patients with HF (De Jong & Randall 






11.1.2 Measurement of autonomic dysfunction using heart rate variability (HRV) in 
heart failure 
The autonomic nervous system in HF is characterized by dysfunction in sympathetic 
activation, parasympathetic withdrawal and peripheral organ non-responsiveness 
(Grassi et al, 1995). As HRV provides a non-invasive indirect measure of autonomic 
control, it is an ideal measurement to use in patients with HF. Time domain HRV 
measurements of rMSSD and pNN50 are accepted measurements of vagus nerve 
activity (Task Force, 1996). Where sympathetic over-activity is prevalent, global R-
R variability measures (SDNN, HRV-index) are reduced (Notarius & Floras 2001). 
The vagal measurement pNN50, has also been cited as a risk factor in CHF by 
Bonaduce et al, 1999; the other vagal measure, rMSSD however has not yet been 
identified as a risk factor. Sympathovagal measures of spectral power (high-
frequency and low-frequency) are also not cited as non-significant predictors for all-
cause mortality (Aronson et al. 2004; Brouwer et al. 1996; Mortara & Tavazzi 1996; 
Nolan et al. 1998). 
 
Patients with CHF have depressed HRV levels which are regularly observed at all 
stages of systolic dysfunction (Fauchier et al. 1997). Reductions in HRV measures 
are commonly identified risk factors in CHF where sudden cardiac death has been 
used as a clinical end point (Sandercock & Brodie 2006). Reduced HRV is thought 
to occur as a result of a failure in the response of the sinoatrial node to autonomic 
regulation (or attenuation in that regulation) (Task Force, 1996). Reduced HRV 
measures predict all cause mortality in several diseases including renal disease 
(Hayano et al. 1999), haemodialysis patients (Fukuta et al. 2003), and particularly in 
congestive heart failure (Bilchick et al. 2002; Binder et al. 1992; Nolan et al. 1998; 
Ponikowski et al. 1997). Reduced HRV demonstrates impaired autonomic function 
and therefore is a useful measurement within these clinical populations. Exercise 
improves HRV in both healthy (de la Cruz Torres, López & Orellana 2008; Gladwell 
et al. 2010; Pober et al. 2004) and clinical populations (Kubinyi et al. 2003; Murad et 
al. 2012; Turker et al. 2013). Cardiac rehabilitation (CR) is a medically supervised 
programme designed to improve the health and wellbeing of people with heart 
problems, and usually involves an exercise programme. To improve HRV and 
alleviate common symptoms of HF, CR programmes have been utilized. Increases in 





have been documented in several studies (Kiilavuori et al. 1995; Kubinyi et al. 2003; 
Malfatto et al. 2002; Murad et al. 2012; Selig et al. 2004). The next section will 
discuss CR and its implications for improving HRV.   
 
11.1.3 Cardiac rehabilitation 
The World Health Organization (WHO) defines cardiac rehabilitation as:  
‘the sum of activities required to influence favourably the underlying cause of the 
disease, as well as the best possible, physical, mental and social conditions, so that 
they (people) may, by their own efforts preserve or resume when lost, as normal a 
place as possible in the community. Rehabilitation cannot be regarded as an isolated 
form or stage of therapy but must be integrated within secondary prevention services 
of which it forms only one facet’ (World Health Organization 1993). 
 
A CR programme usually encompasses an overall approach to helping the patient 
adjust back to an active lifestyle following heart problems. The programme usually 
consists of education that promotes a healthy lifestyle including diet, exercise and 
stress reduction. Rehabilitation teams are typically made up of different 
professionals and should include a cardiologist, nurse specialist, exercise specialist, 
dietician, psychologist, physiotherapist, occupational therapist and clerical 
administrator (BACPR 2012). The benefits of CR involving exercise have been 
reported, including reductions in cardiac mortality by 26-36% and total mortality by 
13-26% (Heran et al. 2011). CR is typically offered to three main groups, those who 
have had a myocardial infarction (MI), percutaneous cardiac interventions (PCI) and 
coronary artery bypass graft (CABG). Many CR programmes exclude HF patients, 
however this number dropped from 20 to 15% from 2010 to 2011 (NACR 2012). 
Currently the most likely group to take part in CR are CABG patients (ibid). Despite 
the known benefits and recommendations, stated by the British Heart Foundation 
(BHF) and National Institute for Clinical Excellence (NICE), most patients do not 
receive exercise-based CR as an essential component of comprehensive cardiac care 
(Bethell et al. 2008). Overall referral, enrolment and completion of CR programmes 







Patients with HF were originally cautioned against physical exercise until the late 
1980s (Coats 2000). This was challenged and the benefit of exercise in patients with 
HF was demonstrated by Coats et al. (1990) where an eight-week training 
programme produced a 20-25% increase in peak oxygen consumption, exercise 
tolerance and reduced questionnaire-rated symptoms associated with their condition. 
Participants in that study also found an increase in the ease and degree of performing 
daily activities (ibid). From the 1990s onwards the research in this area increased 
with larger and better designed studies in patients with HF; particularly assessing the 
physiological benefits and increase in exercise capacity that is possible through CR 
(Coats 1999).  
 
Programmes of CR comprising supervised exercise produces well-documented 
benefits including improved exercise tolerance, improvement in blood lipid levels, 
reduction in cigarette smoking, improvement in psychosocial well-being, reduction 
of stress and reductions in mortality (Wenger 2008). The safety of CR was estimated 
by investigators at 1 in 50,000 to 100,000 injuries during patients-hours of 
supervised exercise (Wenger 2008). Only two fatalities were reported for 1.5 million 
patient hours of supervised exercise (ibid). The overall benefits of exercise have 
been reported in various healthy and diseased populations, emphasizing its 
importance to improved quality of life. 
 
Exercise training improves survival time in patients with HF by improving left 
ventricular systolic dysfunction (ExTraMATCH Collaborative 2004). Varying the 
type of exercise, may have different benefits for patients with HF. There are no clear 
recommendations for endurance versus muscle strengthening programmes in elderly 
patients (Miche et al. 2009).  
 
Despite the known benefits of CR to health and quality of life, participation remains 
suboptimal (Dalal et al. 2010). Women are less likely to be referred for CR 
programmes; and those who are referred are less likely to attend compared with their 
male counterparts (Wenger 2008). This is notwithstanding women’s responses to CR 
being equivalent to those of men’s in improvement of Vo2 peak and as a good 
predictor of cardiac mortality (Kavanagh et al. 2003). Thompson & Clark, (2009) 





different issues. They included distance, transportation, lack of convenience, lack of 
referral by physicians, lack of funds, illness, lack of interest, denial of severity of 
illness, not believing it will work or that it is suitable for them,  and family or work 
obligations being more important. For patients with HF particularly, the barriers are 
even greater as there are still 15% of CR programmes excluding HF patients 
(BACPR 2012). Examining the barriers patients may face in their referral to 
rehabilitation and how to combat them, could help to increase participation. This, 
along with health care teams gaining a better understanding of what will motivate 
patients to seek out CR, are important for the future.   
 
There are two types of CR, home-based and centre-based. Home-based CR is a 
structured programme carried out in the patient’s home with clear objectives for 
participants that include monitoring, follow-up visits, and telephone calls (Dalal et 
al. 2010). Centre-based CR is a supervised group based programme that can be based 
in various settings such as the hospital physiotherapy department, community sports 
centre or University gymnasium (Dalal et al. 2010).  
 
Optimal physical activity levels of those participating in CR have not been 
established (Taylor et al. 2010). Barriers to uptake of centre-based CR include 
difficulties in attending regular sessions, reluctance to take part in group-based 
sessions (ibid), the distance and ease of access (Dollard et al. 2004). To help 
overcome some of these barriers, home-based CR programmes such as the Heart 
Manual (Lewin et al. 1992) and the Angina plan (Lewin et al. 2002) were developed.  
Both programmes involved a specially trained facilitator and included the use of a 
workbook, diary and record sheets aimed to facilitate a walking exercise programme, 
focused on self recording. Standard attendance for centre-based CR programmes has 
been reported at less than 50% in two North American studies, which followed up 
with over 1000 patients (Grace et al. 2011; Martin et al. 2012). In England, in 2003-
2004 only 29% of patients eligible for CR attended (Bethell et al. 2008). This 
number rose to 44% in 2010-2011, however this was in the three main groups 
(myocardial infarction, percutaneous coronary intervention, coronary artery bypass 






Research examining the adherence to CR programmes is conflicting; however this 
may be due to the variation in which adherence is defined and measured (Dalal et al. 
2010). Dalal et al, (2010) reviewed trials of home vs. centre based CR programmes 
and reported that no study found significantly higher adherence in centre-based 
programmes. Two studies within that review found significantly higher adherence in 
home-based CR programmes (Arthur et al. 2002; Marchionni et al. 2003). Home-
based CR provides a more flexible, menu-driven approach to CR and therefore 
presents the opportunity to improve uptake and delivery of CR programmes (Blair et 
al. 2011). With the NHS undergoing major reform and budget cuts, the impact of 
lower public spending on population health has been considered (Stuckler et al. 
2010). Programmes such as centre-based exercise CR may be at risk of closure (a 
situation that already exists at one of the London-based hospitals used in the present 
study), making home-based CR even more important. Exploring ways to make 
home-based CR effective and rewarding for patients are vital to ensuring successful 
clinical outcomes.  
 
Centre-based rehabilitation programmes provide health benefits when patients attend 
(NACR 2012). Typical home-based CR programmes rely on self reporting from 
patients during follow-up phone calls or home/clinic visits at varying intervals (Jolly 
et al. 2003). With home-based programmes it is difficult to assess how hard patients 
work or how many exercise sessions they actually complete.  For patients, the use of 
a monitoring device may help maintain motivation and also track their progress.  For 
a clinician, monitoring devices can eliminate the subjective aspect of home-based 
CR programmes, allowing them to monitor patient progression through the 
programme. Sport science has used HR as a training guide for intensity for over 25 
years (Schonfelder et al. 2011). The use of HR monitoring as a training tool to assess 
exercise intensity allows athletes to maximize training benefits, and avoid 
overtraining and injury (Arts & Kuipers 1994; Bamford 1999; Davis & Convertino 
1975; Gilman & Wells 1993). Changes in the autonomic nervous system of athletes 
corresponding with harder training sessions (Iellamo et al. 2002), prompted the use 
of HRV as a monitoring tool to prevent over-reaching and overtraining (Bosquet et 
al. 2003; Hedelin et al. 2000; Manzi et al. 2009; Mourot et al. 2004a). The 
interaction between intensity, duration and HRV has become a tool in preventing 





result of excessive training loads, without adequate recovery in between. The use of 
telemonitoring equipment, such as a heart rate monitor has been demonstrated as a 
feasible tool for following adherence and providing sustained benefit of exercise 
training in HF patients (Smart et al. 2005). Therefore, the present study has several 
aims which will be categorized as either primary or secondary.  
 
11.1.4 Aims 
The primary aims of the present study were (i) to determine if a home-based cardiac 
rehabilitation programme using Ithlete as a biofeedback tool would be effective and 
beneficial for heart failure patients; (ii) to examine whether or not patients 
participating in the CR programme demonstrated a decrease in HRV following 
exercise as postulated in literature with healthy participants. The secondary aims 
were (i) to explore physiological characteristic differences by NYHA classes and 
gender; (ii) to determine the effectiveness of a home-based walking CR programme 
on improving fitness in each NYHA class; (iii) to determine the effectiveness of a 
home-based walking CR programme on measurements obtained during a 6MWT. 
 
11.2 Methods 
11.2.1 Recruitment of participants 
The researcher attended clinics with either a Consultant Cardiologist or Heart Failure 
Nurse Specialist at three London hospital sites. Each participant was recruited in 
accordance with NHS Research Ethics Committee standards and expectations. 
Participants responded in the clinic or by phone and were given an information pack 
before agreeing to participate. This information pack included: 
1. An information sheet with details of the requirements for each participant 
before and during the research study 
2. An informed consent form 
3. HRV measurement information package 
4. A detailed demographic information sheet 
5. Physical activity calendar 
Participants were requested to read the information pack prior to attending the clinic 
to meet with the researcher and any questions or concerns were addressed. All 







All participants were defined as patients with HF, with varying levels of impairment 
but all were deemed eligible by the medical team at the hospital they attended.  Any 
patient who completed the one-month trial of Ithlete data collection were asked to go 
into phase two of the study which involved a home-based walking cardiac 
rehabilitation programme using Ithlete as a guide to exercise. 
 
Inclusion Criteria: The participants were recruited from hospitals in the London area. 
The participants were heart failure patients within the New York Heart Association 
classifications of I, II & III aged at least 18 years of age. Heart failure treatment was 
under the control of the participant's consultant cardiologist.  
 
Exclusion Criteria: Participants were excluded if they had any of the following 
conditions: consistent atrial fibrillation, unstable coronary artery disease with 
revascularization within the last 6 months or planned revascularization, planned 
heart valve surgery or planned transplantation, uncontrolled arterial hypertension, 
acute myocarditis, worsening clinical condition, inability to read the display of a 
handheld device or deemed unable to comply with home telemonitoring, inadequate 
understanding of English, or any visual or cognitive impairment sufficient to 
interfere with the participant's ability to use the device (Cleland et al. 2005; Dar et al. 
2009; Scherr et al. 2009).  
 
Participants completed their consent form in front of the researcher and the 
researcher countersigned the form. Participants were then given a demonstration of 
how to use the device to take HRV/HR measurements using Ithlete on an iPod touch. 
Patients took home all the paper work with the device which included detailed 
instructions on how to take measurements and how to fill in the calendar with daily 







Phase 1: Following appropriate ethical approval from the NHS Southwest Research 
Ethics Committee and informed consent, participants were asked to visit the clinic at 
their hospital to meet with the researcher for a demonstration. Each participant was 
given a demonstration of how to use the Ithlete software on the iPod touch and 
required to complete two measurements in the presence of a researcher before taking 
the device home.  
 
Then each participant was required to take an HRV measurement once every 
morning when they woke up for 1 month in succession. HRV (rMSSD in ms) and 
heart rate (HR in beats per minute (bpm)) were recorded via Ithlete software for the 
iPod touch (Ithlete 2009). Patients were also asked to take home a pedometer to wear 
daily to count their steps.  Patients’ height and stride length were measured and input 
into the pedometer. Then the researcher demonstrated how to use the pedometer, and 
where it should be worn. Patients tried taking steps with the pedometer before 
leaving the clinic. Finally, patients were asked to record the following on a physical 
activity diary daily: 
1. What (if any) exercise was performed the day before 
2. Duration of that exercise 
3. Intensity of that exercise (Low/Moderate/High) 
4. Daily scale of how you are feeling on a scale of 0-100% (100% being the 
best) 
Patients who successfully completed phase one, were then asked to move on to phase 
two.  
 
Phase 2: During this phase patients were instructed to continue taking Ithlete 
measurements every morning; patients were also asked to wear a pedometer 
everyday and record the total number of steps at the end of each day on their 
physical activity diary.  
 
Phase 3: This phase was an eight-week CR home-based walking programme. 
Participants spent the first month taking readings without following the Ithlete 
indications and then for the following month they were asked to follow the colour 





(green or blue) for each of their training days. Participants in this phase were asked 
to follow an incremental walking exercise programme where they had 4 walking 
levels to progress through.  
 
To measure functional capacity, patients were asked to complete a six-minute walk 
test (6MWT) before the walking programme commenced. The 6MWT is a 
modification from the 12-minute walk/run test, which allows patients to be evaluated 
during normal physical activity, in a non-laboratory setting (Reybrouck 2003). It is a 
reliable test which correlates well with morbidity and mortality in heart and lung 
diseases (Arslan et al. 2007; Cote et al. 2008; Enright 2003; Rostagno et al. 2003).  
There is a good correlation between the distance covered by patients and maximal 
oxygen uptake, ventilator anaerobic threshold or risk of cardiac death (Arslan et al. 
2007; Balady et al. 2010; Ross et al. 2010). The 6MWT is cost effective, non-
invasive and does not need expensive equipment. The test has established standards 
for testing, reference values and is well tolerated by patients with a wide range of 
fitness and ability (Enright 2003; Solway et al. 2001).   
 
The 6MWT is easy to administer as it is an exercise mode familiar to patients, and 
only needs a flat pre-measured surface and a timing device (Enright 2003; Ingle et al. 
2005). Several measurement outcomes can be used, with distance covered being the 
primary measure (Enright 2003). Secondary measurement outcomes include fatigue 
(measured by the Borg or visual analogue scale) and arterial oxygen saturation 
(measured by pulse oximetry) (ibid). The prognostic value of the 6MWT has been 
demonstrated in patients with HF, with reference values indicating a distance 
covered of < or = 300 m signifying patients at higher risk of cardiac death (Arslan et 
al. 2007). 
 
In the present study, the 6MWT was performed in a quiet indoor corridor in the 
hospital. Patients were instructed to walk on a flat surface between two cones 
situated 25 metres apart, as many times as possible in the permitted time. The test 
was performed under the control of a researcher with a Nurse Specialist present, and 
patients were encouraged during the test using phrases like ‘You are doing well’, and 





and their rate of perceived exertion (RPE) was recorded. At the end of the six 
minutes, distance and RPE were recorded by the researcher. 
    
Patients rested in clinic for at least 15 minutes before the test. Blood pressure 
(Omron bp508, USA), HR (Ithlete), HRV (Ithlete) and rate of perceived exertion 
score (Borg rate of perceived exertion scale) were recorded before and after the test. 
The Borg scale is a rate of perceived exertion scale used to document the intensity of 
exertion throughout the test. The Borg scale is a linear scale ranging from 6-20 and is 
thought to coincide with increases in heart rate as exercise intensity increases. Six 
corresponds to easy or very light intensity through to twenty, which corresponds to 
very hard or maximum intensity. After each minute of the 6MWT, patients stated 
which number their intensity corresponded to.  
 
The levels of the walking programme are listed in table 11.1. Ithlete software was 
utilized throughout the CR programme. Ithlete software provides an indication of 
how the body has responded to exercise by displaying a colour behind the change in 
HRV (rMSSD). The change is denoted by colours on a weekly and monthly change 
scale; blue for normal recovery, green for good recovery, amber for not the best 
recovery, and red for bad recovery. During the second month of the CR programme, 
patients were encouraged to look at their recovery and reduce their training plans for 
that day when amber or red colours were displayed by the Ithlete software that 
morning.  
 
Table 11.1 CR home-based walking programme  
Level Distance Frequency 
1 1500 steps (or 15 extra minutes) of walking at least 3 days/week 
2 1500 steps (or 15 extra minutes) of walking at least 5 days/week 
3 3000 steps (or 30 extra minutes) of walking at least 3 days/week 
4 3000 steps (or 30 extra minutes) of walking at least 5 days/week 
 
The walking programme was accompanied by an information sheet which discussed 
warm-ups, stretching, and building up exercises gradually. The information sheet 
encouraged patients to try to fit in exercise every day, even if it was just a few 





each day, before commencing the walking programme. Warm-up exercises included 
arm/leg stretches and instructed patients to walk at a slower pace for at least two-
minutes before commencing their regular walking programme pace. Patients were 
expected to increase their stretching time and add more suggested stretches from the 
information sheet as they progressed to each new level. Patients were also 
encouraged to take breaks during the walking exercises whenever necessary, but 
were asked to consciously try to reduce the frequency or duration of the breaks over 
time. Patients were instructed to progress to the next level when they were able to 
complete the requirements for that level of the walking programme without taking 
breaks or feeling symptoms (i.e. shortness of breath or excessive tiredness following 
the exercise session). Tiredness was explained to HF patients as a temporary loss of 
strength and energy due to excessive hard physical or mental work (Piper 1993). 
Fatigue was explained to HF patients as persistent tiredness that creates the 
perception of difficulty in performing daily activities (Evangelista et al. 2008). 
 
After completing the walking programme, patients completed another 6MWT and 
were asked to fill in a questionnaire regarding their use of the Ithlete device. Patients 
were given the option to fill out the questionnaire with the researcher posing the 
questions, or by them filling it out themselves in the clinic room. The primary 
measurement following the CR programme from the 6MWT was the distance 
covered.  Fatigue (assessed by the Borg scale), BP and resting HR were also 
compared.    
 
11.2.2.1 Heart rate variability analysis using the Ithlete for iPod touch 
For HRV measurement a standard analogue ECG chest strap was worn in the middle 
of the chest just under the sternum. Real time heart and lung animation on the iPod 
touch facilitated paced breathing during measurements and indicated reception of 
each heart beat from the analogue chest strap. Participants followed a breathing 
frequency of 7.5 breaths per minute, designed to maximize RSA response (Brown et 
al. 1993). Each measurement took 1-minute, when this was complete the HR (bpm) 
and HRV (rMSSD in ms) were displayed on the screen and saved to the device. 






11.2.3 Statistical analysis 
All statistical analysis was analysed using PASW 19.0 (SPSS: An IBM Company. 
Somers, NY, USA). Values are reported in the text as mean ± standard deviation. 
The median-split method was used with the HRV data to split each participant’s 
values into two data sets (days when exercise was reported vs. days when no 
exercise was reported). Exercise was coded as 1 and corresponded to everything 
above and equal to the median, anything below the median corresponded to no 
exercise and was subsequently coded 0. The median-split method was used to allow 
comparison between subjects objectively by making HRV values relative to each 
participant. The change in HRV from day-to-day was then calculated for each 
participant by subtracting the HRV value from the day before (i.e. HRV-day-2 minus 
HRV-day-1). Independent t-tests were then used to generate mean and standard 
deviation of the change in HRV from day to day. Participant cases were then 
weighted based on the number of recordings taken for each participant. From these 
data, participants were coded as dippers (those who showed a lower HRV when 
exercise was reported) or non-dippers (no dip in HRV when exercise was not 
reported).  
 
The general linear model was then used to quantify the relationship between exercise 
and HRV. Univariate analysis was performed on the change in HRV at 24 and 48-
hours after exercise was reported/ not reported. Participants were then grouped into 
those who had a dip in HRV when exercise was reported (dippers) vs. those who did 
not have a dip in HRV after exercise was reported (non-dippers). Binary logistic 
regression was then used to predict the presence or absence of exercise. A P-value of 
<0.05 was considered statistically significant.    
 
11.3 Results 
In total, 103 participants responded within the clinics and agreed to participate in the 
study of which 70 were male and 33 were female. Participant age ranged from 24 to 
87 years. Of those 103 participants, 46 took measurements for one calendar month 
(at least 28 days) and were then asked to enter phase two of the research study which 
involved the CR programme. Thirty-three of the 46 patients agreed to go into the 





through the different levels at their own pace, but were encouraged to try to increase 
each time they completed a week successfully without excessive fatigue or other 
symptoms.  
 
Using Ithlete the participants had a biofeedback tool to indicate how their bodies 
were responding to each workout. Participants were able to know when and how 
hard to train and how to identify the need for more rest and recovery from the last 
workout. Participants were asked to give feedback on how they felt each day through 
the day scale on their physical activity calendar (on a scale of 1-100, 100 being 
feeling great, one feeling very poorly). During the rehabilitation phase patients 
indicated if this agreed with the HRV reading that day (i.e. If Ithlete indicated a rest 
day, did they feel that was necessary or not).  
 
Participants spent the first month taking readings without following the Ithlete 
indications and then for the following month they were asked to follow the colour 
indications to rest (red), taper their workout (amber) or complete a full workout 
(green or blue) for each of their exercise days. Figure 11-1 is a flowchart depicting 
how patients moved through the research study after recruitment. Patients were all 
recruited directly into phase one and then depending on their successful use of the 
device, were then recruited into phase two and the CR programme (phase three). 
Successful use of the device was characterized by consistent daily readings for at 

































103 patients recruited from three 
London hospitals 
46 patients took good HRV 
measurements with accompanying 
physical activity calendar. These 
patients were then asked to continue 
to Phase 2 
33 patients agreed to go into 
Phase 2; they continued taking 
measurements and were given a 
pedometer  
23 patients started the home-based 
walking cardiac rehabilitation 
programme of which 19 
completed it. 
57 patients did not complete 
successful measurements, or had no 
accompanying physical activity 
calendar 
10 patients did not complete this 
phase; failure to complete 








In table 11.2 the average age, HRV, HR and ejection fraction (EF) are displayed for 
cardiac rehabilitation participants divided into their NYHA classes. These 
classifications are determined by the Consultant Cardiologist or Heart Failure Nurse 
Specialist following their initial consultation with each patient.   
 
Table 11.2 Average cardiac rehabilitation participant values for age, rMSSD, HR 
and ejection fraction (EF) by NYHA class 






Age (years) 69.0 ± 7.1 63.0 ± 10.5 61.9 ± 12.5 
rMSSD(ms) 81.3 ± 17.2 72.4 ± 12.9 72.3 ± 7.5 
Heart Rate (bpm) 78.0 ± 7.9 81.5 ± 16.4 84.9 ± 4.4 
Ejection Fraction (%) 41.0 ± 3.4 34.1 ± 8.6 33.8 ± 14.8 
 
In the following table average components for each participant are displayed. Ithlete 
software provides an indication of how the body has responded to exercise by 
displaying a colour behind the change in HRV as displayed below on an Iphone 
beside daily and weekly change. These indications are displayed in the table as an 
average number which corresponds to one of the four colour indications (1-1.5=Blue 
for normal recovery, 1.5-2.5=Green for good recovery, 2.5-3.5=Amber for not the 
best recovery, 3.5-4=Red for bad recovery). TRIMP is displayed as an average of 
intensity of exercise multiplied by the duration of exercise and Day Scale (how 
patients felt on a scale of 0-100, 100 being the best and 1 being the worst) is 
displayed as a percentage. More specifically, amber represents the first day when 
HRV is more than 1 x SD (standard deviation of natural log transformed rMSSD) 
below the moving average of the previous seven days (so excluding the most recent 
recorded value); red represents the second day when this condition is true (i.e. two 
successive days when the current value is more than 1x SD below the moving 
average blue line) and green represents a rise of more than 2 x SD compared to the 
previous day. Green is intended to indicate good recovery and signifies that the body 
is ready for harder exercise. An example snap-shot from the Ithlete screen can be 












Table 11.3 Average rMSSD, HR, Indication, TRIMP and Day Scale for cardiac 
rehabilitation participants by gender 
Gender Age rMSSD HR Indication TRIMP Day Scale 
M 62.1 77.5± 17.1 70.0± 8.6 1.5 ± 0.9 157.2 ± 184.0 63.8 ± 15.9 
F  64.0 80.8± 11.5 74.7± 6.5 1.6 ± 1.1 133.8 ± 57.4 89.2 ± 2.8 
 
Table 11.4 displays the mean predicted 6MWT distance for males and females in the 
present study, as predicted from the gender specific regression equations provided by 
Enright & Sherrill, (1998). Table 11.5 displays mean 6MWT results for each gender. 
Table 11.6 displays patients’ measurements divided into NYHA classes, obtained 
during the 6MWT. Walk one was completed the week before the CR programme 
commenced. Walk two occurred within two weeks of completion of the CR 
programme. Before the CR commenced, patients’ height, weight and blood pressure 






Table 11.4 Mean predicted six-minute walk test distance with lower limit of the 
normal range (LLN) for each gender 
 Predicted 6MWD LLN 
Male 543.7 390.7  
Female 476.3 337.3 
 
 









Age 62.1 ± 11.0 62.1 ± 11.0 64.0 ± 7.2 64.0 ± 7.2 
Height (cm) 174.7 ± 8.5 174.7 ± 8.5 164.7 ± 7.6 164.7 ± 7.6 
Weight 
(kg) 




118/74 120/74 126/77 123/78 
HR before test 
(bpm) 
72.3 ± 8.2 69.9 ± 9.4 86 ± 5.6 82.3 ± 6.0 
Borg Scale 
Before test 








126/81 127/76 129/81 130/78 
HR after test 
(bpm) 
74.5 ± 10.0 71.0 ± 9,5 83.3 ± 6.4 80.0 ± 7.6 
Borg Scale  
after test 








Table 11.6 Six-minute walk test results assessed by NYHA Class 


















Age 62.5 ± 9.2 62.5 ± 9.2 66.2 ± 13.2 66.2 ± 13.2 56.8 ± 12.3 56.8 ± 12.3 
Height 
(cm) 
171.0 ± 9.9 171.0 ± 9.9 175.7 ± 11.5 175.7 ± 11.5 177.8 ± 7.7 177.8 ± 7.7 
Weight 
(kg) 




126/67 125/73 117/73 117/71 110/70* 119/73* 
HR before 
test (bpm) 
66.5 ± 9.2 64.5 ± 6.4 71.8 ± 8.3 67.8 ± 10.5 69.0 ± 8.0 65.3 ± 5.2 
Borg Scale 
Before test 








123/70 128/74 123/78* 128/75* 119/89 118/69 
HR after 
test (bpm) 
69.5 ± 13.4 75.0 ± 7.1 82.8 ± 7.3 71.2 ± 13.6 70.3 ± 3.8 69.8 ± 1.7 
Borg Scale  
after test 
13.0 ± 2.8 13.5 ± 3.5 13.0 ± 1.9 13.8 ± 3.1 11.3 ± 5.6* 10.8 ± 3.3* 
*Significant difference at p <0.05 
 
Results from the 6MWT demonstrate changes after the six-eight week CR 
programme. In each NYHA class there was an overall increase in the distance 
patients were able to cover after the CR programme. Sixty-six percent of participants 
in NYHA class I, increased the distance covered in the 6MWT. In NYHA class II it 
was 80% and in class III 75%. This increase could be attributed to the increased 





Other improvements demonstrated in NYHA classes II and III after the CR 
programme included a lower resting HR and a lower initial RPE before the test 
commenced. In NYHA class I, no significant differences were demonstrated between 
any of the variables from walk one to walk two. In NYHA class II a significant 
difference was found in blood pressure between walk one and walk two; and in 
NYHA class III significant differences were found in the resting blood pressure 
taken before the 6MWT and the RPE after the test.  
 
Table 11.7 displays the change in rMSSD measurements obtained for each subject 
during the cardiac rehabilitation programme on the day following exercise and 2 























1 22 No 3.13 17.26 No 5.01 27.12 
2 22 Yes -8.00 21.44 Yes -9.30 24.68 
3 12 Yes -6.66 21.60 Yes -8.31 22.41 
4 23 Yes -2.81 9.10 Yes -2.30 13.01 
5 25 Yes -5.81 13.60 Yes -7.55 17.80 
6 27 Yes -1.29 20.63 No 3.45 28.41 
7 31 Yes -3.47 19.25 Yes -3.15 21.31 
8 53 Yes -1.29 11.58 Yes -2.01 14.33 
9 29 Yes -0.83 19.43 Yes -2.25 21.92 
10 38 Yes -0.60 22.28 No 4.38 29.26 
11 27 No 1.43 14.83 Yes -1.11 21.62 
12 18 Yes -2.52 22.31 Yes -3.14 28.20 
13 29 No 2.06 7.44 No 1.29 12.66 
14 16 Yes -13.45 20.86 Yes -18.38 28.07 
15 18 Yes -5.73 24.77 No 3.66 29.37 
16 27 No 5.44 19.00 Yes -0.84 23.74 
17 29 Yes -0.74 14.79 Yes -2.39 22.76 
18 55 Yes -0.32 15.24 Yes -1.50 23.17 
19 37 Yes -0.45 13.01 No 0.45 13.82 
* Number of recordings refers to the amount of recordings which had corresponding measurements at 24 and 48 hours following reported exercise.  





11.3.1 General linear model: Univariate analysis 
Univariate analysis revealed that 24-hours after exercise was reported, rMSSD was 
not significantly different F (0.164) (p=0.68). Forty-eight hours after exercise was 
reported rMSSD was also not significantly different F (0.427) (p=0.52). When no 
exercise was reported, the overall mean change in rMSSD after 24-hours was -1.56 
(95% CI: -3.85 - 0.73) (n = 233); compared with -2.20 (95% CI: -4.28 - -0.13) (n = 
305) when exercise was reported. The overall mean change in rMSSD 48-hours after 
no reported exercise was -0.99 (95% CI: -4.18 - 2.19) (n = 218); and -2.32 (95% CI: 
-5.26 - 0.59) (n = 283) when exercise was reported.  
 
When participants were grouped into those who had a dip in rMSSD 24-hours after 
exercise was reported (dippers) vs. those who did not have a dip in rMSSD 24-hours 
after exercise was reported (non-dippers), the mean rMSSD was 72.6 for dippers, 
and 76.0 for non dippers. The mean change in rMSSD was -3.60 ± 3.71 for dippers 
and 3.02 ± 1.76 for non-dippers. Forty-eight hours after reported exercise, 
participants were again grouped as dippers and non-dippers with a mean rMSSD of 
73.1 for dippers, and 74.0 for non-dippers. The mean change in rMSSD was -4.79 ± 
4.97 for dippers and 3.04 ± 1.79 for non-dippers.  
 
11.3.2 Binary logistic regression 
In the present study, the presence of exercise appeared to have minimal effect on 
rMSSD 24-hours after exercise. An odds ratio of 1.123 (95%: CI 0.798 - 1.580) (p= 
0.50) was demonstrated when exercise was reported, compared with 1.011 (95% CI: 
0.980 - 1.043) when exercise was not reported. This demonstrated that there was 
very little difference in the odds of a dip in rMSSD on the day following exercise. 
For 48-hours following exercise the odds ratio of a dip in rMSSD was 1.229 (95% 
CI: 0.863 - 1.751) (p = 0.25) when exercise was reported. When exercise was not 
reported the odds ratio for a dip 48-hours after exercise was 0.987 (95% CI: 0.956 - 
1.019). This suggests that exercise has more effect on rMSSD 48-hours following 







The primary aims of the present study were to assess the use of Ithlete HRV 
(rMSSD) measurement daily to gauge how patients with HF responded to exercise 
during a CR programme. A dip in rMSSD following exercise was also assessed. The 
present study also examined differences in physiological characteristics between 
NYHA classes and gender. The outcome of the 6MWT was used to assess the 
effectiveness of the home-based walking CR programme. 
 
Patients reported that using the Ithlete device during the CR programme was 
beneficial because they enjoyed looking at measurements from day to day.  
Participants particularly liked seeing how their body was responding to exercise by 
looking at the indication given by Ithlete for whether or not they had good recovery 
following exercise. Participants also said it was a reassuring tool which they 
followed so that rest days were taken when suggested by the Ithlete software.   
 
Average CR participant values for age, rMSSD, HR and ejection fraction (EF) were 
compared by NYHA class. rMSSD and EF were highest in NYHA class I and lowest 
in NYHA class III.  Resting HR increased with NYHA class. These averages are not 
surprising, considering that NYHA Class I have the highest fitness level and 
therefore would be expected to have the healthiest averages when compared with the 
other NYHA classes.   
 
The average age, rMSSD, day scale and HR values were higher for female 
participants. TRIMP was higher for males and Ithlete indications throughout the CR 
programme were in the good recovery range for both genders over 60% of the time. 
The present study found higher rMSSD values for females, which is consistent with 
the majority of the literature on gender differences (Antelmi et al. 2004; Gregoire et 
al. 1996; Liao et al. 1995). There are also several studies that have reported a lower 
HRV in females when compared with males (Christou et al. 2005; Pavithran et al. 
2008; Ramaekers et al. 1998; Saleem et al. 2012). Day scale was higher in females 
when compared to males indicating that they generally felt better overall. This is in 
contrast to other research which reported worse general health and life satisfaction 





subjects suggested that men within the present study were more active than their 
female counterparts.   
 
11.4.1 6MWT results 
The 6MWT demonstrated an improved in the distance covered for both genders in 
following the CR programme. A smaller increase was demonstrated in females, but 
there were only three participants within this group. Enright et al, (2003) tested over 
2000 participants over the age of 65 to determine the average walking distance for 
that age group. The average walking distance covered by healthy men was 400 m 
and 367 m for healthy women (ibid). Within the present study, none of the 
participants reached those averages. In 1998, Enright & Sherrill published gender 
specific reference equations with a lower limit of the normal range. Using these 
equations within the present study, the mean percentage of the predicted 6MWT 
distance covered was 78.6% for males and 91.2% for females. Following the CR 
programme, three males and one female’s 6MWT distances were within the 
predicted healthy range, suggesting that the CR programme improved their exercise 
tolerance. 
  
When split by NYHA classifications, the smallest increase in the distance covered 
was demonstrated in NYHA class I, but there were only three participants within this 
classification. NYHA class’ II and III demonstrated an increase in at least 75% of 
participants (both groups with 8 members). The demonstrated increase in distance 
could be attributed to increased fitness levels that patients should incur after 
completing the CR programme. Other improvements demonstrated in NYHA classes 
II and III after the CR programme included a lower resting pulse and a lower initial 
Borg scale before the test was initiated. Results of the 6MWT indicated that overall, 
patients benefited from participating in CR. Unexpectedly the greatest distance 
covered within the present study was achieved by NYHA class II, followed by 
NYHA class III and then NYHA class I. All participants were exposed to the same 
procedure for both their pre and post-intervention testing, so this should not have 
impacted on the results. There was however a smaller number of participants in the 
NYHA class I group (n=3) compared to NYHA class II and III (n=8), which may 





to monitor their own walking progress through the use of pedometers, which will be 
discussed in the next section. 
 
11.4.2 Pedometer use in walking programmes 
Pedometers respond to movements and some may have been interpreted as steps 
despite that not being the case.  Steps are counted when vertical accelerations of the 
hip cause a horizontal spring suspended lever arm to moves up and down, opening 
and closing an electric circuit (Berlin et al. 2006). A key problem with pedometer 
measurements is the inability to distinguish between varying intensities of vertical 
displacement (ibid); running 50 steps versus walking 50 steps would register the 
same amount of steps despite evident differences in energy expenditure.  
 
Pedometer derived step ranges proposed in healthy adults suggested that <5,000 
steps/day indicated a sedentary lifestyle, 5,000-7,500 steps/day as low activity, 
7,500-9,999 steps/day as somewhat active, 10,000 to 12,499 steps/day as active and 
>12,500 steps/day as highly active (Tudor-Locke & Bassett 2004). The average for 
HF patients within this research study fell within the sedentary range (2622 
steps/day) which is very similar to the average cited for this particular population 
(2,840 steps/day), and for patients with coronary heart disease and related disorders 
(Tudor-Locke et al. 2011). This implies that participants in the present study were 
mostly sedentary and indicates a need for increased exercise within this population. 
This may help to explain why nearly half of the patients who took measurements 
successfully still decided not to participate in the CR programme; of those that did 
participate, some patients found it particularly difficult to progress through the 
different walking levels within the CR programme because they had a very low 
fitness level to start with. This is however a common characteristic of heart failure 
patients, which leads back to lifestyle changes that need to be made in order to 
improve their quality of life. 
 
11.4.3 Overtraining and HRV 
Ithlete software was designed to detect and prevent overtraining by monitoring 
restoration of vagal tone. In the present study, Ithlete measurements were assessed 
24 and 48-hours after exercise, to see if a dip in HRV (rMSSD) occurred. A dip in 





hours following exercise 68.4% demonstrated a dip in rMSSD. This is in contrast to 
HF patients not involved in a CR programme (observed in chapter 9) who averaged 
46.5%, 24-hours after exercise and 65.1%, 48-hours after exercise. This suggests that 
the walking programme provided enough intensity to facilitate alterations to vagal 
autonomic nervous system activity. 
 
The dip in HRV in the days following exercise may be as a result of increases in 
sympathetic activity outlasting the cessation of exercise, which was originally 
thought to last for up to 24-hours (Furlan et al. 1993). Prolonged heavy exercise has 
been shown to cause attenuated cardiac vagal outflow for several hours following 
exercise, and participants with poorer cardiovascular fitness had decreased vagal 
outflow for a longer period (Hautala et al. 2001). Measurements of rMSSD from HF 
participants when they were not involved in CR, suggest that these patients were 
perhaps not engaging in exercise heavy enough to cause attenuated HRV following 
exercise. The results demonstrated in the present study indicate that the CR 
programme facilitated heavy enough exercise to cause a dip in HRV in almost 80% 
of patients, 24-hours after the cessation of exercise. Due to their symptoms, patients 
with HF, in NYHA classes II-IV have limitations to their ordinary ability to perform 
physical activity. This potentially makes it more difficult to perform exercise heavy 
enough to cause attenuation of HRV. When exercise heavy enough to produce 
attenuated HRV is performed by HF patients, a longer period of reduced vagal 
outflow would be expected.  
 
Measurement of HRV in HF patients has implications in the measurement of 
cardiovascular status. Following exercise a decrease in HRV has been demonstrated 
in aerobically trained athletes (Mourot et al. 2004a), and overtrained female aerobic 
athletes (Uusitalo et al. 2000). A study assessing national level swimmers found that 
reduced HRV levels were associated with increased risk of illness (Hellard et al. 
2011). Various studies have demonstrated that HRV reflects recovery status in 
untrained athletes (Pichot et al. 2002), male rowers from the Italian national team 
(Iellamo et al. 2004) and elite Olympic weightlifters (Chen et al. 2011). When using 
HRV as a guide to exercise, studies have demonstrated better results for those using 





al. 2010; Kiviniemi et al. 2007). The use of HRV to guide exercise for HF patients 
has not yet been reported. 
 
11.4.4 HRV guided exercise using Ithlete 
HRV represents variations in heart rate representative of the sum relationship 
between the activity branches of the autonomic nervous system (ANS). In response 
to subconsciously perceived visceral sensations the ANS excites or inhibits glands, 
cardiac and smooth muscle (Tortoro & Derrickson 2006). The two branches of the 
ANS (parasympathetic and sympathetic) have opposing actions. The sympathetic 
increases HR, force of contraction and blood pressure, increasing blood flow to 
muscles during exercise while the parasympathetic reduces heart rate and blood 
pressure. The balance between the parasympathetic and sympathetic nervous systems 
indicates how relaxed the body is (the greater the parasympathetic input); the higher 
the HRV, the more relaxed the body is.   
 
Autonomic activity becomes altered during exercise, characterized by a marked 
decrease in HRV during exercise (due to vagal withdrawal) which has been 
demonstrated with increased workloads (Bernardi et al. 1990; Blain et al. 2005; 
Perini et al. 2000). This suggests the harder the exercise bout, the bigger the decrease 
in HRV (Kaikkonen et al. 2007; Mourot et al. 2004b; Terziotti et al. 2001). During 
exercise an increase in sympathetic activity and a decrease in parasympathetic 
activity occur (Gladwell et al. 2010; Perini & Veicsteinas 2003); this could outlast 
the cessation of exercise by up to 24-hours (Furlan et al. 1993; Pober et al. 2004).  
 
Following exercise the body needs a recovery period (Wenger & Bell 1986). In the 
present thesis, HRV Ithlete measurements have been demonstrated as an easy, non-
invasive measure which can be used to assess how well the body has recovered from 
exercise. Using the moving average of the previous seven days, Ithlete indicates 
when HRV falls outside 1x SD of the moving average. With different colours 
indicating to the user how well the body has recovered (i.e. HRV 1xSD below 
represented by amber compared with HRV 2xSD above represented by green), 







Periodization involves changing exercise in regular periods or intervals to make the 
body work hard for fitness gains but also provide adequate rest. Ithlete was 
developed for athletes who typically do systematic periodization involving specific 
training periods for their exercise training whereas the patients in this study do not 
necessarily follow that pattern. Patients within the present study were asked to 
follow an incremental walking exercise programme, where they had four walking 
levels to progress through. A meta-analysis of trials comparing training using 
periodization vs. non-periodization found greater training adaptations in those who 
did periodized training for all age groups, both genders and people of different 
training backgrounds (Rhea & Alderman 2004). This form of cardiac rehabilitation 
has been suggested as a useful tool for getting better fitness results (de Macedo et al. 
2011). While the volume and intensity are a long way removed from that undertaken 
by athletes, patients following the CR programme in the present study were 
therefore, undertaking a form of periodization. The periodization occurred as patients 
progressed from one level to the other, and were instructed only to do so, when they 
had successfully completed the level before.    
 
Success within the present study was characterized by patient’s achieving the 
required amount of steps for that week without reporting any severe symptoms of 
fatigue such as shortness of breath or of excessive tiredness following the exercise 
session. Patients could choose to remain on the same level for up to three weeks 
(especially if they were experiencing any symptoms). The potential benefit of Ithlete 
for the patients in the present study however, lies in its short measurement duration 
and detection of changes in HRV over time. Ithlete provides patients with daily 
feedback on their body’s response to the CR programme. Ithlete can also be used as 
an online tool, as patients can upload their measurements through email to their 
practitioner to get feedback from them on how they have performed. Patients were 
not asked to upload measurements within the present study, because they attended 
clinic every 4 weeks with the heart failure specialist nurse. After discussion with the 
clinical team, it was decided that there was not a sufficient amount of time to train 
patients on how to upload their measurements. Potential problems with patient 
confidentiality when sending measurements from the device were also a concern. 
Measurements were consequently downloaded and paperwork was collected each 





Another potential advantage of Ithlete would be the capability to prevent 
overexertion in patients with HF. To keep track of how patients are adapting to 
exercise, practitioners could monitor exercise training goals and follow Ithlete 
readings to see how patients are adapting to the exercise programme. With the use of 
Ithlete practitioners have a useful tool for helping both themselves and the patient 
assess their goals. The cost of the Ithlete kit (iPod touch + charger, Ithlete dongle, 
ECG chest strap) is approximately £230. This is considerably cheaper than other 
measurement devices typically used within the HF population for home 
telemonitoring. The cost of telemonitoring devices is not often reported, instead the 
overall cost of treatment including telemonitoring vs. normal care is often compared 
or the cost of hospitalization for a telemonitored group vs. a control group. The 
Honeywell HomMed Sentry system has been used in various studies (Alaoui et al. 
2003; Dar et al. 2009; Levine et al. 2006; Martínez et al. 2006; Riley & Cowie 
2009), with an approximate cost of $899 (£550). Telemedicine has been adopted as 
an efficient approach and important feature of heart failure management with 
decreased rates of morbidity and mortality (Clark et al. 2007; Clarke et al. 2011; 
Inglis et al. 2011; Klersy et al. 2009). Only a few selected studies have contradicted 
these results. Two random control trials in HF did not find reduced morbidity or 
mortality rates, along with another study including elderly patients with multiple 
health issues. However, overall results for telemonitoring find advantages to its use 
over normal care (Chen et al. 2013). Mobile phone monitoring has been 
demonstrated as useful tool for HF patients, providing improved quality of life 
through improved self care and clinical management (Seto et al. 2012).  
 
11.4.5 Adherence to the cardiac rehabilitation programme 
In the present study, 58% adhered to the CR programme by completing at least two 
levels of the home-based walking programme. Reasons cited by the patients who did 
not complete the programme were that the programme took up too much time, or 
that they did not feel comfortable enough to progress to the next walking level of the 
programme. Some patients fell ill, or had physical injuries such as knee, ankle or hip 
problems that became too painful during their walking exercises. Two patients went 
in for surgical procedures during the CR programme and were unable to complete 
the programme due to not feeling well enough to continue. The length of the CR 





programme lasts for approximately eight-weeks (Brodie et al. 2006). Delaney et al, 
2005 assessed the effect of exercise training on cardiac autonomic function in a six-
month CR programme, and reported the majority of changes in autonomic function 
occurred in the first three months (Delaney et al. 2005). Also an initial increase in 
cardiac autonomic activity was demonstrated in the first 12-weeks followed by a 
‘plateau’ effect (ibid).  
 
Research examining adherence to CR programmes is conflicting, with a comparison 
often being made between home-based and centre-based CR programmes. Two 
reviews of CR programmes reported that most studies found no significant 
difference between the two methods (Dalal et al. 2007; Jolly et al. 2009). In the 
reviews, no studies reported higher adherence in centre-based programmes but two 
studies did report significantly higher adherence in home-based CR programmes 
(Arthur et al. 2002; Marchionni et al. 2003). Home-based rehabilitation provides a 
more flexible, menu-driven approach to CR and therefore presents the opportunity to 
improve uptake and delivery of CR programmes (Blair et al. 2011). With centre-
based CR programme attendance averaging below 50% (Grace et al. 2011; Martin et 
al. 2012), offering alternatives to patients is important with the aim of increasing CR 
uptake and programme completion.  
 
The definition of adherence differs between studies (Dalal et al. 2010).  Therefore 
Dalal et al, (2010) reported adherence based on those who had follow-up data. In the 
present study, 82.6% of participants adhered to the CR programme; adherence was 
defined as those who attended their follow-up appointment and completed a second 
6MWT. The present study had high adherence to the CR programme, which is in 
contrast to many CR programmes where reported attendance was below 50% 
(Beswick et al. 2005; Jolly et al. 2007). A major factor for non-adherence in home-
based CR programmes was due to patients’ lack of motivation to do exercise on their 
own at home (Jolly et al. 2003).  The use of a monitoring device may help to keep 
patients motivated.  
 
Current delivery approaches are not suitable for everyone (Thomas 2007), and 
therefore other resources to help improve CR programme uptake are becoming more 





was launched in Leicestershire in early 2012 http://www.activateyourheart.org.uk/. 
The programme offers educational resources for patients to learn more about their 
diagnosis as well as the anatomy and physiology of the heart. Patients can interact 
with a CR specialist or other participants in the programme in a forum, and can 
monitor their weight, stress and exercise levels online through the website. Initiatives 
like this programme will go a long way towards helping improve both CR uptake 
and participation across the UK.  This is the only programme of its kind at the 
moment so far, and it is important that if successful, it is put into effect all over the 
UK. Depending on patients’ preferences and needs for rehabilitation delivery, 
various options should be available to help maximize uptake (Jolly et al. 2009). The 
use of internet-based technology and mobile phone for programme delivery 
(‘mHealth’) could provide a more effective and efficient ways to reach more people 
and get them involved in rehabilitation (Krishna et al. 2009). Therefore mobile 
applications such as Ithlete could improve CR uptake and compliance. 
 
Walking may be most likely to appeal to inactive people (Scottish 2003). It has been 
suggested that the use of a combined programme including goal-setting and the use 
of pedometers was effective for increasing walking by up to 2500 steps/day (Bravata 
et al. 2007; Kang et al. 2009). In a systematic review focusing on walking 
interventions these authors found that individualised, focused interventions assisted 
extensively with increasing the physical activity levels of the most sedentary. They 
also found, however that improvements were often short term (less than 12 months) 
but that this may have been due to a lack of longitudinal data collected in studies 
(Ogilvie et al. 2007). Furthermore many of the studies in the systematic review did 
not provide much evidence on what occurs when wider implementation of walking 
interventions are put in place because they were based on small, volunteer or 
convenience samples (ibid).  The present study provided patients with HF daily 
feedback on how their body responded to exercise while completing their walking 
programme. The present study sample was relatively small, but over 80% of patients 
reported they would like to continue using the device as an exercise-guidance tool to 
help them maintain their exercise regime. The low cost and easy accessibility to the 
device makes it more likely that patients would continue using the device through 






11.4.6 Cardiac rehabilitation programme recruitment 
In the latest CR report for the UK, patient recruitment from those eligible for CR is 
still under 50% (BACPR 2012). For patients with HF in particular, recruitment is 
lower compared with the three main groups (MI, PCI, CABG) because 15% CR 
programmes in the UK exclude HF patients (ibid). Recruitment of patients proved to 
be a difficult task throughout the present research study. The study began at a 
hospital in London with a Consultant Cardiologist and a Specialist Heart Failure 
Nurse. The Consultant Cardiologist would see approximately 10-15 patients in each 
cardiology clinic and of those patients only three or four would meet the inclusion 
criteria. Of those that were suitable many of the older patients were reluctant to take 
home the device because it was too technical or thought to be too complicated. Some 
reported that they would not have the time to take daily measurements and keep 
record of daily physical activity. Patients also voiced concerns about having enough 
time to meet the walking requirements for each level in the CR programme, despite 
being told how beneficial it could be to their health. Some patients despite meeting 
the criteria were still not deemed suitable because of comorbidities such as chronic 
obstructive pulmonary disorder (COPD) or being wheelchair bound. Comorbidities 
are prevalent in heart failure patients with the most common being diabetes mellitus, 
renal insufficiency, COPD, sleep apnoea and anaemia (Widmer 2011). Due to this 
prevalence, maximizing recruitment was very important. 
 
The researcher attended clinics 5 days/week for 17 months to maximize recruitment; 
this frequently involved attending one hospital in the morning and then another in 
the afternoon.  Following up with patients became increasingly difficult as the study 
progressed and therefore patients had to be prioritized based on what stage in the 
research project they had progressed to.  Some patients received a phone-call follow-
up instead of in person if this was deemed appropriate, and patients were always 
offered an alternative time to see the researcher if they were not able to be present 
during their appointment time with either the consultant cardiologist or the heart 
failure specialist nurse. Telemonitoring together with structured telephone support 
provided a significant reduction in the risk for CHF hospitalization (Inglis et al. 






Brisk walking is moderate-intensity physical activity, which is of sufficient intensity 
to provide health benefits (Ainsworth et al. 2011; Murtagh et al. 2002). Therefore 
each patient was given information about the benefits of walking. Patients were also 
given an information sheet about their home-rehabilitation plan with suggestions on 
how to structure their exercise. The importance of stretching daily was emphasized, 
along with recommendations on what stretches to execute (Page 2012). The 
information sheet discussed warm-ups, static stretching, building up exercises 
gradually and trying to fit in something every day, even if it was just a few minutes 
of stretching. When patients found that exercise sessions became easier (easy was 
defined as when patients were not breaking a sweat or breathing heavier during 
exercise), patients were encouraged to decrease breaks (either frequency or 
duration), increase the duration of exercise (by 5-7.5 minutes) or intensity of their 
exercise (increase walking speed or carry small weights of no more than 2kg to 
provide resistance). Improved muscular strength and reduced body fat are 
demonstrated outcomes of combined aerobic and resistance training in cardiac 
rehabilitation (Oka et al. 2000; Pierson et al. 2001).  
 
11.4.7 Limitations 
Before the CR programme commenced, several participants voiced concerns about 
having enough time to complete the exercise requirements at each stage of the 
exercise programme. This may have accounted for the number of participants who 
did not complete the CR programme. Participants were also asked to use a 
pedometer daily for measurements of their steps. Some patients reported that they 
forgot to wear the pedometer on some days, or only remembered to put it on part-
way through the day. Other issues reported were loss of the pedometer, or the 
pedometer stopped working and this led to some inaccuracies in the amount of steps 
accounted for with some participants. A reported key problem with pedometer 
measurements in general, is the inability to distinguish between varying intensities of 
vertical displacement. This means that sprinting 100 steps vs. walking 100 steps 
would be counted as the same amount of steps despite differences in vertical 
displacement and therefore intensity of exercise (Berlin et al. 2006). This is however, 
less of an issue in the present study population; as patients with HF are unlikely to 
have large variation in the intensity of vertical displacement. Despite these inherent 





ambulatory behaviour (ibid). Pedometers ability to capture intermittent or continuous 
activity participation throughout an assessment period (Berlin et al. 2006), make it 
advantageous for CR programmes. However using pedometers as both the 
intervention and the measurement tool is not ideal. Research has demonstrated that 
pedometer users increase their physical activity by an average of 27% (Bravata et al. 
2007). To counteract this issue, patients served as their own controls in (Phase two) 
by wearing the pedometer initially for at least one month before commencing the CR 
programme.    
 
Participants were also asked to record their exercise activity daily in calendars 
provided. Participants had to choose the workout zone for the rate of intensity they 
had achieved during their workout. The zones were low/moderate/high and this was 
a very subjective measure. For some patients this concept seemed hard to grasp as 
they did not have much energy to carry out their daily activities. They reported that 
everything they did felt like it was at high intensity because it took so much effort to 
carry out. This could have affected the comparisons between participants due to the 
subjectivity of the measurement. It was hard to gauge how well they adhered to the 
described intensity zones within one workout. If participants exercised in more than 
one zone within a given workout, they were instructed to only record the zone they 
thought they did the most exercise in. This again was quite subjective; however a 
large range of activity levels within the participants should have helped counter that 
effect.   
 
11.5 Conclusion 
The CR programme improved functional capacity in patients. Over 65% of patients 
who participated in the CR programme demonstrated a dip in rMSSD at 24 and 48-
hours after exercise was reported. This is in contrast to HF patients not involved in a 
CR programme (observed in chapter nine). This suggests physiological adaptations 
occurred in the CR groups in the days following exercise as a result of the CR 
programme. The CR programme facilitated heavy enough exercise to cause a dip in 
rMSSD in almost 80% of patients for 24-hours after exercise was reported. These 
results are in agreement with research advocating HRV as a guide for exercise 





after 24-hours, this advocates the use of Ithlete daily within the HF population 
during a CR programme to gauge recovery from exercise.  
 
Due to their symptoms, HF patients in NYHA classes II-IV have limitations to their 
ordinary ability to perform physical activity, perhaps making it more difficult to 
perform exercise heavy enough to cause attenuation in HRV. This underlines the 
importance of finding exercises (such as walking) that patients can readily 
participate in and gradually increase. Ithlete measurements demonstrated attenuated 
autonomic function following exercise in patients with HF. The Ithlete device can be 
explored for further use in the clinical setting, to aid CR and provide patients and 
clinical staff with feedback on autonomic function. Ithlete appears to be an easy 
device to use for HRV assessment in the HF population. Ithlete is also cost efficient 
when compared to other medical devices and provides feedback to the user which 
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CHAPTER 12: SUMMARY, RECOMMENDATIONS AND CONCLUSIONS 
The final chapter of this thesis presents a summary of the findings from each 
empirical chapter and discusses overall outcomes from the thesis. The summaries 
follow the British Medical Journal model in the form of brief bullet points. For each 
empirical data chapter what was already known prior to the study is stated, followed 
by what the research in that chapter adds to the body of knowledge. Directions for 
future research and overall conclusions are then drawn to supply the necessary 
significance and impact to conclude this thesis. 
 
12.1 Review of empirical findings by chapter 
Chapter 3: Comparison of heart rate and heart rate variability (rMSSD) analysis 
using Polar s810i and Ithlete 
What is already known: 
• Heart rate variability (HRV) is a reliable and reproducible technique for 
assessing autonomic activity; with high correlations between time and 
frequency domain measures of vagal activity suggesting they can be used 
interchangeably.  
• Ultra-short HRV (rMSSD) measurements of 10 s have high correlations with 
the standard 5-minute short-term recording.  
• Polar s810 models have been validated for HRV measurement against ECG 
and Holter devices.  
What this study adds: 
• With respect to HRV measurement Polar s810i and Ithlete can be used 
interchangeably for measurements of rMSSD.  
• High Pearson correlation coefficients suggest Ithlete is a valid measure for 
rMSSD in both healthy and heart failure subjects. 
• Narrow limits of agreement suggest Ithlete is a valid measure for rMSSD in 
both healthy and heart failure subjects. 
• Measurements of HR using Ithlete had high correlations with the Polar s810i, 






Chapter 4: Measurement options for body composition using bioelectrical 
impedance analysis devices 
What is already known: 
• Bioelectrical impedance analysis (BIA) is a method for estimating body 
composition. 
• BIA devices offer a variety of measurements which can include total body 
water (TBW), free fat mass (FFM), fat mass (FM). 
• Tanita BIA scales have been validated against hydrostatic weighing and dual-
energy x-ray analysis. 
What this study adds: 
• Good relative agreement was demonstrated for body composition 
measurements between five BIA devices.  
• Good relative agreement suggests that it is acceptable to use any of those 
BIA devices, both at home and in the clinical setting. 
• The difference between devices was not significant except for one device 
indicating that price may not be an important factor in deciding which BIA 
device to use. 
• Use of BIA devices in the home and the clinical setting may be more 
affordable than previously thought. 
Chapter 5: The relationship between Ithlete measurements and body composition 
assessed by bioelectrical impedance analysis body composition  
What is already known: 
• An impaired HRV is associated with an increased risk of CV disease, type II 
diabetes and insulin resistance. 
• Increased body fat, BMI and weight are known as risk factors for increased 
CV disease, diabetes, metabolic syndrome etc. 
What this study adds: 
• Relationships were demonstrated between rMSSD, HR and body 
composition measurements when compared by gender, ethnicity, BMI and 





• This study found no significant ethnic or gender differences in rMSSD. 
• HRV was negatively correlated with body fat and age.   
• HR was negatively correlated with height, total body water, muscle, BMR, 
age and alcohol units.  
Chapter 6: Heart rate variability in healthy Caucasian and South Asian participants 
What is already known: 
• Only two studies have assessed the differences in HRV between Caucasians 
and South Asians, neither of which were undertaken in the UK.  
• Higher body fat percentage, abdominal obesity and higher liver fat content 
exist in the South Asian population when compared with their Caucasian 
counterparts of the same BMI. 
What this study adds: 
• No significant difference was found in rMSSD or HR between South Asian 
and Caucasian participants when controlled for gender and age. 
• The average rMSSD values were 71.1 ± 10.1 ms in South Asians compared 
with 67.9 ± 10.5 ms in Caucasians. 
• Significant differences in BMI, TBW and BMR were demonstrated between 
Caucasian and South Asian participants. 
Chapter 7: The relationship between heart rate variability (HRV), body composition 
and aerobic capacity measurements in healthy participants with varying physical 
activity levels. 
What is already known: 
• Exercise capacity has been expressed as the best predictor of mortality. 
• Decreased HRV is an independent risk factor for morbidity and mortality; 
increased HRV is a measure of good health and physical fitness.  
• Different habitual levels of physical activity may cause changes in HRV. 






What this study adds: 
• Resting rMSSD measurements obtained from Ithlete software were correlated 
with Vo2 peak, HR, WC, weight and BMI.   
• Resting HR was correlated with age. 
• A significant correlation was demonstrated between rMSSD and Vo2 peak. 
• The average TBW for both male and female participants in this study was 
below the healthy average. 
• The mean Vo2 peak for males (29.52 ± 6.9 kg/ml/min) and females (25.68 ± 
4.9 kg/ml/min) in this study were lower than published normal sedentary 
averages, suggesting poor fitness levels of the participants. 
• HRV for male and female participants in this study were found to be similar 
to other studies despite the mean Vo2 peak for both males and females being 
lower than average. 
 
Chapter 8: Heart rate variability measurement in healthy subjects with varying 
physical activity levels using Ithlete software 
What is already known: 
• There are no established normal values for HRV which constitute a healthy 
measure; HRV is thought to be a very individual measure. 
• Exercise training has a positive effect on HRV. An initial dip in HRV is 
expected following exercise; however over time exercise improves HRV. 
• TRaining IMPulse (TRIMP) is a method for quantifying training and can be 
important for assessing how much impact training/exercise has on the body. 
What this study adds: 
• Using TRIMP, a dip in HRV following exercise was demonstrated for 24, 48 
and 72-hours following exercise; the highest percentage of participants 
demonstrated a dip at 48 hours. 
• Those who did at least 30-minutes of exercise had a lower resting HR. 
• Ithlete is a feasible HRV measurement device for daily use to assess the 





• The average rMSSD in healthy participants was 72.4 ± 7.4 ms for males and 
69.3 ± 7.7 ms for females. 
Chapter 9: Heart rate variability measurement in patients with heart failure with 
varying physical activity levels using Ithlete software 
What is already known: 
• Heart failure (HF) is associated with reduced autonomic function; depressed 
HRV levels are commonly identified as a risk factor for sudden cardiac 
death.  
• HRV provides a non-invasive indirect measurement of autonomic control of 
the heart, making it an ideal measurement to use in patients with HF.  
What this study adds: 
• A dip in HRV 24 hours following exercise was found in 46.5% of HF 
patients; 48-hours following exercise, 65.1% demonstrated a dip in HRV. 
•  Ithlete measurements of rMSSD and HR in HF patients were completed on a 
consistent basis for at least twenty-eight days by 46% of patients, a further 
23% were able to take measurements, but did not complete a full 28-day 
cycle. 
• Participants reported that the device was easy to use and most did not have 
any trouble taking measurements on a daily basis. 
Chapter 10: Adherence, reference values and user assessment of Ithlete heart rate 
variability (HRV) measurements in patients with heart failure 
What is already known: 
• Average HRV values have been published in various studies in both healthy 
and diseased populations; however there is still no clear standard reference.  
• Clinical use of HRV has not yet been accepted as common practice. 
 
What this study adds: 
• Most participants reported that the device was quick and easy to use on a 





• 100% of patients said they would recommend the device to other patients and 
94% stated that the measurements were not too time-consuming. 
• Average rMSSD values for HF patients were demonstrated within the range 
of 63.7-71.8 ms.  
Chapter 11: Implementation and evaluation of a heart rate variability (HRV) guided 
cardiac rehabilitation programme with heart failure patients using the Ithlete 
What is already known: 
• Cardiac rehabilitation (CR) is a medically supervised programme designed to 
improve the health and wellbeing of people with heart conditions such as 
heart failure, but optimal physical activity levels of those participating in CR 
have not yet been established. 
• CR has demonstrated improvement in physical health and a decrease in 
subsequent morbidity and mortality. 
• There is a good correlation between the distance covered by patients in a 
6MWT and maximal oxygen uptake. 
What this study adds: 
• Decreased rMSSD 24-hours following exercise was demonstrated in 78.9% 
of HF patients who participated in the CR programme, 48-hours following 
exercise 68.4% demonstrated a dip in HRV. 
• The 6MWT demonstrated improvements in each NYHA class in the overall 
distance patients were able to cover in the test after the CR programme. 
• Ithlete appears to be an easy device to use for capturing daily rMSSD and 
HR. 
• Patients reported that it was easy to follow Ithlete indications on when to 
exercise and when to rest.  
• Patients enjoyed receiving feedback from Ithlete and felt more secure about 
their exercise programme.      
• Ithlete is also cost efficient when compared to other medical devices and 







12.2 Evaluation of aims and objectives 
The primary aim of this thesis was to explore the potential of using home-based 
devices such as Ithlete and bioelectrical impedance analysis (BIA) scales to 
supplement clinical care for patients with HF. Each empirical data chapter within 
this thesis provided evidence to support the use of these devices in both healthy and 
HF populations. Chapter three demonstrated that Ithlete is a valid measure of rMSSD 
in patients with HF and healthy participants. Chapter four demonstrated good 
relative agreement between several BIA devices.  Chapter five demonstrated no 
significant differences in rMSSD between Caucasian and South Asian participants, 
but did find significant differences in BMI, TBW and BMR. Chapter six 
demonstrated a significant correlation between rMSSD and Vo2 peak. In chapter 
seven, significant relationships were demonstrated between rMSSD, HR and body 
composition measurements. Chapter eight demonstrated Ithlete as a feasible 
measurement technique for capturing rMSSD daily in healthy participants.  Chapter 
nine demonstrated the feasibility of Ithlete measurements daily in patients with HF. 
In chapter ten, approximately 90% of participants enjoyed using the Ithlete device 
and a reference range for HF patients using Ithlete was established (63.6-71.8 ms). 
Finally in chapter eleven, 90% completed the HRV-guided CR programme and 
reported that daily feedback from the device enhanced their CR programme 
experience. 
 
This thesis also had several secondary aims, first was to determine the feasibility of 
collecting daily HRV measurements using a new personal HRV monitor (Ithlete) in 
participants with HF. The validity of Ithlete rMSSD measurements were tested 
against the Polar heart rate monitor and good correlations were found. Healthy 
participants and patients with HF completed measurements for at least 28 days to test 
the usability of the device.  Normal ranges of rMSSD for both groups using the 
Ithlete device were also analysed. Forty-six percent of HF patients were able to take 
daily measurements for at least 28 days. In healthy subjects the normal range of 
rMSSD using Ithlete was 65.1-87.7 ms; in HF patients the normal range was 63.7- 
71.8 ms rMSSD. The difference in range was to expected as HF patients are known 
to have decreased autonomic function (Fauchier et al. 1997; Marijon et al. 2010; 






This thesis also examined how other correlates such as aerobic capacity, body 
composition, comorbidities and medication might affect daily rMSSD 
measurements. In healthy participants, correlations were demonstrated between 
rMSSD, body composition and aerobic capacity. As Ithlete is a quick and convenient 
measurement device, it has great potential for use in clinical practice. Since Ithlete 
rMSSD measurements have shown the same correlations with aerobic capacity and 
body fat in healthy participants as other measures, the use of Ithlete in conjunction 
with these other measurements could potentially improve patient care by 
highlighting those patients who are at increased risk. Originally participants with HF 
were to be tested using one of the body composition devices validated within this 
thesis (Chapter four), to test if those same correlations exist between Ithlete 
measures in HF patients. Circumstances however, led to that not being possible. The 
main issue was that an unforeseen amount of patients recruited within this study had 
implantable cardioverter defibrillators (ICD), which cannot be used with BIA 
devices.  
 
Finally, the use of Ithlete software to monitor patients during a CR programme using 
daily rMSSD measurements was successful. Patients stated that they enjoyed getting 
feedback from the device daily and took rest days when the device advised them to.  
 
This thesis has served as the spring-board for the potential use of the Ithlete device 
for CR. A few patients reported having trouble using the device or thought daily 
measurements were too time consuming and therefore did not complete the 
measurements. Approximately 50% of heart failure participants enrolled in the study 
completed the required amount of measurements and were satisfied with the device. 
A further 23% were satisfied with the device, but did not complete the required 
amount of measurements. Adherence to telemonitoring in patients with HF has been 
reported as low as 14% (Chaudhry et al. 2007) and as high as 95% (Scherr et al. 
2009); therefore the results from the present study are encouraging. The majority of 
the previous telemonitoring studies based adherence on measurements taken at least 
three times per week. The present study however, based adherence on daily 
measurements and therefore HF patients needed a higher frequency of measurements 





receiving feedback. The clinical staff involved in the study liked the idea of having 
another measure they could analyse and use as an indicator of increased risks i.e. 
worsening symptoms, sudden cardiac death. 
 
12.3 Recommendations 
The prognostic value of HRV measures in patients with heart failure has been 
demonstrated (Adamson et al. 2004; Bilchick et al. 2002; Chattipakorn et al. 2007; 
La Rovere et al. 2003; Ponikowski et al. 1997; Sandercock & Brodie 2006). Several 
studies have reported improvements in HRV in patients with HF following an 
exercise programme (Kubinyi et al. 2003; Murad et al. 2012; Routledge et al. 2010; 
Selig et al. 2004). The use of HRV as a training tool in HF has yet to be explored in 
full detail. With further development of reliable short-term HRV analysis devices, 
individuals and practitioners have easier access to HRV assessment tools at a lower 
cost. Because Ithlete works with smartphones or an iPod touch, it is easily accessible 
to the general public and costs less than other devices. Future research in a larger 
cohort of participants using Ithlete would help clarify its potential use in clinical 
populations. As the popularity of smartphones increases, the use of application 
software such as Ithlete in healthcare will be a useful tool for both patients and 
practitioners.  
 
When considering the relationship between HRV measurements such as rMSSD and 
other cardiovascular risks, further research can elucidate what differences may occur 
between different populations and why. Making individuals aware that they are 
potentially at higher risk may have an affect on their lifestyle choices and 
consequently their health. Future research on the effects of exercise on HRV over 
various time periods with a large cohort of participants could be very beneficial in 
the assessment of the effect of exercise on the body over time. Monitoring body 
composition with BIA devices in clinical practice has potential but needs further 
investigation. Identifying what relationships may exist between HRV/HR and body 
composition in special populations such as heart failure and diabetes may help 
highlight those at increased risk.  Knowledge of these relationships and how they 






For patients with HF, the Ithlete device can be explored for use in the clinical setting 
to aid in CR and provide patients and clinical staff with daily feedback on autonomic 
function. Ithlete could also help keep patients motivated through staff and individual 
monitoring of responses to exercise over time. With Ithlete, patients can correlate 
their body’s response with their exercise patterns and determine what exercise 
regime is best for them. Once patients have completed a six-eight week CR training 
programme, they can continue to use Ithlete to keep them on track and monitor their 
progress.  There are a number of fitness applications on the market; this study has 
demonstrated the potential of one application.  Future research should focus on 
finding other applications that could also be utilized to help patients keep active, 
monitor their progress and reach targets to improve their health and wellbeing. 
 
12.4 Conclusions 
Ithlete monitors the body’s autonomic response to exercise volume on a daily basis.  
Since impaired autonomic function is associated with overtraining, Ithlete was 
developed as a tool to monitor recovery from exercise with the aim of preventing 
overtraining. Within this thesis, Ithlete was tested with both healthy participants and 
patients with HF and appears to be an easy device to use for HRV analysis.  Ithlete is 
also cost efficient when compared to other medical devices and provides immediate 
feedback to the user which can be easily interpreted. The benefit of Ithlete for 
patients lies in its short measurement duration and detection of changes in rMSSD 
over time to give patients feedback on their body’s response to exercise and stress.  
With increasing cutbacks in the NHS this tool could be used to help clinicians 
monitor patients’ recovery from an exercise programme. Ithlete could also be used to 
guide exercise intensity and volume changes throughout an exercise programme. 
Furthermore, clinicians could use Ithlete to monitor HRV over time to identify those 
at increased risk of cardiac events. 
 
In addition, this thesis assessed the important interactions between clinical measures 
such as HRV, HR, aerobic capacity and body composition. Each measurement has 
independently been established as a risk factor for cardiovascular disease. The use of 
these measurements together may provide clinicians with a clearer idea of the 





piece of work, many of which are at low cost compared to conventional medical 
devices and therefore contribute valuable information for clinicians as they try to 
improve patient care on increasingly lower budgets.  This thesis provides evidence 
for the use of new technology in clinical practice and advocates more research to be 
undertaken to ensure patient care can indeed improve, despite the increasingly tough 
economic climate in healthcare. The findings of this thesis support the use of mobile 
applications as tools in medical practice and further encourage the use of HRV in 
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Average HRV, HR, Indication, TRIMP and Day Scale for each healthy participant 
Age Gender HRV HR Indication TRIMP Day Scale 
30 F 78.6 ± 2.9 70.0 ± 3.6 1.33 (N) 83.1 ± 49.6 84.5 ± 7.8 
25 F 60.1 ± 5.9 102.8 ± 
8.1 
1.46 (N) 44.6 ± 96.9 67.7 ± 
13.3 
33 F 65.9 ± 5.9 64.6 ± 3.6 1.44 (N) 106.1 ± 130.3   
30 M 59.4 ± 6.0 82.8 ± 7.7 1.48 (N) 123.6 ± 97.2 68.4 ± 
40.3 




1.25 (N) n/a n/a 
25 M 73.4 ± 5.6 68.3 ± 3.6 1.29 (N) 125.6 ± 149 80.8 ± 
28.3 
28 F 80.3 ± 4.1 65.0 ± 4.1 1.44 (N) 105.0 ± 110.1 62.0 ± 
13.0 
32 M 78.4 ± 7.3 60.4 ± 6.0 1.37 (N) 71.7 ± 55.7 72.6 ± 8.9 
34 M 73.1 ± 6.4 75.1 ± 9.1 1.62 (G) 59.2 ± 70.1 74.0 ± 7.5 
64 M 83.1 ± 8.4 48.2 ± 3.9 1.22 (N) 50.0 ± 47.9 58.4 ± 9.9 
28 F 68.8 ± 5.5 85.2 ± 9.7 1.33 (N) n/a n/a 
31 F 76.1 ± 9.7 66.7  ± 
8.4 
1.22 (N) 149.0 ± 185.4 55.2 ± 
12.7 
25 F 70.0 ± 7.5 77.9 ± 7.5 1.45 (N) 34.1 ± 42.9 64.1 ± 
15.5 
36 M 78.4 ± 4.7 63.1 ± 4.0 1.41 (N) 0 62.7 ± 
14.8 




1.38 (N) 73.2 ± 86.7 47.0 ± 
32.1 
51 M 65.3 ± 4.1 80.0 ± 5.9 1.48 (N) 123.4 ± 76.2 88.3 ± 3.8 
27 F 71.3 ± 7.0 75.2 ± 9.7 1.42 (N) 40.4 ± 32.8 90.0 ± 0.0 




1.20 (N) 121.8 ± 215.8 46.4 ± 
33.6 
28 F 77.7 ± 
15.4 
64.9 ± 4.7 1.72 (G) 54.0 ± 48.1 71.7 ± 7.4 
29 M 59.5 ± 6.2 79.5 ± 5.0 1.38 (N) n/a n/a 
28 F 72.7 ± 6.2 74.6 ± 7.3 1.34 (N) 43.7 ± 43.0 72.7 ± 8.0 





56 M 65.8 ± 
14.5 
76.1 ± 4.1 1.34 (N) 54.8 ± 58.3 69.3 ± 
38.6 
27 F 74.2 ± 6.2 70.5 ± 6.8 1.28 (N) 67.7 ± 70.4 76.1 ± 
23.5 
32 F 74.2 ± 6.2 70.5 ± 6.8 1.38 (N) 67.7 ± 70.4 76.1 ± 
23.5 
29 F 76.9 ± 6.2 65.4 ± 4.1 1.35 (N) 160.5 ± 176.2 78.9 ± 8.3 
28 M 80.6 ± 6.6 63.3 ± 7.3 1.31 (N) 52.2 ± 71.6 84.9 ± 5.6 
29 F 58.8± 4.7 100.0 ± 
6.7 
1.38 (N) 113.3± 76.7 90.7± 5.8 
28 M 82.4± 3.9 57.2± 3.4 1.52 (G) 113.1± 88.2 78.3± 29.2 
 
Appendix I is a table demonstrating average components for each healthy participant 
from Chapter 8.  Age is displayed in years, HRV is displayed in rMSSD, HR is 
displayed in beats per minute (bpm), and Indication is displayed as an average 
number which corresponds to 1 of the 4 colour indications.  These indications are 
displayed in the table as an average number which corresponds to 1 of the 4 colour 
indications (1-1.5=Blue for normal recovery, 1.5-2.5=Green for good recovery, 2.5-
3.5=Amber for not the best recovery, 3.5-4=Red for bad recovery). More 
specifically, amber represents the first day when HRV is more than 1 x SD (standard 
deviation of natural log transformed rMSSD) below the moving average of the 
previous 7 days (so excluding the most recent recorded value); red represents the 
second day when this condition is true (i.e. two successive days when the current 
value is more than 1x SD below the moving average blue line) and green represents 
a rise of more than 2 x SD compared to the previous day.  Green is intended to 
indicate good recovery and signifies that the body is ready for harder training. 
TRIMP is displayed as an average of intensity multiplied by duration and Day Scale 







Average HRV, HR, Indication, TRIMP and Day Scale for each heart failure 
participant 
Age Gender HRV HR Indication TRIMP Day Scale 
48 M 74.2 86.7 1.4 ± 0.8 190.9 ± 
113.9 
65.6 ± 5.4 
63 M 50 88.8 1.7 ± 1.3 44.7 ± 60.1 41.0 ± 15.6 
59 M 68.4 75.4 1.5 ± 0.8 208.6 ± 
234.5 
58.3 ± 32.5 
60 M 78.2 111.7 1.4 ± 0.8 183.6 ± 95.1 45.1 ± 6.0 
82 M 87.3 82.4 1.8 ± 1.1 173.0 ± 
189.7 
30.7 ± 26.4 
78 M 54.3 89.4 1.9 ± 1.2 32.1 ± 27.4 17.3 ± 34.5 
74 M 87.6 81.9 1.5 ± 0.9 55.3 ± 97.0 75.8 ± 7.1 
69 M 72.4 77.9 1.6 ± 1.0 308.1 ± 
251.7 
42.0 ± 36.1 
54 M 88.4 76 2.1 ± 1.4 138.1 ± 
126.1 
58.6 ± 20.4 
54 M 74 86 1.4 ± 0.8 165.4 ± 
213.4 
53.8 ± 35.4 
69 M 77 84.7 1.5 ± 1.0 84.1 ± 68.0 57.5 ± 12.7 
61 M 75.3 95.5 1.4 ± 0.7 22.9 ± 40.2 0 
36 M 63.2 89.9 1.2 ± 0.6 90.0 ± 67.1 31.4 ± 20.5 
68 M 84.2 76 1.7 ± 0.9 85.7 ± 85.0 64.7 ± 18.1 
56 M 66.7 77 1.5 ± 0.9 61.7 ± 82.7 68.1 ± 5.7 
56 M 90.8 71.9 1.6 ± 1.1 39.1 ± 17.3 66.5 ± 5.8 
71 M 90.5 74.6 1.1 ± 0.4  69.1 ± 92.6 88.2 ± 3.1 
44 F 75.3 79.3 1.1 ± 0.3 212.1 ± 
109.4 
73.6 ± 10.8 
73 F 78.2 94.2 1.6 ± 1.0 127.1 ± 57.3 88.1 ± 5.4 
80 M 70.2 80.9 1.5 ± 0.9 128.3 ± 90.6 80.0 ± 0 
43 F 67.8 107.5 1.4 ± 0.9 48.6 ± 32.2 61.0 ± 34.3 





68 M 87.4 81.3 1.5 ± 0.9 117.9 ± 
106.9 
62.5 ± 12.2 
70 M 94.4 80.4 1.3 ± 0.7 120.0 ± 62.0 80.0 ± 16.9 
56 M 66.4 91.2 1.3 ± 0.7 52.7 ±62.6 56.8 ± 6.6 
71 F 85.5 70.1 1.5 ± 0.8 71.6 ± 58.5 47.0 ± 17.8 
77 M 76.8 72.3 1.4 ± 0.8 185.0 ± 
154.2 
47.0 ± 23.4 
64 F 69.1 83.6 1.5 ± 0.9 98.0 ± 57.9  72.7 ± 17.6 
74 M 93.4 72.4 1.6 ± 1.1 35.6 ± 40.7 62.7 ± 10.5 
74 M 74.5 79.2 1.6 ± 1.0 77.1 ± 49.9 55.7 ± 15.7 
63 M 72.2 88.6 1.5 ± 1.0 129.4 ± 
116.9 
93.6 ± 3.1 
63 M 76.6 86.9 1.5 ± 0.9 171.4 ± 95.1 87.1 ± 24.7 
59 M 63.8 71.1 1.3 ± 0.8 135.0 ± 
156.1 
85.6 ± 5.1 
59 M 71.9 70.7 1.5 ± 1.0 229.7 ± 
214.8 
81.0 ± 11.0 
64 M 81.7 75.9 1.5 ± 1.0 16.1 ± 11.0 41.3 ± 6.4 
60 M 72.7 77 1.3 ± 0.8 46.6 ± 31.3 0 
78 M 80.2 85.1 1.2 ± 0.6 220.7 ± 
103.2 
0 
74 M 94.7 81.4 1.4 ± 0.9 35.5 ± 30.3 63.2 ± 9.7 
24 M 77.8 85.1 1.1 ± 0.5  23.9 ± 6.5 59.8 ± 7.5 
43 M 76.7 86.1 1.5 ± 1.0 24.5 ± 23.2 88.3 ± 2.9 
56 M 88.6 72.2 1.2 ± 0.5 76.7 ± 34.8 69.4 ± 12.2 
65 M 74.9 87.3 1.5 ± 1.0 22.5 ± 23.4 46.2 ± 6.3 
64 M 78.2 111.7 1.4 ± 0.9  192.5 ± 
110.3 







APPENDIX III Heart failure patient statistics 
Frequency of patient co-morbidities by percentage within the study population 
Comorbidity Patient Percentage 
Ischaemic heart disease 38.8% 
Dilated Cardiomyopathy 34.0 % 
Hypertensive 21.4 % 
Chronic heart failure 10.7% 
COPD 7.7% 
Myocardial Infarction 7.7% 
Hypercholesterolemia 5.8% 
Type 1 Diabetes 5.8% 








Coefficient of variation for rMSSD between HF patient taking/not taking the 
following medications 
Medication Yes No 
Beta Blockers 13.4 12.1 
ACE Inhibitors 12.7 12.3 
Diuretics 14.7 11.9 
Angiotensin II Receptor 12.9 13.1 
Aldosterone Antagonists 15.3 12.1 
Nitrate 9.4 13.6 
Digoxin 10.4 13.3 
Diabetic medication 10.6 13.3 
Amiodarone 12.6 13.3 
 
 
Coefficient of variation of rMSSD for HF patient comorbidities 
Comorbidity Yes No 
Dilated Cardiomyopathy 11.8 15.6 
Ischaemic Heart Disease 16.9 9.5 
Hypertension 10.8 14.9 
Diabetes 14.2 13.8 
 
Binary logistic regression 
Binary logistic regression was carried out on participant results to control for the 
different comorbidities and medication that patients were taking during the study to 
assess their impact on HRV. Without controlling for medication or comorbidities, 
HRV values had an odds ratio of 1.007 (CI 0.802, 1.264) (p= 0.95). For two days 
following exercise the odds ratio was 0.976 (CI 0.774, 1.230) (p= 0.84). When 
controlling for medication and comorbidities the odds ratios and confidence intervals 
are listed in the table below. An odds ratio of 1 indicates no difference in risk 
between the groups, if >1 the rate of that event is increased.  The confidence interval 
indicates the range that is likely to contain the true value within it (in studies where 
only a sample of the whole population is tested). When given with odds ratios this 





difference in odds). This means that none of the confidence intervals below are 
significant as they all include one; several of the odds ratios below are slightly over 
one but the values are all small amounts (<0.075) therefore the likelihood of HRV 
being different due to that medication or comorbidity is low.    
 
 
Binary logistic regression values for HF medication and common comorbidities 
found in the present study’s patient population 
Medication/ 
Comorbidity 
Odds Ratio P-Value Confidence 
Interval 
Beta blockers 0.996 0.397 0.987-1.005 
Diuretics 1.057 0.667 0.821-1.361 
ACE inhibitor 1.003 0.978 0.791-1.273 
AngiotensinII 
receptor 
1.020 0.884 0.783-1.329 
Amiodarone 1.067 0.649 0.806-1.412 
Aldosterone 
antagonist 
1.002 0.989 0.777-1.291 
Nitrate 1.052 0.802 0.709-1.560 
Digoxin 0.954 0.860 0.565-1.610 
Diabetic medication 0.897 0.505 0.653-1.234 
Dilated 
cardiomyopathy 
0.984 0.904 0.761-1.273 
Ischaemic heart 
disease 
1.075 0.579 0.833-1.388 
Hypertension 0.850 0.252 0.644-1.123 






APPENDIX IV Modified Bruce Protocol 
 
Modified Bruce Protocol 
Stage Speed Grade Duration 
1 1.7 miles per hour 0% 3 Minutes 
2 1.7 miles per hour 5% 3 Minutes 
3 1.7 miles per hour 10% 3 Minutes 
4 2.5 miles per hour 12% 3 Minutes 
5 3.4 miles per hour 14% 3 Minutes 
6 4.2 miles per hour 16% 3 Minutes 







APPENDIX V Posters 
Heart rate variability measured by a novel 
device in participants with heart failure
Authors: D. Matthew1, S. D. Rosen3, G. Sandercock2 & D. Brodie1
1Faculty of Society and Health, Cardiovascular Health Research Group, Bucks New University, UK; 2Centre for 
Sports and Exercise Science, School of Biological Sciences, University of Essex, UK; 3Ealing Hospital and NHS 
Trust, London, UK.
Ealing Hospital NHS Trust
Background: Heart rate variability (HRV) is a non-invasive measure that examines autonomic
influences on the heart, indicating how the body is trying to preserve its equilibrium. Thus HRV
has the potential to monitor the autonomic response to exercise volume on a daily basis. A
reduced level of HRV has been demonstrated to be a significant predictor of cardiac event
and death.
Purpose: The aim of this study was to determine the feasibility of HRV measurements using a
new personal heart rate variability monitor (Ithlete) while estimating the normal pattern for
HRV in participants with heart failure.
Conclusion: This study is the first to look
at measurements of HRV in heart failure
patients using the Ithlete device. This study
could be the basis for more research into
what HRV measurements are to be
expected in this population and how they
can be used to benefit the health and care
of heart failure patients.
Discussion: At rest HRV (rMSSD) was
lower than that recorded in the literature for
a healthy population. Participants with heart
failure varied in their level of use of the
device. Some found the device very easy
to use while others cited problems. The
relationship between HRV and HR was
similar to the findings from other studies.
Results: Almost half of the 85 participants
took sufficient correct measurements while
they had the Ithlete device. The average
HRV measurement found in this study was
48.6 ms (rMSSD). The relationship between
HRV and HR was found to be negatively
correlated.
Methods: Eighty-five participants were
tested, of which 65 were male and 20 were
female. Each participant received a device
for daily measurement of HRV and heart rate
(HR) in the seated position first thing in the
morning. HRV and heart rate (HR) was
measured in the seated position for at least
28 days. Participants were also asked to fill
in a daily exercise diary which included










































Heart rate variability (HRV)
in heart failure
l Study supervised by Dr 
Stuart D Rosen, 
Consultant Cardiologist 
and team
l Aim: to evaluate HRV 
daily using a new easy to 
use monitoring device in 
heart failure patients and 
compare the results in 
healthy volunteers.
l Involves simple 1-minute 
daily measurements
l For further information 
please contact: Dionne 
Matthew-PhD research 
student Bucks New 
University
l Tel: 01494522141extn 
4415 or speak to your 
Cardiologist in the clinic
l Thank you for your time
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